Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCB8 "EST328128, M-ABC1, MABC1, MITOSUR" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 81.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 10.3 20.4 9.3 8.4 10.3 8.1 8.6 9.7 13.7 16.6 11.3 12.1 10.9 14.9 7.9 18.3 11.0 6.0 13.2 9.5 8.6 15.0 22.3 10.8 7.5 11.5 10.3 11.6 10.0 11.5 19.6 8.4 12.2 11.0 5.3 8.7 8.9 6.6 7.9 10.6 11.3 7.1 8.3 11.2 12.2 12.4 11.1 7.2 15.6 5.8 6.2 8.9 10.6 14.3 26.1 40.1 10.1 32.3 15.8 9.2 20.0 13.6 13.8 20.6 21.9 16.1 42.7 13.8 17.7 14.4 25.2 27.1 15.0 28.1 9.3 17.2 16.5 10.9 16.2 19.7 10.3 8.5 25.9 15.7 20.8 25.1 10.3 7.8 21.4 29.5 57.8 18.3 16.1 58.4 32.3 15.9 6.9 19.6 45.8 14.8 6.4 49.0 14.2 10.9 9.8 19.6 14.5 40.4 13.0 7.9 15.6 11.0 13.3 19.3 5.1 14.1 20.6 18.7 9.8 9.8 27.6 19.9 20.2 11.8 3.2 2.5 4.9 4.7 3.4 2.8 3.4 3.9 4.3 2.1 3.1 4.4 0.7 3.0 3.3 7.1 3.8 2.8 9.3 10.3 9.7 13.7 9.5 8.6 11.5 10.3 12.2 8.3 11.1 14.3 7.3 12.8 1.1 16.6 12.1 3.7 6.6 10.6 6.2 24.9 6.4 4.7 7.0 7.2 7.2 11.0 37.5 36.2 12.0 28.5 3.9 15.9 3.1 14.8 12.8 4.8 0.0 13.7 15.9 20.0 22.5 9.8 36.7 12.1 49.6 57.8 6.1 25.2 28.0 30.3 17.8 14.0 18.3 6.0 3.9 2.8 6.5 8.2 8.8 2.8 9.7 9.0 17.5 7.1 11.8 21.5 8.5 12.4 22.9 7.0 20.6 14.3 8.8 36.6 26.3 8.9 9.5 9.9 13.5 12.0 7.4 81.8 11.3 28.1 18.7 7.6 ACAN "AGC1, CSPG1, CSPGCP, MSK16" ENSG00000157766 Aggrecan P16112 15 88803436-88875353 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.5;seminal vesicle: 3.1" "Group enriched" "Detected in some" 15 "Extravillous trophoblasts: 127.1;Granulosa cells: 132.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "WM-115: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016377, HPA038241, HPA038242" Enhanced "Secreted to extracellular matrix" NA NA 17000000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910" "unprognostic (2.69e-3)" "unprognostic (4.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.13e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (7.12e-2)" "unprognostic (8.57e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (7.79e-2)" "unprognostic (1.53e-1)" "unprognostic (7.71e-2)" "unprognostic (7.27e-2)" 1.2 0.2 0.6 0.9 1.0 0.1 0.1 2.2 1.6 0.9 0.1 0.3 0.1 0.4 0.2 0.1 0.2 0.7 0.5 0.7 6.5 0.7 0.1 0.7 0.1 2.1 1.6 0.4 0.2 0.1 0.4 0.2 1.5 0.5 0.3 0.1 0.1 3.1 0.2 0.2 0.1 0.5 1.3 0.2 0.2 1.4 1.5 0.0 0.3 0.0 0.0 0.8 0.7 1.4 0.0 0.0 0.0 0.0 0.8 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 2.2 1.6 0.7 6.5 2.1 1.6 1.5 1.3 1.5 1.4 0.1 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 1.2 0.0 127.1 0.7 0.0 0.4 1.3 132.4 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.5 2.1 0.0 0.2 1.8 1.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 8.4 2.3 6.3 0.0 0.4 3.6 0.1 1.8 0.0 0.4 ACSM3 "SA, SAH" ENSG00000005187 "Acyl-CoA synthetase medium chain family member 3" Q53FZ2 16 20610243-20797581 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 85.1;liver: 178.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 446.7;Hepatic stellate cells: 100.6;Proximal tubular cells: 136.0;Theca cells: 208.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 95.1;HMC-1: 381.7;K-562: 285.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041013 Uncertain NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA041013: AB_10671693" "unprognostic (1.62e-4)" "unprognostic (1.30e-2)" "unprognostic (2.12e-2)" "unprognostic (9.50e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.42e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "prognostic favorable (1.97e-4)" "unprognostic (3.56e-2)" "unprognostic (1.95e-3)" "prognostic favorable (9.88e-6)" "unprognostic (1.27e-1)" "unprognostic (6.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.84e-2)" 4.5 3.2 1.7 2.4 1.6 15.3 60.2 2.1 3.1 10.3 1.9 26.4 7.7 19.9 5.7 3.2 26.8 10.4 8.6 1.7 0.8 85.1 178.5 8.1 3.1 3.1 2.7 74.8 30.4 15.2 0.9 2.5 2.5 22.0 25.6 1.0 4.8 6.9 0.8 4.3 8.2 5.1 1.0 1.9 28.1 5.9 2.2 2.8 2.8 1.0 2.9 4.9 5.2 5.3 1.0 12.4 2.3 0.7 3.9 2.3 1.5 0.2 1.3 0.3 1.0 1.0 18.2 1.6 20.1 0.4 0.7 1.6 0.2 2.1 1.6 4.5 6.6 95.1 0.2 7.7 1.3 10.9 381.7 3.7 2.2 0.5 1.4 1.9 0.2 0.7 285.1 15.3 0.1 1.5 0.7 3.5 0.7 14.5 3.8 3.1 0.1 20.3 18.3 1.1 0.8 0.7 0.4 5.4 0.3 0.8 6.1 0.9 1.3 1.2 1.2 0.9 0.7 21.9 18.6 1.2 1.2 7.5 0.5 2.6 2.0 23.5 3.6 1.2 4.2 1.6 4.5 3.3 0.2 2.8 6.9 8.2 0.5 2.3 4.0 2.3 5.6 2.9 1.7 1.6 2.1 3.1 1.7 0.8 3.1 2.7 2.5 1.0 2.2 5.3 0.3 3.2 31.3 1.0 16.5 2.8 34.6 1.5 8.0 0.0 6.3 6.1 3.2 20.0 1.7 12.9 0.0 19.1 1.5 7.0 84.1 84.8 25.0 14.0 4.3 3.4 2.4 25.4 0.3 12.5 2.1 23.7 8.6 32.8 0.0 446.7 100.6 38.2 3.2 0.0 0.3 11.8 0.0 5.4 1.7 12.3 27.7 3.4 0.0 0.0 3.1 0.0 4.1 0.0 0.1 8.9 20.3 12.8 1.0 14.5 4.7 136.0 1.5 0.0 0.0 0.4 52.7 6.9 2.2 3.8 1.8 19.2 4.3 208.3 23.0 11.3 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140672945-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 10.4 9.1 23.7 10.2 25.1 8.8 11.3 24.6 25.9 11.9 16.5 13.4 7.4 9.7 8.9 17.5 16.0 8.3 10.7 24.3 24.2 12.4 13.3 10.8 14.8 29.1 25.6 11.8 14.4 19.5 12.8 11.2 25.9 13.2 10.9 6.3 15.6 10.7 14.1 26.3 11.0 9.0 26.3 12.2 13.1 6.5 26.4 12.4 12.8 8.4 14.1 11.9 13.7 30.2 32.6 23.2 5.6 24.9 19.3 21.5 31.7 16.5 20.0 17.2 11.2 21.7 22.5 42.4 24.0 11.7 39.4 26.3 27.5 19.0 5.1 31.3 26.1 9.2 8.8 11.1 26.5 6.2 21.8 17.7 56.8 9.9 13.5 17.3 14.8 30.9 16.1 20.9 6.1 41.0 46.4 15.3 8.2 27.0 23.1 36.3 0.3 21.0 9.9 34.9 20.6 14.5 22.7 32.7 23.3 10.1 29.2 12.2 15.6 21.3 7.3 35.0 32.0 14.2 23.2 32.4 31.3 23.9 25.7 0.0 3.0 3.0 4.2 4.1 4.0 7.0 3.8 4.3 4.8 3.0 5.8 3.7 0.1 4.4 2.6 10.1 5.4 2.0 23.7 25.1 24.6 25.9 24.3 24.2 29.1 25.6 25.9 26.3 26.4 30.2 9.0 9.6 3.6 2.3 9.8 12.4 21.3 4.4 5.7 11.4 15.3 11.7 6.4 7.2 3.5 9.2 0.0 32.9 17.8 15.0 5.9 6.3 37.9 5.6 3.4 8.8 16.8 12.2 6.5 7.5 20.2 6.2 5.1 9.3 11.4 98.0 7.1 9.9 31.5 11.8 6.7 13.5 6.1 11.4 16.1 16.4 3.4 14.3 3.6 6.5 8.4 13.3 9.2 8.0 10.8 6.1 15.8 13.5 5.1 19.6 8.3 5.7 4.8 5.9 0.0 9.5 7.2 7.0 6.4 7.3 13.9 33.8 9.6 14.9 14.0 21.2 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7;pituitary gland: 19.9" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;dendritic cells: 5.2;Granulosa cells: 4.9;Theca cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 2.4 3.1 14.7 1.0 15.6 1.2 1.7 26.7 17.0 3.8 0.0 17.4 2.1 4.7 0.2 3.2 4.1 0.4 5.3 18.3 1.8 3.6 4.9 2.2 0.5 6.2 2.9 1.4 7.4 0.8 19.9 0.6 2.8 7.7 0.8 0.8 2.3 1.3 3.1 2.6 5.7 0.5 0.0 5.0 5.9 6.4 3.4 0.3 3.2 0.5 0.3 9.3 3.6 4.7 3.0 2.3 0.3 0.9 0.4 0.3 3.7 2.3 0.4 0.3 0.1 0.8 1.5 1.8 1.9 0.6 0.7 3.2 0.3 0.9 0.0 4.6 1.7 0.4 5.2 0.7 1.2 1.1 3.2 0.7 1.1 0.3 0.2 1.8 0.2 0.8 2.8 1.1 0.5 3.3 0.3 3.6 0.9 2.4 3.0 2.2 0.7 5.9 0.7 0.5 5.6 2.0 1.5 5.8 3.3 0.4 4.6 2.2 2.4 3.8 2.6 1.3 1.4 5.0 3.7 0.6 6.6 3.6 0.9 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.5 1.1 0.0 0.2 14.7 15.6 26.7 17.0 18.3 1.8 6.2 2.9 2.8 0.0 3.4 4.7 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 0.0 0.0 5.5 0.0 0.6 5.2 0.0 0.0 1.8 0.0 0.8 1.1 0.2 0.0 0.0 0.0 0.5 0.9 0.4 0.0 1.8 1.3 4.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 1.0 2.3 0.0 0.0 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605941-95656711 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 120.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 48000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 15.3 16.1 12.2 21.2 12.6 16.7 20.2 12.4 13.1 33.4 21.0 51.9 89.3 18.5 30.9 21.0 21.9 25.2 11.5 12.2 13.6 17.7 24.3 10.8 22.0 12.4 14.7 16.7 61.8 33.5 28.2 26.3 13.1 24.2 49.3 11.4 120.1 24.9 4.3 22.4 73.1 26.3 12.7 12.1 40.5 11.7 14.0 17.2 37.5 5.5 26.9 25.2 14.3 13.1 66.5 61.6 57.9 152.7 76.0 72.9 62.2 75.6 112.8 75.1 93.7 124.4 51.6 223.7 68.9 119.7 36.2 85.6 117.1 77.8 84.6 64.0 92.0 71.2 40.5 177.9 49.7 125.6 76.1 77.0 46.8 61.5 119.1 124.5 79.9 82.6 67.5 46.0 57.1 95.0 114.5 80.5 68.6 109.2 60.7 105.9 66.3 76.9 88.3 49.7 57.5 56.9 60.1 47.1 56.9 66.0 70.5 57.9 66.7 31.1 49.0 80.9 88.2 52.4 41.7 135.8 60.4 142.8 40.7 0.1 2.6 0.2 27.3 5.2 28.7 23.0 24.5 28.3 9.6 16.1 20.7 23.1 0.5 26.3 8.3 5.9 25.8 15.5 12.2 12.6 12.4 13.1 12.2 13.6 12.4 14.7 13.1 12.7 14.0 13.1 4.6 6.4 9.2 7.2 12.6 11.2 8.3 8.9 14.2 6.3 15.6 12.4 4.6 11.5 14.3 20.2 0.0 43.9 6.7 80.5 1.9 13.7 1.3 12.7 18.1 8.0 19.8 17.9 15.7 21.1 31.6 16.2 18.8 16.9 8.2 81.6 5.3 27.3 11.5 10.1 13.6 41.3 8.2 3.5 3.8 1.6 9.3 3.5 16.0 11.2 2.6 7.1 8.2 17.6 12.8 11.7 56.4 12.0 30.1 18.4 79.4 8.4 15.2 3.4 0.0 10.5 10.1 8.2 9.9 17.6 8.1 30.2 9.0 10.8 38.7 9.4 ALG1L2 ENSG00000251287 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4;retina: 2.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 6.0;Erythroid cells: 6.1;Granulosa cells: 16.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favorable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.1 0.2 0.5 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.1 0.3 0.0 1.4 0.3 0.2 0.2 0.0 0.5 0.7 1.2 0.0 2.6 0.7 1.7 0.0 6.0 0.0 0.0 1.7 1.4 1.7 0.4 0.0 0.6 1.8 4.2 0.3 0.9 0.8 1.9 0.2 0.4 0.7 3.0 0.9 0.0 6.1 0.8 0.0 0.3 1.7 1.5 0.9 0.0 16.7 0.7 0.4 0.2 5.0 0.6 1.4 0.0 0.0 0.0 0.0 3.7 0.9 0.0 0.0 0.3 3.2 0.0 0.5 0.8 0.0 0.0 2.6 1.1 3.3 1.2 1.1 0.7 3.0 0.0 3.3 2.2 1.3 0.2 0.5 0.0 0.0 1.5 1.5 1.5 1.7 ALKAL2 "AUGA, FAM150B" ENSG00000189292 "ALK and LTK ligand 2" Q6UX46 2 279558-288851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 205.4" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 20.3;Ductal cells: 37.0;Endometrial ciliated cells: 24.0;Glandular and luminal cells: 50.3;Granulosa cells: 64.3;Proximal tubular cells: 28.1" "Cancer enhanced" "Detected in many" "renal cancer: 5.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "AF22: 138.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "amygdala: 4.3;basal ganglia: 3.0;cerebral cortex: 2.5;hippocampal formation: 3.4;spinal cord: 2.3" "Secreted - unknown location" NA NA "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.39e-3)" "unprognostic (1.44e-2)" "unprognostic (2.41e-2)" "unprognostic (2.03e-3)" "unprognostic (2.88e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.35e-1)" "unprognostic (9.29e-3)" "unprognostic (5.19e-2)" "unprognostic (3.68e-1)" 28.8 205.4 4.6 2.0 6.3 0.6 26.6 3.5 2.9 4.9 4.8 8.2 3.7 26.4 13.4 2.0 26.2 10.7 2.2 3.1 5.4 21.1 4.5 34.0 0.9 3.6 2.1 74.4 64.3 2.3 8.6 9.6 2.7 6.5 6.5 0.4 5.4 2.6 1.5 17.3 7.7 9.9 1.8 12.3 17.3 35.5 5.1 1.7 10.4 0.5 1.6 4.7 5.3 4.8 0.0 0.0 138.8 0.1 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.4 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.3 0.0 0.1 0.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.3 0.7 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 4.6 6.3 3.5 2.9 3.1 5.4 3.6 2.1 2.7 1.8 5.1 4.8 2.5 0.0 11.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 14.6 20.3 0.0 0.0 0.0 1.8 0.0 0.1 1.4 0.0 3.9 37.0 0.0 24.0 6.3 4.5 0.0 0.0 0.0 0.7 0.1 3.1 0.0 50.3 0.0 64.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.1 0.6 0.9 0.0 0.0 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "pituitary gland: 3.9;testis: 10.5" "Cell type enriched" "Detected in many" 61 "Granulosa cells: 1567.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 16.9;NTERA-2: 6.4;REH: 7.0;SH-SY5Y: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" NA NA 1580000 280000 "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Aggresome" "HPA066973: AB_2732754" "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.2 0.2 0.7 0.0 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.8 0.0 0.3 0.0 0.3 0.4 0.0 0.2 0.2 0.4 0.5 0.3 0.3 0.0 0.4 0.5 1.1 1.2 0.0 3.9 0.0 0.4 0.5 0.0 0.0 0.2 0.0 1.5 0.2 0.4 0.0 0.6 0.2 0.2 10.5 0.6 0.0 0.3 0.0 0.0 0.2 0.3 0.4 2.8 0.2 0.1 0.4 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 16.9 0.1 0.8 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.4 0.0 0.5 0.1 1.3 6.4 0.0 1.5 7.0 1.4 0.9 0.0 0.2 0.4 7.7 0.1 0.0 1.7 0.0 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.7 3.7 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 1.2 1.3 0.2 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.3 0.0 0.0 2.0 0.0 0.1 0.2 0.1 0.6 12.1 1.6 2.2 1.1 1.5 0.0 0.0 2.1 0.3 0.4 1.1 0.0 0.3 2.0 0.7 0.8 0.5 1.2 0.4 1.6 0.2 0.3 0.4 0.0 1.5 0.0 1567.5 0.7 0.3 0.1 8.4 11.5 1.0 0.0 0.0 0.0 9.2 1.5 2.3 0.0 1.9 0.1 6.3 0.0 1.0 2.2 0.0 0.0 0.4 0.1 0.1 0.9 0.2 0.1 2.3 0.0 9.2 25.6 8.1 0.6 0.7 0.1 0.0 0.4 0.0 0.8 0.2 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079959 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 390000 "Cluster 32: T-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 10.8 19.8 4.5 7.0 4.9 3.5 22.8 3.6 5.4 20.3 2.3 39.4 3.3 30.7 7.9 4.0 36.4 19.3 5.6 3.2 8.8 7.7 4.6 20.0 12.4 9.1 37.9 28.7 3.6 6.4 5.3 13.2 19.6 11.3 9.0 25.7 4.5 11.0 1.1 4.4 12.6 34.3 4.3 17.4 5.5 10.7 13.1 2.8 4.2 2.2 7.6 22.6 14.3 3.9 44.4 105.5 6.3 0.2 2.5 0.2 17.2 14.8 39.3 4.7 3.8 0.3 192.0 0.0 47.6 183.2 117.0 64.8 0.0 117.6 5.5 8.6 0.7 0.0 11.0 0.1 3.8 1.2 1.7 0.9 20.1 122.6 59.5 312.2 15.0 0.9 8.5 0.0 179.2 2.1 3.6 0.1 4.5 21.2 27.1 0.3 46.5 0.1 52.3 251.9 18.8 0.0 76.2 9.0 0.5 3.4 11.2 1.0 4.1 2.6 149.9 1.7 121.3 1.9 0.4 0.2 10.0 3.4 2.8 0.0 0.1 0.0 4.4 0.2 6.0 3.7 6.8 6.9 0.7 1.6 15.3 12.1 0.1 8.6 0.0 8.8 4.4 4.7 4.5 4.9 3.6 5.4 3.2 8.8 9.1 37.9 19.6 4.3 13.1 3.9 7.2 9.6 3.1 1.0 3.6 2.4 13.1 39.4 15.4 62.6 10.8 37.7 1.6 1.5 4.9 1.8 0.0 1.0 12.4 0.4 1.9 5.3 1.4 31.5 6.0 12.7 60.4 5.7 2.6 19.3 28.1 11.1 0.5 72.8 7.0 76.8 32.2 1.2 4.8 0.0 0.2 3.1 2.0 3.5 1.1 2.3 2.5 7.2 1.8 1.9 5.3 15.6 2.1 0.0 0.1 40.4 1.5 0.7 3.8 10.7 0.0 0.1 2.9 4.9 0.0 3.2 27.7 0.7 2.4 2.5 0.4 8.5 7.6 12.8 0.3 33.9 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433152-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell type enhanced" "Detected in many" "Astrocytes: 35.3;Granulosa cells: 53.9;Inhibitory neurons: 54.3;Oligodendrocyte precursor cells: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;BEWO: 44.9;HAP1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310" "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.5 1.8 15.3 2.6 16.5 1.4 3.6 24.7 14.8 5.0 10.5 2.8 0.7 5.2 1.8 4.1 9.1 4.7 7.8 13.6 17.6 4.9 4.1 4.9 2.3 11.2 9.7 12.8 3.8 6.5 3.4 3.7 9.5 2.6 0.9 3.0 5.1 1.7 3.8 1.6 1.5 4.0 8.8 1.8 2.2 5.3 26.7 3.8 4.7 3.1 1.7 3.5 2.8 6.7 0.0 2.0 15.1 6.6 0.1 0.7 44.9 0.2 0.2 0.1 1.0 0.5 1.2 0.0 1.5 0.0 7.0 0.0 15.2 8.2 0.6 0.1 10.0 5.5 0.0 0.5 0.2 0.0 2.0 1.0 2.3 0.0 0.0 0.0 1.6 1.4 0.4 3.6 0.0 1.9 0.2 0.6 4.4 0.6 1.5 5.7 0.0 0.0 2.9 8.0 9.5 3.6 1.2 10.7 4.6 9.0 3.1 3.5 0.0 2.3 0.9 0.2 1.3 0.5 0.1 0.0 0.4 0.0 1.8 0.0 0.1 0.9 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 15.3 16.5 24.7 14.8 13.6 17.6 11.2 9.7 9.5 8.8 26.7 6.7 6.8 16.0 19.4 35.3 1.6 0.9 5.6 4.7 10.2 0.9 4.4 4.6 5.7 11.5 6.4 1.8 12.5 3.6 1.3 0.1 11.7 5.9 2.6 12.0 2.9 5.7 1.8 1.7 23.8 11.2 10.8 7.2 5.6 3.9 10.8 53.9 5.0 2.8 2.6 0.0 54.3 0.0 8.2 2.6 2.1 6.1 9.6 2.5 3.6 25.3 2.9 7.2 3.1 32.6 6.6 5.1 0.1 27.8 4.0 2.5 0.0 4.1 8.2 1.7 6.6 3.4 5.2 5.3 5.3 4.3 1.1 1.9 1.5 4.3 0.0 4.9 ANXA6 ANX6 ENSG00000197043 "Annexin A6" P08133 5 151100706-151157785 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 343.8;monocytes: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 861.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002462, CAB005077, HPA009650, HPA009977" Enhanced Approved Cytosol NA NA 1800000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: " "unprognostic (1.74e-1)" "unprognostic (5.85e-2)" "unprognostic (1.03e-1)" "unprognostic (5.81e-2)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (9.63e-2)" "unprognostic (1.60e-2)" "unprognostic (1.08e-3)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.31e-5)" "unprognostic (6.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (1.38e-3)" 292.9 135.4 98.1 164.2 104.1 109.7 188.3 94.0 150.6 148.9 151.8 196.0 44.5 181.5 105.0 94.7 149.9 108.7 188.7 102.5 123.1 82.6 214.4 131.6 161.8 144.2 109.4 181.7 78.3 29.6 161.9 141.1 146.2 124.9 78.2 133.6 70.3 208.6 331.3 62.7 119.9 300.1 92.3 150.9 111.4 52.5 127.4 160.8 86.7 371.5 176.4 206.5 107.4 104.8 3.0 30.4 212.8 317.1 861.2 417.8 55.1 397.4 526.4 323.5 477.6 106.7 15.6 26.9 138.5 578.6 268.1 0.5 165.9 200.2 300.3 110.5 52.1 15.3 62.1 204.7 295.0 97.6 94.7 508.6 1.5 282.3 42.0 476.9 420.6 197.5 22.0 396.1 737.6 100.4 181.8 151.7 56.2 1.2 92.4 120.4 592.9 31.0 42.2 0.3 12.2 49.3 39.9 282.7 175.6 308.4 488.3 201.1 326.8 296.6 84.2 19.4 107.1 205.4 289.5 4.5 154.5 459.7 46.2 89.7 89.4 82.9 290.4 54.7 190.4 175.4 213.4 263.3 118.3 179.0 145.8 181.6 17.6 261.9 25.0 30.2 190.9 331.7 98.1 104.1 94.0 150.6 102.5 123.1 144.2 109.4 146.2 92.3 127.4 104.8 90.3 16.0 17.3 19.2 146.8 11.0 11.5 2.2 1.8 16.5 30.7 24.0 59.5 12.8 1.1 23.9 6.2 64.3 110.3 0.3 25.4 6.5 56.9 1.8 38.5 45.6 21.4 36.4 36.5 17.8 33.7 105.9 9.2 1.7 57.5 343.8 57.1 147.1 85.4 15.2 36.3 2.4 0.0 41.0 77.8 46.8 123.3 41.2 55.2 10.3 445.2 45.6 187.4 18.6 5.6 12.1 1.2 211.4 120.3 7.3 1.0 48.4 4.7 125.8 230.1 55.3 150.6 2.5 1.5 0.6 8.1 177.2 143.4 149.4 2.5 1.5 AP003108.2 ENSG00000256591 "Novel transcript" 11 61429220-61485822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 1.4;Endometrial stromal cells: 1.5;Glandular and luminal cells: 1.4;Granulosa cells: 3.4;Respiratory ciliated cells: 1.5;Theca cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 28.0" "Low region specificity" "Detected in all" HPA039732 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "HPA039732: AB_10962868" "unprognostic (1.23e-1)" "unprognostic (8.61e-2)" "unprognostic (9.60e-2)" "unprognostic (4.91e-2)" "unprognostic (5.69e-2)" "unprognostic (5.98e-2)" "unprognostic (4.41e-2)" "unprognostic (6.40e-2)" "unprognostic (3.53e-2)" "unprognostic (5.83e-2)" "unprognostic (4.98e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-7)" "unprognostic (5.74e-2)" "unprognostic (9.69e-2)" "unprognostic (1.40e-1)" "unprognostic (4.66e-3)" 5.1 4.7 2.7 4.0 3.1 8.7 4.0 3.0 3.9 5.9 2.6 2.7 2.2 3.6 3.1 3.4 3.2 4.8 7.0 3.1 3.4 3.6 2.4 3.8 4.6 3.2 3.3 2.1 2.0 2.3 1.3 3.1 3.3 3.3 3.3 1.0 2.6 2.7 1.8 1.7 2.6 4.2 3.0 4.4 3.4 2.9 3.2 7.7 5.1 5.9 4.8 5.4 1.9 3.1 6.8 3.3 3.8 6.1 9.7 8.1 2.0 8.9 7.6 6.6 6.2 2.6 4.5 7.1 14.5 8.3 5.5 3.0 4.5 6.3 3.9 6.3 5.3 5.4 0.9 0.9 11.4 4.2 2.0 15.6 3.8 9.8 7.8 4.2 16.7 9.2 5.8 6.0 10.9 5.3 14.1 4.0 8.5 5.8 4.5 8.4 5.8 8.6 4.4 5.4 3.0 3.8 3.7 3.5 12.6 2.5 4.9 4.8 28.0 8.4 4.7 4.5 5.0 2.2 9.5 4.8 7.2 5.5 6.3 5.9 8.0 8.4 11.6 7.3 14.6 5.9 11.5 11.8 6.3 6.8 13.2 12.3 11.2 7.4 6.8 6.8 12.9 10.2 2.7 3.1 3.0 3.9 3.1 3.4 3.2 3.3 3.3 3.0 3.2 3.1 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.6 3.7 0.0 0.3 1.4 0.0 0.0 0.2 0.0 0.7 1.5 0.6 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.4 1.3 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.0 0.0 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.1;Granulosa cells: 83.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 4.8 23.9 4.5 1.1 4.7 0.0 7.5 0.4 5.1 3.9 0.0 3.3 3.2 4.1 2.5 6.4 9.8 5.3 1.9 5.0 4.3 31.5 6.4 7.3 0.4 1.6 2.0 19.0 20.7 1.2 6.0 0.5 3.2 5.0 3.7 6.0 19.2 3.6 0.9 14.8 2.5 3.5 1.4 2.8 21.8 1.5 3.2 4.0 13.6 0.9 2.9 3.7 6.6 2.8 30.1 21.0 0.1 2.6 2.6 3.6 0.0 10.8 21.5 13.5 13.3 6.3 12.8 0.1 22.5 3.7 30.4 10.0 1.4 17.4 20.2 0.2 3.1 0.6 3.3 27.2 20.9 0.0 0.0 3.3 7.0 21.0 97.8 25.2 44.4 0.6 0.0 0.0 92.2 2.8 0.0 0.0 0.2 7.9 8.5 0.0 5.5 3.7 36.4 18.0 2.0 3.9 5.3 0.8 0.6 0.0 4.6 0.1 59.8 6.6 9.2 0.5 10.3 1.1 0.0 0.2 10.1 1.4 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 4.7 0.4 5.1 5.0 4.3 1.6 2.0 3.2 1.4 3.2 2.8 9.1 28.9 16.4 3.9 0.2 25.7 14.1 14.1 40.5 4.9 7.5 11.0 2.0 24.3 15.5 31.3 0.0 0.3 2.1 3.7 15.6 13.0 9.6 32.7 1.7 12.8 11.4 2.7 73.1 11.3 0.3 3.1 35.7 12.6 1.3 83.2 2.2 7.3 0.3 13.5 34.5 10.7 40.7 0.3 0.9 2.6 10.2 3.3 1.8 32.8 0.6 26.8 1.0 34.7 15.2 26.3 4.6 5.7 1.2 16.0 3.9 26.7 50.4 1.6 6.6 0.5 7.0 1.0 1.3 20.4 25.6 0.1 1.2 32.3 6.7 17.3 ARHGEF6 "alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46" ENSG00000129675 "Rac/Cdc42 guanine nucleotide exchange factor 6" Q15052 X 136665547-136780932 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8" "Cancer enhanced" "Detected in all" "glioma: 24.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003578 Approved Approved Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA003578: AB_1078203" "unprognostic (9.64e-2)" "unprognostic (3.47e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-2)" "unprognostic (7.28e-2)" "unprognostic (2.06e-3)" "unprognostic (9.08e-2)" "unprognostic (7.87e-3)" "unprognostic (4.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-3)" "unprognostic (5.29e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-3)" 44.0 16.2 23.4 30.5 24.4 31.4 23.5 25.0 19.5 10.7 11.6 13.2 7.5 12.9 5.3 7.6 7.0 17.3 32.9 25.2 26.9 6.7 8.5 25.6 41.8 26.8 29.2 16.5 3.9 10.3 6.2 46.9 27.8 7.8 11.1 4.6 8.7 8.8 68.7 6.2 14.4 16.6 29.0 39.4 12.3 3.8 26.5 51.4 5.6 54.7 39.6 14.3 8.7 30.1 1.1 0.0 5.1 0.0 11.2 28.5 0.1 1.6 9.5 1.5 8.2 0.0 0.0 5.5 2.3 8.0 7.8 0.8 6.1 0.0 1.5 28.1 2.0 117.6 0.1 0.0 4.2 153.7 532.0 30.9 0.1 5.4 0.1 10.1 3.0 152.7 0.5 22.1 20.4 0.2 70.6 88.4 4.9 0.0 2.3 26.6 37.2 0.1 1.6 29.5 0.3 6.7 0.2 1.2 4.0 2.6 3.5 61.2 0.5 7.6 1.2 9.3 7.2 3.6 0.1 57.3 35.1 158.2 10.1 57.2 16.4 71.3 13.8 18.9 16.0 6.2 15.4 11.3 19.1 5.4 13.7 12.3 9.1 12.4 16.1 6.0 21.5 15.3 23.4 24.4 25.0 19.5 25.2 26.9 26.8 29.2 27.8 29.0 26.5 30.1 18.1 6.4 8.9 57.1 22.4 1.1 0.9 0.8 1.2 0.8 16.1 10.8 60.0 0.0 2.4 1.8 0.0 0.3 23.6 0.1 1.9 0.6 12.0 0.9 2.4 13.2 0.0 11.3 20.6 1.8 0.4 10.7 5.6 1.6 193.9 128.2 12.5 2.5 15.2 13.5 21.6 0.4 0.0 46.5 25.1 35.8 14.9 40.3 3.6 77.8 36.1 4.7 36.0 48.2 4.3 0.7 0.0 14.7 12.8 0.4 0.0 0.2 2.2 0.3 13.1 33.5 18.5 0.7 0.7 0.6 1.7 0.4 40.5 30.1 0.1 0.7 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoplasm "HPA020537: AB_2670467, HPA020546: AB_2670470" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favorable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favorable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 24.1 39.1 11.5 3.2 11.6 0.1 21.9 12.5 12.4 32.6 10.0 18.4 1.6 18.6 4.2 32.3 24.3 5.1 30.1 10.5 11.2 21.4 19.8 15.9 1.6 14.5 12.7 58.3 22.2 11.7 18.6 8.0 13.2 31.0 5.2 3.0 38.0 8.0 42.9 52.9 11.0 5.9 12.7 5.0 25.4 18.2 13.4 1.0 29.0 11.7 4.2 21.3 33.4 12.1 1.8 1.8 17.6 11.6 31.8 29.9 21.6 3.2 3.8 4.9 6.3 1.3 0.1 9.2 3.7 6.3 2.9 8.4 12.2 2.9 2.8 0.4 1.6 0.5 4.8 11.8 17.1 0.0 0.9 38.4 4.4 7.9 7.1 14.6 3.9 1.3 6.4 0.0 3.1 3.9 1.3 0.1 3.0 5.0 4.2 4.9 1.9 0.0 3.4 3.7 0.6 6.0 14.1 3.5 3.5 8.7 13.2 0.1 1.4 2.1 5.2 5.9 0.2 3.9 4.2 1.1 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.5 11.6 12.5 12.4 10.5 11.2 14.5 12.7 13.2 12.7 13.4 12.1 4.5 9.6 6.7 35.9 0.3 2.0 1.5 2.0 2.8 1.1 6.3 3.7 15.5 0.0 4.1 3.7 0.0 2.1 0.0 6.7 3.9 5.8 5.1 2.4 7.3 6.6 1.2 0.0 7.6 6.1 43.3 12.2 10.2 4.4 1.3 28.3 3.9 4.0 1.8 0.0 4.9 8.5 2.0 0.0 1.3 8.1 12.5 0.4 0.0 7.5 0.1 8.3 0.0 18.1 4.2 2.5 2.1 13.5 0.2 2.4 0.8 5.4 4.3 0.6 0.0 2.0 3.4 8.2 11.8 3.7 4.3 1.4 0.2 15.9 5.2 2.1 ASPG C14orf76 ENSG00000166183 Asparaginase Q86U10 14 104085686-104115582 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 102.4;liver: 151.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA069761 Enhanced NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Granulosa cells - Unknown function" "HPA069761: AB_2686191" "unprognostic (1.45e-2)" "unprognostic (7.43e-3)" "unprognostic (2.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-2)" "unprognostic (1.74e-2)" "unprognostic (1.72e-2)" "unprognostic (3.47e-2)" "unprognostic (1.98e-1)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "unprognostic (1.10e-1)" "unprognostic (8.75e-2)" "unprognostic (7.98e-2)" "unprognostic (3.85e-1)" "unprognostic (1.52e-2)" "unprognostic (2.32e-2)" 1.1 1.4 0.1 0.2 0.2 0.0 0.7 0.0 0.4 5.4 0.2 4.7 1.5 2.2 1.1 34.0 6.2 0.1 102.4 0.3 0.3 12.8 151.1 2.3 0.0 0.4 0.6 11.4 0.2 0.8 2.3 1.8 0.2 0.3 1.9 0.3 2.8 0.1 0.5 9.9 0.5 1.2 0.0 0.2 3.1 1.1 1.1 0.1 5.9 0.0 3.7 2.3 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.6 0.5 0.4 0.3 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.3 0.4 0.6 0.2 0.0 1.1 0.0 0.0 6.4 1.7 0.3 0.5 1.8 0.2 0.7 0.0 1.1 0.6 0.8 21.4 2.8 2.4 0.0 0.0 0.2 0.0 21.2 3.9 0.0 0.4 0.7 0.1 0.5 1.8 0.0 0.1 0.2 0.2 4.3 4.6 0.7 0.0 66.8 3.6 93.9 0.2 5.0 0.1 16.0 0.0 1.6 0.3 0.7 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 7.6 1.2 0.0 0.1 0.9 49.7 1.6 0.3 0.0 0.0 0.6 0.3 1.5 8.4 9.1 0.5 0.3 3.9 5.4 3.0 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 46000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 35.0 40.8 7.3 7.4 7.4 29.4 40.3 6.6 9.9 50.2 3.9 46.3 11.9 46.0 16.7 56.6 45.6 11.5 31.2 7.9 9.1 36.7 35.1 35.6 14.2 7.7 7.7 57.1 43.4 14.1 43.0 8.8 7.6 43.7 14.0 8.1 44.9 6.3 22.4 53.3 46.9 8.9 7.1 60.0 45.4 29.3 7.4 16.7 51.1 5.0 17.0 44.3 47.0 7.1 2.5 6.3 18.1 29.7 17.8 18.9 11.5 9.8 13.3 13.7 20.8 25.2 20.9 30.4 26.8 60.1 14.5 17.0 23.5 37.2 8.1 18.3 34.5 11.2 36.1 24.7 28.9 2.9 40.0 17.2 16.1 5.4 31.4 25.5 44.0 47.9 38.0 32.9 39.9 18.3 25.5 17.4 5.1 20.8 5.4 7.5 7.6 20.7 17.5 6.3 1.8 6.4 35.2 13.9 40.5 5.0 39.5 12.5 17.1 3.6 13.0 13.7 15.6 33.8 20.4 17.0 15.5 18.5 21.9 4.2 1.1 0.7 1.9 1.7 1.5 1.6 1.0 0.9 2.3 1.1 0.6 1.4 0.9 2.5 1.5 1.4 1.7 2.2 7.3 7.4 6.6 9.9 7.9 9.1 7.7 7.7 7.6 7.1 7.4 7.1 39.1 12.8 15.2 31.6 72.7 24.9 37.6 83.0 33.6 89.3 31.8 26.0 2.0 50.1 53.1 55.2 95.9 88.4 64.9 52.9 5.9 48.1 3.3 22.0 24.5 40.3 53.5 39.8 29.5 42.8 50.2 29.8 39.8 27.8 16.5 148.5 43.5 18.5 52.8 43.7 29.9 53.9 79.3 55.4 40.5 8.9 70.8 42.0 32.0 28.1 65.4 35.0 124.6 21.6 24.1 37.2 58.6 51.9 40.3 30.6 64.3 14.6 43.5 98.0 59.2 30.5 29.8 64.3 58.6 36.1 25.3 89.2 58.6 49.5 55.7 39.8 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1035.0;Endometrial ciliated cells: 1524.2;Exocrine glandular cells: 672.1;Granulosa cells: 1030.6;Proximal tubular cells: 1502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favorable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favorable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 96.9 215.1 98.4 50.6 98.6 144.3 108.8 95.6 140.0 123.3 95.2 234.8 163.1 113.0 44.5 184.5 139.4 28.0 585.8 100.0 106.5 384.9 342.6 116.0 64.5 99.6 96.8 134.9 163.4 90.1 246.5 37.6 97.8 156.0 59.4 71.0 145.3 37.1 456.7 165.0 199.6 28.5 93.7 153.7 215.7 355.5 99.6 60.0 169.2 179.8 47.9 116.6 134.0 104.1 271.9 136.4 79.3 75.1 58.0 62.7 94.1 118.6 57.9 98.6 96.2 132.0 192.5 189.1 173.8 72.1 37.6 161.5 91.2 118.0 77.6 143.9 306.0 162.9 612.7 180.8 62.9 125.5 158.1 73.5 190.2 88.2 70.4 96.2 95.7 222.0 292.9 167.9 71.2 178.0 187.6 230.4 262.7 100.9 167.8 177.3 87.5 270.2 196.9 175.5 158.9 114.2 146.5 150.8 160.4 76.5 224.4 136.6 100.6 31.9 88.0 126.5 142.1 432.0 282.8 268.6 151.1 338.8 38.1 133.3 116.6 126.1 144.2 111.1 145.8 195.2 154.3 155.5 142.8 154.0 144.1 139.3 102.7 142.9 102.7 213.5 226.9 214.1 98.4 98.6 95.6 140.0 100.0 106.5 99.6 96.8 97.8 93.7 99.6 104.1 207.3 205.1 284.9 0.0 61.7 0.0 0.0 0.0 0.0 0.0 251.1 314.3 0.0 0.0 150.4 546.2 0.0 453.8 165.4 0.0 1035.0 396.6 0.0 1524.2 210.6 84.0 0.0 0.0 0.0 672.1 226.0 114.6 0.0 453.2 172.8 1030.6 0.0 0.0 372.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.6 0.0 0.0 123.0 0.0 0.0 0.0 0.0 550.3 0.0 0.0 30.3 0.0 0.0 1502.7 621.6 0.0 0.0 0.0 90.6 0.0 0.0 0.0 0.0 251.7 92.0 281.6 0.0 0.0 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471018-3651118 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" NA NA 27000000000 "Cluster 52: Eosinophils - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.8 19.1 10.5 10.3 12.2 8.6 17.2 9.3 13.2 16.5 8.9 11.8 55.8 11.8 15.6 10.4 11.7 13.9 19.1 13.4 12.2 23.9 62.8 14.4 7.5 8.0 8.7 14.0 20.2 40.1 8.7 22.6 9.0 12.8 12.3 24.2 13.9 13.2 11.6 14.9 33.4 14.9 11.3 13.8 24.0 16.6 10.8 7.8 32.3 14.2 9.6 15.7 9.1 15.8 40.8 37.6 21.9 18.4 37.9 61.5 28.1 26.6 37.5 27.4 23.1 16.3 27.1 0.0 17.5 37.4 33.8 55.6 15.0 58.1 36.4 4.5 12.8 12.7 10.0 35.1 22.8 27.2 8.3 33.1 46.0 29.0 27.8 34.3 36.0 8.7 20.2 19.2 27.0 11.7 11.1 10.4 14.7 13.2 22.3 9.2 50.9 30.8 24.8 28.5 12.9 20.2 26.7 48.9 36.3 21.3 26.2 25.5 44.7 29.0 17.0 30.8 26.6 13.4 20.1 0.1 17.9 17.9 29.6 3.6 3.2 2.0 2.3 2.8 1.0 1.4 1.2 1.4 2.8 1.7 2.0 1.7 0.0 1.5 3.1 2.6 1.8 1.0 10.5 12.2 9.3 13.2 13.4 12.2 8.0 8.7 9.0 11.3 10.8 15.8 11.1 16.0 10.4 70.2 5.8 6.4 4.3 14.1 6.8 22.5 9.9 8.8 12.6 20.0 10.3 11.0 37.5 7.4 8.0 6.5 1.9 8.2 7.1 9.9 15.1 11.1 9.6 7.4 101.6 14.6 8.4 12.7 20.4 11.8 7.0 39.3 17.9 50.9 10.4 37.0 101.1 10.7 4.1 14.2 6.7 5.4 12.5 11.5 7.2 64.6 10.1 11.8 5.2 89.5 85.7 10.0 14.3 7.9 11.4 7.0 34.6 7.3 10.2 20.1 32.9 14.3 10.9 21.3 21.1 8.5 7.2 5.1 5.8 21.0 12.6 5.2 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687241 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 100.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 32.1 41.5 18.5 6.5 25.4 5.0 21.2 21.9 23.2 38.1 16.2 24.6 14.0 11.2 4.7 26.2 18.9 10.4 22.4 18.3 19.8 12.1 46.9 22.5 2.4 23.7 20.2 85.6 9.4 5.6 19.2 16.9 21.9 26.3 18.9 25.5 22.7 16.6 12.5 100.7 15.6 5.3 22.4 20.8 30.5 16.0 20.8 2.0 9.1 3.9 4.4 25.5 46.0 29.5 38.8 99.8 0.5 14.3 20.2 9.1 20.0 18.5 100.7 25.0 37.5 18.8 47.2 0.8 13.0 10.5 18.0 40.0 7.6 32.3 9.4 1.0 8.9 2.6 119.7 52.6 119.1 2.6 3.0 14.6 230.5 18.7 49.1 22.8 3.4 3.6 5.7 2.0 14.0 33.4 1.7 3.1 3.5 10.6 9.3 1.3 11.3 1.5 24.9 20.9 1.7 4.0 63.9 22.7 194.5 3.2 17.2 3.1 5.5 5.9 11.7 134.4 4.6 4.4 3.3 0.8 22.2 8.1 3.8 0.0 6.2 2.3 4.2 5.7 2.0 2.8 2.8 3.1 11.1 2.0 3.0 3.7 0.5 2.0 0.5 2.3 2.6 2.9 18.5 25.4 21.9 23.2 18.3 19.8 23.7 20.2 21.9 22.4 20.8 29.5 6.3 19.2 19.0 0.7 8.0 96.0 87.6 246.7 145.1 9.6 13.6 16.8 9.7 52.9 63.4 38.6 6.2 149.6 15.4 137.5 43.0 18.8 60.9 33.2 17.1 11.4 31.8 2.1 3.6 24.1 64.8 23.4 58.1 57.9 6.3 385.5 34.2 42.4 41.8 13.5 4.3 70.4 48.8 21.7 326.1 278.5 10.2 49.6 83.6 0.0 6.4 128.2 2.1 0.5 4.4 43.3 100.6 14.7 5.9 55.2 109.0 11.2 16.7 14.6 6.6 10.2 19.3 3.5 4.9 68.0 108.4 194.7 19.0 10.9 100.6 106.3 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677510-28682932 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 81.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: AB_2668371, HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favorable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 4.4 44.1 13.8 2.3 16.3 6.0 23.7 18.4 17.6 5.7 20.7 3.8 1.6 17.9 2.9 2.1 6.3 5.4 43.5 13.6 15.9 19.9 23.9 12.0 2.0 19.9 16.9 81.6 6.9 8.2 8.5 39.3 21.1 7.4 4.7 13.4 6.4 16.7 1.8 5.4 2.1 12.2 16.6 18.0 3.8 8.7 14.8 0.4 1.2 1.9 1.4 30.0 5.4 22.7 1.0 41.0 4.2 2.2 4.8 0.1 24.5 9.7 3.5 15.4 10.0 166.7 17.3 0.5 5.7 7.4 8.8 12.2 10.2 1.6 7.2 10.1 21.0 39.5 6.2 63.7 5.9 2.4 51.5 3.7 2.3 10.4 1.6 96.7 2.4 2.1 22.1 18.7 3.1 70.1 0.2 3.3 71.6 34.5 9.9 0.3 7.8 3.6 12.9 40.4 6.8 5.2 13.2 78.5 199.0 357.8 23.2 3.0 0.3 10.4 7.3 17.0 4.7 0.5 15.0 0.0 1.0 8.9 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 16.3 18.4 17.6 13.6 15.9 19.9 16.9 21.1 16.6 14.8 22.7 6.6 9.6 5.9 15.0 5.7 4.0 7.6 0.6 13.1 14.3 174.7 163.2 34.9 58.6 3.5 11.0 4.2 12.0 9.3 33.8 1.9 20.8 0.1 14.3 15.3 7.3 26.8 0.0 0.5 0.2 22.2 46.1 58.6 21.1 1.3 334.8 14.6 16.0 6.7 6.7 0.2 3.8 0.0 1.6 4.2 1.2 3.4 5.4 16.0 15.9 0.7 50.2 0.0 46.3 21.2 12.1 34.6 2.2 4.3 10.8 1.1 16.1 1.4 5.9 0.0 4.2 42.7 1.9 15.5 13.5 1.3 8.5 7.8 6.2 3.8 14.1 BMP3 ENSG00000152785 "Bone morphogenetic protein 3" P12645 4 81030708-81057627 "Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.3;lung: 5.5;urinary bladder: 9.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 32.2;Distal enterocytes: 68.9;Granulosa cells: 104.0;Paneth cells: 32.8;Proximal enterocytes: 25.2" "Group enriched" "Detected in some" 4 "lung cancer: 4.2;urothelial cancer: 7.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 10.3;Daudi: 16.3;RT4: 13.5;SK-BR-3: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.21e-3)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (3.36e-2)" "unprognostic (2.73e-3)" "unprognostic (9.11e-2)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.16e-4)" "unprognostic (2.26e-2)" "unprognostic (3.86e-1)" "unprognostic (1.11e-1)" "unprognostic (4.22e-2)" 1.5 0.4 0.3 0.3 0.2 0.8 1.2 0.2 0.3 0.4 0.1 9.3 3.2 0.0 0.1 0.0 0.9 2.0 0.0 0.1 0.6 0.1 0.0 5.5 0.3 0.7 0.7 2.5 0.0 0.0 0.0 0.0 0.5 0.2 6.8 0.5 1.3 0.0 0.0 0.3 7.2 0.5 0.6 0.0 1.1 0.1 1.4 0.0 0.0 0.6 1.5 9.5 0.2 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.3 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.5 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.3 0.1 0.6 0.7 0.7 0.5 0.6 1.4 0.0 0.0 3.2 32.2 0.0 0.2 0.1 0.5 0.7 0.0 2.2 0.1 0.0 1.3 0.0 15.1 0.0 0.0 0.0 0.0 68.9 0.0 0.0 0.0 0.9 0.1 0.3 0.0 0.0 1.6 0.0 0.0 2.1 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 5.6 5.0 6.1 0.0 1.2 0.0 0.9 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.2 32.8 0.0 0.0 0.5 25.2 0.1 9.4 0.1 0.0 0.3 1.2 0.2 0.3 0.0 0.4 0.0 0.0 0.1 14.1 3.8 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376327-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 202.2;Inhibitory neurons: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.5 21.6 8.2 10.9 14.1 2.2 13.2 3.2 16.8 22.6 0.3 13.6 8.5 20.0 11.3 12.4 14.9 17.3 21.5 16.0 14.8 17.4 15.6 29.1 7.2 6.2 7.7 16.8 10.4 17.5 8.5 34.0 10.0 17.1 13.0 26.7 11.0 13.9 10.9 10.9 8.6 24.3 3.9 13.1 11.7 11.3 10.6 9.0 18.2 23.1 9.4 20.6 12.4 5.9 13.3 12.3 12.6 19.7 34.2 31.9 23.8 27.2 28.3 23.6 23.9 10.8 19.6 4.7 30.7 58.2 19.9 24.5 16.8 21.4 41.6 13.8 11.2 14.2 12.6 16.8 22.7 4.0 10.7 24.2 21.5 17.1 22.8 40.6 73.9 5.6 9.3 22.5 33.8 24.8 3.4 3.6 6.9 6.6 11.1 9.1 24.3 7.1 21.3 27.9 12.6 12.7 28.9 17.7 32.7 32.0 13.2 9.5 75.9 48.0 24.4 16.3 16.7 3.1 4.1 1.3 11.3 9.0 13.9 0.1 0.6 0.2 0.9 0.5 0.6 0.3 0.3 0.5 0.6 0.4 0.7 0.3 0.1 0.3 0.9 0.7 1.0 0.3 8.2 14.1 3.2 16.8 16.0 14.8 6.2 7.7 10.0 3.9 10.6 5.9 116.9 105.8 40.3 104.5 15.2 33.4 18.0 34.9 13.6 54.3 29.2 29.7 55.5 15.7 38.8 20.2 81.3 16.9 17.8 25.2 1.9 27.2 2.8 23.1 54.5 152.2 25.1 6.9 202.2 28.1 22.6 47.7 16.8 36.4 23.5 155.1 143.1 19.9 18.7 35.3 190.2 16.3 20.3 24.2 31.7 4.6 33.8 23.5 42.7 170.5 20.2 39.9 16.5 152.8 55.1 46.8 21.1 42.9 9.5 23.9 16.4 12.4 28.0 31.7 65.7 48.8 62.4 33.2 25.0 21.2 35.9 20.0 13.1 0.8 15.5 24.8 BTBD2 ENSG00000133243 "BTB domain containing 2" Q9BX70 19 1985438-2034881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.77e-2)" "unprognostic (1.41e-2)" "unprognostic (2.79e-2)" "unprognostic (5.42e-3)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (7.27e-2)" "unprognostic (1.20e-1)" "unprognostic (5.89e-2)" "unprognostic (8.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.10e-1)" "unprognostic (1.50e-2)" "unprognostic (2.51e-1)" "unprognostic (3.36e-1)" "unprognostic (7.35e-2)" 42.5 39.8 57.9 27.6 58.7 25.2 38.1 27.2 98.9 45.9 13.1 50.4 37.6 47.9 12.1 55.9 43.7 24.8 47.2 69.6 37.2 41.3 34.7 27.9 27.1 39.0 39.2 61.1 44.0 19.2 36.6 23.2 39.8 42.9 15.1 17.0 38.0 21.8 74.2 49.9 36.2 17.1 33.0 32.6 41.4 16.6 48.0 23.5 33.7 29.4 12.6 46.4 43.7 46.5 91.1 68.3 54.2 91.7 62.8 83.4 52.5 46.7 47.0 39.4 35.6 33.3 56.5 64.4 56.3 62.8 19.4 81.7 31.8 35.2 23.5 58.6 51.8 28.5 44.5 67.7 49.3 20.6 36.0 64.3 38.0 17.9 41.3 66.3 42.3 56.1 32.7 97.0 25.7 80.6 85.4 25.4 77.9 54.2 55.7 93.5 17.5 72.2 24.0 99.7 83.4 105.2 47.3 72.8 62.1 22.7 60.6 69.0 59.7 49.8 16.7 87.8 27.9 43.8 51.1 34.4 70.6 40.4 63.2 5.0 3.6 2.9 2.7 1.5 1.4 2.0 1.9 1.9 2.4 1.9 1.9 1.4 0.7 0.7 0.9 1.3 3.2 2.4 57.9 58.7 27.2 98.9 69.6 37.2 39.0 39.2 39.8 33.0 48.0 46.5 18.2 0.0 3.6 14.4 9.5 7.0 5.9 7.8 5.7 19.2 21.5 27.9 5.6 11.5 4.9 20.2 2.1 11.9 9.5 26.8 7.9 9.2 0.8 11.5 27.6 9.2 13.8 2.1 14.0 16.1 13.8 13.9 19.9 20.2 3.8 48.8 12.5 10.6 12.4 25.2 17.6 25.4 8.2 16.7 8.0 1.8 15.2 12.4 3.6 4.7 11.0 14.6 2.1 9.0 11.9 13.6 19.4 13.2 4.4 7.0 30.3 17.7 3.0 12.6 6.6 16.3 10.4 1.0 5.1 16.3 11.8 8.6 9.0 21.2 29.4 7.2 C17orf113 ENSG00000267221 "Chromosome 17 open reading frame 113" A0A1B0GUU1 17 42038232-42050601 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.4;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.0;Exocrine glandular cells: 1.4;Granulosa cells: 2.4;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.06e-2)" "unprognostic (3.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.47e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (2.24e-3)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" "unprognostic (8.86e-4)" "unprognostic (2.73e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.24e-7)" "unprognostic (7.06e-2)" "unprognostic (2.22e-1)" "unprognostic (1.85e-3)" "unprognostic (1.28e-1)" 0.9 0.4 1.7 0.4 1.6 0.7 1.4 3.4 1.8 1.8 0.3 1.2 0.6 1.0 0.7 0.6 1.6 0.3 1.2 1.4 1.3 2.4 0.5 0.7 0.4 1.5 1.5 2.3 3.2 1.0 2.2 0.3 1.6 1.7 0.6 2.3 1.7 0.6 1.2 0.9 1.2 0.3 1.1 0.7 1.2 2.8 1.6 0.6 1.9 0.6 0.2 1.3 1.2 2.5 0.4 0.9 0.7 0.0 0.1 0.2 0.5 0.0 0.1 0.3 0.2 0.7 1.5 0.0 0.6 0.0 0.0 1.1 0.5 0.2 0.1 0.6 1.3 0.6 0.3 0.3 0.3 0.8 0.7 0.1 1.4 0.0 0.8 0.4 0.2 1.0 0.2 0.1 0.0 0.9 2.0 0.5 0.3 1.4 0.4 1.1 0.0 2.1 0.2 1.0 1.4 0.9 0.6 1.6 0.2 0.4 2.0 0.5 0.0 0.1 0.9 0.1 0.0 1.2 0.3 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 1.6 3.4 1.8 1.4 1.3 1.5 1.5 1.6 1.1 1.6 2.5 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41954018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 51.6;Cone photoreceptor cells: 83.4;Granulosa cells: 100.0;Theca cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 79.1;SK-BR-3: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 39.9 126.3 18.6 8.3 18.0 1.3 23.3 18.4 19.8 12.0 16.9 12.9 4.9 8.3 8.4 10.7 9.4 8.3 7.5 16.4 18.6 10.1 8.6 7.9 9.7 21.8 20.9 18.9 11.3 29.2 7.2 5.2 20.2 17.3 5.8 24.6 10.8 11.5 2.8 15.6 9.0 7.8 20.5 41.4 11.7 3.3 23.4 6.7 8.5 4.1 7.9 12.8 11.4 26.1 13.4 5.5 3.9 8.9 79.1 21.7 15.1 9.3 14.4 5.7 5.2 8.7 15.0 0.2 5.0 18.0 14.0 1.5 13.9 9.7 7.2 0.9 6.2 2.3 7.1 7.1 10.6 1.0 0.0 14.0 8.9 30.3 11.7 12.5 27.1 0.7 8.4 0.1 15.3 1.2 1.9 2.7 21.4 5.7 18.7 1.4 5.7 8.0 8.5 27.8 6.3 2.8 10.1 44.6 8.1 7.6 11.7 5.9 9.3 13.5 1.9 4.5 7.6 5.0 7.9 1.1 39.2 7.7 2.8 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.5 0.3 0.1 0.3 0.1 0.0 0.3 0.1 18.6 18.0 18.4 19.8 16.4 18.6 21.8 20.9 20.2 20.5 23.4 26.1 24.8 3.2 15.5 20.5 4.4 4.1 9.1 7.6 15.9 51.6 8.2 7.0 3.1 8.6 8.3 3.7 83.4 12.8 4.4 3.4 0.0 5.6 0.3 6.0 6.7 19.3 4.9 5.9 20.3 8.5 4.8 11.9 17.9 8.3 0.0 100.0 46.1 5.2 3.6 1.7 14.4 6.9 6.1 7.0 10.5 0.2 3.7 5.6 1.8 24.4 2.5 3.6 3.1 11.6 18.8 8.1 5.0 2.2 8.1 15.9 3.0 2.5 7.7 36.9 13.1 7.4 17.9 0.1 3.0 14.3 2.6 9.3 2.8 82.4 6.9 16.6 C2CD4D FAM148D ENSG00000225556 "C2 calcium dependent domain containing 4D" B7Z1M9 1 151837819-151840557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;skin 1: 2.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Enteroendocrine cells: 5.4;Granulosa cells: 11.5;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HDLM-2: 19.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (8.17e-3)" "unprognostic (5.08e-1)" "unprognostic (3.00e-1)" "unprognostic (3.60e-2)" "unprognostic (1.62e-2)" "unprognostic (9.03e-4)" "unprognostic (2.69e-1)" "unprognostic (9.66e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.84e-3)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (2.41e-3)" "unprognostic (1.51e-1)" "unprognostic (2.62e-1)" "unprognostic (3.28e-2)" 0.1 0.3 0.6 0.2 0.7 0.0 0.3 0.4 1.1 0.2 0.1 0.3 0.2 0.0 0.0 0.3 0.2 0.2 0.2 1.3 0.0 0.5 0.2 0.3 0.3 0.9 0.7 0.0 0.8 0.0 0.6 0.0 1.0 0.6 0.0 0.0 1.4 0.2 0.2 2.3 0.2 0.0 0.3 0.2 0.7 0.3 0.8 0.0 0.2 0.0 0.0 0.1 0.2 1.8 2.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 19.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.7 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 2.0 1.3 1.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 1.1 1.3 0.0 0.9 0.7 1.0 0.3 0.8 1.8 0.1 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 0.0 3.0 2.4 0.5 1.5 0.0 0.0 0.0 1.0 0.6 0.9 9.8 0.2 0.0 1.6 0.2 0.3 5.4 0.0 1.5 0.5 0.2 0.2 1.5 1.8 0.0 11.5 0.0 0.1 0.1 0.0 0.2 2.7 2.0 0.0 0.3 0.3 0.6 0.1 3.6 0.0 0.0 2.0 1.0 0.0 2.2 0.4 2.1 0.4 1.7 1.3 0.3 0.8 0.0 0.2 0.0 0.8 0.2 0.2 0.7 0.4 1.0 10.7 2.5 0.0 2.5 1.6 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 40.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 9: Intestine - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favorable (9.93e-4)" 6.5 6.7 3.9 8.4 4.0 10.8 10.5 4.3 5.4 7.6 4.0 35.3 40.8 7.7 5.1 7.4 7.6 9.3 5.6 3.8 4.0 11.5 18.1 7.8 9.6 3.7 3.7 8.3 13.3 4.8 4.2 4.8 3.8 9.1 31.5 3.0 8.6 6.5 3.3 10.7 36.8 7.4 3.8 8.0 15.8 1.8 3.7 11.5 8.5 2.4 7.7 8.1 7.0 4.3 26.6 8.4 16.5 14.8 11.0 11.2 24.3 15.3 9.2 12.4 13.4 13.8 50.3 2.7 16.4 14.7 17.3 12.1 19.7 21.8 8.4 43.5 13.0 22.8 7.1 12.9 9.4 23.5 15.7 12.6 15.1 12.4 2.8 17.1 22.9 30.1 29.9 76.1 19.2 13.7 62.0 14.4 12.7 17.1 16.1 20.5 10.8 13.3 39.6 24.8 17.2 13.2 15.0 25.7 8.8 19.6 11.0 8.0 20.3 12.8 14.6 6.6 16.7 11.4 23.0 2.8 17.1 26.9 7.1 16.3 6.9 8.9 6.3 6.9 7.0 6.1 23.8 12.3 8.8 8.6 28.0 16.1 1.4 7.5 11.2 11.6 24.8 9.4 3.9 4.0 4.3 5.4 3.8 4.0 3.7 3.7 3.8 3.8 3.7 4.3 10.5 16.0 14.6 5.2 7.7 10.8 10.2 26.7 12.0 6.9 23.6 16.0 4.1 28.6 23.2 20.2 6.2 20.9 7.6 54.0 9.8 40.8 2.6 19.8 9.5 12.2 59.2 19.7 6.4 46.4 41.1 13.4 18.3 23.3 10.1 112.3 9.7 20.4 19.8 0.0 7.3 53.9 32.6 8.7 9.3 1.7 12.8 14.5 1.8 2.8 17.9 16.0 6.2 5.5 5.8 45.9 52.5 9.8 8.8 7.4 71.7 35.7 18.6 1.3 6.6 7.6 12.3 1.9 8.6 10.8 11.6 5.7 17.5 12.4 74.2 8.0 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183668-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "parathyroid gland: 654.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039686, HPA050335" Enhanced NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Granulosa cells - Unknown function" "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.1 0.1 1.5 0.1 1.0 0.8 0.0 1.7 1.6 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.1 4.2 0.0 1.0 0.6 22.4 0.2 0.0 0.2 0.6 1.1 0.5 9.6 654.4 0.2 0.0 0.8 0.1 0.2 1.5 0.1 0.0 0.1 0.2 0.5 0.0 0.2 0.1 2.8 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 1.7 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.5 1.0 1.7 1.6 1.0 0.6 0.6 1.1 0.8 0.2 1.7 1.7 0.0 25.6 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 27.1 5.6 3.7 0.0 0.0 0.0 0.0 13.7 4.3 0.5 0.0 0.0 0.5 11.5 0.0 0.3 0.2 0.0 1.6 0.0 0.0 1.3 20.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 1.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.0 0.0 0.2 15.3 1.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.9 0.8 0.0 0.0 CBLL2 "CT138, FLJ25735, HAKAIL, ZNF645" ENSG00000175809 "Cbl proto-oncogene like 2" Q8N7E2 X 22272913-22274461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Granulosa cells - Unknown function" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512181-57536571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Peritubular cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 5.0 3.7 1.8 2.7 1.6 0.5 4.8 1.7 2.4 10.9 4.1 11.1 2.3 11.0 1.1 3.5 8.8 1.5 6.8 1.6 1.7 5.2 1.5 4.5 3.0 2.5 2.4 8.0 3.3 1.5 2.3 2.5 2.0 8.4 0.5 0.1 4.0 3.8 1.6 4.9 4.7 2.4 2.1 5.1 4.8 3.0 2.4 1.6 5.8 0.5 1.7 11.9 8.2 1.5 6.6 7.9 3.0 4.3 1.0 1.4 6.2 4.2 2.3 2.4 1.2 3.2 7.5 6.0 16.4 1.3 3.2 4.8 1.5 2.2 0.9 4.9 6.8 0.8 3.8 1.3 3.7 0.4 7.7 3.5 1.4 2.0 0.5 5.2 1.9 2.1 4.6 0.0 0.8 2.7 5.4 5.3 7.1 0.7 14.6 4.8 3.4 2.4 3.0 1.0 0.5 7.8 6.6 2.1 3.2 1.1 4.5 2.9 5.2 4.4 14.5 0.4 3.8 6.9 2.7 2.2 2.5 2.1 7.4 0.0 0.0 0.0 1.1 0.0 0.9 0.9 0.2 1.2 0.0 0.5 0.5 0.8 0.1 0.6 0.0 0.3 0.0 0.2 1.8 1.6 1.7 2.4 1.6 1.7 2.5 2.4 2.0 2.1 2.4 1.5 8.8 0.0 3.0 0.7 8.2 12.9 8.0 2.4 14.8 0.0 4.9 10.3 3.1 5.7 2.2 7.3 0.0 1.6 16.3 0.5 9.8 1.9 0.6 6.0 8.5 10.6 0.0 3.4 0.0 0.9 1.1 13.2 2.0 1.8 0.0 14.6 7.1 0.9 0.3 0.0 0.1 1.0 0.0 0.6 2.8 1.3 19.6 1.5 1.8 1.0 0.5 3.5 18.6 0.0 0.0 0.9 0.1 34.6 18.8 10.6 1.1 10.5 3.1 0.2 19.7 10.8 11.8 2.8 8.9 2.3 5.7 0.3 10.5 3.3 1.0 3.2 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259806-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "brain: 14.1;pancreas: 27.1;stomach 1: 42.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 73.4" "Low region specificity" "Detected in many" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.1 0.2 8.2 0.0 11.7 0.0 0.0 6.3 14.1 0.0 0.3 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.0 11.9 1.7 0.0 0.0 0.0 0.0 3.7 1.8 0.1 27.1 0.0 0.9 0.0 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 42.0 0.5 2.6 0.0 0.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 73.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 11.7 6.3 14.1 11.9 1.7 3.7 1.8 3.8 1.3 2.6 6.6 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 14.6 1.3 0.0 0.2 14.3 0.1 0.0 23.3 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4269771-4305353 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 20.0 52.6 5.4 8.7 12.9 20.3 13.0 0.0 13.5 26.9 0.0 40.8 17.4 26.1 7.5 12.2 22.1 2.7 51.9 14.4 1.1 9.7 1.9 17.2 5.3 9.6 0.2 14.2 24.5 9.9 23.5 12.9 2.7 20.7 10.4 0.7 10.8 9.1 1.8 12.6 25.9 9.8 7.8 19.7 12.7 4.0 0.0 3.2 20.3 0.0 5.1 26.5 19.9 4.5 0.0 0.0 152.4 0.0 10.1 0.4 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 0.4 0.0 0.0 16.2 0.1 136.6 0.0 238.8 2.5 0.7 0.0 0.0 0.0 57.0 12.6 23.8 2.4 0.0 97.0 0.0 0.0 0.8 17.0 287.9 6.8 0.0 0.0 52.8 50.8 0.0 0.0 0.0 202.7 114.2 0.0 8.1 0.0 0.0 0.0 0.0 0.0 89.6 0.0 0.0 4.2 0.0 39.3 0.0 0.0 1.4 60.7 0.0 0.0 32.3 0.0 6.6 0.4 4.7 11.1 0.0 17.1 3.1 16.3 13.8 0.4 1.7 10.4 12.1 1.1 9.4 0.0 1.1 13.6 6.8 5.4 12.9 0.0 13.5 14.4 1.1 9.6 0.2 2.7 7.8 0.0 4.5 23.9 60.9 46.6 10.1 82.9 106.8 23.9 73.4 174.2 7.6 3.4 41.8 354.3 2.8 37.4 12.9 0.0 4.0 128.7 37.5 0.0 3.1 0.8 3.3 110.8 35.7 64.8 37.2 54.1 68.3 2.7 123.6 4.6 3.6 55.8 438.5 19.6 2.2 13.0 3.3 55.2 147.7 12.2 11.9 255.3 3.3 52.5 39.3 39.2 19.7 9.8 170.0 89.6 55.3 4.0 20.7 49.4 124.1 371.2 35.8 34.4 1.4 10.3 6.5 26.3 21.4 112.6 0.8 5.1 50.9 39.6 6.3 122.6 41.5 159.7 8.4 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691187-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 62000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 476.3 143.3 132.0 119.2 142.1 105.4 327.7 148.8 135.4 367.4 126.5 353.2 148.5 305.5 132.4 208.8 249.4 264.5 343.7 128.8 247.5 112.7 227.7 256.5 146.6 210.9 178.1 303.0 234.6 46.8 132.9 194.8 216.8 270.3 152.9 15.1 184.2 258.4 163.7 284.7 210.0 226.1 224.4 186.0 209.1 199.6 139.4 562.1 152.6 168.3 129.2 296.3 314.6 227.6 259.4 276.5 308.5 424.8 1217.7 939.2 195.0 681.6 1050.1 419.2 604.8 412.3 179.1 18.3 130.0 929.4 217.5 99.4 124.1 168.4 337.5 350.8 321.2 53.1 179.5 353.4 390.1 81.7 375.0 580.1 204.9 223.7 155.6 271.8 766.4 256.3 66.4 0.9 391.9 191.2 672.3 266.8 107.5 28.6 310.0 118.7 273.2 513.5 240.7 165.4 1.0 141.2 168.7 138.2 432.6 744.9 129.6 229.4 750.2 509.7 86.1 487.1 230.2 1.0 0.8 116.1 338.1 203.1 323.8 23.6 526.0 18.3 1089.2 131.2 620.5 340.1 730.3 961.1 496.5 231.8 267.4 549.7 45.1 377.3 32.3 682.1 833.7 1421.2 132.0 142.1 148.8 135.4 128.8 247.5 210.9 178.1 216.8 224.4 139.4 227.6 297.7 64.1 68.3 20.5 172.0 250.6 207.4 274.4 138.9 5.1 66.9 48.3 86.6 112.9 88.4 71.7 0.0 223.6 507.7 68.4 13.7 145.3 8.8 180.2 279.7 387.7 80.8 136.5 0.9 138.4 189.7 604.7 116.7 188.8 230.4 1614.3 512.9 123.0 799.8 0.0 1.1 150.8 54.9 187.4 579.9 26.4 645.2 342.4 691.9 37.5 175.9 52.0 632.4 1.0 0.9 139.9 158.2 511.2 300.2 385.8 230.9 63.3 117.5 3.2 341.8 231.1 351.9 16.4 56.9 147.9 222.9 123.0 468.9 403.2 262.3 307.0 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27932879-28177946 "CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 196.0" "Cell type enhanced" "Detected in many" "Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9" "Cancer enhanced" "Detected in all" "glioma: 39.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.7;neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Cluster 10: Basophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 66.5 27.4 2.6 29.0 0.2 0.3 20.6 31.6 6.6 7.9 4.8 0.8 6.2 1.1 0.4 10.5 3.1 196.0 30.0 31.6 18.1 57.2 1.0 1.9 21.7 26.3 6.7 0.9 29.8 8.1 0.4 20.1 2.4 1.1 60.3 0.4 10.8 0.4 0.3 1.4 6.8 24.1 13.5 5.9 44.4 33.3 3.8 6.2 2.2 1.6 1.1 2.7 22.7 0.3 25.8 278.2 0.3 48.1 7.8 0.2 230.7 72.0 94.9 80.8 0.1 0.4 0.0 128.3 459.1 46.0 36.7 50.0 0.2 130.4 0.4 35.8 0.0 66.8 86.7 48.0 0.0 0.1 4.6 0.4 198.6 37.4 212.9 84.0 15.4 0.0 0.1 77.8 0.0 59.4 0.1 43.8 0.1 30.5 0.2 37.1 45.6 0.1 9.9 83.4 144.4 0.1 0.2 26.8 116.8 0.3 0.5 11.6 206.6 63.6 2.9 181.6 0.2 0.3 0.3 40.6 0.2 163.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 27.4 29.0 20.6 31.6 30.0 31.6 21.7 26.3 20.1 24.1 33.3 22.7 0.8 0.0 0.6 217.7 1.2 0.3 0.0 3.4 0.0 38.7 1.6 0.4 368.8 67.2 1.2 11.0 150.1 0.1 0.0 0.0 0.0 12.9 53.2 1.4 15.2 9.8 0.0 6.1 311.2 0.4 0.0 16.7 0.0 2.6 0.0 312.5 12.5 125.3 0.3 3.3 198.2 0.0 2.0 2.2 0.4 17.7 2.1 1.2 3.6 106.8 0.1 157.9 0.0 267.9 138.6 19.2 0.0 12.8 0.0 0.1 0.0 47.5 1.7 99.9 6.6 0.4 45.8 4.8 24.1 0.0 0.0 0.3 0.6 1.6 0.0 0.1 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "CEA cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.5;lymphoid tissue: 10.2" "Cell type enriched" "Detected in some" 10 "Granulosa cells: 150.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8" HPA043411 Uncertain NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.3 0.7 1.4 2.2 0.8 17.5 0.8 0.8 1.3 2.2 0.6 0.8 0.6 2.6 0.3 0.4 0.7 0.5 0.5 0.8 2.8 0.7 1.2 3.8 5.3 1.9 2.7 0.4 0.2 0.1 0.4 1.5 2.2 0.6 0.6 0.0 0.5 3.6 0.1 0.2 2.6 0.5 1.8 10.2 0.9 1.1 3.9 2.2 0.6 0.1 3.5 0.8 0.3 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.8 1.0 1.0 0.0 5.8 0.0 0.1 6.0 27.3 29.7 11.7 20.1 10.8 25.6 20.8 6.9 15.1 21.3 21.0 30.2 19.2 7.0 12.4 26.6 17.9 1.4 0.8 0.8 1.3 0.8 2.8 1.9 2.7 2.2 1.8 3.9 1.2 1.5 0.0 0.0 0.3 5.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.6 1.8 0.0 0.1 7.2 0.0 0.0 0.0 5.4 7.3 0.1 2.0 0.0 5.7 0.1 0.0 0.1 0.3 0.0 2.2 4.5 150.8 10.0 0.3 9.4 0.0 0.7 0.0 0.0 9.0 0.6 10.3 0.0 6.2 1.8 15.0 1.0 0.0 9.2 0.0 0.1 0.0 0.0 0.4 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.6 0.0 0.0 0.3 8.8 0.0 0.0 0.0 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45647689-45665622 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.6;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Early spermatids: 75.9;Granulosa cells: 138.1;Spermatocytes: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 9.2;WM-115: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 10000 "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.3 3.7 31.4 0.5 34.2 0.3 1.9 0.4 35.6 2.7 0.0 1.8 0.5 2.3 0.1 1.0 5.5 0.6 5.7 32.6 13.4 8.7 2.1 4.5 0.7 6.9 12.7 5.3 1.3 3.3 11.9 0.4 6.8 2.0 0.1 1.0 6.4 0.3 8.7 1.1 1.6 0.5 2.4 7.6 1.5 4.0 24.2 0.5 20.5 1.0 0.4 2.0 2.1 16.4 0.0 0.3 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.0 0.0 0.2 0.3 9.3 0.1 0.0 0.1 0.8 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.5 0.7 0.2 0.0 9.2 1.8 2.6 0.0 0.0 0.0 0.0 0.0 3.8 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 31.4 34.2 0.4 35.6 32.6 13.4 6.9 12.7 6.8 2.4 24.2 16.4 4.4 0.0 0.0 38.5 0.0 0.1 2.9 0.4 0.0 10.0 1.4 0.4 2.1 0.0 0.3 1.8 0.0 0.0 0.2 0.0 0.0 2.6 75.9 0.7 1.1 21.1 0.0 0.0 23.9 0.2 0.1 2.3 0.5 2.5 0.0 138.1 10.4 0.3 0.2 0.0 10.2 0.0 0.0 0.9 1.7 15.0 5.6 0.9 0.0 4.7 0.0 4.5 0.0 3.0 3.9 0.3 0.0 4.9 0.0 2.4 0.0 0.1 0.2 0.5 26.3 0.7 2.6 96.8 1.4 0.2 0.0 0.0 0.5 2.3 0.0 0.9 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964395-72013558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 690000 "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 18.4 13.4 10.7 5.5 17.9 0.0 11.4 16.8 11.5 10.7 6.2 11.9 0.9 16.0 3.7 6.4 12.9 4.7 14.3 9.9 12.9 7.9 1.2 7.9 1.6 27.9 18.2 20.6 4.6 1.2 4.6 8.0 19.8 11.1 2.1 2.1 6.4 14.8 17.7 8.7 5.4 17.1 14.0 2.5 14.7 18.1 17.3 4.2 5.5 9.0 1.4 9.4 8.4 25.3 15.4 16.4 8.2 20.3 36.6 14.4 0.3 32.0 30.4 19.3 12.8 14.4 30.1 0.0 21.4 37.9 15.5 19.7 7.4 21.9 15.3 0.4 5.5 0.1 27.8 13.8 18.7 0.0 0.1 19.8 24.9 19.0 25.9 37.3 5.7 0.7 4.7 0.0 20.6 0.4 0.0 0.1 3.5 0.5 5.3 0.2 9.9 0.0 26.9 15.7 0.5 8.1 24.2 0.6 24.1 9.9 1.8 3.1 11.9 23.6 27.1 39.6 65.1 0.0 0.1 0.1 17.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 17.9 16.8 11.5 9.9 12.9 27.9 18.2 19.8 14.0 17.3 25.3 23.9 0.0 1.9 14.0 0.1 2.8 4.9 6.1 13.6 0.1 4.3 8.0 10.4 5.7 2.5 7.3 0.0 4.6 0.0 0.1 3.9 9.7 0.8 20.1 24.7 5.6 0.0 0.0 0.2 2.7 2.2 9.3 2.6 17.9 1.3 26.9 13.6 0.3 0.8 0.0 0.3 0.0 2.0 0.6 1.9 3.2 20.5 0.7 8.8 4.7 0.7 6.6 0.0 26.7 27.1 12.7 0.0 21.8 0.0 4.2 0.0 3.6 2.0 0.2 6.6 26.8 13.9 1.0 2.1 7.5 2.4 1.1 0.4 5.5 0.1 1.3 CLIP3 "CLIPR-59, RSNL1" ENSG00000105270 "CAP-Gly domain containing linker protein 3" Q96DZ5 19 36014660-36033343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 158.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.9;Excitatory neurons: 24.8;Granulosa cells: 25.7;Horizontal cells: 42.1;Inhibitory neurons: 30.7;Muller glia cells: 26.9;Peritubular cells: 24.5" "Cancer enhanced" "Detected in all" "glioma: 65.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 83.3;fHDF/TERT166: 61.5;HSkMC: 93.1;hTERT-RPE1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079430 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA079430: " "unprognostic (1.91e-2)" "unprognostic (8.70e-2)" "unprognostic (1.16e-2)" "unprognostic (5.01e-2)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (3.60e-2)" "unprognostic (2.92e-2)" "unprognostic (2.55e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.80e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.56e-10)" "unprognostic (6.31e-3)" "unprognostic (1.52e-1)" "unprognostic (9.63e-2)" "unprognostic (1.09e-2)" 16.4 13.5 109.8 9.7 117.0 0.5 14.0 92.0 142.5 50.9 0.3 75.3 6.5 66.2 12.7 16.3 35.7 23.5 12.7 122.5 121.5 11.5 2.9 10.0 7.0 105.2 158.4 48.6 3.6 2.6 46.9 9.3 140.0 29.2 8.6 54.9 6.3 33.4 3.4 7.8 21.4 37.9 60.3 9.9 25.7 12.0 92.6 9.4 5.5 3.5 6.2 68.2 32.4 106.2 1.3 3.8 33.0 1.4 53.8 83.3 1.1 19.1 45.9 15.6 23.4 4.0 1.3 1.8 7.6 61.5 1.3 1.6 0.6 0.2 11.1 2.4 1.3 1.0 4.1 0.8 54.1 1.0 1.0 93.1 0.9 13.4 0.3 80.8 17.7 13.0 1.9 3.5 35.2 2.9 18.6 1.3 4.0 1.3 0.9 2.4 0.6 1.1 0.5 1.2 32.2 37.6 2.2 0.8 1.0 13.5 1.2 0.4 4.9 26.8 21.9 1.3 1.2 2.8 2.5 1.4 41.1 1.8 10.2 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.3 0.2 0.1 0.4 0.0 0.1 0.2 0.1 109.8 117.0 92.0 142.5 122.5 121.5 105.2 158.4 140.0 60.3 92.6 106.2 1.1 0.0 0.0 11.4 0.1 0.6 0.6 0.5 0.6 30.9 0.4 4.3 4.3 0.0 0.1 1.8 2.1 0.6 0.0 0.3 0.0 0.1 11.3 0.7 15.3 3.6 2.4 0.0 24.8 0.2 0.5 16.1 1.1 0.7 0.0 25.7 5.0 0.2 0.8 42.1 30.7 0.9 0.0 0.3 2.3 19.2 22.1 0.5 3.6 10.3 0.0 26.9 0.0 14.6 15.3 0.3 0.0 24.5 0.2 0.4 0.3 0.3 0.7 13.7 6.6 8.7 12.8 2.3 3.5 0.5 1.3 1.2 0.6 2.9 0.2 0.1 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 164.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013870, HPA072695" Approved Approved Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA013870: AB_1847003, HPA072695: AB_2732210" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavorable (4.42e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 49.3 16.6 15.5 25.0 14.3 20.0 32.8 15.6 28.1 40.2 9.5 16.8 7.1 30.4 16.6 10.4 25.5 32.7 26.2 15.6 18.0 19.7 10.7 35.4 32.3 24.9 15.8 38.9 7.9 29.4 10.1 44.4 19.3 23.4 12.1 3.0 17.4 16.7 6.4 22.2 18.8 27.7 17.0 36.1 11.9 59.7 19.1 35.5 16.1 13.0 20.9 34.3 26.7 20.4 6.7 33.8 93.4 66.2 68.4 42.6 59.2 17.5 78.6 34.4 34.0 18.6 21.0 0.2 47.7 49.0 59.7 7.8 63.7 57.4 27.3 34.6 23.2 21.5 4.4 53.5 92.2 65.8 77.4 85.5 4.5 36.6 7.7 141.3 78.9 59.5 34.6 0.7 42.8 7.8 53.1 108.9 45.0 0.5 31.8 164.7 65.6 3.3 16.4 0.8 9.9 33.9 8.5 0.3 58.5 59.9 0.7 59.3 54.0 48.7 58.8 12.0 21.1 4.4 0.7 21.8 30.5 50.0 53.7 7.9 14.2 9.9 9.2 13.9 12.9 2.6 10.3 10.5 12.3 0.9 8.0 9.8 8.0 8.6 8.9 24.9 15.7 5.8 15.5 14.3 15.6 28.1 15.6 18.0 24.9 15.8 19.3 17.0 19.1 20.4 38.0 0.0 7.1 0.3 12.9 14.7 33.5 10.0 6.8 0.5 12.3 25.7 2.0 4.3 6.4 5.5 0.0 10.7 101.2 0.4 0.0 28.1 2.8 4.9 56.0 50.4 12.5 12.8 0.6 6.4 222.1 62.6 2.6 6.2 91.3 140.8 44.3 1.3 119.8 0.0 0.3 0.7 8.2 74.7 77.9 9.4 39.4 78.0 28.4 10.3 61.5 10.0 82.4 8.0 0.2 41.0 0.1 24.5 5.7 40.8 0.1 4.4 3.1 0.8 6.6 26.3 36.1 4.9 8.1 1.1 8.7 9.4 68.9 10.5 0.2 21.6 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696743 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 68.0;Granulosa cells: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 4.5 5.0 36.4 2.7 34.1 2.5 5.7 32.8 34.5 3.9 28.3 16.1 11.9 4.4 20.1 6.0 10.6 2.9 4.1 43.1 37.1 26.3 4.1 8.4 0.6 42.1 41.7 3.4 19.2 32.7 14.4 2.1 35.4 7.7 12.6 7.8 11.1 3.8 3.3 7.7 12.9 3.4 41.8 2.0 31.4 6.9 45.5 0.5 38.6 2.1 1.1 3.2 4.1 41.6 16.0 12.9 7.8 19.1 2.6 4.2 31.7 6.6 5.9 3.5 5.6 24.2 17.7 0.7 10.8 3.9 4.8 20.0 19.7 7.8 5.2 1.3 17.2 1.7 5.3 15.2 5.6 1.4 3.0 6.7 13.4 4.2 8.1 11.9 2.0 2.3 8.0 4.1 5.1 18.5 0.1 3.2 8.7 28.6 8.6 3.5 10.6 4.9 15.2 14.2 17.9 7.1 27.4 14.6 9.3 5.6 15.3 3.4 4.3 6.5 7.0 1.8 6.6 1.4 3.3 0.7 8.1 3.2 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 36.4 34.1 32.8 34.5 43.1 37.1 42.1 41.7 35.4 41.8 45.5 41.6 2.6 22.4 11.1 32.7 0.8 5.2 8.8 21.9 4.6 9.5 23.5 10.8 7.1 15.7 19.3 23.9 8.4 5.0 1.6 51.7 13.7 15.9 1.9 20.7 2.7 4.3 39.0 0.8 68.0 24.0 29.6 3.5 27.5 12.3 4.5 67.6 1.8 6.1 2.4 30.3 37.7 24.1 20.3 2.8 0.9 3.0 2.5 1.9 3.6 7.5 4.4 24.2 0.0 37.7 51.3 30.8 19.5 3.0 0.6 29.0 30.7 19.9 40.0 11.1 6.6 3.1 8.8 6.4 7.7 7.5 5.5 2.9 0.9 2.5 43.4 19.4 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370321 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 47.7" "Cell type enhanced" "Detected in many" "Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BEWO: 208.4;SK-BR-3: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 14.8 12.9 6.0 3.3 5.8 1.2 15.5 4.9 6.7 5.9 5.9 7.0 7.3 4.4 17.4 3.5 8.4 3.4 13.6 5.5 5.0 10.2 41.2 17.9 3.9 6.2 5.4 1.4 47.7 12.0 3.6 17.4 6.3 11.7 7.4 1.1 19.7 6.0 4.7 9.2 6.2 2.5 5.5 1.3 14.9 1.0 7.0 9.5 13.6 5.1 4.1 4.8 3.7 4.9 10.6 10.8 2.1 13.5 9.5 14.7 208.4 0.1 0.3 1.1 1.2 15.0 14.9 0.0 21.8 0.0 0.0 5.8 17.2 3.5 0.9 0.0 31.5 6.8 2.1 25.2 0.6 2.8 5.3 28.8 10.8 1.5 10.4 5.2 8.4 11.2 0.1 0.0 10.7 7.8 8.9 1.0 4.4 16.4 9.9 12.4 2.5 2.1 13.1 12.1 3.7 3.0 1.7 59.3 5.8 2.5 17.0 1.4 7.6 0.0 15.5 0.0 3.2 0.5 0.4 0.1 0.0 4.8 3.7 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 6.0 5.8 4.9 6.7 5.5 5.0 6.2 5.4 6.3 5.5 7.0 4.9 94.7 38.5 36.3 1.0 2.8 11.6 35.2 4.6 18.8 0.1 75.4 45.6 2.2 17.2 16.1 0.0 0.0 107.6 2.3 13.7 11.7 18.1 13.0 22.1 5.6 51.9 22.2 5.7 2.2 37.0 67.5 17.7 32.1 29.2 0.0 129.9 54.7 79.5 9.8 0.0 41.6 40.7 16.2 5.3 15.0 2.4 2.5 3.6 5.4 36.5 1.2 35.6 0.0 17.6 1.0 25.8 17.7 1.2 1.4 64.9 21.3 24.3 9.9 2.7 0.0 2.2 12.3 3.5 3.7 12.1 6.5 116.2 18.6 10.9 21.0 49.7 COASY "DPCK, NBP, PPAT" ENSG00000068120 "Coenzyme A synthase" Q13057 17 42561467-42566277 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022875, HPA022912, HPA023273" Approved "Intracellular and membrane" NA NA 20000 "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068" "unprognostic (2.83e-1)" "unprognostic (8.35e-2)" "unprognostic (1.81e-1)" "prognostic favorable (2.15e-4)" "unprognostic (1.01e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.54e-5)" "unprognostic (4.06e-2)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (5.55e-1)" "unprognostic (1.62e-1)" "unprognostic (2.16e-1)" 27.4 60.0 24.0 23.1 24.0 29.5 32.8 24.7 28.1 27.6 26.7 35.6 43.3 25.2 17.2 54.4 29.8 16.9 29.4 25.4 23.9 45.6 70.9 30.3 25.0 27.8 24.7 26.0 59.0 39.0 30.3 25.5 28.1 32.4 24.3 13.3 58.5 28.7 38.6 46.6 36.9 17.2 23.8 35.9 47.2 32.4 25.7 27.6 39.0 25.3 25.2 26.8 31.1 24.6 94.2 149.1 27.2 55.2 55.5 34.8 89.2 38.3 52.9 65.8 46.5 85.7 89.2 52.7 65.6 50.4 69.5 146.9 66.1 81.4 43.7 47.6 122.2 52.5 91.2 140.9 70.2 56.4 73.1 51.5 97.8 62.4 66.6 52.4 63.2 70.5 98.7 70.8 46.6 59.2 71.5 87.2 36.7 125.8 75.1 39.1 93.5 88.1 89.9 66.7 63.3 50.1 34.9 37.3 75.4 52.2 158.0 70.4 41.6 68.3 62.3 52.4 40.1 84.6 127.4 31.0 80.9 55.3 47.5 23.3 29.8 26.8 19.7 31.8 20.5 15.8 15.8 19.1 33.6 15.7 15.7 16.3 19.5 21.0 22.5 23.6 18.1 24.0 24.0 24.0 24.7 28.1 25.4 23.9 27.8 24.7 28.1 23.8 25.7 24.6 15.4 6.4 23.8 9.8 24.1 15.0 21.7 49.5 25.6 17.8 38.2 22.9 22.9 40.0 33.3 71.7 0.0 89.4 21.2 53.7 33.2 44.8 4.4 31.5 20.6 20.6 17.4 30.3 5.6 52.5 51.6 18.7 40.2 28.0 10.2 101.2 23.9 94.2 40.3 33.7 5.7 36.7 42.7 23.6 16.1 7.7 14.9 19.9 14.2 4.7 36.2 29.4 20.6 3.5 5.9 38.9 32.4 16.6 25.3 31.2 66.3 94.8 36.5 18.0 26.3 15.2 18.6 46.7 31.1 33.4 17.8 77.2 16.9 36.6 45.1 30.7 COL4A4 CA44 ENSG00000081052 "Collagen type IV alpha 4 chain" P53420 2 227002714-227164453 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Collecting duct cells: 46.0;Cone photoreceptor cells: 56.3;Granulosa cells: 62.6;Muller glia cells: 78.6;Oligodendrocyte precursor cells: 55.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.1" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Cell line enhanced" "Detected in some" "HeLa: 34.3;hTERT-RPE1: 27.2;Karpas-707: 8.9;RPTEC TERT1: 14.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.31e-2)" "unprognostic (7.56e-2)" "unprognostic (6.65e-2)" "unprognostic (4.88e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (8.50e-3)" "unprognostic (5.14e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "prognostic favorable (2.30e-13)" "unprognostic (1.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.30e-1)" "unprognostic (4.15e-2)" 1.0 6.9 1.3 2.1 1.1 0.1 0.7 0.9 0.9 0.5 14.2 0.9 0.9 2.0 7.2 1.1 2.1 4.4 9.2 1.0 1.3 14.0 1.6 8.3 2.8 3.1 2.2 2.0 5.5 0.6 10.2 0.3 2.6 4.5 0.8 8.4 0.7 8.3 6.9 0.3 2.4 1.6 1.5 1.9 1.2 1.3 4.4 0.9 9.9 5.7 4.5 2.9 0.9 1.3 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.1 0.6 0.0 0.7 0.0 1.7 0.0 0.7 0.1 3.1 1.1 0.2 0.0 3.4 0.0 34.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 27.2 0.0 1.1 0.0 8.9 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 14.5 5.6 0.8 0.0 2.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 2.7 0.0 0.3 6.7 5.3 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 1.1 0.9 0.9 1.0 1.3 3.1 2.2 2.6 1.5 4.4 1.3 2.0 73.7 24.1 3.6 11.1 0.5 0.4 0.2 0.0 29.1 0.5 1.3 3.5 8.6 6.2 46.0 56.3 0.0 1.4 0.1 1.9 0.3 0.8 0.3 1.8 5.2 1.2 0.0 2.5 3.8 0.0 8.1 1.5 0.9 0.0 62.6 2.5 0.7 0.1 0.0 10.4 0.1 2.0 0.3 1.5 4.3 25.1 0.8 0.0 12.2 0.0 78.6 0.0 55.3 3.4 4.1 0.1 27.1 14.9 0.2 0.0 3.6 0.0 8.5 0.0 16.8 8.6 0.1 0.6 0.2 0.0 0.0 1.4 0.9 0.3 0.1 CRHBP "CRF-BP, CRFBP" ENSG00000145708 "Corticotropin releasing hormone binding protein" P24387 5 76953045-76981158 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 166.5" "Group enriched" "Detected in some" 6 "Granulosa cells: 480.8;Hepatic stellate cells: 1319.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036234, HPA046120" Approved Supported "Secreted to blood" NA NA 69000000 "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA036234: , HPA046120: AB_10959760" "unprognostic (1.41e-1)" "unprognostic (2.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.36e-3)" "unprognostic (4.44e-5)" "unprognostic (2.16e-1)" "unprognostic (7.08e-2)" "unprognostic (4.98e-4)" "unprognostic (1.09e-1)" "unprognostic (6.63e-5)" "unprognostic (2.76e-2)" "unprognostic (4.64e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-2)" 22.2 13.7 4.1 0.7 5.6 3.2 6.2 3.2 7.5 3.7 2.2 0.4 0.6 2.6 0.9 0.2 1.8 0.8 7.4 5.8 15.8 36.5 166.5 0.5 0.9 7.0 9.1 1.3 0.1 0.6 0.1 10.2 11.9 1.1 0.4 0.1 1.1 4.1 0.9 0.5 0.7 1.5 3.7 37.2 0.3 0.8 20.1 0.5 4.1 1.3 0.6 0.9 0.8 7.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 4.4 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 7.6 4.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.1 5.6 3.2 7.5 5.8 15.8 7.0 9.1 11.9 3.7 20.1 7.0 134.9 0.0 0.0 1.3 8.8 0.4 0.0 0.0 0.0 0.0 0.4 1.1 0.7 17.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 45.9 0.0 39.4 0.8 0.2 0.2 0.3 0.0 0.0 0.0 480.8 1319.7 9.9 1.8 0.0 32.4 0.0 0.0 75.0 2.1 1.0 0.3 3.8 0.0 4.7 0.3 0.0 0.0 0.5 11.1 0.0 0.0 0.0 0.9 0.0 0.0 3.6 0.0 0.0 0.0 0.1 2.3 0.5 1.9 0.1 0.0 0.0 1.7 0.0 0.0 0.1 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.3;testis: 25.7" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 16 "myeloid DC: 44.6" "Lineage enriched" "Detected in many" 16 "dendritic cells: 44.6" "Cell line enhanced" "Detected in some" "HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036198 Uncertain Approved "Nuclear speckles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.8 0.6 10.1 1.7 10.2 2.6 0.9 11.3 16.5 2.4 8.1 1.1 2.0 1.3 1.6 0.7 2.0 0.6 24.3 10.1 10.4 5.3 10.4 0.6 5.4 9.4 9.4 2.1 1.6 2.1 2.3 0.2 9.4 5.7 0.4 2.5 0.8 8.0 0.4 1.8 3.5 0.6 9.0 7.9 0.8 25.7 10.0 1.6 2.0 0.0 5.9 1.1 1.4 10.4 0.0 0.8 0.2 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.1 0.6 2.8 0.1 0.0 0.0 3.3 0.0 3.5 6.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.6 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.7 0.9 0.0 1.7 0.0 2.3 0.0 0.0 44.6 2.6 0.0 0.0 0.8 0.3 2.3 0.4 0.0 1.8 10.1 10.2 11.3 16.5 10.1 10.4 9.4 9.4 9.4 9.0 10.0 10.4 0.2 0.0 0.0 9.4 2.8 0.6 0.3 0.0 0.0 0.9 0.1 0.8 3.2 5.7 0.1 0.0 0.0 0.0 0.1 0.3 9.8 1.1 3.9 1.1 0.2 0.2 0.0 0.8 4.7 0.2 0.0 0.2 0.0 0.1 0.0 12.5 0.0 2.9 0.2 0.0 3.5 0.1 0.0 0.9 3.4 7.9 1.2 0.7 0.0 1.0 1.4 0.5 1.0 6.6 3.4 0.3 0.1 0.0 0.1 0.1 0.7 4.5 0.3 0.8 0.0 0.3 0.4 5.3 1.6 0.0 0.0 0.0 0.3 1.0 0.4 0.1 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.7" "Group enriched" "Detected in some" 13 "Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2" "Group enriched" "Detected in some" 14 "cerebral cortex: 1.2;hippocampal formation: 1.5" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124524 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "ovary: 8.0" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 140.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 10.0" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved Vesicles,Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA041269: AB_2732491, HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.5 0.7 8.0 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.8 0.5 0.6 0.5 0.7 0.6 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.1 0.0 4.6 0.3 0.0 0.1 0.9 0.0 0.0 0.0 140.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 34.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.9 0.1 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 86.7" "Cell type enhanced" "Detected in many" "Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 62.6" "Group enriched" "Detected in all" 5 "B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6" "Cell line enhanced" "Detected in many" "A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Golgi apparatus" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 19.4 12.5 20.3 8.8 15.7 11.1 7.4 4.8 18.3 18.0 0.7 4.7 3.5 7.0 5.4 31.2 11.8 16.1 35.8 16.3 11.5 6.0 2.8 11.7 7.6 6.3 11.2 57.0 7.9 11.4 3.0 38.8 7.6 31.8 2.5 2.5 6.8 9.8 5.8 4.8 4.7 12.3 6.7 8.7 6.9 2.8 8.9 11.7 86.7 11.0 8.8 23.4 8.1 10.7 2.1 57.8 0.5 0.0 9.3 2.1 7.9 1.4 32.3 0.3 0.3 3.1 1.0 0.0 0.3 0.0 22.9 0.7 0.0 0.0 0.4 7.5 0.4 0.2 16.2 1.9 4.1 0.0 0.1 0.9 1.6 0.7 0.3 0.4 11.6 0.2 0.0 0.1 0.1 2.6 2.9 0.2 0.3 8.3 1.7 0.3 0.1 0.0 39.6 1.6 0.2 0.3 17.2 6.9 2.4 1.5 0.1 0.4 1.0 1.1 1.3 36.8 0.9 0.3 0.0 0.0 26.0 3.4 11.4 0.1 2.9 24.9 5.6 0.1 0.6 44.5 25.7 8.5 2.8 15.9 44.6 11.6 15.6 8.4 0.4 4.2 62.6 11.7 20.3 15.7 4.8 18.3 16.3 11.5 6.3 11.2 7.6 6.7 8.9 10.7 33.3 3.2 1.1 494.3 27.3 4.5 7.4 0.2 0.6 0.3 4.1 0.8 45.8 0.0 0.9 12.9 10.4 1.9 6.2 0.0 1.9 5.7 6.9 7.5 1.2 38.5 3.0 3.2 144.4 1.7 14.6 20.9 2.0 2.0 0.0 214.1 26.7 0.2 15.8 18.5 76.5 0.0 16.2 27.4 6.5 7.4 5.3 14.1 12.4 224.9 3.5 1.0 6.2 355.9 4.6 3.1 0.0 12.0 21.3 21.8 0.0 0.1 1.5 1.0 6.6 2.1 12.0 0.7 0.1 0.5 3.1 8.3 9.6 77.0 0.1 2.8 CST2 ENSG00000170369 "Cystatin SA" P09228 20 23823769-23826729 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 637 "salivary gland: 5987.1" "Group enriched" "Detected in some" 4 "Granulosa cells: 5.2;Melanocytes: 16.0" "Cancer enhanced" "Detected in many" "prostate cancer: 24.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "RT4: 67.7" "CAB024963, HPA043706, HPA044763" Enhanced "Secreted to digestive system" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 15: RT4 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080" "unprognostic (1.57e-2)" "unprognostic (3.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.10e-1)" "unprognostic (1.64e-2)" "unprognostic (5.17e-3)" "unprognostic (1.28e-2)" "unprognostic (2.75e-3)" "unprognostic (2.73e-1)" "unprognostic (4.82e-3)" "unprognostic (6.43e-3)" "unprognostic (2.51e-1)" "unprognostic (4.58e-11)" "unprognostic (1.29e-3)" "unprognostic (3.22e-1)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" 1.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.1 0.2 0.1 0.0 0.2 4.8 2.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 1.6 9.3 0.1 2.0 1.0 0.0 2.5 0.0 0.0 5987.1 1.3 0.0 0.4 0.2 3.8 0.0 0.1 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 1.8 67.7 0.0 0.0 0.0 0.0 5.4 0.9 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 16.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 207.9;Skeletal myocytes: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 280.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 84000000 "Cluster 14: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 25.2 22.0 31.5 17.9 32.6 5.4 26.6 30.7 30.7 26.2 25.5 38.8 24.0 32.1 16.2 28.3 31.8 26.4 68.9 30.1 28.9 28.1 43.0 31.8 9.4 33.3 31.4 24.6 51.4 44.3 18.6 77.0 28.6 29.5 30.6 9.8 31.8 37.9 93.8 28.5 24.0 45.9 30.2 12.6 32.0 26.9 34.1 10.5 25.5 95.7 14.3 27.8 22.0 31.2 92.3 92.4 61.9 152.3 80.3 38.8 280.9 63.9 93.7 108.0 69.0 74.2 96.0 13.0 62.2 103.2 87.6 168.4 55.6 81.2 67.2 12.7 18.6 9.6 84.3 87.2 35.5 11.2 17.4 33.3 72.5 100.3 33.3 96.7 97.1 15.3 14.5 9.8 31.2 75.5 10.1 8.1 66.4 110.0 31.2 5.5 60.5 22.3 82.5 126.4 21.8 45.2 74.8 206.0 105.5 170.3 171.6 22.8 51.8 39.1 63.9 76.0 91.4 11.0 24.2 8.1 50.4 12.6 245.9 2.3 1.2 0.7 1.1 1.3 1.2 1.2 0.9 0.9 0.7 1.0 1.0 1.0 2.2 1.1 2.5 1.3 0.7 1.4 31.5 32.6 30.7 30.7 30.1 28.9 33.3 31.4 28.6 30.2 34.1 31.2 19.0 54.5 18.4 32.0 4.0 14.3 8.0 31.7 17.1 7.4 36.1 46.4 56.6 30.0 20.6 35.0 4.2 116.4 5.8 37.3 1.9 32.4 30.0 30.2 17.3 20.9 33.0 14.3 15.6 79.6 118.4 26.1 37.8 37.9 7.0 207.9 16.8 59.9 21.2 3.3 16.5 29.7 14.2 8.6 7.0 20.0 21.5 6.3 33.8 9.4 5.6 27.1 5.2 19.6 10.7 57.2 21.4 36.9 5.1 14.4 18.9 7.6 23.2 8.7 46.0 326.1 36.2 7.1 19.9 19.0 17.0 95.9 5.9 10.0 29.2 10.2 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;epididymis: 21.4" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 0.8 0.9 1.9 0.0 2.0 0.0 0.4 0.1 2.2 1.4 0.0 0.7 0.0 2.4 21.4 0.1 2.3 0.1 0.0 2.5 3.5 0.2 0.0 0.0 0.1 9.3 1.5 1.4 0.0 2.5 1.3 0.0 4.2 1.5 0.0 0.2 0.3 4.3 0.1 0.2 0.2 1.3 1.6 0.0 0.3 5.5 3.1 0.0 0.1 0.9 0.2 1.2 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.1 2.2 2.5 3.5 9.3 1.5 4.2 1.6 3.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 163.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 200.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 23.9 32.2 38.5 21.4 46.0 21.7 16.7 53.5 49.2 25.0 76.1 33.5 25.1 26.0 17.2 28.4 38.6 22.6 122.3 36.6 39.8 35.6 24.9 25.0 21.6 45.5 51.3 22.9 16.8 47.9 21.5 16.6 42.1 22.8 30.4 8.3 32.2 34.1 143.0 25.6 23.7 32.0 38.0 33.6 38.1 19.0 45.4 27.3 30.1 163.6 19.9 31.9 20.2 45.2 6.2 16.4 8.0 20.1 32.8 30.6 21.0 6.6 17.7 19.3 19.6 10.9 46.7 41.3 46.0 18.8 24.9 18.0 23.0 24.7 7.9 22.8 9.5 27.7 9.1 13.8 47.8 28.5 38.2 47.5 10.5 10.6 4.0 25.3 34.6 22.8 14.0 54.4 18.4 1.4 22.7 27.0 16.4 0.8 1.4 38.2 15.7 30.9 32.7 25.9 22.4 11.2 10.4 17.8 7.3 8.4 32.0 24.5 24.7 5.7 4.8 17.1 5.9 30.9 23.8 14.0 29.6 36.8 3.8 67.5 48.8 30.8 30.1 69.4 30.3 34.0 19.3 24.5 72.9 22.4 15.9 20.0 200.5 21.0 60.7 22.0 45.2 29.0 38.5 46.0 53.5 49.2 36.6 39.8 45.5 51.3 42.1 38.0 45.4 45.2 19.2 28.9 16.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 11.5 13.2 0.0 0.0 5.6 29.5 0.0 30.9 12.5 0.0 21.5 17.6 0.0 29.4 14.8 6.2 0.0 0.0 0.0 5.8 15.8 7.4 0.0 25.0 7.6 49.8 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 2.7 0.0 0.0 17.0 5.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 16.8 8.7 35.6 0.0 0.0 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog signaling molecule" O43323 12 49086656-49094801 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 16.7" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 17.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "spinal cord: 8.2" "Secreted in male reproductive system" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.8 0.2 0.2 0.5 0.3 0.0 0.7 0.7 0.5 0.5 0.1 0.4 0.0 0.6 0.2 0.3 0.4 0.3 0.6 0.2 0.1 0.7 0.1 0.5 0.1 0.5 0.4 0.3 0.1 0.0 0.6 0.6 0.4 0.4 0.1 0.0 0.3 0.3 0.1 0.3 0.4 0.4 0.6 0.2 0.3 16.7 0.4 0.0 0.3 0.4 0.0 0.7 0.5 0.8 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.5 0.2 0.1 0.5 0.4 0.4 0.6 0.4 0.8 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390808-147510068 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0" "Cancer enhanced" "Detected in all" "glioma: 109.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 685.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 740000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 58.4 18.6 63.4 54.4 68.6 0.8 37.5 60.3 55.8 66.1 30.4 142.1 18.4 119.9 73.9 69.0 63.4 65.1 59.2 57.0 116.0 7.7 4.4 45.2 18.1 123.7 94.2 88.0 5.5 2.7 12.7 19.8 81.8 104.6 37.6 163.8 24.5 162.0 68.7 23.8 43.3 217.6 115.2 26.4 40.9 19.9 95.2 7.1 22.4 36.0 27.0 118.0 50.6 105.1 0.5 36.1 63.9 0.1 2.3 63.3 1.6 34.1 163.0 71.4 94.4 114.5 3.1 0.0 9.6 100.1 37.4 3.7 13.1 1.4 79.1 16.3 29.2 0.1 30.0 0.2 63.1 0.3 0.2 12.2 0.6 153.8 60.3 178.7 206.9 0.0 0.0 1.3 41.1 0.3 0.2 0.6 135.9 0.2 53.7 0.2 135.1 0.5 63.0 14.2 47.1 685.4 0.3 0.3 10.8 87.9 0.5 1.0 91.1 51.6 38.5 127.0 127.3 113.9 21.7 0.2 47.5 1.4 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 68.6 60.3 55.8 57.0 116.0 123.7 94.2 81.8 115.2 95.2 105.1 59.9 0.0 2.8 101.5 0.0 9.4 3.4 1.5 2.2 14.2 8.1 6.6 7.8 1.5 4.0 0.0 331.5 0.1 0.0 0.2 0.0 9.1 16.8 0.3 4.6 62.6 6.6 0.0 11.3 8.4 0.3 79.8 3.1 1.2 1.3 261.9 57.8 0.4 1.6 5.0 12.9 0.2 24.4 1.2 11.9 19.2 42.9 3.1 19.6 5.6 0.0 28.3 0.0 83.9 0.7 13.7 0.0 205.7 0.3 10.1 0.0 0.1 2.8 125.0 0.0 23.6 40.9 1.8 3.2 3.7 8.2 0.4 1.5 49.6 0.3 4.5 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 112.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014764 Uncertain "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "HPA014764: AB_1856587" "unprognostic (1.28e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 27.8 10.7 3.6 26.8 4.5 18.4 18.3 3.9 4.4 13.8 10.4 7.7 6.4 10.5 8.3 13.7 14.6 14.9 12.4 3.2 4.3 8.6 11.3 15.3 16.4 7.0 5.8 13.8 3.8 11.1 6.0 23.1 5.6 8.5 8.0 3.5 6.9 10.2 6.9 13.8 9.0 15.0 4.6 18.6 6.4 6.1 8.5 10.3 6.6 10.7 9.7 19.7 14.3 5.9 32.7 7.0 23.6 22.2 62.0 40.7 26.5 37.6 88.2 46.4 67.4 0.2 8.9 0.9 3.3 66.3 46.4 60.8 3.3 88.7 60.1 33.9 14.6 2.2 9.8 0.3 69.0 1.5 1.7 86.8 37.4 51.5 50.0 24.0 27.7 8.3 0.8 14.4 22.4 1.0 4.4 1.8 12.7 0.2 1.8 5.6 21.6 15.6 30.4 2.2 7.8 5.9 36.4 0.1 0.8 16.2 0.3 3.9 10.5 46.4 13.4 11.8 30.6 3.1 1.1 1.6 24.6 4.0 5.5 0.4 2.0 0.1 0.6 2.5 0.3 2.0 0.5 0.3 5.9 2.1 0.6 0.3 1.6 0.1 1.6 2.7 0.1 0.8 3.6 4.5 3.9 4.4 3.2 4.3 7.0 5.8 5.6 4.6 8.5 5.9 9.4 16.0 4.1 64.9 15.4 52.0 26.4 42.2 78.6 6.3 7.4 10.7 8.3 2.8 20.7 3.7 0.0 2.9 16.5 0.3 7.9 4.8 52.2 11.0 21.9 15.4 1.2 11.4 46.8 8.5 7.0 73.7 3.6 3.1 22.8 100.9 56.4 5.7 39.8 1.7 48.9 0.6 8.2 83.6 77.1 24.9 55.0 112.2 10.6 51.5 79.4 3.4 5.2 73.4 86.4 13.6 0.4 30.1 8.9 32.0 0.4 7.7 30.3 3.0 32.9 16.4 33.4 6.1 5.5 76.6 39.9 4.9 14.0 17.2 1.0 51.0 DUSP16 "KIAA1700, MKP-7, MKP7" ENSG00000111266 "Dual specificity phosphatase 16" Q9BY84 12 12473282-12562863 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 114.9;Oligodendrocytes: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.9" "Lineage enriched" "Detected in single" 5 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "NTERA-2: 37.7;RT4: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020326 Approved Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA020326: AB_1847890" "unprognostic (8.05e-2)" "unprognostic (9.47e-2)" "unprognostic (1.49e-3)" "unprognostic (4.14e-2)" "unprognostic (9.86e-2)" "prognostic favorable (1.01e-4)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (2.82e-1)" "unprognostic (2.34e-3)" "unprognostic (6.35e-3)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (5.76e-2)" 9.3 47.8 4.9 7.8 8.3 3.6 15.0 7.7 5.3 12.2 6.3 11.3 13.6 11.3 6.2 12.7 10.5 8.0 7.2 4.8 6.0 7.6 33.3 12.0 6.4 7.3 8.1 10.7 18.8 8.0 12.9 5.5 6.2 19.7 10.9 7.5 14.6 3.4 11.3 11.1 13.1 4.9 5.4 6.8 13.2 7.1 6.7 15.2 8.8 4.7 9.0 10.7 17.0 11.8 4.5 6.5 7.6 4.2 2.8 3.3 13.6 2.6 5.8 6.4 9.1 18.1 8.6 0.4 1.4 2.9 11.3 2.9 14.1 2.4 8.6 14.4 7.0 0.7 6.8 19.2 5.4 1.3 3.0 2.8 6.7 5.1 16.3 6.8 5.0 7.3 4.0 11.8 0.4 8.6 1.7 0.9 37.7 11.1 1.9 2.0 2.6 8.6 3.6 34.3 12.3 11.5 10.6 13.6 6.7 28.2 5.5 2.2 4.5 2.9 8.3 1.8 2.9 8.3 10.6 1.5 3.8 2.9 4.0 0.0 0.0 0.0 0.5 0.0 2.3 0.0 1.6 0.7 0.1 0.0 0.5 0.3 0.8 0.0 0.0 0.0 3.9 0.3 4.9 8.3 7.7 5.3 4.8 6.0 7.3 8.1 6.2 5.4 6.7 11.8 9.6 28.9 55.5 30.3 3.3 2.8 14.9 1.5 3.4 4.8 23.8 13.1 11.5 20.0 9.7 3.7 2.1 10.5 5.6 35.7 0.0 14.3 1.3 15.1 10.2 9.2 49.6 0.0 19.5 24.6 4.1 9.9 11.7 19.9 23.5 114.9 7.5 34.2 5.3 6.7 24.8 10.0 2.0 9.4 1.9 2.3 5.9 5.7 5.4 38.4 2.9 36.8 0.0 56.3 196.3 20.9 25.3 6.8 4.3 34.3 25.4 5.2 10.4 4.8 0.0 11.1 10.3 3.0 5.8 6.2 1.8 30.1 27.9 9.9 18.7 24.5 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130233-82262734 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 6.2 7.4 5.0 8.2 5.3 8.8 9.9 4.9 5.4 7.3 6.7 13.3 11.6 7.1 7.5 8.3 7.7 7.0 7.3 4.6 5.4 8.6 9.3 6.9 9.6 5.0 5.1 4.9 6.2 14.7 4.6 6.9 5.7 7.2 16.5 7.2 6.7 6.8 11.6 9.0 12.8 8.8 4.8 7.0 8.3 11.2 5.3 16.6 7.8 12.4 10.8 8.1 7.2 6.0 9.8 24.5 18.0 14.9 11.7 16.1 11.6 28.0 33.1 19.9 26.1 12.2 16.7 24.0 11.4 21.4 25.2 24.9 47.5 18.5 31.8 21.8 23.1 26.8 20.2 9.3 18.3 17.0 18.3 7.9 28.9 20.5 46.0 23.7 27.0 30.8 20.5 10.8 23.6 14.1 22.5 13.9 16.0 17.5 12.6 23.8 26.4 13.3 14.1 29.7 15.8 16.8 17.7 20.5 21.6 30.7 15.6 15.1 22.9 28.1 18.5 71.6 28.6 13.4 54.9 20.1 25.1 32.2 10.5 23.1 5.7 14.6 8.6 8.2 6.9 9.4 8.0 7.5 7.0 9.9 6.9 6.0 1.0 6.5 9.9 3.3 7.9 4.8 5.0 5.3 4.9 5.4 4.6 5.4 5.0 5.1 5.7 4.8 5.3 6.0 4.1 3.2 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.7 3.9 0.0 0.0 4.3 0.0 0.0 7.1 5.5 0.0 3.9 6.8 0.0 9.2 5.1 1.4 0.0 0.0 0.0 6.0 4.0 2.5 0.0 9.5 5.1 16.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.4 0.0 0.0 5.5 7.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 6.8 2.9 4.9 0.0 0.0 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68829021-68842160 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" NA NA 1300000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "CAB031489: AB_631414, HPA067188: AB_2685799" "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 47.0 23.7 9.3 8.2 9.5 2.3 41.2 8.7 11.8 27.1 8.7 27.6 19.1 19.4 10.7 32.0 19.6 18.3 32.5 9.1 8.9 44.0 11.6 41.6 4.3 9.4 9.1 14.3 7.6 16.5 10.3 25.4 8.9 19.8 13.2 1.2 11.2 16.2 9.1 52.5 20.6 8.8 9.6 26.1 18.1 6.3 9.7 5.6 19.6 9.5 4.8 25.9 27.9 9.3 10.4 5.3 41.9 15.6 21.7 13.4 21.9 8.7 9.5 3.8 2.8 4.8 19.0 2.5 56.7 3.3 5.0 54.3 40.0 97.0 2.1 4.3 10.2 2.6 2.3 8.5 20.0 1.9 21.3 25.0 74.1 9.4 42.4 3.4 29.3 5.3 2.8 0.2 3.3 8.5 4.2 2.0 29.0 63.5 70.9 18.6 4.4 16.6 15.9 36.1 15.6 7.5 6.7 2.0 2.6 31.7 1.6 3.6 49.7 7.2 8.9 19.6 3.3 0.1 2.3 2.5 3.6 11.3 4.7 0.0 0.6 0.3 0.4 1.7 0.3 0.3 0.4 0.4 3.5 0.2 0.3 0.2 0.1 0.7 1.1 0.5 0.2 0.5 9.3 9.5 8.7 11.8 9.1 8.9 9.4 9.1 8.9 9.6 9.7 9.3 81.1 3.2 1.1 2.6 3.2 117.3 66.2 60.7 93.4 3.3 3.6 11.2 8.2 20.0 12.8 22.0 0.0 11.4 5.9 59.4 0.0 16.4 0.4 2.6 7.6 42.4 8.4 2.7 1.0 15.6 75.9 20.5 21.4 4.5 4.5 134.5 143.5 4.8 12.4 1.7 1.0 27.6 8.2 9.1 23.8 1.3 27.4 8.6 21.4 2.8 5.9 12.5 2.1 0.5 0.6 46.3 52.6 8.2 2.3 40.2 28.6 5.7 2.8 1.3 13.1 8.7 12.5 2.0 3.8 76.2 120.5 11.2 4.7 116.2 29.8 93.6 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164595-32168281 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Granulosa cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.2;SK-MEL-30: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 13.3 7.2 3.8 0.5 3.5 1.1 13.6 3.6 5.7 23.4 4.1 19.8 0.6 10.0 0.8 12.3 16.3 3.0 14.2 3.9 3.9 16.3 7.4 9.4 0.3 3.8 3.9 31.2 5.1 0.4 8.2 2.9 3.7 16.9 0.5 0.0 7.9 1.4 3.8 12.8 8.8 0.3 3.8 7.9 10.2 4.4 4.1 0.6 8.7 2.5 0.2 13.5 17.2 3.8 0.2 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.5 0.0 0.3 3.2 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.7 0.5 0.0 0.0 0.6 1.0 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 3.4 0.0 1.0 0.7 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 5.7 3.9 3.9 3.8 3.9 3.7 3.8 4.1 3.8 1.2 6.4 4.1 0.0 0.3 1.5 0.6 0.3 4.6 1.5 0.5 0.3 0.1 0.0 1.6 1.8 2.1 0.8 0.6 0.2 0.0 0.4 0.1 1.0 1.9 1.7 0.0 1.7 0.0 0.2 0.4 1.5 4.6 1.3 0.0 10.4 3.3 0.3 0.2 0.0 0.0 1.1 0.0 0.6 1.6 0.2 3.7 0.7 0.0 0.0 0.0 0.9 3.1 0.0 0.0 0.3 0.2 1.2 2.1 0.7 0.4 0.1 1.6 1.5 0.0 2.0 1.5 0.5 0.4 4.0 2.3 0.8 0.9 1.5 1.3 0.5 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130063955-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 34.3;Granulosa cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 15: RT4 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Nucleoplasm "HPA058595: AB_2683768, HPA060277: AB_2684239" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.42e-4)" 12.2 3.7 1.8 14.6 1.6 53.1 9.6 2.8 2.0 9.4 2.6 18.1 14.2 10.6 2.0 11.7 12.1 9.3 5.6 1.8 2.4 6.0 2.8 15.9 18.3 2.8 2.4 17.5 2.6 4.8 4.2 23.7 2.4 6.1 17.7 0.6 5.5 4.1 2.0 10.9 17.0 10.6 1.5 18.1 20.3 2.6 2.9 19.6 3.9 3.6 18.0 18.8 9.1 3.1 56.0 20.7 3.7 0.4 9.1 19.3 52.6 25.3 32.1 30.4 33.4 28.7 38.9 28.6 49.5 34.8 42.3 35.2 20.5 30.0 29.9 31.0 16.8 56.7 27.3 13.6 20.2 49.7 69.3 20.4 32.6 49.1 48.0 19.0 30.0 6.5 22.0 7.7 16.5 32.8 8.2 28.2 2.4 28.4 19.4 17.6 6.5 12.2 18.3 63.9 13.6 6.0 22.8 21.9 6.9 19.1 11.0 46.9 27.6 21.2 16.6 39.5 47.7 4.2 1.8 22.6 24.6 44.8 5.0 1.6 4.0 5.8 7.1 7.6 5.6 2.6 4.2 6.1 4.5 2.7 4.2 4.8 6.9 6.5 5.5 2.7 4.8 4.2 1.8 1.6 2.8 2.0 1.8 2.4 2.8 2.4 2.4 1.5 2.9 3.1 10.7 9.6 4.4 0.0 8.0 13.6 8.2 2.9 9.1 0.0 2.1 1.5 0.8 0.0 4.4 0.0 0.0 10.6 12.2 24.1 0.0 2.3 0.1 8.9 3.8 8.4 9.0 7.4 0.2 4.0 34.3 6.4 17.9 17.1 1.3 27.5 6.4 1.0 9.7 0.0 0.3 8.3 2.0 12.2 9.2 0.6 1.8 14.8 3.6 5.6 13.1 0.0 16.5 0.0 1.2 9.1 17.4 1.2 2.0 7.5 11.6 0.3 5.4 0.0 6.6 2.6 2.5 0.0 4.0 6.5 10.4 11.2 9.5 5.2 7.1 18.9 ELK1 ENSG00000126767 "ETS transcription factor ELK1" P19419 X 47635521-47650604 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 251.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003808, HPA036084, HPA064381" Enhanced Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 10: Brain - Neuronal signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250" "unprognostic (2.25e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (1.40e-2)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (2.59e-3)" "unprognostic (1.17e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.02e-1)" "unprognostic (2.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.67e-2)" 16.8 30.7 71.7 12.4 53.1 13.7 12.0 37.1 62.5 15.0 19.9 12.8 9.0 17.0 17.4 15.0 18.6 10.1 19.3 58.5 32.8 12.6 26.4 16.2 12.3 26.7 26.2 54.2 12.9 17.0 12.7 9.2 27.5 15.4 9.6 7.7 13.1 11.2 32.9 15.2 12.9 10.9 23.4 18.9 13.6 21.2 52.2 12.9 10.5 18.5 12.3 14.8 11.9 40.6 35.6 27.2 14.3 39.1 23.3 26.5 19.8 31.1 34.9 34.8 34.5 19.3 26.4 29.0 16.1 31.0 59.9 21.2 37.6 31.7 31.5 31.1 34.8 23.4 25.0 17.9 49.3 26.3 39.4 27.9 27.2 53.4 33.5 28.8 20.8 40.4 47.9 32.9 27.8 46.5 28.2 30.8 33.7 16.7 59.1 30.0 36.0 45.8 19.7 15.3 31.0 25.6 48.5 17.8 43.4 31.8 44.7 16.7 16.1 39.5 41.2 53.9 29.2 53.5 83.2 27.8 44.5 45.3 25.0 1.7 6.3 2.8 5.3 7.2 6.4 5.2 6.8 6.3 9.5 4.6 5.7 5.0 3.1 3.4 6.5 6.5 9.8 5.6 71.7 53.1 37.1 62.5 58.5 32.8 26.7 26.2 27.5 23.4 52.2 40.6 10.1 0.0 6.7 4.2 12.0 16.8 14.3 7.5 15.9 15.2 15.0 10.4 9.0 5.7 5.3 7.3 4.2 7.7 6.3 7.5 5.9 7.6 4.0 8.0 13.3 9.8 10.2 14.9 7.7 7.3 9.6 18.0 6.6 9.2 8.2 251.8 20.3 14.6 10.3 5.0 5.7 7.8 4.1 9.5 19.0 3.3 14.0 15.0 7.2 2.8 16.8 9.0 6.2 5.0 2.9 7.1 5.6 29.7 10.3 12.8 4.6 6.3 2.1 7.2 6.6 18.7 20.0 2.6 11.1 12.3 15.9 8.9 11.1 48.8 10.0 11.8 EML5 "EMAP-2, FAP16, HuEMAP-2" ENSG00000165521 "EMAP like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;ovary: 17.4;retina: 9.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Excitatory neurons: 79.5;Granulosa cells: 98.7;Inhibitory neurons: 106.8;Oligodendrocyte precursor cells: 98.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 17.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 11.5;SH-SY5Y: 23.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 41.5" "HPA054019, HPA055379" Uncertain NA NA "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.4 3.8 3.3 0.7 2.8 0.3 0.8 17.7 2.8 0.7 0.0 1.3 0.2 0.4 0.2 0.8 1.1 0.1 0.2 3.4 2.4 1.4 1.6 0.6 0.2 0.5 5.5 17.4 0.9 2.4 3.9 0.0 1.5 4.4 0.3 9.5 0.8 0.2 0.1 0.5 0.8 0.2 0.3 0.9 0.6 2.7 2.7 0.7 1.6 0.1 0.6 0.8 0.5 1.1 1.3 0.5 0.0 1.0 0.0 0.0 2.6 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.2 3.5 4.1 0.1 0.1 2.2 2.2 1.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.5 11.5 0.1 1.2 2.9 0.0 0.2 0.4 1.0 1.4 0.0 0.4 0.1 3.1 3.9 23.8 1.1 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.7 4.7 1.0 3.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 17.7 2.8 3.4 2.4 0.5 5.5 1.5 0.3 2.7 1.1 0.2 0.0 5.8 31.3 3.5 0.5 1.0 0.0 0.6 28.2 2.0 0.9 1.5 1.5 1.3 0.0 60.5 0.2 0.7 1.2 0.0 0.9 3.1 2.0 1.2 0.8 10.7 2.1 79.5 0.4 0.1 1.2 3.1 1.9 1.3 98.7 0.0 0.1 0.0 20.2 106.8 0.3 0.0 0.0 0.0 2.9 0.6 0.3 3.6 17.8 0.2 3.6 0.0 98.0 34.5 0.3 1.1 1.2 4.5 5.7 0.0 0.4 4.6 30.1 0.0 1.9 7.4 13.6 8.1 1.5 0.4 0.1 1.7 5.1 0.1 0.6 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 15000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 26.3 20.2 30.3 16.5 25.9 0.5 13.4 21.1 20.3 13.5 2.0 30.9 12.5 23.6 13.7 16.2 15.0 23.6 25.2 27.2 35.7 7.0 7.5 17.3 4.7 35.5 34.2 22.6 22.3 17.9 6.5 18.2 28.1 21.4 10.1 8.1 20.9 30.6 20.4 10.6 10.8 57.6 22.4 24.8 23.3 25.0 40.9 9.0 7.3 11.5 4.6 30.1 13.8 28.7 91.6 71.9 87.1 79.0 33.3 43.7 111.9 99.1 47.3 58.4 43.9 46.4 33.0 38.7 256.8 153.9 52.5 79.0 102.7 37.4 55.2 0.6 63.4 40.3 62.4 63.1 99.4 4.8 1.5 67.9 44.2 75.9 96.2 47.8 47.0 10.7 2.7 1.9 58.6 17.7 18.5 4.7 146.8 23.9 64.3 27.6 122.9 1.1 26.9 69.5 85.3 68.9 194.6 73.3 63.3 66.1 87.5 5.9 92.2 150.4 109.8 126.8 198.6 4.2 11.4 25.7 82.7 5.0 78.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 30.3 25.9 21.1 20.3 27.2 35.7 35.5 34.2 28.1 22.4 40.9 28.7 117.0 12.8 37.3 81.9 3.8 129.0 172.5 64.4 26.2 11.2 96.2 57.9 119.3 54.3 56.5 22.0 62.6 65.0 1.7 14.8 3.9 84.7 74.8 127.2 60.5 79.3 41.4 0.0 86.3 100.5 18.5 71.6 63.2 75.0 5.1 194.2 23.9 12.9 11.2 16.8 155.0 27.3 26.4 1.6 29.7 24.3 58.1 4.3 83.6 41.2 3.8 32.6 3.1 160.4 151.3 61.5 16.5 168.9 1.6 133.1 3.5 19.6 137.8 19.0 92.1 69.4 166.1 13.4 37.2 25.6 134.1 60.5 4.8 220.7 31.3 100.3 ENDOD1 KIAA0830 ENSG00000149218 "Endonuclease domain containing 1" O94919 11 95089846-95132645 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 194.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008932, HPA010517" Enhanced Approved "Nuclear membrane" "Secreted - unknown location" NA NA 5200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" "HPA008932: AB_2262252, HPA010517: AB_1852351" "unprognostic (8.81e-3)" "unprognostic (1.92e-2)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (2.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (2.84e-1)" "prognostic favorable (6.64e-7)" "unprognostic (5.92e-2)" "unprognostic (2.35e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (3.27e-4)" 21.9 17.3 32.6 10.7 56.4 5.8 16.7 48.0 38.5 22.2 12.8 34.7 10.8 17.6 15.1 24.7 18.5 15.8 13.1 30.3 43.2 24.3 5.9 13.9 10.2 48.2 49.9 14.6 5.7 36.3 14.9 15.9 55.8 47.5 38.6 3.4 17.1 28.3 52.3 30.1 19.4 20.8 43.4 32.5 10.3 10.3 47.4 4.0 16.2 34.7 8.8 13.6 23.4 77.9 3.7 5.8 7.0 4.3 194.4 61.9 29.3 27.2 6.0 7.2 7.4 28.3 48.8 26.4 32.7 21.7 16.0 36.0 6.9 37.3 2.8 21.3 5.2 57.4 2.6 12.1 21.3 10.7 71.0 56.3 47.6 4.1 13.3 48.5 24.9 24.8 11.8 16.7 26.8 9.9 4.5 0.4 1.6 41.2 18.2 19.5 0.0 11.1 21.0 30.6 3.7 2.9 11.5 11.4 21.2 9.6 11.6 2.9 17.9 38.6 11.3 26.1 11.7 13.8 11.0 2.2 11.7 5.6 87.8 1.2 0.8 0.6 3.6 2.2 3.4 4.6 2.3 3.1 1.9 4.7 1.9 2.3 0.4 2.2 3.9 0.8 1.5 4.2 32.6 56.4 48.0 38.5 30.3 43.2 48.2 49.9 55.8 43.4 47.4 77.9 34.1 9.6 19.4 22.9 15.6 8.0 18.9 14.9 7.4 2.4 8.4 15.9 10.9 20.0 16.2 11.0 0.0 3.6 9.9 99.5 1.9 5.5 2.7 7.1 13.8 32.4 16.2 29.9 24.9 8.9 7.8 16.9 10.2 22.9 14.5 93.4 43.2 3.9 3.1 0.0 30.2 22.2 8.2 3.4 4.9 4.4 10.2 15.6 28.4 16.9 4.3 2.2 23.7 19.1 122.9 7.9 44.5 15.1 3.3 17.7 26.9 9.2 5.8 0.8 39.5 15.9 34.5 0.4 2.5 27.8 12.5 12.4 8.8 18.5 21.0 8.8 EPDR1 "EPDR, MERP-1, MERP1, UCC1" ENSG00000086289 "Ependymin related 1" Q9UM22 7 37683843-37951936 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 95.5;Peritubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-937: 122.2;WM-115: 114.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026298, HPA072321" Enhanced "Secreted in other tissues" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "CAB026298: AB_425991, HPA072321: " "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (4.44e-3)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic unfavorable (6.97e-4)" "unprognostic (2.53e-2)" "unprognostic (2.75e-1)" "unprognostic (3.13e-1)" "unprognostic (7.23e-2)" "unprognostic (1.85e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (4.13e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.00e-4)" 23.1 40.3 46.3 4.2 41.4 4.5 11.3 38.4 82.3 38.5 27.3 10.5 13.4 41.7 13.6 8.4 28.1 10.1 27.4 45.4 67.5 16.4 10.9 27.1 4.9 81.9 50.4 34.0 9.4 8.0 9.4 4.9 83.2 34.5 8.4 14.3 13.8 41.0 122.9 3.2 13.2 29.9 50.9 17.2 5.7 13.0 58.5 11.4 31.0 72.1 3.0 8.8 17.0 38.9 0.2 77.9 6.4 0.1 57.9 20.8 0.1 5.9 0.0 3.0 9.1 7.7 5.1 0.0 84.2 86.0 88.7 0.2 1.8 0.7 0.0 0.1 9.8 34.9 10.2 49.5 0.5 29.1 0.2 35.1 0.0 21.1 0.4 20.0 0.0 34.3 0.0 25.2 51.6 5.1 11.3 25.1 24.0 0.0 11.6 35.2 22.3 30.6 47.3 19.3 8.4 29.3 0.0 3.8 28.2 15.3 0.1 20.4 0.0 16.6 27.8 46.6 36.7 33.8 15.4 0.5 75.5 122.2 114.7 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.8 0.0 2.2 0.0 0.1 46.3 41.4 38.4 82.3 45.4 67.5 81.9 50.4 83.2 50.9 58.5 38.9 6.4 32.1 46.2 12.7 1.4 1.3 7.8 3.5 1.2 5.7 1.1 10.5 20.7 7.2 12.7 1.8 0.0 0.5 6.8 5.1 17.6 10.0 0.3 5.5 31.8 2.4 3.6 25.6 36.9 8.0 0.2 15.0 1.5 5.9 2.5 95.5 7.5 10.7 3.1 11.8 39.3 5.1 0.0 1.6 2.0 2.1 28.3 3.1 28.4 14.0 14.2 13.3 2.1 24.6 13.0 19.7 6.9 98.9 0.2 14.6 19.3 14.8 5.7 7.2 6.6 46.4 23.9 0.3 1.8 0.5 0.3 0.1 1.2 28.7 6.4 2.6 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104" "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 6.8 13.0 10.5 6.9 10.3 4.8 6.5 8.4 11.7 7.5 8.4 7.5 4.9 9.7 3.2 6.3 8.0 4.1 7.0 10.8 9.3 7.6 9.0 5.8 5.8 10.6 9.9 7.8 7.7 7.7 9.7 4.5 9.6 6.7 4.0 3.1 7.3 6.7 11.7 7.2 6.6 6.9 8.1 8.1 7.5 13.9 10.1 5.3 8.4 6.3 5.2 7.5 5.9 8.9 28.0 13.3 27.1 38.4 16.3 19.4 15.2 38.8 27.4 50.2 40.2 32.6 18.6 10.0 21.6 39.9 19.1 14.0 19.1 32.9 18.5 24.4 31.8 16.9 26.8 35.4 33.3 27.1 28.4 22.4 5.6 55.8 31.9 28.2 29.1 28.8 41.8 10.9 34.8 14.7 16.1 17.9 12.7 27.2 24.6 30.3 19.4 8.3 14.0 24.9 15.8 17.1 34.2 23.9 13.6 20.6 22.8 35.4 37.9 46.4 25.3 19.9 88.0 24.9 15.8 14.2 13.8 16.4 21.2 0.0 17.2 6.5 9.1 18.0 11.9 9.1 8.9 8.9 21.8 6.5 8.2 8.7 0.5 15.6 14.9 10.4 9.8 12.1 10.5 10.3 8.4 11.7 10.8 9.3 10.6 9.9 9.6 8.1 10.1 8.9 4.2 6.4 3.4 6.2 5.8 6.2 5.5 8.6 4.6 0.0 6.1 4.3 6.7 8.6 8.7 5.5 0.0 10.5 4.1 5.9 13.7 10.7 4.7 3.3 4.5 5.5 7.2 5.5 2.9 8.2 12.1 6.8 6.1 3.8 0.0 34.1 7.9 12.3 11.5 0.0 3.1 8.5 4.1 8.2 4.2 2.8 6.5 6.3 3.6 1.0 4.2 0.0 5.2 5.0 1.4 8.1 3.1 7.9 7.5 4.2 4.1 13.0 7.5 0.0 0.0 3.5 9.9 30.5 13.1 5.1 5.7 4.8 4.7 29.1 8.8 3.2 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 6.1" "Cell type enhanced" "Detected in many" "Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 6.1" "HPA068406, CAB079300" Enhanced Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Vesicles "CAB079300: , HPA068406: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 1.5 6.1 1.2 1.2 0.6 1.0 0.9 3.0 0.8 1.4 3.5 0.9 1.0 1.2 0.4 0.7 1.0 0.5 0.6 0.5 0.9 1.5 0.7 0.6 2.1 0.7 0.6 5.4 2.1 0.1 0.8 0.2 1.0 1.5 1.0 2.0 0.8 0.2 1.4 1.0 1.3 0.3 0.3 1.8 1.0 5.7 1.7 2.5 0.6 0.2 1.6 1.1 0.6 0.9 0.8 0.4 0.7 0.6 0.0 0.1 1.5 0.2 0.0 0.1 0.1 0.3 0.9 3.1 0.1 0.1 0.4 1.0 0.8 0.0 0.1 0.7 0.4 0.3 1.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 1.1 0.5 4.2 0.2 0.8 0.5 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.3 2.2 0.6 0.4 0.2 1.1 0.4 0.7 0.1 0.5 0.4 1.0 0.2 0.1 9.8 3.1 16.4 0.2 0.1 0.8 0.3 0.1 0.5 0.3 0.2 0.2 0.5 0.2 0.4 0.0 0.7 0.4 0.3 0.6 0.2 0.3 1.1 0.2 0.1 1.2 0.6 3.0 0.8 0.5 0.9 0.7 0.6 1.0 0.3 1.7 0.9 0.9 6.4 0.0 6.8 5.5 0.3 2.2 0.4 2.8 1.6 0.3 0.1 0.9 4.3 0.9 0.0 6.2 0.7 5.2 0.1 0.0 0.3 61.4 3.5 0.9 3.0 0.0 0.4 12.4 0.7 0.5 2.2 0.0 4.9 1.3 26.6 1.1 0.1 0.1 0.0 17.9 0.8 0.0 0.0 0.3 93.7 0.9 0.2 1.8 7.5 0.1 0.9 6.2 10.6 7.6 0.5 0.1 1.2 16.6 3.8 0.4 0.1 1.7 35.6 0.0 1.5 1.4 28.0 1.4 0.5 0.1 1.1 3.0 16.4 0.8 1.8 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 12.5" "Cell type enhanced" "Detected in many" "Early spermatids: 57.8;Granulosa cells: 39.0;Theca cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059961 Approved Uncertain Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 2.3 1.8 2.1 2.6 1.9 5.8 1.2 2.7 3.5 1.7 4.0 1.8 0.9 3.8 1.8 1.8 2.5 1.8 1.5 2.0 2.0 1.5 1.8 2.1 4.3 2.1 1.7 12.5 0.7 1.5 1.5 1.6 1.8 1.8 1.6 5.7 4.0 1.6 1.6 1.7 1.4 3.1 1.7 3.9 2.8 6.1 1.7 4.3 1.6 1.4 2.2 2.0 1.1 3.3 1.1 1.3 4.1 4.2 1.0 1.6 2.4 3.6 3.1 3.2 4.3 3.0 4.2 1.4 5.3 1.5 6.8 1.6 3.4 1.3 2.3 3.7 1.4 2.5 15.3 1.3 1.2 3.8 2.1 1.6 0.6 3.1 1.9 2.0 2.7 11.0 10.8 8.1 2.3 6.5 3.9 3.1 2.2 1.1 3.1 6.7 2.8 3.2 1.0 0.9 1.6 2.8 2.2 0.6 3.4 2.9 1.0 1.0 0.8 1.9 1.2 2.9 2.3 3.0 3.0 6.1 2.6 4.2 2.1 1.8 1.2 3.5 1.1 1.4 1.2 2.3 1.3 1.7 0.9 1.6 1.6 1.4 2.1 2.2 3.0 3.3 1.2 0.9 2.1 1.9 2.7 3.5 2.0 2.0 2.1 1.7 1.8 1.7 1.7 3.3 2.9 6.4 4.5 14.7 4.8 1.3 2.1 1.8 0.0 4.1 1.9 1.9 2.1 0.0 2.9 1.8 14.6 1.7 2.9 1.7 1.9 1.3 57.8 4.4 3.9 6.5 1.2 6.9 6.7 1.8 2.7 4.3 6.6 6.9 12.7 39.0 7.5 0.9 2.2 3.3 7.0 3.0 0.0 4.1 3.0 9.6 4.1 3.4 3.6 12.2 3.8 3.8 3.1 11.1 12.1 1.9 1.7 2.2 5.9 1.5 4.5 1.7 8.8 14.1 0.0 3.2 3.9 10.4 2.6 1.5 1.1 1.9 11.7 35.5 1.8 2.8 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 15.6 22.7 42.8 5.4 51.1 3.2 13.5 25.0 57.6 17.3 20.5 26.4 7.5 19.1 5.0 13.2 20.6 10.2 29.6 68.2 39.2 13.3 5.5 16.9 4.4 29.5 27.5 24.1 13.7 14.5 54.8 5.8 29.9 17.0 3.7 4.8 10.8 12.3 17.3 30.1 13.8 10.0 22.5 10.7 16.6 16.4 38.8 3.1 12.8 18.0 2.9 17.1 15.2 40.1 14.5 6.1 9.5 16.3 12.1 10.2 8.8 6.5 13.7 9.6 7.5 4.7 5.1 2.1 25.9 6.0 20.7 13.5 0.0 11.8 5.8 15.7 16.0 0.1 9.4 10.2 12.4 0.3 10.8 7.3 1.9 8.4 19.2 9.2 19.4 9.7 3.2 2.1 3.3 11.3 5.6 0.3 16.1 8.7 11.8 10.4 4.0 14.0 9.8 0.5 28.2 29.3 4.1 10.5 14.7 5.9 31.9 3.3 20.2 12.1 9.3 9.9 20.0 22.9 15.4 1.5 38.5 2.1 8.3 1.5 3.8 4.8 1.1 4.9 1.2 1.4 0.8 1.1 4.2 1.4 0.9 1.1 8.3 1.2 2.7 1.7 1.7 2.2 42.8 51.1 25.0 57.6 68.2 39.2 29.5 27.5 29.9 22.5 38.8 40.1 15.5 6.4 5.0 13.7 5.5 11.1 20.0 6.1 5.7 24.0 8.0 11.0 7.6 14.3 4.1 14.7 14.6 9.0 4.6 11.6 1.9 6.0 4.4 6.5 10.5 11.5 9.6 6.1 30.8 3.5 3.5 9.7 5.1 11.0 7.0 55.9 13.6 1.4 7.9 23.5 16.6 7.5 6.1 5.7 14.2 2.5 18.6 7.7 1.8 11.2 9.6 13.1 6.2 6.6 11.9 10.7 9.6 20.7 2.5 15.2 15.7 3.4 15.8 15.9 6.6 13.0 14.4 12.9 7.1 3.5 14.6 33.2 5.0 20.0 8.7 15.9 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.7;testis: 31.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 2.9 2.0 3.8 13.8 5.6 21.7 1.7 3.6 6.3 1.4 1.8 2.4 2.7 1.5 0.3 1.7 1.3 3.1 26.5 5.1 3.7 1.6 1.5 6.1 24.5 5.6 4.1 1.4 1.1 1.1 1.2 5.3 4.9 1.4 1.6 4.6 2.7 0.9 53.7 1.2 8.9 1.8 4.6 21.6 3.8 31.9 5.8 21.1 1.6 20.2 14.9 3.5 1.1 5.7 0.7 0.3 2.5 5.6 1.7 0.5 39.3 0.3 0.3 0.5 0.2 0.3 0.2 17.1 0.2 0.3 0.8 0.1 16.0 0.2 0.1 4.4 1.4 38.6 0.6 0.3 0.6 38.7 1.5 0.4 0.8 0.0 0.1 0.5 22.2 10.8 13.8 4.7 0.5 6.0 1.7 60.7 2.6 0.3 0.6 4.0 2.3 23.7 0.2 0.1 1.5 2.1 2.3 0.8 2.4 0.9 1.4 53.5 0.6 2.3 2.4 1.3 0.1 3.4 1.9 9.7 0.3 35.9 0.6 0.5 9.7 17.6 9.2 12.6 7.4 14.2 8.9 10.1 6.0 15.9 11.0 9.3 9.8 3.1 9.9 2.7 9.5 8.7 3.8 5.6 3.6 6.3 5.1 3.7 5.6 4.1 4.9 4.6 5.8 5.7 3.2 0.0 1.5 0.0 15.5 0.9 0.0 0.0 0.0 55.7 0.4 0.5 17.6 0.0 0.0 1.8 0.0 1.1 19.0 0.0 0.0 0.1 90.6 0.1 0.2 6.8 0.0 3.4 5.0 0.0 37.6 3.1 0.5 0.1 1.3 167.2 6.4 0.5 25.7 0.0 1.7 0.0 0.0 21.7 10.6 120.3 5.0 14.8 1.8 15.9 15.6 0.8 30.9 1.0 0.1 0.1 0.0 3.4 12.0 0.0 0.0 0.2 0.0 1.8 0.0 0.6 6.3 2.2 1.2 0.0 0.9 1.4 17.4 1.0 0.0 0.1 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.4;pituitary gland: 6.4" "Cell type enhanced" "Detected in many" "Granulosa cells: 17.5;Proximal tubular cells: 10.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.5 0.7 0.9 0.4 2.2 0.5 1.0 0.2 5.4 2.2 0.0 1.4 0.8 2.3 0.4 0.6 2.4 0.5 0.9 2.6 0.1 1.1 0.3 0.8 0.3 2.0 0.0 3.7 0.9 0.4 6.4 0.1 0.1 2.4 0.0 1.7 0.8 0.3 0.8 1.0 0.6 0.1 0.0 0.6 0.7 0.5 0.5 0.1 1.3 0.0 0.0 1.2 1.5 0.0 0.2 1.2 0.0 2.5 0.0 0.4 1.0 2.0 0.2 0.6 0.3 0.7 0.5 0.5 0.1 0.1 0.7 2.2 0.4 0.7 0.2 0.2 0.3 0.1 0.3 0.3 1.1 0.9 0.9 0.1 0.2 0.2 1.7 0.4 0.1 0.9 0.8 0.7 0.0 1.1 0.0 0.6 0.8 0.7 0.2 0.7 0.5 0.1 0.1 0.6 2.1 0.4 0.2 0.2 0.3 0.2 1.0 0.0 0.0 0.4 0.4 1.8 0.5 0.2 0.6 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.2 5.4 2.6 0.1 2.0 0.0 0.1 0.0 0.5 0.0 1.2 3.2 1.8 0.7 0.9 1.1 3.1 1.0 3.4 2.1 4.7 5.0 0.5 8.6 3.0 1.8 2.1 1.5 0.4 0.8 5.9 5.1 5.8 4.7 2.3 1.6 4.2 1.3 0.3 1.8 1.6 2.6 1.5 1.5 1.3 17.5 2.5 1.3 1.9 1.7 0.3 1.5 0.0 1.3 0.6 6.2 1.8 0.7 3.6 0.0 0.1 2.7 4.1 0.0 0.1 3.5 0.3 2.6 0.1 7.0 0.8 10.3 8.5 1.7 0.0 3.3 2.1 0.9 0.8 3.8 1.3 1.1 0.8 2.3 2.4 1.8 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.1;Muller glia cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;HDLM-2: 7.6;NTERA-2: 17.6" HPA060078 Approved Nucleoplasm,Nucleoli NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.4 2.0 3.3 1.2 3.9 0.4 0.3 1.4 3.8 0.5 0.0 0.4 0.8 1.6 1.3 1.0 1.4 2.3 1.8 4.0 0.7 0.7 0.1 1.3 1.0 0.0 0.0 4.2 1.7 0.3 1.9 0.6 0.0 1.5 0.1 4.4 2.0 0.7 0.7 2.0 0.5 0.4 0.0 0.8 0.6 1.8 0.0 0.1 2.5 0.1 0.4 0.3 0.4 1.3 0.0 0.0 0.7 1.2 0.2 0.0 4.9 0.3 0.4 0.1 0.0 0.0 2.0 0.3 0.8 0.1 0.2 0.0 3.2 0.0 0.0 7.6 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.4 1.2 0.2 0.1 2.2 0.2 0.7 2.8 0.4 0.0 1.0 0.1 2.5 17.6 0.0 0.0 0.2 0.1 0.0 1.1 0.4 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.7 0.0 0.2 0.1 0.3 2.8 0.0 1.8 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 3.9 1.4 3.8 4.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.6 0.4 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.5 0.1 0.2 0.2 0.0 0.4 1.4 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.4 0.0 0.3 0.0 1.2 0.5 0.0 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.1 1.3 0.0 0.5 0.4 0.5 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.4 0.6 0.1 0.0 0.1 0.0 0.4 0.1 FAT1 "CDHF7, CDHR8, FAT" ENSG00000083857 "FAT atypical cadherin 1" Q14517 4 186587794-186726722 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 119.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 285.7;LHCN-M2: 206.7" "Low region specificity" "Detected in all" "HPA001869, HPA023882" Enhanced "Intracellular and membrane" NA NA 4600000 "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA001869: AB_1078818, HPA023882: AB_1848429" "unprognostic (1.98e-1)" "unprognostic (4.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.86e-1)" "unprognostic (1.53e-2)" "unprognostic (5.82e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.15e-3)" "unprognostic (6.80e-2)" "unprognostic (3.57e-2)" "unprognostic (8.03e-3)" "unprognostic (9.41e-2)" "unprognostic (6.25e-3)" "unprognostic (4.27e-2)" 20.1 1.3 14.5 7.2 20.2 0.8 21.9 31.1 12.4 20.0 119.2 35.0 25.9 23.4 16.0 13.3 9.8 23.5 24.8 14.3 27.0 22.1 10.0 12.9 2.4 40.1 42.3 10.4 12.6 11.4 9.7 17.0 24.4 21.4 31.4 3.4 18.7 24.2 3.5 17.5 24.2 25.7 22.1 2.2 16.8 9.7 22.2 6.0 14.6 3.9 4.4 32.0 11.0 22.0 22.2 83.5 80.9 0.3 79.1 94.5 19.9 110.9 181.9 52.8 33.5 50.0 49.0 0.0 26.0 285.7 34.1 40.4 32.0 136.7 71.6 0.2 13.2 0.0 30.5 50.8 39.4 37.3 29.2 34.5 48.4 98.7 63.5 72.4 1.1 44.8 0.6 0.0 206.7 27.1 66.2 0.1 18.1 42.2 13.9 0.3 22.3 1.8 79.2 79.0 8.6 32.3 19.2 32.2 12.7 54.9 0.3 13.3 23.8 149.8 57.9 2.0 69.8 0.4 0.2 0.5 34.1 0.1 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 20.2 31.1 12.4 14.3 27.0 40.1 42.3 24.4 22.1 22.2 22.0 6.1 16.0 6.7 55.2 0.3 85.0 27.2 115.4 27.3 5.2 26.5 27.6 27.6 38.6 40.7 53.3 0.0 1.6 0.2 71.2 5.9 25.2 0.7 25.7 17.2 5.0 14.5 0.0 5.8 26.5 3.6 28.8 54.0 29.6 16.5 75.0 1.1 26.1 0.4 0.0 30.3 56.4 18.3 0.8 7.3 0.9 14.6 1.7 12.4 5.6 0.0 4.5 0.0 14.1 12.4 30.3 30.0 37.2 0.2 55.8 78.2 26.7 37.0 0.4 39.5 23.1 65.1 1.5 10.4 10.2 46.9 1.6 1.9 11.7 45.1 38.9 FBXO30 "Fbx30, MGC21674" ENSG00000118496 "F-box protein 30" Q8TB52 6 145793502-145814795 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 9.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012583 Approved Approved Microtubules NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 40: Granulosa cells - Unknown function" Microtubules "HPA012583: AB_2668686" "unprognostic (8.69e-2)" "unprognostic (3.35e-3)" "unprognostic (2.92e-2)" "unprognostic (4.29e-2)" "unprognostic (5.47e-3)" "unprognostic (8.36e-2)" "unprognostic (7.61e-7)" "unprognostic (5.79e-2)" "unprognostic (1.63e-1)" "unprognostic (6.32e-2)" "unprognostic (1.18e-2)" "unprognostic (9.25e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (5.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.78e-1)" 4.5 4.0 3.8 4.2 5.0 7.2 4.0 4.6 3.9 4.1 2.7 9.7 4.1 6.7 3.1 9.6 3.2 5.6 7.2 3.1 6.0 4.1 3.4 3.2 4.3 4.5 5.5 5.9 3.8 4.0 1.6 4.8 4.7 6.0 4.7 5.3 4.4 6.8 11.5 2.6 3.5 8.0 4.2 3.7 3.7 6.5 5.1 2.9 8.0 9.1 4.1 5.7 2.9 5.3 3.7 6.9 9.7 13.2 9.9 8.8 9.9 10.3 9.6 6.9 6.8 8.7 3.3 17.0 7.8 11.8 12.6 5.7 8.4 7.5 10.4 10.0 5.8 10.8 9.1 8.8 17.8 14.1 10.8 14.6 8.3 8.6 11.4 9.0 10.1 4.1 12.6 11.9 13.6 2.9 6.4 7.5 11.2 2.4 5.1 8.2 21.7 5.9 7.2 3.8 4.3 6.9 12.6 6.5 6.1 9.6 3.0 13.8 13.4 7.1 6.0 9.1 10.4 8.8 7.2 6.8 11.4 6.0 7.7 9.3 1.3 1.6 0.4 1.1 0.3 0.6 0.4 0.8 1.6 1.3 0.6 0.6 1.2 0.5 0.9 0.5 0.3 0.6 3.8 5.0 4.6 3.9 3.1 6.0 4.5 5.5 4.7 4.2 5.1 5.3 11.1 3.2 5.9 7.2 5.4 14.3 5.3 4.2 12.5 8.8 10.5 8.3 22.9 10.0 4.7 3.7 4.2 5.8 5.7 4.9 11.7 4.7 10.9 4.1 13.7 13.8 6.0 36.7 5.3 3.2 3.4 15.4 7.1 6.2 12.0 37.1 11.4 9.7 7.5 26.9 6.4 5.0 2.0 11.9 20.8 4.4 11.1 10.2 7.2 7.5 7.5 12.0 0.0 5.0 7.6 5.1 3.2 10.1 11.1 7.1 4.3 8.2 2.8 8.7 0.0 26.5 18.4 19.7 10.5 12.4 17.3 5.6 6.2 7.2 5.0 5.0 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496234 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2" "Cancer enhanced" "Detected in all" "testis cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000911, HPA076516" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cytosol" "HPA000911: AB_1078853, HPA076516: " "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 3.9 5.1 8.2 1.6 6.2 0.0 3.6 5.3 7.6 7.0 2.4 5.6 1.0 7.1 1.6 5.8 5.1 2.2 5.0 8.3 5.2 3.5 1.1 2.8 0.5 3.8 4.1 7.4 3.2 3.6 3.6 3.4 3.7 4.3 1.6 1.6 3.4 3.3 1.3 5.4 2.8 5.4 3.5 2.4 3.5 2.4 4.9 0.4 3.3 1.0 1.0 4.8 5.4 4.6 18.5 6.9 13.2 19.3 7.8 13.8 6.2 10.4 12.8 10.6 8.5 0.6 0.4 0.0 8.2 19.9 9.6 5.3 14.6 9.0 5.8 1.0 8.9 0.0 5.0 2.2 8.3 0.0 0.0 11.3 5.6 16.1 7.6 9.4 9.7 2.3 2.0 0.0 8.4 2.4 0.7 0.0 12.6 0.0 10.2 9.4 6.7 0.0 9.1 0.3 13.1 11.9 10.3 0.2 16.6 21.0 10.3 0.4 6.9 10.5 8.7 23.0 9.4 0.1 0.2 0.1 11.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 6.2 5.3 7.6 8.3 5.2 3.8 4.1 3.7 3.5 4.9 4.6 3.2 0.0 0.0 4.6 0.0 2.9 1.2 2.0 5.2 2.5 3.2 3.9 3.4 0.0 0.7 0.0 0.0 0.5 0.1 0.2 0.0 1.6 0.4 1.3 7.0 4.2 1.2 0.0 16.1 1.1 1.0 5.1 1.5 2.1 0.0 12.6 2.9 0.3 0.4 1.7 15.2 1.0 0.0 0.0 1.0 0.6 2.8 0.1 7.2 5.6 0.0 2.3 0.0 7.1 1.8 0.5 0.5 4.1 0.1 1.6 0.1 1.4 0.3 3.5 0.0 2.3 4.0 0.3 2.2 5.5 4.1 0.3 0.1 2.9 2.8 1.0 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911931-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 16.0 14.6 22.6 11.7 22.4 12.5 14.2 22.6 28.7 18.6 15.9 19.3 12.9 17.7 4.8 12.8 17.0 13.0 19.0 18.9 20.8 12.8 8.3 14.0 11.3 33.2 23.3 20.6 10.7 14.7 16.4 8.2 30.0 17.2 3.7 13.3 13.7 12.5 32.8 20.4 14.4 7.6 19.2 18.7 13.4 4.0 27.3 9.1 15.5 10.7 6.2 21.8 16.2 23.7 10.0 34.8 7.8 23.2 12.4 12.5 23.6 18.2 14.1 9.0 9.2 5.8 31.8 24.4 47.3 14.0 14.7 20.5 6.5 12.2 1.8 40.8 19.6 8.2 30.9 19.5 27.7 10.9 27.3 11.2 37.9 19.1 13.8 16.7 12.9 16.0 18.6 25.0 7.0 23.8 25.1 13.3 12.7 7.5 23.6 43.5 11.6 44.0 10.6 6.7 16.7 15.5 19.1 20.6 24.1 4.3 16.1 19.6 24.4 15.0 13.6 29.4 12.4 37.1 34.5 22.7 16.4 17.8 17.9 1.2 0.8 0.3 1.3 0.4 2.3 0.9 2.1 2.7 0.8 2.6 1.7 1.5 0.1 0.5 0.4 0.5 1.1 1.1 22.6 22.4 22.6 28.7 18.9 20.8 33.2 23.3 30.0 19.2 27.3 23.7 16.7 0.0 4.2 34.3 10.4 12.4 9.3 9.2 23.3 42.1 8.6 11.3 12.3 8.6 5.1 22.0 35.5 21.2 14.3 6.5 1.9 6.1 0.4 6.0 7.7 13.4 2.4 6.5 26.9 6.5 8.5 13.9 12.2 8.9 0.0 48.3 11.0 6.8 8.5 33.7 29.0 4.9 4.1 9.9 5.1 1.2 11.1 8.9 8.8 13.1 7.9 18.8 9.2 18.6 25.6 7.1 2.9 14.3 10.4 5.3 8.9 6.3 8.3 39.3 0.0 16.6 20.9 0.9 3.2 13.1 13.9 8.8 11.9 5.3 7.4 5.6 FNDC10 C1orf233 ENSG00000228594 "Fibronectin type III domain containing 10" F2Z333 1 1598012-1600135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.4;brain: 24.4" "Group enriched" "Detected in some" 6 "Granulosa cells: 57.0;Theca cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 27.8" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (8.35e-2)" "unprognostic (7.32e-3)" "unprognostic (4.33e-2)" "unprognostic (3.33e-1)" "unprognostic (3.12e-1)" "unprognostic (2.72e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (1.50e-1)" "unprognostic (6.00e-2)" "unprognostic (5.76e-2)" 1.5 25.4 11.0 1.5 11.4 2.6 1.4 11.2 24.4 2.3 6.2 1.5 2.1 1.1 0.0 9.5 0.8 2.2 3.0 12.6 22.0 3.7 0.5 2.3 1.0 20.6 17.8 1.8 0.9 7.4 10.9 1.0 19.0 0.9 0.5 0.6 2.2 0.4 0.3 10.0 1.6 0.6 10.0 3.1 2.9 8.3 14.3 0.3 5.2 0.3 0.8 1.2 3.7 12.9 0.0 4.1 3.9 12.1 7.9 1.8 5.5 9.6 1.9 15.1 0.8 3.7 17.2 0.0 11.2 4.7 0.1 2.5 0.9 2.1 1.3 0.0 3.5 0.2 4.1 9.1 1.8 3.0 27.8 2.6 9.5 0.7 0.1 1.8 1.0 11.0 8.0 0.0 1.8 18.7 2.3 9.1 16.6 5.8 5.9 0.0 0.0 9.7 5.4 0.9 17.9 14.8 10.2 15.1 10.6 2.5 0.0 9.3 1.6 0.0 2.9 6.5 0.0 2.9 0.3 0.2 0.0 6.2 4.3 0.0 0.7 1.6 0.1 0.5 0.1 0.0 0.3 0.3 0.7 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.3 0.2 11.0 11.4 11.2 24.4 12.6 22.0 20.6 17.8 19.0 10.0 14.3 12.9 0.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.9 8.5 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 3.9 1.3 0.0 2.4 3.0 0.5 0.0 0.0 0.0 0.9 2.5 2.4 0.0 4.7 0.0 57.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 46.3 0.0 0.0 FO393400.1 ENSG00000285382 "Novel protein" 20 32632183-32743567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;choroid plexus: 1.0;retina: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HEL: 4.6" HPA054119 Approved Vesicles NA NA "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA054119: AB_2682388" 0.0 0.0 1.4 0.0 1.4 0.0 0.1 1.5 1.8 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.5 0.1 0.3 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 1.5 1.8 1.3 1.5 1.4 1.4 1.5 1.3 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947137 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 208.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA069613 Enhanced Supported Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 2.6 1.0 0.0 0.8 0.0 0.0 0.6 0.8 12.8 0.3 0.0 0.0 7.3 0.4 0.0 11.9 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.8 0.8 44.8 0.1 12.5 10.0 0.1 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.8 0.0 0.0 0.7 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.7 4.9 1.8 0.2 3.4 0.0 0.0 1.4 0.1 0.0 0.4 0.0 0.0 0.3 0.0 2.2 5.6 0.2 1.1 0.0 0.0 0.1 0.0 0.0 8.1 0.9 0.0 0.0 0.1 0.0 0.0 7.1 0.0 0.0 1.1 0.0 0.0 8.4 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 5.6 0.0 0.0 0.3 0.0 5.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.6 0.8 0.6 0.6 0.8 0.8 0.8 0.8 1.2 0.7 0.2 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 41.8 1.6 0.0 0.0 0.0 0.2 0.3 20.9 0.0 1.0 0.0 208.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 6.2 1.8 1.4 0.0 1.0 0.0 0.3 48.4 0.0 0.0 FOXL2NB "C3orf72, FLJ43329" ENSG00000206262 "FOXL2 neighbor" Q6ZUU3 3 138947217-138953990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 50.1;parathyroid gland: 32.7" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.0;Granulosa cells: 3.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4;fHDF/TERT166: 9.2;HEL: 8.7;hTCEpi: 4.4;SiHa: 6.6" "HPA061017, HPA071790" Enhanced "Nucleoli fibrillar center" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli fibrillar center" "HPA061017: AB_2684415, HPA071790: AB_2686447" "unprognostic (3.32e-1)" "unprognostic (1.13e-1)" "unprognostic (3.86e-2)" "unprognostic (4.07e-2)" "unprognostic (4.40e-5)" "unprognostic (3.30e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-10)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (2.77e-1)" "unprognostic (1.22e-2)" 0.1 1.8 1.2 0.3 1.0 0.8 0.2 2.0 1.6 16.4 0.6 0.2 0.2 17.9 2.0 0.4 14.9 0.2 0.1 1.1 1.0 0.1 0.1 0.1 0.7 0.9 0.9 50.1 0.9 32.7 8.4 0.4 1.2 0.2 0.2 0.6 0.2 1.1 0.3 0.8 0.2 4.2 0.3 0.4 0.2 0.8 1.2 0.1 0.2 0.1 0.5 0.0 3.4 1.2 1.8 1.1 0.5 4.4 0.2 0.1 2.0 0.1 0.0 0.2 0.0 0.2 0.4 0.2 0.9 9.2 0.1 0.5 0.2 0.0 0.2 0.1 0.2 8.7 3.0 0.2 0.0 0.2 0.3 0.1 4.4 0.1 0.1 0.4 0.0 0.2 3.4 0.3 2.5 0.3 0.1 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.4 1.2 0.2 0.1 6.6 0.2 0.1 0.7 0.2 2.6 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.2 1.0 2.0 1.6 1.1 1.0 0.9 0.9 1.2 0.3 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40555667-40666641 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.0" "Cell type enhanced" "Detected in many" "Astrocytes: 177.3;Endometrial stromal cells: 161.0;Granulosa cells: 177.9;Oligodendrocytes: 131.5;Skeletal myocytes: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 40.4;Daudi: 45.3;HSkMC: 53.6;U-698: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 59: Non-specific - Translation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 43.2 9.7 11.2 13.1 16.1 13.8 27.6 10.0 10.9 19.1 16.7 13.8 5.0 39.1 6.5 13.0 25.7 14.5 13.9 9.1 11.8 11.8 38.5 16.8 23.8 14.1 12.7 65.6 16.5 5.3 7.6 11.2 12.7 10.1 9.6 3.9 9.8 10.1 91.0 18.0 10.9 27.0 10.5 15.7 9.5 8.9 11.3 11.6 19.0 22.2 24.0 13.4 17.4 14.3 0.7 1.7 12.4 0.3 40.4 7.9 11.8 1.8 2.5 0.5 0.3 3.7 3.0 45.3 8.1 1.2 1.9 10.7 9.8 5.3 0.7 20.9 10.1 0.0 1.4 10.1 19.1 0.4 1.2 53.6 35.5 0.2 6.7 2.5 31.7 3.3 0.9 14.0 3.1 1.6 0.1 0.6 18.0 6.2 3.1 32.4 14.3 3.6 22.9 5.8 2.6 0.6 1.6 8.5 1.8 14.1 1.5 1.1 18.6 0.3 2.3 0.1 1.1 7.9 3.3 57.8 1.2 2.1 5.7 0.9 0.6 0.5 1.3 0.8 1.8 3.7 3.6 2.2 0.4 5.8 5.5 4.3 2.5 1.4 1.4 0.0 5.1 1.0 11.2 16.1 10.0 10.9 9.1 11.8 14.1 12.7 12.7 10.5 11.3 14.3 57.9 0.0 4.4 177.3 29.3 29.3 19.1 13.0 27.9 3.7 12.9 17.3 11.5 10.0 9.9 9.2 12.5 0.5 22.9 27.5 0.0 11.1 7.2 55.4 161.0 50.2 52.2 3.2 7.4 18.0 3.8 40.8 18.8 118.8 1.3 177.9 84.3 47.9 6.5 5.0 23.0 21.0 8.2 14.6 26.9 4.0 18.6 18.6 12.4 117.1 18.4 5.5 8.2 47.3 131.5 19.5 16.3 13.2 32.9 10.1 7.7 8.8 9.2 9.8 6.6 131.7 31.3 6.4 14.6 25.3 26.7 0.8 40.3 64.0 12.5 13.0 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99703970-99766635 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 10.8;Microglial cells: 13.1;Squamous epithelial cells: 7.2;Theca cells: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 8 "eosinophil: 12.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "HEL: 34.7;K-562: 23.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017883 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 1.7 3.2 0.8 1.2 1.2 2.9 3.3 1.0 1.1 2.9 2.2 4.3 3.1 1.8 7.3 6.0 2.2 3.3 1.7 0.9 1.1 1.6 28.6 2.5 1.1 1.4 0.6 2.4 1.1 1.2 0.3 10.1 1.2 2.4 4.1 1.1 1.5 2.6 1.0 9.2 2.3 1.9 0.2 1.2 4.8 1.1 1.3 1.2 2.2 1.6 2.4 2.6 3.8 2.4 6.9 1.2 2.9 2.7 8.5 4.3 14.2 1.9 3.2 1.8 6.8 8.1 9.0 3.8 6.9 2.0 3.0 16.0 4.3 6.8 2.3 8.1 2.9 34.7 3.9 8.7 1.2 4.4 9.2 6.6 8.6 4.0 1.7 0.5 0.4 2.6 23.4 2.0 1.3 2.2 1.4 2.7 2.1 15.2 5.9 0.3 10.8 1.7 1.2 17.3 0.8 0.3 3.0 13.1 6.9 2.1 5.0 4.9 0.8 3.8 5.0 3.3 2.0 3.1 0.4 6.7 8.1 1.9 1.9 1.3 1.0 12.6 0.3 1.4 0.2 0.9 0.2 0.3 1.3 0.6 0.2 0.5 0.8 0.6 0.3 1.0 0.3 0.3 0.8 1.2 1.0 1.1 0.9 1.1 1.4 0.6 1.2 0.2 1.3 2.4 1.1 0.0 0.0 0.0 1.2 1.9 1.9 1.9 10.8 0.1 0.9 1.3 1.5 0.0 1.2 1.8 0.0 3.1 0.3 1.3 0.0 0.3 0.2 1.9 6.2 0.5 0.0 2.1 0.5 0.0 1.8 4.0 6.6 3.1 0.0 6.2 0.4 2.8 1.0 0.0 0.6 0.4 0.0 2.2 0.0 0.4 0.9 2.1 0.0 13.1 1.1 1.0 0.0 1.0 0.2 0.4 1.4 0.0 3.1 1.2 1.7 0.3 2.2 0.1 0.0 0.5 1.1 0.0 0.2 7.2 2.7 3.7 0.3 12.3 0.5 3.1 FSHR "FSHRO, LGR1, ODG1" ENSG00000170820 "Follicle stimulating hormone receptor" P23945 2 48962157-49154527 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.0;ovary: 2.0;testis: 2.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 10.1;Granulosa cells: 33.8;Late spermatids: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.94e-2)" "unprognostic (4.06e-3)" "unprognostic (5.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.8 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.0 0.6 0.8 0.4 0.3 0.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.1 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FST FS ENSG00000134363 Follistatin P19883 5 53480626-53487134 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.7" "Cell type enriched" "Detected in many" 6 "Granulosa cells: 700.1" "Cancer enhanced" "Detected in all" "liver cancer: 45.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA016612, CAB026025" Approved Approved Vesicles "Secreted to blood" NA NA 1800000 "Cluster 32: T-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "CAB026025: , HPA016612: " "unprognostic (1.43e-1)" "unprognostic (6.50e-2)" "unprognostic (1.44e-1)" "unprognostic (7.73e-3)" "unprognostic (2.30e-1)" "unprognostic (1.50e-3)" "unprognostic (8.02e-2)" "unprognostic (2.32e-2)" "unprognostic (3.06e-1)" "unprognostic (1.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.44e-5)" "unprognostic (1.21e-3)" "unprognostic (2.48e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-1)" 26.1 6.2 0.8 3.0 0.5 0.4 15.2 0.4 0.7 7.7 0.7 9.8 1.8 4.2 3.7 6.5 11.8 7.2 9.4 2.0 2.0 2.9 68.7 8.2 1.6 1.8 1.0 9.9 2.6 0.5 5.9 24.1 0.9 15.5 3.0 0.3 11.3 10.8 9.2 18.0 8.8 4.7 0.5 0.3 11.1 5.0 1.1 2.3 4.0 7.7 12.9 40.4 7.5 0.7 20.0 1.8 33.7 0.0 38.6 13.5 55.4 76.3 351.1 46.4 45.4 0.3 0.2 0.0 0.6 19.9 2.3 292.3 0.0 191.3 32.7 0.8 0.2 4.0 1.7 31.3 20.4 0.3 206.5 31.0 0.5 84.5 55.0 31.3 40.0 0.0 0.0 0.6 29.7 0.1 0.1 1.6 52.1 0.0 558.2 4.2 43.6 0.0 0.0 31.9 0.5 0.1 3.1 0.2 2.0 83.9 0.3 0.3 0.2 124.1 35.3 13.2 11.1 0.4 0.1 0.1 14.8 4.1 116.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.4 0.7 2.0 2.0 1.8 1.0 0.9 0.5 1.1 0.7 5.2 0.0 1.1 0.0 1.0 20.0 31.5 64.4 13.1 0.0 0.9 23.4 11.4 0.0 8.3 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.4 0.1 3.4 2.9 0.0 0.0 0.1 4.6 14.8 107.7 3.6 0.1 0.0 700.1 1.1 57.2 1.8 0.0 0.7 0.0 2.0 0.8 16.4 1.5 3.1 1.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 11.3 0.2 37.1 0.0 0.1 1.6 0.0 13.1 29.6 33.3 0.3 12.2 4.0 4.7 6.0 2.0 0.3 0.0 51.8 GATA4 ENSG00000136574 "GATA binding protein 4" P43694 8 11676959-11760002 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 88.6;ovary: 95.4;pancreas: 53.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1" "Cancer enhanced" "Detected in many" "stomach cancer: 21.8;testis cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013125, HPA073899" Uncertain Supported "Nuclear bodies" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "CAB013125: AB_2533804, HPA073899: AB_2686641" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (8.68e-4)" "unprognostic (2.66e-3)" "unprognostic (1.71e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-2)" "unprognostic (5.47e-2)" "unprognostic (2.55e-1)" "unprognostic (2.78e-2)" "unprognostic (2.49e-1)" "unprognostic (1.67e-8)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.29e-2)" 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.2 0.2 0.0 0.0 2.3 4.0 88.6 0.0 0.0 0.0 36.6 0.2 0.0 0.0 0.0 95.4 53.5 0.0 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.1 35.2 32.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.7 20.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.2 1.3 0.0 0.0 1.5 20.5 0.0 0.0 0.1 3.9 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 16.1 0.0 0.1 6.1 0.0 0.0 0.1 33.7 0.2 12.0 61.2 0.0 0.0 158.4 57.8 12.1 0.6 0.0 0.1 0.8 0.0 2.8 0.0 37.0 41.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 41.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.3 2.4 2.2 0.0 0.0 0.8 0.1 80.1 0.9 0.0 GDF3 ENSG00000184344 "Growth differentiation factor 3" Q9NR23 12 7689784-7695775 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "kidney: 2.9" "Cell type enriched" "Detected in some" 25 "Granulosa cells: 30.2" "Cancer enriched" "Detected in some" 422 "testis cancer: 383.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "NTERA-2: 452.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA018468 Uncertain "Secreted to blood" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "HPA018468: AB_1849586" "unprognostic (9.48e-2)" "unprognostic (3.90e-2)" "unprognostic (3.30e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-1)" "unprognostic (5.40e-2)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (2.89e-1)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (1.25e-3)" "unprognostic (8.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 2.9 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 452.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 77.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435595-121449727 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 121.2 287.6 313.5 24.7 310.2 0.9 60.6 260.1 409.0 261.7 193.1 17.5 18.2 98.7 10.6 74.9 32.7 99.9 168.9 273.6 362.6 21.2 10.6 67.9 21.1 340.3 380.9 43.5 19.4 236.2 31.3 290.2 307.4 83.3 19.7 3.3 35.6 148.0 10.3 388.2 24.7 112.5 335.9 4.2 30.7 36.9 373.3 24.3 169.1 22.1 34.9 116.0 184.9 341.0 0.1 43.5 186.8 0.4 99.7 61.5 0.4 142.5 286.9 46.9 113.7 0.7 0.4 0.0 15.8 55.8 40.2 18.3 5.1 87.4 151.3 0.1 51.6 2.3 15.7 0.0 124.1 0.0 0.4 164.6 92.1 172.5 61.7 462.7 362.3 0.0 0.1 4.3 9.4 8.4 0.1 80.6 365.8 0.1 47.2 0.1 0.0 3.7 188.6 21.0 0.4 2.9 0.0 0.3 0.1 453.4 14.9 0.3 269.5 143.8 39.4 122.8 93.5 0.1 0.1 0.1 350.4 0.1 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.5 310.2 260.1 409.0 273.6 362.6 340.3 380.9 307.4 335.9 373.3 341.0 152.2 250.0 80.0 276.2 0.1 234.9 133.6 71.1 77.4 0.3 9.5 20.1 199.7 0.0 17.5 1.8 2.1 53.4 0.4 0.0 0.0 76.9 0.5 21.5 215.5 166.6 0.0 0.0 0.3 4.2 7.9 124.4 0.5 51.7 8.8 494.3 33.9 0.1 8.6 0.0 0.6 0.0 4.1 0.9 55.3 1.7 2.5 3.6 44.4 15.0 0.6 0.3 0.0 4.0 1.0 10.8 0.0 4.1 0.1 29.7 0.0 0.1 6.2 0.3 0.0 5.9 80.2 0.9 1.8 68.3 378.2 20.0 4.9 127.1 0.4 52.7 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" A0A1B0GV03 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;U-266/70: 1.3;U-266/84: 1.3" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.7 0.0 0.5 0.1 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.5 1.0 0.3 0.1 1.4 0.6 1.6 0.1 0.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646230-150697154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 313.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 10.9 14.3 8.8 11.8 9.3 6.0 20.8 9.3 11.4 21.8 13.5 31.1 17.9 14.7 33.3 30.3 25.3 14.1 10.3 8.7 11.4 18.6 9.6 13.6 12.6 9.3 13.3 21.4 22.8 19.0 11.0 13.0 11.7 15.8 36.4 12.8 23.3 17.6 14.7 18.9 20.1 15.2 9.0 11.0 22.7 14.4 10.9 15.8 25.7 13.5 18.5 21.5 13.5 8.5 25.2 23.0 12.2 7.6 31.8 22.5 21.8 22.6 33.0 23.7 32.9 10.3 45.1 29.3 31.5 14.7 16.1 21.6 20.8 18.5 28.6 21.1 21.5 33.8 13.2 15.2 26.7 27.8 28.2 16.1 31.8 24.2 54.4 26.1 37.5 21.1 27.6 19.6 14.1 25.4 24.2 13.1 25.7 46.1 21.6 16.8 14.5 36.5 30.6 17.5 19.3 18.8 11.6 33.2 18.0 31.4 25.6 32.5 29.3 7.3 13.3 10.2 18.5 23.8 22.9 313.5 22.3 28.3 10.9 7.5 1.6 2.8 9.5 1.6 13.0 10.5 9.9 9.7 8.7 9.8 12.7 9.4 1.4 18.0 3.6 12.6 11.6 5.4 8.8 9.3 9.3 11.4 8.7 11.4 9.3 13.3 11.7 9.0 10.9 8.5 11.7 9.6 10.3 12.1 9.8 12.9 11.3 16.7 9.6 9.0 26.3 14.4 10.4 24.3 22.6 12.9 6.2 22.1 9.7 50.0 25.4 21.6 22.2 27.5 10.3 14.1 21.0 10.9 12.7 36.6 17.9 12.9 17.9 15.6 11.4 48.6 16.1 10.9 12.4 0.0 13.6 46.6 14.2 9.1 7.4 12.7 16.4 7.5 16.0 24.4 13.1 14.9 6.2 11.6 13.5 21.2 34.6 19.9 15.0 27.7 31.6 26.9 51.2 13.3 0.0 10.0 9.5 14.6 4.3 15.7 17.8 30.8 10.4 22.0 36.0 39.6 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.2" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 12.3;Granulosa cells: 42.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 1.5 2.7 0.1 0.2 0.9 0.0 0.7 0.5 0.3 2.6 12.2 0.3 0.1 0.5 0.2 4.5 0.5 1.2 1.6 0.6 0.3 0.4 0.0 0.2 0.8 0.0 0.0 1.3 0.0 0.4 0.2 3.9 0.0 0.2 0.3 0.7 0.9 0.1 0.7 4.8 0.3 1.0 0.0 0.0 0.1 0.9 0.2 0.0 0.3 2.4 0.3 1.0 5.6 0.0 2.2 0.2 1.8 0.0 0.4 7.5 0.6 14.4 24.7 8.8 7.4 0.0 0.0 0.0 0.8 7.3 0.6 0.2 0.7 0.0 2.9 0.0 0.3 0.0 4.2 0.0 133.9 0.0 0.0 5.5 61.8 12.5 20.0 10.2 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 6.9 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.3 6.1 2.9 0.0 0.0 1.6 0.1 0.0 0.3 10.5 4.8 12.5 1.1 0.0 0.0 0.0 3.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 12.3 4.5 0.0 0.0 0.0 42.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.9 1.2 0.0 0.0 0.8 1.0 0.7 0.5 0.0 0.0 0.4 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492417-164621482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.6;tongue: 20.3" "Group enriched" "Detected in many" 4 "Distal tubular cells: 92.0;Granulosa cells: 272.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.5" "Region enhanced" "Detected in single" "hippocampal formation: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: AB_2674432" "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 0.7 3.0 0.0 0.3 0.4 0.0 0.3 0.0 0.6 0.1 0.1 0.9 0.9 0.2 5.4 1.2 0.1 0.1 2.7 1.3 0.1 6.6 12.6 0.4 0.0 0.3 0.2 2.0 4.7 0.0 0.3 1.7 0.0 0.3 0.3 0.4 0.3 0.3 2.4 0.2 0.2 0.4 0.0 0.2 0.2 2.6 0.3 0.0 0.9 20.3 0.0 0.0 0.1 0.0 0.8 5.5 0.3 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 2.5 0.5 0.0 2.9 0.0 0.9 0.3 0.8 1.2 0.3 0.0 4.1 0.0 0.3 1.3 0.1 0.0 0.0 0.3 0.8 1.8 0.0 1.6 9.6 0.0 0.0 0.0 1.5 2.1 0.0 0.0 1.9 0.2 1.2 0.0 0.0 0.1 9.1 0.4 3.1 0.3 0.0 0.3 0.0 1.1 0.7 0.0 11.8 0.1 1.2 0.0 0.1 0.4 0.1 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.6 1.3 0.1 0.3 0.2 0.0 0.0 0.3 0.0 4.5 0.0 5.4 0.7 0.1 0.1 0.3 0.0 0.0 1.3 1.6 1.4 17.7 22.8 0.0 16.5 0.0 0.2 1.3 0.3 92.0 13.5 1.5 0.6 0.2 3.0 0.0 0.0 24.5 3.3 0.2 2.4 0.0 1.9 0.0 272.4 1.1 40.4 0.0 0.0 6.2 2.6 0.0 1.0 0.3 4.4 9.3 3.2 19.6 1.9 1.0 0.3 0.0 3.5 2.3 4.0 0.0 17.3 0.0 0.8 0.3 14.7 0.0 0.8 13.1 0.8 10.9 0.7 6.4 0.1 0.0 0.1 0.2 30.4 1.6 0.2 GREB1 KIAA0575 ENSG00000196208 "Growth regulating estrogen receptor binding 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "ovary: 278.3" "Cell type enriched" "Detected in many" 9 "Granulosa cells: 545.2" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.8 3.4 8.5 0.7 9.6 0.4 13.7 2.1 9.9 60.2 0.8 1.0 0.7 61.3 7.0 0.6 53.4 2.8 4.6 7.8 20.4 1.8 3.1 1.4 0.6 8.7 8.5 278.3 7.6 0.7 8.9 3.0 4.4 63.4 0.2 1.5 1.1 3.8 4.0 2.7 0.9 12.8 3.2 0.2 3.0 14.9 10.7 0.3 0.6 4.8 0.3 1.7 21.5 6.5 0.1 1.0 40.3 0.5 0.2 0.2 1.8 0.0 0.1 0.1 0.3 0.3 0.2 2.5 0.3 0.0 6.9 0.2 3.1 0.2 0.1 5.1 3.6 0.4 0.3 39.6 0.5 0.3 2.1 0.5 2.2 0.6 0.4 0.4 0.0 3.9 0.5 1.0 0.3 61.8 1.2 2.0 13.0 0.1 0.1 29.1 0.0 1.9 0.1 0.0 11.8 40.5 0.9 1.1 30.4 5.2 138.0 0.7 0.0 4.1 2.0 0.4 0.1 6.0 4.4 24.7 6.8 11.9 1.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.0 8.5 9.6 2.1 9.9 7.8 20.4 8.7 8.5 4.4 3.2 10.7 6.5 0.4 0.0 0.5 20.2 0.7 0.8 1.9 0.0 0.6 4.8 24.7 13.7 8.3 5.7 0.6 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.8 35.7 36.0 1.3 0.0 0.0 15.0 0.2 3.6 16.9 0.0 23.4 3.8 545.2 0.7 8.9 3.2 3.3 46.9 0.0 0.0 0.0 1.2 2.5 20.2 1.4 5.4 1.0 0.0 0.2 0.0 11.6 20.9 0.4 0.0 55.3 5.0 14.3 0.0 2.5 2.9 0.5 0.0 7.2 14.8 1.1 2.9 0.3 0.3 0.3 1.1 33.1 0.0 2.5 GREB1L "C18orf6, FLJ13687, KIAA1772" ENSG00000141449 "GREB1 like retinoic acid receptor coactivator" Q9C091 18 21242242-21525417 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 9.2" "Cell type enhanced" "Detected in many" "Granulosa cells: 95.2;Inhibitory neurons: 39.2;Leydig cells: 46.0;Oligodendrocytes: 252.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 50.7;BEWO: 100.9;CACO-2: 45.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041647, HPA044218" Uncertain Approved Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA041647: AB_2677597, HPA044218: AB_2678859" "unprognostic (1.88e-3)" "unprognostic (9.01e-4)" "unprognostic (2.92e-1)" "unprognostic (2.45e-1)" "unprognostic (5.03e-2)" "unprognostic (3.67e-3)" "unprognostic (3.65e-1)" "unprognostic (1.11e-2)" "unprognostic (1.07e-1)" "unprognostic (1.97e-1)" "unprognostic (4.32e-3)" "unprognostic (2.87e-2)" "unprognostic (3.30e-8)" "unprognostic (4.72e-3)" "unprognostic (1.89e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-1)" 2.6 1.4 5.5 0.1 4.3 0.2 3.3 3.5 3.6 1.2 0.0 0.6 0.1 2.6 2.8 0.2 4.4 0.1 5.3 2.6 8.1 0.4 1.8 0.2 0.1 4.0 4.7 3.7 0.1 0.3 1.2 2.1 4.1 1.6 0.1 3.1 0.5 2.9 9.2 1.3 0.5 0.8 1.7 0.0 0.6 6.2 6.4 0.0 3.8 6.8 0.0 0.1 0.7 4.4 0.0 0.9 50.7 0.0 11.4 0.0 100.9 2.4 2.4 4.3 3.8 45.7 3.7 0.1 5.1 7.6 0.1 9.7 19.4 2.4 7.5 0.7 9.3 0.0 13.4 0.4 0.3 0.0 0.0 0.0 0.7 0.1 9.3 0.5 0.0 1.4 0.0 0.3 10.5 3.5 0.2 0.2 4.9 0.4 6.0 0.2 0.0 2.0 4.8 8.7 3.2 0.0 0.1 1.6 0.2 13.2 2.7 0.2 20.9 0.5 2.9 4.9 0.0 0.1 0.7 0.0 2.2 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 4.3 3.5 3.6 2.6 8.1 4.0 4.7 4.1 1.7 6.4 4.4 0.4 0.0 0.5 0.7 0.4 0.1 0.1 1.0 0.0 32.3 3.1 1.1 13.4 0.0 1.1 3.7 2.1 3.2 1.8 0.1 0.0 0.2 8.3 2.2 3.4 0.5 0.0 0.0 23.1 0.4 13.2 6.2 0.0 7.0 0.0 95.2 0.0 3.1 0.5 0.0 39.2 0.2 0.0 0.0 1.1 17.9 46.0 0.3 1.8 2.8 0.1 0.8 2.1 8.0 252.5 2.8 0.0 35.7 0.0 0.6 0.3 0.0 2.3 1.6 6.6 2.8 2.3 4.3 5.6 0.0 0.9 1.5 0.3 10.5 1.5 0.2 GREM1 "CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS" ENSG00000166923 "Gremlin 1, DAN family BMP antagonist" O60565 15 32718004-32745106 "Disease related genes, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 113.0;smooth muscle: 68.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4" "Cancer enhanced" "Detected in many" "stomach cancer: 24.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8" "Group enriched" "Detected in many" 5 "hippocampal formation: 3.2;olfactory bulb: 10.9" "Low region specificity" "Detected in many" HPA007526 Uncertain "Secreted to blood" NA NA 242000000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA007526: AB_1849971" "unprognostic (4.74e-2)" "unprognostic (2.78e-1)" "unprognostic (4.63e-2)" "unprognostic (6.80e-2)" "unprognostic (3.58e-1)" "unprognostic (1.72e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-3)" "unprognostic (2.79e-1)" "unprognostic (2.13e-11)" "unprognostic (1.77e-2)" "unprognostic (6.60e-2)" "unprognostic (3.29e-2)" "unprognostic (1.16e-3)" 32.7 0.5 1.4 6.5 3.6 0.2 5.5 1.1 2.4 44.7 0.0 36.1 2.6 9.6 0.0 13.6 1.1 113.0 1.3 1.5 1.3 1.2 1.1 2.2 1.1 3.1 3.0 0.3 2.2 0.0 0.2 0.3 1.8 8.2 26.7 0.1 0.6 3.8 0.6 7.6 52.3 68.2 1.1 0.8 36.8 0.5 3.8 0.0 2.3 0.0 1.7 21.7 50.4 6.1 0.0 3.5 0.0 0.0 11.1 12.5 0.0 294.7 468.5 112.5 286.8 0.3 0.0 0.0 0.0 957.0 0.0 0.0 0.0 0.0 109.7 0.0 0.1 0.0 0.1 0.0 3.3 0.0 0.0 3.1 0.0 227.8 0.1 70.6 0.0 0.0 0.0 0.0 143.4 0.1 0.0 0.0 1.2 0.0 0.9 0.0 20.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 57.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 3.6 1.1 2.4 1.5 1.3 3.1 3.0 1.8 1.1 3.8 6.1 0.7 0.0 0.0 0.3 0.4 6.6 6.5 0.0 0.6 2.1 1.7 0.9 3.4 0.0 0.0 66.2 2.1 0.2 0.7 0.4 0.0 0.4 0.2 0.6 2.3 1.9 0.0 0.0 2.5 0.0 0.1 17.7 0.0 0.7 0.0 121.1 0.7 1.2 1.0 1.7 0.5 0.6 0.0 0.3 12.8 0.0 0.0 2.3 3.6 0.0 2.7 0.3 0.0 1.5 40.5 0.3 0.0 0.4 0.2 9.9 0.1 0.3 0.0 1.3 0.0 181.4 16.1 0.1 1.4 0.3 4.5 0.3 2.1 0.1 0.1 6.5 GRK4 "GPRK2L, GPRK4" ENSG00000125388 "G protein-coupled receptor kinase 4" P32298 4 2963571-3040760 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;testis: 42.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 123.0;Early spermatids: 357.7;Late spermatids: 500.3;Spermatocytes: 180.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057023 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "HPA057023: AB_2683313" "unprognostic (1.86e-2)" "unprognostic (2.88e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (3.65e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-1)" "unprognostic (2.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.87e-1)" "unprognostic (3.90e-4)" "unprognostic (3.20e-1)" "unprognostic (1.01e-2)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.89e-1)" 2.8 3.3 6.2 1.1 6.2 1.3 2.4 19.3 8.4 3.0 0.3 2.8 1.0 2.7 2.3 1.8 2.1 2.4 4.9 6.5 5.7 2.2 2.0 2.0 1.2 6.0 5.5 3.5 5.4 4.4 6.2 1.6 5.7 2.0 1.4 10.1 2.9 2.1 4.8 2.3 1.4 2.1 3.6 1.4 3.0 42.3 6.4 1.6 3.3 4.4 1.2 2.3 2.2 7.2 2.3 0.8 2.7 7.9 6.3 6.1 1.6 4.3 1.9 2.4 2.1 2.3 0.7 5.1 1.9 7.1 4.8 0.7 3.6 3.6 2.1 3.4 3.4 5.6 3.2 2.6 3.8 2.3 1.9 4.1 5.7 4.3 2.0 2.7 4.7 5.5 5.4 6.6 5.8 2.6 4.8 4.8 2.1 3.3 6.0 6.1 3.4 2.1 2.3 2.9 15.2 4.8 2.7 1.2 4.1 1.9 6.0 3.5 5.5 6.6 1.7 4.5 4.0 6.5 4.0 3.8 3.3 5.0 2.2 2.1 0.3 0.6 0.3 0.7 0.4 0.3 0.2 0.2 0.1 0.3 0.5 0.4 1.1 0.5 0.2 0.7 0.1 0.4 6.2 6.2 19.3 8.4 6.5 5.7 6.0 5.5 5.7 3.6 6.4 7.2 3.9 3.2 7.4 34.6 2.1 11.2 3.2 5.0 7.4 57.1 5.0 5.5 11.4 4.3 5.6 3.7 123.0 2.1 4.7 0.8 13.7 2.7 357.7 4.2 7.2 4.2 10.3 8.6 53.9 3.8 5.3 8.7 5.1 3.8 5.7 75.0 6.1 3.0 3.4 18.5 71.1 2.4 4.1 2.9 4.6 500.3 13.1 3.1 7.2 9.4 3.0 11.4 2.1 48.2 29.3 2.1 0.4 8.2 5.3 1.8 2.0 5.0 1.2 58.2 6.6 8.4 5.7 180.4 22.3 6.5 11.4 3.0 4.0 34.6 1.3 2.4 GSR ENSG00000104687 "Glutathione-disulfide reductase" P00390 8 30678066-30727846 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 32.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001538, CAB008632, HPA064806" Approved Supported Cytosol NA NA 81000000 "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: " "unprognostic (1.23e-1)" "prognostic favorable (3.37e-4)" "prognostic favorable (4.08e-5)" "unprognostic (2.89e-3)" "unprognostic (1.62e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (4.15e-2)" "unprognostic (2.83e-2)" "unprognostic (6.92e-3)" "prognostic favorable (1.80e-4)" "unprognostic (2.31e-3)" "unprognostic (2.26e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 13.6 23.3 12.3 18.7 11.1 25.9 11.0 10.6 11.7 28.5 25.8 42.5 54.3 16.0 21.6 37.3 21.6 30.5 25.4 12.9 12.5 45.3 35.8 17.4 23.6 9.5 14.2 23.1 26.5 82.3 14.8 23.5 12.0 35.3 46.6 12.8 25.8 29.4 28.9 12.8 50.8 17.9 10.7 22.1 41.8 11.6 17.6 26.7 16.9 21.3 24.0 22.5 27.7 11.2 49.4 197.8 35.9 40.1 35.8 38.3 29.1 23.4 46.8 31.8 36.7 66.0 31.3 95.8 94.8 32.0 96.1 59.2 62.3 51.1 33.1 22.6 40.7 104.6 67.0 197.8 88.4 38.6 159.7 72.6 28.5 48.9 20.9 33.5 43.3 57.3 73.2 55.1 67.9 44.1 147.1 32.0 65.4 191.9 31.5 43.8 41.9 59.3 56.0 124.3 28.2 31.8 31.2 87.8 58.8 40.7 37.5 32.6 63.8 21.0 34.7 37.3 35.2 20.2 29.4 70.0 51.9 51.8 62.4 32.3 5.9 15.0 5.0 5.4 8.8 3.6 4.5 5.4 6.0 2.3 2.8 3.7 8.2 3.6 7.9 3.9 4.5 3.1 12.3 11.1 10.6 11.7 12.9 12.5 9.5 14.2 12.0 10.7 17.6 11.2 8.2 3.2 20.8 12.7 13.7 4.2 15.2 9.4 52.3 6.7 6.7 5.0 26.8 30.0 15.0 12.9 16.7 17.0 20.3 61.8 9.8 11.4 8.4 61.4 13.4 9.9 34.1 28.6 18.1 19.8 6.3 10.0 33.1 41.3 6.3 64.3 12.1 43.4 18.2 3.3 27.4 51.7 8.2 40.5 5.8 18.9 7.2 22.1 8.8 11.2 20.6 12.6 17.5 12.5 10.0 15.2 32.0 10.9 15.6 27.5 75.7 19.0 11.7 8.0 6.6 7.0 8.6 1.2 3.4 39.6 5.4 6.4 17.3 17.2 47.5 33.5 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791371-52803860 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 916.5;kidney: 943.1;liver: 2610.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2" "Cancer enriched" "Detected in many" 4 "liver cancer: 555.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 263.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.5 916.5 0.0 2.5 0.0 0.0 4.2 0.0 0.2 2.0 0.0 7.3 672.0 0.4 7.0 5.3 86.1 119.5 0.2 0.0 0.0 943.1 2610.5 12.2 0.5 0.0 0.0 78.9 148.6 0.0 0.2 0.5 0.0 18.7 8.1 0.0 21.5 0.6 0.1 1.2 674.6 0.3 0.0 0.2 135.5 336.8 0.3 0.1 0.1 0.0 11.5 2.2 5.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.1 263.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.4 2.1 0.0 0.2 1.5 2.1 0.3 0.0 0.0 1.1 0.0 0.2 0.5 0.5 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 6.4 7.7 0.0 13.5 0.0 5.0 35.7 0.0 0.0 7.0 1.5 0.0 453.2 159.9 73.5 0.0 0.1 0.1 5.8 536.1 71.3 11.8 0.4 0.1 3.1 3.0 45.5 0.0 1652.6 0.2 7.3 116.7 0.5 2.5 3177.1 26.4 1013.9 0.1 0.0 0.0 165.6 42.7 31.5 0.0 43.0 65.6 25.3 0.0 0.0 13.3 0.0 1.0 0.0 0.1 629.1 187.4 4.5 0.2 27.6 4294.8 3190.6 533.5 0.0 0.0 0.0 98.6 36.8 3.4 6.8 0.0 0.5 10.4 4578.2 295.3 58.7 GSTA4 ENSG00000170899 "Glutathione S-transferase alpha 4" O15217 6 52977948-52995304 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 295.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 280.0;Granulosa cells: 335.6;Syncytiotrophoblasts: 450.3;Theca cells: 415.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "non-classical monocyte: 20.0" "Lineage enriched" "Detected in many" 6 "monocytes: 20.0" "Cell line enhanced" "Detected in many" "AF22: 95.4;ASC TERT1: 93.1" "Low region specificity" "Detected in all" HPA048934 Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "HPA048934: AB_2680563" "unprognostic (5.13e-3)" "unprognostic (2.75e-1)" "unprognostic (5.04e-2)" "unprognostic (1.38e-1)" "unprognostic (5.24e-2)" "unprognostic (3.63e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-2)" "unprognostic (5.05e-3)" "unprognostic (9.26e-2)" "unprognostic (3.31e-3)" "unprognostic (2.29e-2)" "unprognostic (1.34e-2)" "unprognostic (2.21e-1)" "unprognostic (4.07e-3)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 19.2 295.7 51.2 6.9 52.6 1.7 36.0 55.6 61.0 37.0 37.7 19.2 20.4 27.5 61.2 53.4 24.7 22.9 20.4 53.8 55.5 32.1 34.8 38.7 7.3 44.1 43.5 51.9 31.3 74.4 43.1 48.0 45.2 40.7 24.5 31.2 32.8 28.5 35.9 136.0 19.0 26.2 43.0 13.6 37.2 37.3 48.7 9.9 25.0 36.7 21.4 15.6 40.3 53.8 1.3 10.3 95.4 80.3 56.1 93.1 8.9 13.6 33.7 9.4 16.0 15.6 0.3 1.0 9.1 25.8 10.1 3.9 69.7 13.5 11.8 2.3 29.2 3.3 8.2 54.4 39.8 0.0 2.3 80.1 20.6 12.0 10.1 28.5 59.1 14.1 12.9 15.0 31.9 0.0 1.2 0.3 36.4 58.5 17.3 2.4 41.2 18.6 34.3 1.7 42.2 62.1 0.4 9.9 24.9 48.9 2.5 2.8 28.5 10.0 22.6 9.3 11.6 18.4 2.5 0.5 15.2 1.5 11.0 0.0 0.0 0.0 2.6 0.9 2.0 0.8 0.7 1.2 0.9 2.9 0.5 0.7 0.0 3.2 20.0 1.7 0.8 0.9 51.2 52.6 55.6 61.0 53.8 55.5 44.1 43.5 45.2 43.0 48.7 53.8 15.4 51.3 84.3 22.9 2.2 44.9 22.0 79.0 35.3 39.7 26.1 31.2 10.0 15.7 44.4 27.6 0.0 280.0 3.6 5.6 54.8 14.0 1.4 3.5 24.1 20.0 23.9 9.5 63.4 9.0 108.8 40.5 23.0 4.1 5.7 335.6 31.4 21.1 69.8 37.0 88.2 41.8 57.0 2.5 14.6 9.6 41.7 3.5 96.0 13.1 2.8 70.1 4.1 75.9 62.7 10.8 9.6 39.1 0.8 25.8 12.7 47.7 15.6 11.3 19.7 28.5 36.3 4.7 10.5 96.3 135.5 450.3 3.9 415.9 18.0 21.1 GXYLT1 "FLJ43151, GLT8D3" ENSG00000151233 "Glucoside xylosyltransferase 1" Q4G148 12 42081845-42144874 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 3200000 "Cluster 52: Eosinophils - Transcription" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (1.22e-1)" "unprognostic (9.89e-2)" "unprognostic (5.22e-3)" "unprognostic (1.77e-2)" "unprognostic (4.42e-3)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-2)" "unprognostic (8.16e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-2)" "prognostic favorable (3.91e-4)" 5.8 4.8 4.0 5.9 4.3 7.5 4.9 4.6 3.4 4.0 4.2 4.1 4.0 3.9 3.7 3.2 4.5 4.0 3.0 3.4 5.7 6.4 12.2 5.5 5.2 5.0 4.6 5.5 4.2 6.0 3.6 11.1 4.7 4.1 4.9 6.1 3.5 3.3 2.4 4.2 5.6 3.7 5.0 6.7 4.6 9.5 4.5 6.8 8.9 3.9 4.6 4.6 3.4 4.9 12.9 10.8 12.2 11.9 8.5 22.1 45.6 28.4 19.0 20.7 20.9 25.1 25.9 11.2 21.7 15.8 14.9 6.0 20.6 9.2 38.1 18.7 23.2 18.4 9.1 20.5 13.4 20.1 16.9 17.1 7.8 31.6 13.9 12.3 27.7 12.6 11.8 19.3 26.7 8.9 13.0 12.2 14.8 4.9 10.2 6.1 24.6 10.0 12.5 19.1 6.2 10.5 20.2 11.4 16.8 22.6 23.4 15.6 23.9 14.7 49.8 8.7 18.1 25.2 30.4 14.1 19.9 53.8 9.2 0.1 0.6 1.8 0.4 1.2 0.2 0.4 0.6 0.5 1.0 0.4 0.5 0.5 0.4 0.9 1.5 0.2 0.7 0.3 4.0 4.3 4.6 3.4 3.4 5.7 5.0 4.6 4.7 5.0 4.5 4.9 22.1 16.0 15.0 10.1 21.5 3.2 14.3 7.9 8.6 9.0 13.3 8.6 7.4 7.2 8.8 35.0 8.4 42.7 34.2 10.5 1.9 9.5 1.6 7.2 11.9 16.4 3.0 8.0 14.3 10.4 39.8 15.7 6.6 10.7 19.1 57.6 24.3 27.8 13.8 15.2 16.1 9.5 6.1 16.2 7.4 3.4 11.8 13.2 5.4 25.3 20.5 10.3 15.5 16.6 17.8 8.9 12.5 7.5 21.5 14.5 12.3 3.9 12.1 15.5 13.1 13.3 11.7 25.2 33.4 11.0 4.4 45.6 22.2 13.9 9.1 12.7 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828822-2882820 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "adipose tissue: 156.3" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Cluster 57: Non-specific - Angiogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 156.3 2.2 10.3 1.9 10.8 0.2 38.9 18.4 8.8 3.0 8.5 3.9 1.5 6.6 1.0 0.9 5.1 2.2 1.4 11.2 18.9 2.0 18.5 0.5 0.6 29.4 24.5 2.5 5.4 1.0 0.8 2.1 27.3 4.0 2.8 1.4 4.7 6.6 0.3 1.9 2.1 3.7 36.0 0.3 4.5 0.9 13.7 0.4 1.7 0.5 0.3 3.7 2.0 35.4 0.1 11.5 39.1 0.2 20.5 0.0 28.5 2.0 6.3 6.1 8.2 30.4 0.6 0.0 3.1 5.2 6.6 0.0 22.5 0.5 6.8 0.2 6.3 0.1 0.7 32.6 6.7 0.0 8.9 8.1 0.4 1.0 0.0 0.2 0.0 0.0 0.3 0.1 6.6 1.9 0.0 1.0 38.4 0.4 0.2 6.1 13.0 0.0 0.0 0.1 0.0 0.7 0.1 0.3 87.6 59.0 4.1 25.4 0.0 0.0 6.7 3.8 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.3 10.8 18.4 8.8 11.2 18.9 29.4 24.5 27.3 36.0 13.7 35.4 0.3 0.0 0.0 10.7 0.2 0.4 1.1 0.5 0.0 1.2 2.1 0.8 1.2 4.3 0.2 0.0 4.2 6.0 0.0 1.2 5.9 1.0 0.4 3.8 1.0 0.3 20.4 0.0 5.9 4.0 7.9 1.6 4.6 0.7 0.0 10.2 0.0 20.2 1.1 0.0 4.9 1.7 0.0 1.0 0.0 0.5 0.6 0.1 3.6 0.0 0.0 1.6 0.0 0.5 0.1 2.1 0.6 3.0 0.0 1.0 0.4 2.4 1.1 0.1 0.0 0.3 1.2 0.3 1.5 0.0 0.3 2.3 0.0 3.2 3.5 0.7 HELZ2 "KIAA1769, PDIP1, PRIC285" ENSG00000130589 "Helicase with zinc finger 2" Q9BYK8 20 63558086-63574239 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 46.1;Urothelial cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 59.4;GAMG: 34.5;SK-MEL-30: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051267 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA051267: " "unprognostic (1.86e-1)" "unprognostic (7.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.93e-3)" "unprognostic (1.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.36e-2)" "unprognostic (5.06e-2)" "unprognostic (1.52e-1)" "unprognostic (1.73e-2)" "unprognostic (3.61e-2)" "unprognostic (2.19e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (9.76e-2)" "unprognostic (1.16e-1)" 6.6 4.2 4.0 5.6 2.9 15.6 5.6 2.3 2.1 5.7 1.6 5.5 3.8 4.2 0.6 7.4 5.0 3.0 7.0 1.9 2.6 6.6 7.7 9.9 4.8 6.2 3.1 3.9 5.8 0.8 5.1 2.3 4.1 4.6 0.9 0.1 12.2 1.1 1.8 4.8 6.3 1.0 6.4 12.3 7.6 1.2 4.7 3.0 5.9 0.9 1.8 3.9 3.9 2.7 10.0 3.7 1.2 3.7 2.2 2.8 7.1 3.5 5.2 59.4 23.0 10.1 12.4 0.2 7.5 1.3 34.5 15.3 0.7 3.6 2.3 3.7 1.7 0.2 4.6 3.5 4.8 0.3 23.4 3.5 2.5 4.3 0.7 1.3 2.8 0.2 1.8 4.1 0.7 9.9 1.1 10.2 1.9 2.6 11.4 2.2 2.0 3.9 1.7 11.4 0.9 3.3 10.9 0.7 25.4 0.7 3.4 3.0 4.5 5.7 8.4 4.7 3.6 5.2 0.7 0.2 6.2 1.6 5.2 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 4.0 2.9 2.3 2.1 1.9 2.6 6.2 3.1 4.1 6.4 4.7 2.7 24.7 9.6 6.0 0.3 10.5 8.7 22.7 8.8 4.6 1.0 8.8 5.5 4.5 8.6 12.1 9.2 0.0 2.1 15.9 26.0 0.0 8.8 0.1 11.6 9.6 24.9 30.9 3.2 0.1 7.7 13.4 11.6 26.0 17.5 0.0 46.1 10.4 6.0 3.5 0.0 0.3 19.5 4.1 4.3 17.1 0.0 7.2 10.8 3.6 4.7 7.0 1.7 24.7 1.0 0.4 20.4 20.7 2.2 6.4 28.9 17.9 0.8 9.6 2.7 6.6 12.2 9.9 0.7 0.3 5.1 8.4 1.9 14.7 17.7 14.5 47.4 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322179 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 59: Non-specific - Translation" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 5.3 5.7 2.5 2.3 2.9 4.0 4.9 1.5 3.1 5.5 3.0 9.3 2.6 7.6 1.7 5.2 6.1 2.2 7.4 2.3 1.1 3.7 3.7 5.1 2.3 2.0 1.8 8.3 6.1 5.4 6.3 2.7 2.7 4.4 2.8 5.3 4.8 2.9 14.2 5.3 6.1 3.7 0.4 4.3 6.3 4.8 2.7 4.4 5.8 9.3 2.4 5.6 5.0 6.2 8.5 16.5 11.2 4.7 9.2 6.9 3.2 6.0 7.1 7.6 7.3 8.6 1.1 8.5 7.2 10.4 11.5 8.5 12.0 5.9 5.6 5.2 7.8 54.0 20.2 2.9 3.5 12.8 4.1 5.7 4.5 9.0 11.2 4.9 10.2 7.0 21.2 3.4 7.3 3.9 2.9 4.3 3.4 6.4 7.1 10.2 16.0 0.7 2.6 18.2 12.3 7.1 14.6 4.1 4.5 5.8 4.8 14.8 15.3 14.0 9.2 5.5 9.1 2.2 3.3 7.7 6.5 5.9 7.6 0.1 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.0 0.1 0.1 0.6 0.2 0.1 2.5 2.9 1.5 3.1 2.3 1.1 2.0 1.8 2.7 0.4 2.7 6.2 56.2 22.4 23.5 68.9 34.3 16.4 15.3 18.1 27.9 107.9 39.1 31.2 66.6 21.5 23.6 64.4 148.0 25.9 28.5 31.8 1.9 28.7 13.0 35.0 55.8 73.3 28.1 67.9 88.9 30.4 15.5 34.3 43.3 29.6 3.8 135.0 38.9 36.7 19.0 122.8 82.9 32.1 16.2 22.3 20.7 15.8 56.2 22.1 69.4 84.3 26.9 41.0 45.3 65.9 89.7 36.6 30.8 52.3 56.6 20.5 31.1 19.8 19.6 142.9 65.7 46.0 43.2 72.5 66.4 38.3 21.0 17.8 30.0 62.7 35.5 11.5 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443097 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 13: T-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 4.1 5.5 6.5 5.4 7.2 7.9 6.2 5.2 8.8 14.2 4.3 6.1 5.3 8.5 4.2 20.9 9.7 10.7 9.6 7.0 7.6 6.0 4.8 8.1 5.0 8.2 6.6 8.3 5.4 7.1 4.4 5.5 7.3 8.4 6.1 4.4 30.5 5.1 3.0 4.1 5.3 8.0 11.7 8.2 7.2 3.9 6.9 12.3 4.3 4.7 5.3 6.0 11.2 6.8 6.7 4.5 0.3 0.9 0.3 3.8 1.2 0.8 22.1 116.1 85.8 0.4 8.3 0.0 1.5 2.1 18.8 2.5 10.9 5.7 7.6 13.9 2.2 6.3 3.8 0.6 3.7 11.3 4.2 5.2 1.3 9.1 0.3 7.0 3.4 5.2 0.0 1.5 2.6 4.1 5.3 3.6 1.5 6.0 2.2 3.6 0.1 0.5 7.8 8.2 0.3 2.7 8.2 2.7 13.5 5.6 4.8 2.0 1.2 1.6 2.1 0.2 2.1 0.3 0.1 0.0 5.2 2.5 5.4 4.4 3.2 4.7 6.4 3.4 12.8 3.5 8.9 6.3 2.8 3.0 6.9 4.7 1.9 6.0 7.4 0.3 12.5 4.2 6.5 7.2 5.2 8.8 7.0 7.6 8.2 6.6 7.3 11.7 6.9 6.8 11.4 12.8 10.6 14.4 5.8 2.8 5.2 3.3 4.6 18.1 4.9 4.6 13.9 7.2 9.8 5.5 16.7 5.8 5.0 8.3 0.0 7.8 1.3 6.4 3.9 11.5 1.8 4.8 21.5 17.4 1.8 6.6 5.6 5.0 5.7 25.9 5.3 2.2 5.0 1.7 25.8 2.9 4.1 2.2 0.8 1.6 4.4 4.7 5.4 28.1 5.7 3.7 4.1 24.1 2.8 13.3 2.4 5.7 3.8 8.3 6.2 4.1 14.6 1.0 6.6 2.0 3.6 0.8 2.1 18.4 1.1 2.5 8.2 13.3 2.5 8.0 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.5 0.9 8.8 1.0 12.0 0.1 5.7 9.4 7.6 8.0 3.0 2.5 1.3 7.5 16.4 1.8 13.5 1.7 30.7 7.2 10.4 3.1 5.3 3.2 0.5 12.7 10.0 7.1 3.3 2.6 5.5 3.7 10.6 2.1 1.3 5.7 2.0 2.7 16.2 2.4 2.1 1.7 14.1 1.9 2.0 6.6 11.8 0.7 3.1 4.9 0.6 2.7 4.7 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.5 7.1 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.6 0.0 0.4 0.0 0.0 3.2 0.0 0.3 0.5 0.6 0.9 0.0 0.1 2.3 0.0 0.0 0.0 6.6 3.2 1.9 0.0 14.8 0.3 0.0 0.1 0.8 17.6 0.3 0.1 0.6 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 12.0 9.4 7.6 7.2 10.4 12.7 10.0 10.6 14.1 11.8 12.2 2.8 3.2 1.1 12.4 0.7 3.8 0.5 8.7 3.4 0.4 9.8 5.7 21.5 0.0 2.7 0.0 8.4 0.0 1.4 0.1 9.8 0.1 49.9 46.1 4.2 6.0 0.0 2.7 0.1 1.8 0.1 3.3 1.1 36.8 0.0 73.9 1.8 8.0 0.1 1.7 0.4 0.0 2.0 0.8 3.0 80.6 6.5 0.6 3.6 5.6 0.0 34.8 3.1 2.5 23.4 1.1 0.1 23.3 3.1 0.3 0.0 6.4 5.4 5.2 52.6 17.5 41.8 16.2 15.1 7.7 2.0 0.0 2.0 2.8 0.1 0.3 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 subunit alpha" Q16665 14 61695513-61748259 "Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 448.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 155.0" "Lineage enriched" "Detected in all" 7 "granulocytes: 155.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 941.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 64.9 133.7 22.1 146.6 24.0 448.3 36.2 28.2 26.1 132.9 24.7 42.8 33.6 52.4 74.8 62.1 41.1 145.4 36.5 21.1 28.4 104.2 51.6 75.7 71.4 29.7 29.7 35.3 36.0 91.7 30.7 77.6 33.3 46.9 41.7 35.5 45.3 67.2 12.1 34.2 37.3 59.1 27.2 72.4 37.6 32.4 38.5 55.8 49.5 17.6 88.2 169.9 43.1 26.5 313.6 123.6 112.7 344.7 185.2 297.1 161.5 253.8 270.1 288.7 258.9 54.1 100.3 75.8 186.2 293.0 73.6 71.8 71.0 416.1 352.5 33.7 41.0 46.5 105.3 93.1 414.8 20.1 49.3 523.4 129.2 216.5 225.6 408.6 198.1 44.4 32.3 0.4 941.4 65.6 59.2 24.3 108.9 49.6 159.7 4.3 269.1 22.8 400.2 204.3 100.3 111.9 472.5 67.0 170.7 148.9 70.6 36.3 119.2 700.2 157.3 235.9 215.2 39.1 61.2 84.1 369.9 38.5 194.7 43.8 22.3 155.0 11.5 18.0 14.4 19.5 15.0 13.3 19.6 19.0 22.6 15.6 56.3 19.7 19.4 9.2 11.0 18.4 22.1 24.0 28.2 26.1 21.1 28.4 29.7 29.7 33.3 27.2 38.5 26.5 93.3 70.5 116.0 69.2 157.3 106.4 101.8 102.6 97.9 54.1 38.5 30.1 43.5 87.2 69.0 261.1 50.1 24.8 65.1 44.1 103.7 278.5 3.6 95.6 131.3 152.3 66.4 35.3 45.6 251.6 67.1 81.4 49.5 272.3 223.6 339.7 176.0 30.7 136.4 156.5 39.3 39.0 57.0 145.9 111.7 6.2 24.2 240.2 103.2 53.4 87.1 134.0 26.8 78.9 35.8 236.9 21.9 48.5 60.0 59.3 20.2 192.1 37.7 54.8 52.6 75.8 136.9 80.5 44.2 128.7 87.9 25.4 91.6 92.2 51.8 116.0 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 12.4" "Region enhanced" "Detected in many" "medulla oblongata: 16.7;pons: 16.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3" "Region enriched" "Detected in single" 24 "pons and medulla: 9.4" "Group enriched" "Detected in some" 49 "medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0" HPA053910 Supported Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 8.6 4.5 0.1 2.1 0.1 0.1 5.2 0.1 0.2 1.0 0.1 2.1 1.1 4.7 7.2 8.1 27.0 0.4 0.5 0.2 0.2 13.5 0.1 0.8 3.6 16.7 1.1 11.1 0.3 0.1 0.1 6.3 16.2 1.6 0.2 0.0 0.3 0.9 9.1 6.2 6.8 4.8 6.4 1.8 5.2 3.3 0.3 0.4 1.0 0.0 1.9 0.7 0.8 3.7 5.3 5.1 0.0 23.8 9.4 4.9 0.0 2.4 2.5 2.4 1.7 0.2 4.3 20.5 0.2 18.5 0.1 4.7 0.4 0.6 1.5 31.2 33.0 0.2 2.9 0.0 1.1 2.5 0.7 12.5 2.3 13.7 2.4 0.0 0.3 6.7 1.1 0.0 8.9 0.3 2.8 0.5 0.1 0.9 0.1 6.7 7.2 0.0 10.2 0.0 0.0 27.3 3.8 1.2 13.7 1.1 18.0 1.2 0.0 12.0 6.9 1.0 12.8 5.3 6.0 10.6 0.7 2.3 12.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.2 16.7 1.1 16.2 6.4 0.3 3.7 1.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 9.1 0.0 1.4 3.4 0.5 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.9 0.0 4.1 12.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.6 0.1 0.0 10.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 2.9 3.1 0.2 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.1 0.0 1.5 3.7 0.0 0.1 2.9 0.0 0.0 6.6 3.9 3.6 2.7 0.5 8.2 0.0 0.3 1.6 2.7 0.1 0.0 HS2ST1 KIAA0448 ENSG00000153936 "Heparan sulfate 2-O-sulfotransferase 1" Q7LGA3 1 86914635-87109982 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043069, HPA043603, HPA075001" Supported Approved Mitochondria "Intracellular and membrane" No No "Cluster 38: Basophils - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (1.28e-3)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.20e-2)" "unprognostic (5.34e-2)" "unprognostic (7.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.45e-1)" "unprognostic (5.80e-2)" "unprognostic (1.63e-2)" "unprognostic (5.07e-2)" "unprognostic (3.24e-1)" "unprognostic (7.58e-2)" 8.0 25.7 11.5 9.4 13.8 3.8 8.1 8.0 12.2 10.5 13.2 9.3 9.7 9.1 9.9 7.0 6.7 10.6 7.0 11.9 11.4 13.8 17.2 8.2 11.8 10.1 11.0 12.7 10.1 13.4 6.6 8.3 8.1 9.5 9.0 19.3 6.7 9.9 4.4 8.2 9.3 7.8 8.8 12.7 8.3 9.3 12.2 10.6 12.9 4.7 11.6 9.4 5.9 8.4 24.4 20.4 59.0 38.5 31.9 92.3 20.4 23.3 30.5 19.2 21.2 78.1 30.6 53.3 22.1 16.4 33.2 14.5 27.2 19.5 30.8 42.1 22.2 64.0 21.0 63.0 13.4 33.6 31.0 38.2 17.0 31.0 25.6 30.4 28.8 29.7 44.6 27.4 28.1 8.6 33.8 20.2 19.8 26.5 12.9 41.2 55.7 11.6 23.5 50.3 12.6 19.0 30.6 26.2 27.2 15.2 17.2 15.2 25.7 24.0 29.8 42.2 29.7 25.1 19.9 49.7 14.8 23.6 25.0 6.2 1.1 1.0 1.3 0.6 1.6 1.1 1.5 1.5 0.7 2.8 1.4 0.9 1.2 1.1 2.8 0.7 0.9 1.0 11.5 13.8 8.0 12.2 11.9 11.4 10.1 11.0 8.1 8.8 12.2 8.4 13.0 16.0 12.4 160.9 14.2 16.6 8.6 9.3 19.9 10.9 11.9 7.6 12.8 14.3 15.2 20.2 4.2 8.2 5.7 13.5 13.7 18.2 5.5 7.1 23.6 13.8 23.4 12.2 126.1 11.5 9.3 16.9 11.2 8.0 19.0 74.2 18.2 28.9 37.7 8.4 130.1 12.5 18.3 12.8 13.5 3.8 6.8 15.3 12.4 53.4 8.2 28.8 5.2 95.0 54.5 11.3 7.7 20.3 24.0 7.3 17.6 18.3 11.2 17.7 0.0 21.1 16.8 10.1 15.0 12.8 15.8 4.4 12.9 77.4 13.5 7.1 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429564 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ovary: 31.9" "Cell type enhanced" "Detected in many" "Club cells: 112.0;granulocytes: 96.3;Granulosa cells: 285.0;Peritubular cells: 90.3;Urothelial cells: 92.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.4" "Group enriched" "Detected in some" 36 "memory B-cell: 14.9;naive B-cell: 26.6;plasmacytoid DC: 42.3" "Group enriched" "Detected in many" 108 "B-cells: 26.6;dendritic cells: 42.3" "Cell line enhanced" "Detected in some" "A-431: 5.8;CAPAN-2: 20.6;HaCaT: 6.0;RPTEC TERT1: 13.2;RT4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favorable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favorable (8.67e-4)" 2.6 2.5 2.3 2.7 1.9 2.0 1.9 25.4 6.9 2.4 0.0 2.1 3.7 3.4 1.3 11.6 4.4 12.7 1.9 1.6 4.7 5.9 0.4 1.8 2.3 4.7 3.3 31.9 1.0 0.1 4.7 0.7 3.8 2.0 1.1 1.0 5.6 1.5 0.4 0.5 2.9 0.9 4.4 3.3 6.5 1.3 5.8 1.3 1.6 0.2 1.2 14.5 2.6 6.1 5.8 1.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.6 0.0 0.4 0.0 0.0 6.0 0.0 2.8 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.1 1.6 2.2 1.2 0.0 0.0 13.2 14.5 4.6 0.0 0.0 0.1 0.4 0.2 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.2 14.9 0.0 0.0 0.7 26.6 0.0 0.0 0.0 0.0 0.0 42.3 0.0 1.1 2.3 1.9 25.4 6.9 1.6 4.7 4.7 3.3 3.8 4.4 5.8 6.1 3.5 3.2 5.8 0.0 13.1 9.1 13.5 70.1 5.2 3.7 2.4 9.3 3.2 32.9 112.0 20.2 4.2 0.5 21.6 5.2 0.0 25.0 1.7 3.6 1.0 28.9 2.4 0.0 13.4 2.1 42.1 13.2 23.9 14.9 96.3 285.0 25.0 0.4 37.6 1.7 35.0 7.2 71.2 3.5 3.7 2.0 8.7 12.5 1.8 6.5 4.9 32.9 8.2 24.1 0.7 51.9 6.5 90.3 0.0 5.6 2.7 19.1 61.2 2.6 0.0 0.5 17.5 5.4 5.6 36.6 8.1 1.4 1.4 68.5 4.3 92.9 HS3ST3A1 "30ST3A1, 3OST3A1" ENSG00000153976 "Heparan sulfate-glucosamine 3-sulfotransferase 3A1" Q9Y663 17 13494032-13601929 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 8.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 5.9" "Immune cell enhanced" "Detected in some" "T-reg: 2.2" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 2.2" "Group enriched" "Detected in many" 4 "PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2" "Region enhanced" "Detected in many" "olfactory bulb: 5.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.3" "HPA062518, HPA071530" Uncertain Approved Microtubules NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 40: Granulosa cells - Unknown function" Microtubules "HPA062518: AB_2684789, HPA071530: AB_2686411" "unprognostic (2.88e-3)" "unprognostic (4.21e-2)" "unprognostic (8.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-3)" "unprognostic (4.44e-2)" "unprognostic (2.01e-1)" "unprognostic (4.46e-3)" "unprognostic (2.12e-4)" "unprognostic (1.12e-2)" "unprognostic (8.52e-2)" "unprognostic (1.55e-1)" "unprognostic (1.85e-9)" "unprognostic (1.83e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (4.70e-3)" 0.4 2.0 0.1 1.9 1.0 1.0 0.4 0.0 0.6 4.5 3.2 1.2 1.4 0.7 0.1 4.6 1.3 0.3 2.5 0.2 0.0 1.4 1.9 1.2 2.6 5.9 1.4 8.1 0.3 0.0 0.7 2.7 1.1 3.1 0.3 1.3 2.0 4.9 0.1 0.7 1.2 0.2 3.5 6.4 0.6 2.3 0.1 0.3 0.3 0.0 1.6 0.5 3.4 0.5 0.1 0.3 3.3 0.0 2.7 6.8 5.1 18.2 4.4 3.2 2.0 0.0 0.6 0.0 2.6 11.2 0.0 0.0 0.1 0.0 3.1 1.1 18.3 4.9 1.5 2.0 1.6 0.0 1.2 4.9 0.1 8.5 2.2 5.5 0.0 0.2 19.2 0.0 3.8 2.5 0.1 3.3 3.5 0.0 40.9 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 2.0 0.1 0.6 0.2 3.1 0.4 0.1 123.0 0.0 0.0 0.0 73.2 0.0 9.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.5 0.0 0.0 0.5 0.5 0.2 0.3 0.0 1.7 2.2 0.3 0.1 1.0 0.0 0.6 0.2 0.0 5.9 1.4 1.1 3.5 0.1 0.5 0.2 0.0 0.0 9.8 0.0 0.6 0.0 0.0 5.7 0.3 0.0 0.3 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.4 0.3 1.1 0.0 0.0 1.8 0.2 0.0 4.7 0.0 0.2 0.0 11.6 7.1 0.0 1.6 26.9 4.1 0.0 0.0 0.8 0.3 0.1 13.7 0.0 0.0 1.9 0.0 2.4 0.0 0.5 0.2 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 4.0 0.3 0.4 9.3 0.6 0.1 0.1 0.0 0.0 0.0 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318868 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Transferase "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 75.4;Granulosa cells: 285.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044586 Approved Nucleoplasm "Intracellular and membrane" NA NA 72000 "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA044586: AB_10963057" "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 16.2 63.4 36.2 8.8 33.8 5.1 16.1 24.4 45.5 15.5 10.9 15.4 8.7 12.3 6.1 34.1 17.5 21.0 19.0 35.4 26.5 71.4 46.8 17.0 8.4 32.1 34.7 26.4 30.8 8.8 15.2 12.0 33.6 28.2 6.9 26.4 26.0 22.8 36.2 26.5 15.1 6.4 31.2 32.1 12.7 25.0 39.9 14.5 14.2 18.7 7.4 19.4 23.1 28.9 12.5 17.4 46.0 26.5 17.5 32.5 24.7 15.1 19.1 14.8 8.1 9.0 8.0 11.9 131.2 19.4 6.9 32.5 17.5 29.1 5.5 19.9 18.1 10.5 6.4 87.9 21.1 18.4 206.6 43.9 33.9 11.9 3.6 4.9 8.0 31.8 6.7 12.1 5.4 25.7 49.6 81.0 55.3 4.7 10.7 16.1 12.6 61.9 13.4 36.3 112.9 28.4 12.1 30.1 6.7 30.6 12.2 6.9 9.6 13.1 28.9 49.1 12.3 7.2 7.6 2.7 7.9 13.0 9.7 3.0 0.7 0.6 1.0 0.4 0.1 0.7 0.4 0.6 0.5 0.7 0.4 0.4 0.2 0.2 1.5 2.3 0.2 0.6 36.2 33.8 24.4 45.5 35.4 26.5 32.1 34.7 33.6 31.2 39.9 28.9 9.5 25.6 8.9 20.9 4.9 16.2 11.2 16.1 14.8 9.4 15.1 12.8 7.3 10.0 10.3 75.4 31.3 9.7 7.3 22.3 5.9 15.4 0.9 22.9 11.5 12.6 3.0 6.9 24.2 5.8 36.9 12.6 4.1 39.7 57.0 285.6 30.0 23.8 10.7 21.9 20.3 6.5 8.2 14.2 9.2 3.3 11.8 9.1 7.2 5.6 6.7 8.2 1.0 6.6 10.4 6.6 12.0 17.0 3.2 9.7 6.9 3.3 8.7 32.8 6.6 7.6 9.4 1.1 3.1 18.3 17.0 23.3 3.5 27.1 3.7 8.9 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42552922-42555214 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "placenta: 82.3" "Group enriched" "Detected in many" 4 "Granulosa cells: 1574.2;Syncytiotrophoblasts: 1495.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 399.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA 19000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 4.4 1.9 3.8 1.7 4.2 0.8 3.0 3.9 4.6 3.0 2.7 2.2 2.1 2.1 0.7 6.0 3.2 0.5 2.1 3.8 3.5 2.4 2.0 1.5 1.0 4.8 3.5 6.8 3.0 0.6 2.4 82.3 4.4 2.6 0.1 0.6 3.7 0.5 4.4 6.3 2.1 0.2 3.2 2.0 2.2 3.8 3.9 0.4 2.8 0.0 0.4 1.7 3.1 6.1 7.0 6.0 1.8 20.2 1.0 0.3 399.0 4.3 0.0 0.0 0.0 2.9 2.8 0.1 4.0 0.2 1.8 9.7 0.7 3.9 0.0 7.6 10.7 3.7 3.8 4.3 0.9 2.7 3.9 0.9 13.2 0.5 2.7 1.5 0.1 2.6 5.7 1.2 0.0 4.8 3.2 2.3 0.4 1.4 2.8 3.9 3.0 2.5 0.5 3.4 4.3 5.6 2.4 41.4 4.2 0.9 48.5 1.1 4.3 2.7 5.4 2.4 2.7 7.7 4.6 1.5 1.9 1.9 2.8 1.0 2.2 2.5 1.1 2.4 1.3 1.2 1.4 1.1 1.3 1.4 1.0 1.0 2.2 1.6 1.5 0.9 0.8 2.0 3.8 4.2 3.9 4.6 3.8 3.5 4.8 3.5 4.4 3.2 3.9 6.1 2.3 0.0 2.2 6.5 2.2 3.1 8.0 14.9 6.2 8.3 11.6 10.7 3.0 4.3 5.3 5.5 12.5 333.0 3.3 4.7 23.5 1.7 1.4 3.3 9.3 4.2 4.2 0.8 1.4 5.6 30.4 11.6 1.5 3.8 2.5 1574.2 3.6 6.4 29.7 10.1 1.6 2.7 8.2 0.6 1.2 1.9 1.8 3.6 1.8 1.9 1.0 11.2 2.1 2.0 3.3 2.0 2.0 3.4 1.4 11.6 2.5 20.5 4.2 8.9 0.0 6.7 29.2 0.8 2.7 14.6 7.4 1495.8 2.6 30.0 2.6 10.4 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122141-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 45.4;Rod photoreceptor cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No "Cluster 34: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 7.5 15.4 14.3 7.1 14.6 4.4 11.9 10.9 13.0 10.6 10.7 7.4 6.2 13.2 10.5 7.8 12.6 7.1 15.7 14.0 18.3 10.8 5.1 9.1 9.0 15.0 14.8 22.0 4.9 15.1 11.9 9.1 18.6 9.8 6.9 34.3 7.3 11.1 20.7 8.0 5.7 10.8 9.5 8.0 6.4 13.2 17.0 14.1 26.8 30.5 9.2 7.3 7.1 10.2 11.1 12.6 57.4 19.8 20.7 14.5 14.6 13.8 13.1 17.0 8.9 14.5 18.8 22.7 24.7 12.4 18.8 7.6 31.1 12.1 26.9 4.9 18.9 10.9 7.9 32.5 21.0 17.1 19.2 11.0 20.0 24.1 15.4 21.9 20.9 30.6 23.0 28.2 34.3 27.3 37.8 17.4 29.5 6.4 13.3 36.7 20.4 8.4 16.6 12.0 27.1 20.2 35.0 5.6 39.0 28.5 34.4 10.2 17.5 19.2 22.9 13.9 11.3 44.1 38.1 36.9 22.8 12.3 18.2 21.2 5.0 11.1 3.8 3.4 5.0 5.0 4.1 4.6 2.8 7.5 5.3 5.6 5.5 4.3 6.3 0.0 5.4 4.4 14.3 14.6 10.9 13.0 14.0 18.3 15.0 14.8 18.6 9.5 17.0 10.2 8.9 12.8 16.4 7.8 8.2 4.8 4.6 6.4 8.6 20.2 10.2 8.3 16.7 1.5 8.6 3.7 14.6 6.9 4.4 3.7 5.9 7.9 38.5 11.4 10.5 7.7 9.5 5.7 12.4 6.7 6.6 7.7 3.6 11.0 1.3 38.6 9.3 4.1 12.2 45.4 15.8 3.7 4.1 6.9 3.5 12.2 5.9 10.4 5.4 11.2 6.1 28.4 5.2 15.6 13.0 6.8 2.5 10.1 10.1 5.2 3.9 8.0 13.7 44.2 0.0 8.0 7.8 35.8 30.1 8.8 7.0 8.8 6.6 12.7 4.5 4.8 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112380080-112472405 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 181.3" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favorable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favorable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 76.3 63.6 28.1 13.3 30.1 11.6 22.8 25.1 29.5 23.3 27.6 31.7 38.9 22.8 11.5 29.8 21.2 19.0 89.9 24.8 33.1 69.0 149.0 28.7 13.9 25.4 33.2 50.8 20.0 21.8 8.8 16.8 27.1 20.3 26.9 12.6 18.8 15.9 151.7 31.1 32.2 20.5 26.6 18.6 24.6 14.0 32.0 19.6 30.4 181.3 15.8 29.2 15.0 28.5 45.0 39.4 29.0 14.8 49.0 48.4 33.4 30.1 18.6 21.1 17.7 77.0 49.4 28.5 16.2 44.4 26.9 50.6 31.9 42.2 25.8 120.9 21.0 30.0 58.5 76.1 30.7 17.1 18.5 52.0 29.9 31.3 22.8 30.5 24.8 34.7 42.3 18.9 58.2 29.6 42.5 15.3 17.2 106.9 50.3 27.1 87.4 42.7 44.5 40.4 20.7 14.5 75.8 49.5 26.0 23.7 70.0 20.0 28.3 30.2 27.9 85.2 29.6 21.5 57.3 13.5 37.0 24.8 18.2 54.3 8.4 32.8 4.6 8.1 6.8 6.9 4.8 5.0 9.5 8.4 5.6 5.9 48.0 5.9 11.5 9.4 8.7 4.9 28.1 30.1 25.1 29.5 24.8 33.1 25.4 33.2 27.1 26.6 32.0 28.5 32.0 99.3 84.3 48.6 14.1 13.3 17.5 21.6 29.6 9.3 12.0 13.3 214.8 14.3 32.2 14.7 6.2 26.5 18.3 23.7 64.6 15.5 153.9 38.6 38.3 19.1 14.9 32.8 10.8 18.7 30.9 31.1 29.0 27.8 30.4 187.2 17.2 124.2 35.7 6.7 12.2 32.2 8.2 23.6 12.5 163.0 27.4 27.5 8.8 15.9 47.3 24.1 6.2 16.1 19.3 13.2 23.5 47.0 20.9 16.0 52.4 111.1 37.7 14.5 46.0 18.1 46.9 12.9 16.4 34.2 16.2 31.7 16.2 108.9 36.2 29.5 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822244-21937310 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1400000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 140.7 54.7 3.8 36.1 5.2 1.7 96.2 3.7 4.8 65.9 18.8 153.1 18.3 151.9 6.6 44.1 85.0 53.4 156.6 3.6 2.9 37.6 10.6 49.0 14.2 5.6 4.6 31.3 31.7 13.1 11.8 30.3 5.7 60.3 8.6 0.3 45.0 56.5 65.1 41.0 54.9 96.2 4.0 37.4 76.1 9.0 7.6 6.7 69.1 40.8 3.5 110.2 59.7 4.7 44.0 40.7 13.8 45.9 131.0 99.4 51.5 70.2 17.8 21.1 18.7 50.5 86.7 3.3 293.0 112.9 0.8 26.9 3.1 31.9 5.4 0.6 4.3 15.7 46.0 35.7 27.0 0.0 4.1 61.6 9.4 19.9 6.0 28.1 620.8 0.3 21.4 5.7 32.4 11.8 0.0 20.0 11.7 19.6 17.9 6.3 87.8 6.1 35.1 6.5 1.3 4.1 51.4 20.0 28.7 14.0 8.1 7.2 504.3 41.1 51.8 29.7 2.3 0.5 7.3 2.6 9.7 0.1 54.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 5.2 3.7 4.8 3.6 2.9 5.6 4.6 5.7 4.0 7.6 4.7 366.8 70.5 28.6 3.6 3.9 26.4 13.5 81.1 21.1 0.6 6.2 21.5 5.8 38.6 30.3 92.0 0.0 11.0 3.4 52.9 0.0 76.1 1.4 24.2 47.7 322.9 2.4 22.9 0.8 25.0 89.0 141.3 62.2 39.8 23.4 776.0 600.4 6.6 6.8 3.3 0.8 12.6 16.2 22.1 19.2 5.8 75.2 4.6 60.5 15.9 1.8 1.6 0.0 2.5 4.3 87.5 29.9 69.2 4.6 19.3 19.2 0.9 28.7 0.6 32.9 82.5 69.8 0.3 4.8 10.0 17.8 9.3 5.0 83.3 20.1 11.8 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122458551-122514907 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" NA NA 24800000 7600000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.62e-6)" 246.0 81.3 382.1 37.0 436.6 0.5 202.8 422.6 595.7 352.1 316.2 154.8 20.8 197.1 247.1 57.8 122.9 301.2 114.7 377.7 411.4 230.9 226.4 69.9 39.9 427.1 447.0 425.5 55.9 111.8 184.1 281.9 425.3 85.7 51.8 243.6 101.1 114.5 31.1 130.5 73.5 152.3 382.1 54.2 87.3 19.5 423.6 21.2 78.8 80.9 27.3 137.3 188.3 464.2 0.3 45.6 19.4 5.7 2417.8 889.4 0.8 108.3 196.8 44.4 23.6 0.2 0.6 0.0 29.0 862.3 68.6 12.8 7.6 124.4 6.2 0.1 4.9 0.1 65.4 0.3 123.7 0.1 0.9 1581.4 444.6 25.8 205.3 503.6 207.1 0.0 0.1 1.5 1238.2 22.3 0.1 0.7 20.9 0.2 67.6 0.2 1.3 0.4 282.6 2.2 1.2 3.9 272.1 0.2 122.2 91.4 8.6 0.2 136.0 309.9 4.5 141.3 94.1 0.2 0.1 0.3 1004.6 0.2 148.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 382.1 436.6 422.6 595.7 377.7 411.4 427.1 447.0 425.3 382.1 423.6 464.2 55.1 22.4 6.9 116.5 0.9 44.1 32.5 10.8 23.9 53.3 5.4 31.2 26.4 14.3 0.9 64.4 54.2 30.9 1.3 0.0 0.0 2.0 3.5 11.3 76.5 107.0 0.0 2.7 2.2 4.6 164.6 269.3 4.6 14.4 1.3 731.6 57.8 157.8 51.3 625.9 31.2 0.3 8.2 18.1 59.9 4.2 31.7 22.0 46.2 86.2 8.5 373.8 0.0 193.0 112.5 2.7 1.3 77.5 1.9 8.7 0.2 22.6 10.1 150.3 6.6 63.3 140.5 0.2 0.7 7.0 30.5 87.7 7.2 2.5 0.6 11.9 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1" Q7Z6Z7 X 53532096-53686728 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Granulosa cells: 507.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 73000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 37.7 46.1 55.6 21.1 57.4 26.7 37.4 57.6 69.6 39.8 42.0 49.4 17.6 45.6 52.6 48.4 40.7 18.5 57.1 62.6 61.3 45.2 41.8 36.1 26.6 58.7 67.8 54.0 45.9 43.2 54.2 24.0 73.2 38.4 22.7 40.0 38.9 28.6 101.0 59.3 40.2 28.8 49.1 42.5 45.5 43.0 65.1 41.2 42.9 58.1 30.3 44.6 40.2 57.2 166.8 100.4 64.0 45.4 109.2 64.8 78.5 48.8 62.6 50.2 52.3 77.0 52.2 86.6 32.3 89.4 90.4 77.8 145.6 81.8 68.3 125.6 64.6 69.1 91.9 60.5 100.2 104.5 40.6 62.4 59.8 120.8 137.6 49.7 88.3 66.4 70.3 54.5 66.3 102.4 57.0 58.2 87.7 45.4 71.3 52.0 87.9 52.8 84.0 113.3 53.1 38.4 137.7 60.5 44.1 118.7 87.0 50.1 113.8 46.0 65.8 66.5 62.9 47.3 50.2 73.1 49.2 100.1 67.6 2.8 2.3 4.3 3.3 1.9 4.0 2.4 3.1 3.5 3.3 2.4 2.2 2.2 1.9 3.5 3.8 3.5 2.9 1.9 55.6 57.4 57.6 69.6 62.6 61.3 58.7 67.8 73.2 49.1 65.1 57.2 41.4 51.3 46.1 70.2 41.9 30.1 32.6 30.4 44.9 57.8 37.0 35.6 110.4 37.1 35.4 40.5 50.1 31.0 40.0 29.2 1.9 42.8 28.6 45.6 59.8 38.3 47.6 47.7 94.4 35.4 34.8 38.6 57.1 69.6 22.1 507.7 32.9 48.1 24.8 82.4 85.8 28.1 18.3 31.4 30.8 32.8 28.3 34.1 26.6 59.0 43.7 22.6 35.0 83.9 95.3 49.3 20.5 39.1 50.9 44.1 27.1 14.7 35.7 33.3 13.1 69.6 56.4 34.5 44.6 53.3 41.6 37.9 46.7 114.1 31.7 42.0 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1" O75874 2 208236229-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 536.3" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 768.1;RT4: 524.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 16000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 150.8 230.8 24.0 37.5 23.9 10.7 63.0 24.6 30.9 67.9 40.8 124.9 179.4 22.9 164.9 92.2 36.6 69.5 25.3 23.5 26.1 122.0 536.3 49.8 33.3 26.4 25.7 84.4 39.9 42.0 16.7 82.5 25.9 214.6 131.2 35.0 59.3 79.1 25.7 23.6 117.4 43.8 25.5 40.1 113.6 57.0 30.0 21.8 45.5 28.1 29.8 153.1 39.9 30.6 66.5 109.6 152.5 63.3 275.1 191.4 86.7 26.3 122.3 44.2 107.3 176.1 159.1 13.1 168.8 84.4 181.6 101.4 112.4 130.7 43.0 8.8 41.7 56.7 87.3 768.1 367.3 37.0 54.7 169.5 278.0 102.7 74.2 69.8 126.1 37.2 58.1 44.5 68.9 42.8 26.3 66.2 284.5 479.7 43.9 25.2 54.8 37.8 206.3 524.0 25.9 45.2 100.5 99.7 351.7 161.2 37.9 111.0 81.1 45.2 44.1 65.3 29.6 20.8 34.5 16.9 148.2 226.7 37.0 12.4 70.1 11.0 9.1 32.3 10.6 10.6 8.2 10.9 50.9 10.1 6.7 7.8 13.8 17.2 15.5 18.8 15.1 29.9 24.0 23.9 24.6 30.9 23.5 26.1 26.4 25.7 25.9 25.5 30.0 30.6 13.9 12.8 49.5 39.2 20.2 12.4 18.8 60.5 52.3 19.5 61.8 31.5 21.8 45.8 69.1 29.5 25.0 320.2 23.7 106.8 21.5 31.1 13.8 31.0 23.4 22.0 58.4 30.3 16.6 86.5 178.8 29.6 76.0 108.8 14.0 257.5 39.7 328.2 175.3 11.8 16.2 98.4 57.0 130.2 23.8 11.2 24.5 71.7 26.6 19.7 47.8 25.4 18.6 66.4 20.0 44.8 55.5 29.3 13.7 53.2 181.2 108.5 21.9 56.6 13.1 7.8 23.6 8.0 26.2 82.4 14.9 95.6 19.8 127.1 129.3 46.7 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006740-43014456 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" "Secreted to blood" NA NA 120000 "Cluster 7: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 27.5 41.3 15.4 27.2 16.4 24.9 24.2 15.6 18.2 18.4 16.2 27.4 24.6 17.4 11.7 10.2 20.8 20.1 20.9 14.9 16.7 29.7 30.6 25.6 26.4 20.2 16.6 23.8 13.6 10.5 14.2 15.0 17.3 27.8 20.4 1.5 29.4 15.2 6.3 11.3 30.2 21.3 20.3 39.9 22.7 5.0 17.0 23.4 20.8 9.3 19.0 21.1 15.4 17.0 12.7 28.8 0.2 1.5 24.2 29.1 6.1 8.2 84.6 204.5 299.2 10.7 46.2 3.9 16.1 24.7 108.0 7.0 1.6 12.9 16.3 33.5 6.1 9.3 10.5 39.5 59.6 10.5 19.3 40.3 4.9 29.0 3.6 18.6 18.8 8.0 5.4 61.2 8.2 12.5 22.7 8.5 0.1 11.6 13.0 18.4 0.1 23.7 25.7 10.9 5.4 0.2 16.4 6.3 88.2 0.6 26.5 20.3 9.3 15.1 0.3 4.8 13.3 54.1 21.8 1.1 27.1 8.2 14.8 60.7 102.7 61.6 44.3 127.8 40.4 37.8 34.0 41.7 62.0 40.0 26.8 33.6 62.1 56.9 122.0 67.0 51.8 80.5 15.4 16.4 15.6 18.2 14.9 16.7 20.2 16.6 17.3 20.3 17.0 17.0 65.2 16.0 9.7 2.6 28.6 10.5 29.6 31.8 12.5 0.8 16.5 11.3 5.5 11.5 22.7 18.4 2.1 22.7 36.7 83.1 41.1 47.8 9.4 12.3 27.4 32.1 31.7 12.8 0.7 64.0 32.5 32.8 26.5 16.2 7.6 122.4 37.1 31.3 84.8 1.7 0.6 39.4 12.2 36.8 19.2 39.5 28.9 47.8 24.9 5.6 75.5 10.4 64.9 1.0 1.0 41.8 116.7 23.7 54.0 19.1 128.0 93.7 18.0 0.8 6.6 13.2 36.3 0.5 0.4 5.1 9.2 10.4 32.3 25.0 34.6 29.6 IFNA13 ENSG00000233816 "Interferon alpha 13" P01562 9 21367424-21368962 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.4" "Cell type enriched" "Detected in single" 17 "Granulosa cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Granulosa cells - Unknown function" "HPA047557: AB_2680087" 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.2 1.0 0.6 0.5 0.6 0.7 0.5 0.1 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648539-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 239.4;Inhibitory neurons: 194.6;Microglial cells: 245.4;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 261.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 6 "granulocytes: 4.3;T-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved NA NA 46000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "CAB010268: AB_671792, HPA045563: AB_2679368" "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 7.3 11.3 10.1 3.6 11.2 11.0 12.2 12.0 12.0 10.1 35.5 12.5 2.5 11.0 11.1 7.5 13.0 4.5 9.6 9.5 8.2 11.6 0.9 9.5 2.7 12.4 13.4 15.8 15.4 2.1 8.8 12.1 11.2 14.7 4.5 16.0 10.0 9.6 7.0 11.1 6.5 6.1 10.3 5.8 9.6 8.4 13.2 6.1 12.9 11.6 3.4 9.9 10.0 11.1 6.1 34.0 22.6 0.2 11.9 8.3 16.3 8.0 14.5 2.5 2.2 15.6 17.5 1.6 22.1 13.8 14.7 31.6 10.9 25.0 1.9 0.1 11.1 27.5 32.3 31.2 10.4 11.1 2.5 12.1 14.9 4.5 18.6 9.3 8.4 2.8 1.4 5.4 9.9 48.1 5.4 9.8 23.0 11.8 1.3 7.7 19.3 6.7 7.4 37.8 8.1 35.9 56.0 3.3 30.1 50.2 16.7 3.8 24.5 1.5 26.5 6.5 12.0 1.9 9.8 5.9 4.6 10.0 5.9 1.9 0.3 0.9 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.4 1.4 0.4 4.3 0.5 0.3 0.1 0.0 0.3 10.1 11.2 12.0 12.0 9.5 8.2 12.4 13.4 11.2 10.3 13.2 11.1 30.8 28.9 13.4 157.7 3.5 32.8 28.8 31.1 35.3 51.5 58.3 33.4 30.8 5.7 30.2 22.0 91.8 33.7 8.0 10.7 1.9 16.6 27.6 79.7 39.6 26.1 35.0 7.8 239.4 11.2 20.3 25.2 11.2 91.3 0.0 106.5 52.5 1.5 6.5 75.7 194.6 21.1 20.3 6.6 8.3 53.4 18.0 8.3 21.4 245.4 8.5 45.6 14.4 237.7 261.0 29.1 12.9 13.5 4.3 70.9 5.3 21.8 55.4 36.1 0.0 20.4 27.6 4.0 17.2 17.9 32.0 27.5 6.4 20.9 24.5 51.5 IGFBP2 IBP2 ENSG00000115457 "Insulin like growth factor binding protein 2" P18065 2 216632828-216664436 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 956.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077723 Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 303000000 810000000 "Cluster 48: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "HPA077723: AB_2686853" "unprognostic (2.58e-1)" "unprognostic (5.95e-2)" "unprognostic (1.94e-1)" "unprognostic (3.32e-3)" "unprognostic (9.50e-3)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (9.11e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (5.04e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (1.22e-1)" 219.5 58.8 15.9 28.3 14.8 21.4 90.5 15.6 30.2 86.9 123.3 85.5 76.8 232.5 59.9 145.6 157.0 26.9 169.2 15.6 16.3 187.3 607.7 71.0 8.8 15.3 21.7 281.7 956.0 12.4 66.9 81.0 19.3 217.3 35.0 2.4 76.4 196.2 23.3 30.8 44.6 49.7 13.2 398.9 492.2 58.0 16.0 33.6 57.8 21.9 14.5 132.6 97.4 13.2 0.1 52.3 402.1 396.3 2139.8 652.9 8.5 125.2 61.9 6.1 0.6 1.2 1.5 0.1 171.7 0.8 15.2 11.5 145.4 156.9 0.6 0.8 84.9 91.3 0.2 26.3 53.3 38.6 5110.0 219.3 15.8 2.5 7.1 12.5 0.2 184.7 3.9 11.7 2.8 103.1 162.8 1106.5 437.4 98.2 4.8 139.2 9.1 2.0 2.0 117.1 84.1 443.4 0.3 3.4 2.6 362.2 332.4 67.3 0.5 1.6 2.4 1.6 6.2 6.2 0.9 9.7 6.0 177.4 478.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 15.9 14.8 15.6 30.2 15.6 16.3 15.3 21.7 19.3 13.2 16.0 13.2 354.3 3.2 0.6 2.0 3.3 13.8 534.0 238.2 19.4 0.2 79.0 498.0 12.5 11.5 40.1 264.8 2.1 1.8 5.4 86.4 29.4 3.0 1.0 153.2 1379.1 149.2 321.0 31.1 4.5 128.4 7.7 296.7 411.8 176.0 4.5 1649.7 92.1 658.6 5.3 0.0 0.8 191.6 54.9 24.1 5.0 4.9 5.6 21.8 3.6 13.1 1.3 3.6 3.1 1.0 1.0 60.7 51.3 79.4 0.4 255.7 4.2 1.2 195.9 1.7 105.2 17.9 435.7 6.0 35.8 103.3 5.5 2.2 16.0 2199.1 133.8 304.0 IHH "BDA1, HHG2" ENSG00000163501 "Indian hedgehog signaling molecule" Q14623 2 219054424-219060921 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 14.0;intestine: 22.3;stomach 1: 15.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 31.5;Enteroendocrine cells: 49.2;Granulosa cells: 122.4;Intestinal goblet cells: 34.7;Proximal enterocytes: 18.8;Undifferentiated cells: 23.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.8;endometrial cancer: 30.9" "Region enriched" "Detected in single" 6 "cerebral cortex: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 16.4;OE19: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 23000000 "Cluster 9: Intestine - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.63e-2)" "prognostic favorable (3.67e-6)" "unprognostic (4.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.28e-1)" "unprognostic (1.06e-1)" "unprognostic (5.86e-2)" "unprognostic (2.74e-1)" "unprognostic (6.31e-2)" "unprognostic (3.33e-3)" "unprognostic (1.81e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-1)" "unprognostic (1.51e-2)" "unprognostic (2.91e-2)" 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.1 2.4 4.9 0.0 22.3 12.2 14.0 0.0 0.3 0.9 0.7 0.0 0.0 0.0 2.4 3.5 1.3 0.0 0.3 0.1 0.4 0.0 0.0 0.5 0.1 0.4 2.4 12.4 0.0 0.0 0.7 0.0 0.0 12.9 0.7 0.2 0.0 15.0 0.1 0.1 0.0 1.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.3 0.1 0.4 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.8 0.0 1.8 0.0 0.0 0.4 31.5 0.0 0.1 0.0 6.0 0.5 0.1 49.2 0.0 0.0 3.3 0.0 0.1 12.2 8.9 0.0 122.4 0.0 0.6 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 14.0 0.0 0.0 1.8 18.8 3.2 0.9 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 23.6 0.3 ING2 "ING1L, p33ING2" ENSG00000168556 "Inhibitor of growth family member 2" Q9H160 4 183505058-183512429 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019486, HPA021517" Supported Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA019486: AB_1851780, HPA021517: AB_10601914" "prognostic favorable (5.43e-4)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (3.74e-2)" "unprognostic (3.89e-3)" "unprognostic (4.56e-2)" "prognostic unfavorable (8.87e-4)" "unprognostic (7.47e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-3)" "unprognostic (1.65e-2)" "unprognostic (1.97e-1)" "unprognostic (2.30e-3)" "unprognostic (6.19e-2)" "unprognostic (4.43e-1)" "unprognostic (5.52e-2)" "unprognostic (7.82e-2)" 9.5 42.3 5.2 5.2 5.8 21.7 8.7 6.8 6.8 7.2 5.5 9.4 10.6 5.2 10.2 14.6 8.8 8.9 7.5 5.0 9.6 12.2 10.5 8.6 5.9 6.4 6.4 37.4 15.8 6.1 23.3 6.1 6.0 8.7 6.7 8.6 10.7 4.5 26.1 12.1 14.3 4.6 4.6 9.1 11.5 33.3 8.0 12.5 9.3 14.8 6.7 11.4 9.9 5.3 19.1 11.4 15.5 12.3 28.1 16.4 12.7 20.1 17.4 15.6 13.3 10.4 20.2 13.5 5.2 14.7 12.7 8.3 10.4 15.6 19.8 10.4 7.6 23.4 11.4 13.5 8.5 19.3 25.1 12.7 14.3 17.0 7.1 12.8 7.5 13.0 13.2 49.8 11.5 18.8 24.7 19.6 12.5 5.5 11.1 10.3 8.6 22.5 18.8 8.7 15.3 11.5 13.3 17.6 5.3 10.0 8.3 13.9 6.4 10.5 16.5 7.2 13.0 10.7 8.6 9.1 19.3 14.3 7.6 15.2 6.3 19.7 3.2 6.6 5.0 11.9 6.3 5.7 7.8 8.4 8.8 7.6 6.4 3.8 8.5 7.6 5.4 3.7 5.2 5.8 6.8 6.8 5.0 9.6 6.4 6.4 6.0 4.6 8.0 5.3 18.7 6.4 21.0 6.2 20.1 49.3 20.5 20.7 105.9 25.7 36.3 41.8 12.1 25.8 18.2 16.5 12.5 26.1 18.8 32.7 74.3 20.9 68.4 93.0 26.3 21.7 18.6 26.7 7.1 34.9 94.9 29.1 11.7 82.9 40.0 85.4 15.4 24.1 30.0 25.2 5.3 24.2 16.2 24.2 43.3 35.2 82.6 27.3 26.6 1.0 13.9 40.5 6.2 3.5 5.1 33.3 28.3 53.8 19.5 34.2 112.9 47.8 39.8 23.6 19.7 23.7 28.0 95.3 74.9 71.6 46.2 21.2 25.6 50.4 23.0 39.3 INHA ENSG00000123999 "Inhibin subunit alpha" P05111 2 219569162-219575711 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 75.6;ovary: 104.4;testis: 95.3" "Cell type enhanced" "Detected in some" "Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 1.2 75.6 3.4 0.2 3.7 0.1 1.4 2.7 4.8 2.0 2.2 0.9 0.2 2.0 2.2 0.8 3.0 0.4 16.3 3.5 3.2 3.1 0.7 0.8 0.1 3.4 2.9 104.4 12.3 0.7 6.6 11.3 3.5 3.1 0.0 1.9 1.5 1.1 0.8 2.1 0.4 0.4 2.5 0.4 0.7 95.3 3.4 0.0 3.3 0.0 0.0 1.0 1.8 3.0 0.4 0.2 0.0 1.9 0.6 0.1 3.5 0.3 0.2 0.5 0.2 0.3 3.2 0.0 0.2 0.7 0.5 2.0 0.2 0.5 0.0 0.0 0.6 4.5 1.8 2.4 0.3 0.0 0.0 0.6 0.8 0.0 0.5 1.4 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.1 1.2 0.1 0.9 0.1 0.2 0.0 0.5 0.2 0.3 0.8 1.1 9.9 0.3 4.9 0.5 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 2.7 4.8 3.5 3.2 3.4 2.9 3.5 2.5 3.4 3.0 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.8 0.0 2.7 0.3 0.3 2.2 0.0 0.1 7.3 2.1 11.8 0.0 0.0 0.0 2.8 0.8 0.5 0.5 0.2 0.0 0.0 5.9 8.9 35.5 1.2 0.0 0.5 0.0 254.3 0.7 0.1 2.6 6.7 6.9 0.0 0.0 0.3 0.0 5.0 4.1 0.2 0.0 0.0 0.0 3.7 0.0 1.0 0.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 3.4 0.6 0.0 0.0 331.0 0.0 75.6 0.0 0.0 INHBB ENSG00000163083 "Inhibin subunit beta B" P09529 2 120346136-120351803 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 52.5;breast: 43.3" "Group enriched" "Detected in many" 7 "Adipocytes: 200.5;Granulosa cells: 653.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 44.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 47.6;ASC diff: 63.1;BJ hTERT+ SV40 Large T+ RasG12V: 38.5;MCF7: 58.4;PC-3: 91.7;SK-BR-3: 163.4;T-47d: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 130000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.80e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.26e-2)" "unprognostic (4.26e-2)" "unprognostic (3.61e-3)" "unprognostic (2.13e-2)" "unprognostic (5.52e-2)" "unprognostic (6.99e-2)" "unprognostic (3.59e-1)" "unprognostic (1.59e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.57e-3)" "unprognostic (4.14e-1)" "prognostic favorable (1.02e-4)" "unprognostic (1.76e-2)" 52.5 3.7 5.6 0.9 5.5 0.2 43.3 8.0 4.0 6.9 3.4 3.4 1.3 7.4 2.6 2.5 6.2 2.5 6.4 3.9 4.8 4.3 20.2 4.4 1.1 9.7 7.4 2.5 4.2 6.3 8.0 1.2 6.0 8.2 0.3 1.0 16.4 0.8 10.4 17.1 2.4 2.2 6.2 0.5 3.6 17.1 7.9 0.4 20.9 2.4 0.7 8.2 6.4 4.2 24.5 47.6 0.2 0.0 63.1 4.9 0.0 3.3 3.8 20.7 38.5 1.0 0.0 0.0 8.3 1.2 0.1 0.1 3.7 0.0 28.9 0.1 0.8 0.0 0.0 1.2 1.0 0.0 0.1 2.6 3.5 0.7 0.0 0.3 0.4 0.0 0.0 0.0 0.1 58.4 0.0 0.1 0.0 4.7 91.7 0.0 0.0 1.2 5.6 0.0 5.4 0.0 0.2 163.4 0.0 0.0 39.2 0.5 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 5.5 8.0 4.0 3.9 4.8 9.7 7.4 6.0 6.2 7.9 4.2 200.5 3.2 2.2 8.1 0.2 4.0 2.2 5.5 0.0 0.1 53.7 24.4 0.7 8.6 9.2 1.8 25.0 0.1 0.7 0.1 0.0 0.4 0.6 9.2 1.6 24.3 0.0 2.7 0.1 0.0 0.2 9.8 0.0 12.5 0.0 653.3 24.7 19.4 0.1 0.0 1.3 0.0 8.2 1.3 6.6 3.6 11.8 1.3 1.8 1.0 0.0 0.2 0.0 2.5 0.0 0.2 0.0 6.8 0.3 8.9 0.0 0.0 30.0 0.6 0.0 37.3 3.1 0.8 6.0 0.6 3.0 0.1 0.6 0.2 0.0 3.2 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930865-54934485 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.0;skin 1: 16.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" No NA "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favorable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 1.7 0.6 1.3 0.0 1.5 0.0 14.0 4.1 0.4 1.8 0.3 0.2 0.0 0.1 0.0 7.2 0.2 0.1 9.8 0.3 1.9 6.9 0.0 6.4 0.0 3.6 4.1 0.3 0.1 0.3 0.4 0.0 3.1 3.4 0.0 1.3 10.2 0.2 1.4 16.9 0.0 0.0 3.6 0.0 2.6 0.7 4.6 0.3 0.1 1.1 0.0 0.6 5.9 3.5 0.8 0.5 8.6 3.2 3.1 0.6 0.4 3.3 8.2 1.1 0.8 1.9 0.8 0.0 0.7 4.5 0.3 8.4 3.0 3.6 0.6 6.0 4.1 0.9 3.4 0.0 0.1 2.0 3.3 0.8 15.1 5.4 2.3 1.5 0.0 4.8 0.5 0.0 6.2 3.3 9.6 12.3 0.1 1.3 2.4 5.0 4.4 0.5 27.1 0.2 2.9 3.0 1.4 7.3 3.9 0.0 36.6 20.2 0.5 5.9 0.2 4.2 1.3 3.6 2.3 2.9 9.6 3.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 4.1 0.4 0.3 1.9 3.6 4.1 3.1 3.6 4.6 3.5 2.4 9.6 21.9 0.0 0.1 8.3 9.7 6.7 15.9 8.6 40.3 55.5 11.1 0.0 15.4 0.0 0.0 0.2 1.0 0.2 0.0 0.3 1.0 9.6 1.2 1.6 0.0 0.0 0.0 0.6 0.0 5.3 7.7 12.2 0.0 43.8 0.0 0.0 0.2 1.7 0.0 0.8 4.1 0.0 2.7 2.4 0.0 0.6 5.4 0.0 0.0 43.1 0.0 0.0 0.0 2.9 0.3 0.0 0.3 4.8 0.0 1.5 13.0 1.9 0.0 8.3 5.2 0.7 2.8 33.9 8.0 0.0 0.4 0.0 0.5 8.5 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 64000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 102.7 32.5 24.4 26.0 33.4 3.3 71.3 32.6 20.3 84.7 71.0 48.1 33.1 75.9 16.4 54.9 33.2 71.7 68.8 24.6 28.7 48.6 51.4 53.9 6.0 38.2 32.9 28.0 23.1 21.8 20.5 82.3 35.4 37.3 24.9 14.3 49.6 46.9 30.0 88.9 32.5 60.1 32.3 41.0 29.7 13.5 32.5 12.2 34.3 33.7 9.9 40.3 70.0 35.8 189.1 459.9 32.4 82.7 296.6 84.2 166.3 197.5 120.0 35.9 57.6 92.6 240.3 0.8 93.5 336.3 177.0 148.0 29.5 102.7 31.2 2.0 20.1 66.3 69.5 98.0 51.0 0.4 116.8 51.2 23.2 91.1 46.9 508.7 121.2 0.2 60.7 98.1 122.7 190.0 0.8 1.1 145.8 105.1 50.4 0.4 52.2 71.8 98.8 41.2 0.9 67.5 146.6 214.5 165.7 56.4 121.9 4.2 318.2 134.9 200.7 118.5 103.7 16.6 18.4 1.3 141.3 0.8 477.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 2.5 24.4 33.4 32.6 20.3 24.6 28.7 38.2 32.9 35.4 32.3 32.5 35.8 50.4 6.4 6.7 55.5 1.0 17.2 23.1 18.8 6.2 8.1 20.6 27.2 28.9 42.9 10.0 29.5 4.2 68.5 0.6 34.9 11.7 38.3 10.7 22.0 21.4 27.5 3.5 2.7 0.9 18.8 7.4 52.1 11.2 13.4 0.0 135.9 31.1 39.1 72.3 35.3 18.1 12.9 2.0 36.8 17.5 4.1 20.2 28.5 10.6 60.9 0.4 50.2 0.0 16.6 12.5 70.4 27.0 16.6 0.6 24.9 21.0 10.7 6.2 14.9 39.5 31.3 52.1 2.6 7.0 15.6 22.3 55.1 1.7 1.0 16.3 14.8 IVNS1ABP "ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317273 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 452.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 250.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 43.9 17.8 16.7 46.6 26.5 452.5 50.5 21.1 20.8 24.9 26.9 40.2 38.4 22.4 18.1 27.0 19.6 36.4 28.9 15.2 19.7 94.1 23.0 27.7 26.4 20.9 18.3 28.4 25.5 32.4 17.3 26.0 22.3 22.2 51.1 15.0 55.2 26.4 23.1 33.5 34.8 16.9 18.3 27.3 42.2 15.9 20.0 24.9 34.3 21.6 24.1 37.7 29.8 35.0 24.6 22.1 79.2 31.6 27.1 9.0 68.4 46.6 15.3 30.1 27.5 26.2 39.7 36.8 36.8 24.0 13.4 32.9 29.0 31.8 32.1 24.9 21.6 36.8 39.1 22.6 10.9 26.2 13.9 6.7 35.7 23.1 73.2 67.6 39.6 38.6 23.6 21.2 54.6 18.0 44.6 18.1 48.7 61.8 5.6 24.7 20.2 21.0 250.7 31.4 52.5 44.5 40.6 35.4 31.4 103.4 16.2 13.3 27.2 41.9 24.5 10.4 34.9 28.0 23.8 22.8 32.1 26.0 19.4 7.9 10.9 10.5 10.5 7.1 9.6 6.1 8.0 7.7 12.6 3.7 8.5 8.3 33.0 10.4 10.3 3.4 8.9 12.1 16.7 26.5 21.1 20.8 15.2 19.7 20.9 18.3 22.3 18.3 20.0 35.0 159.1 44.8 59.0 13.7 61.3 188.9 90.4 40.9 163.4 14.5 74.0 51.3 56.0 22.8 57.4 128.8 52.1 17.3 102.0 288.3 164.4 41.6 34.4 93.2 36.7 85.8 60.4 52.8 18.2 41.5 67.5 50.3 90.7 159.7 41.1 309.2 26.4 23.3 34.8 21.9 26.2 109.6 36.7 107.2 242.3 34.9 5.9 141.5 101.4 33.7 41.3 11.3 63.8 37.7 72.9 24.0 56.4 2.6 62.7 60.9 103.2 86.3 45.8 32.7 6.6 51.4 52.6 33.2 19.8 108.9 181.6 18.3 120.0 54.2 102.7 91.7 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012803-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (2.54e-4)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 31.2 7.5 13.5 5.2 21.2 0.1 13.0 5.1 13.0 6.5 3.1 36.0 1.4 17.3 7.5 5.9 12.5 10.4 18.3 10.8 7.2 6.7 1.8 24.2 3.5 12.5 8.4 10.9 16.9 4.9 4.5 33.6 10.1 7.8 3.9 13.1 2.4 9.5 9.9 3.7 3.7 17.3 7.3 0.9 4.5 14.0 13.3 6.1 13.6 14.8 1.8 18.3 4.4 8.1 15.3 6.7 5.9 0.0 3.7 0.9 8.6 8.1 8.5 1.2 2.0 2.6 0.1 0.0 0.6 29.3 1.7 0.3 1.6 0.5 3.3 1.7 3.6 0.0 0.0 0.1 16.0 0.0 1.0 9.1 0.2 19.9 1.5 0.5 29.9 0.4 0.0 0.0 24.9 0.5 0.0 0.7 1.2 0.9 10.2 0.0 3.3 0.0 1.2 0.3 0.8 0.1 0.3 0.1 0.0 8.4 0.0 1.4 67.8 14.9 3.6 4.7 0.7 6.2 0.8 0.0 3.5 10.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 21.2 5.1 13.0 10.8 7.2 12.5 8.4 10.1 7.3 13.3 8.1 106.8 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 16.4 0.0 1.3 8.5 30.3 0.0 0.0 0.0 0.4 0.9 2.2 0.0 0.8 1.3 72.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 0.2 7.1 0.0 0.0 KANSL3 "FLJ10081, KIAA1310, NSL3, Rcd1" ENSG00000114982 "KAT8 regulatory NSL complex subunit 3" Q9P2N6 2 96593170-96642787 "Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035017, HPA035018" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 52: Non-specific - Ribosome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Vesicles "HPA035017: AB_2674414, HPA035018: AB_10601763" "unprognostic (2.19e-1)" "unprognostic (6.94e-2)" "unprognostic (5.62e-2)" "unprognostic (8.72e-3)" "unprognostic (3.28e-1)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (6.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.01e-2)" "unprognostic (2.99e-2)" "unprognostic (2.04e-3)" "unprognostic (3.28e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-3)" "unprognostic (4.99e-3)" 11.8 9.9 1.9 8.6 2.4 14.9 12.3 1.6 3.1 13.7 8.1 11.8 7.2 15.0 7.7 8.9 12.5 6.9 10.7 2.9 2.6 8.8 6.4 9.9 8.2 2.1 2.9 15.1 9.8 15.1 8.8 9.0 2.3 11.2 6.9 6.3 12.5 14.7 33.9 10.8 12.0 10.6 3.3 10.1 9.8 12.8 3.3 13.1 12.9 21.1 8.9 13.0 10.8 2.3 13.1 7.9 26.0 19.4 10.6 6.4 11.4 9.7 15.2 20.1 21.4 15.1 7.8 18.1 14.6 16.2 14.7 8.2 18.8 9.4 17.5 12.8 14.8 26.0 8.1 16.2 15.0 17.4 9.0 15.0 5.8 12.8 11.4 12.0 11.0 21.0 18.6 12.8 12.8 6.9 32.3 13.5 12.5 6.7 12.8 26.2 16.5 10.6 12.4 12.7 26.8 16.9 12.3 11.8 11.8 14.7 11.4 5.5 15.9 13.5 11.8 9.8 8.9 10.1 6.7 15.7 7.0 19.9 12.2 2.4 1.3 0.5 2.8 1.5 2.1 1.6 1.7 2.9 0.7 1.5 1.2 2.3 0.2 3.1 1.3 0.7 1.1 1.7 1.9 2.4 1.6 3.1 2.9 2.6 2.1 2.9 2.3 3.3 3.3 2.3 11.6 44.8 30.8 29.0 10.5 4.6 9.9 8.1 9.1 15.0 14.8 12.2 23.8 10.0 18.8 11.0 43.8 8.1 10.0 15.0 3.9 10.5 13.4 13.0 13.7 12.1 13.1 6.7 35.6 9.6 4.3 12.7 17.3 13.5 18.3 33.1 15.7 12.7 8.1 15.2 36.2 18.4 10.2 12.5 5.6 28.6 9.9 11.2 7.2 16.9 13.7 10.2 9.2 29.7 37.3 13.2 7.9 12.8 10.6 10.3 10.7 5.8 13.1 29.5 13.1 16.0 13.6 23.3 9.7 11.3 6.5 11.1 14.2 18.3 15.6 10.1 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 19.2 6.3 29.4 11.3 28.0 6.1 14.2 24.9 34.9 38.8 15.0 41.3 7.0 43.1 3.2 34.8 36.1 10.8 19.1 28.7 29.6 24.7 12.9 24.7 3.0 26.0 30.2 22.7 32.5 4.5 10.3 11.0 24.2 25.0 6.0 15.2 11.6 19.0 6.0 73.2 15.7 20.7 25.8 17.4 23.3 10.5 30.2 1.3 23.0 6.4 4.1 32.0 31.3 23.3 16.7 37.5 33.2 50.8 10.8 5.7 26.2 21.6 4.0 11.7 6.1 21.2 11.1 0.1 47.6 30.3 5.5 19.3 24.3 16.9 4.4 18.1 42.7 68.5 25.3 20.7 29.8 13.3 12.0 11.2 69.4 4.5 26.5 0.0 23.2 9.8 17.3 0.4 2.0 42.0 0.5 37.8 30.4 27.9 62.8 32.0 17.9 6.3 13.3 7.5 25.7 88.0 42.0 59.0 80.0 14.1 43.7 34.7 38.3 54.7 48.9 1.1 3.8 40.9 2.3 27.2 0.1 23.0 68.4 0.6 1.8 5.9 0.0 3.3 0.1 0.0 0.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.7 29.4 28.0 24.9 34.9 28.7 29.6 26.0 30.2 24.2 25.8 30.2 23.3 17.8 0.0 1.7 44.4 0.3 15.8 3.3 4.1 10.8 3.5 5.4 5.0 3.2 1.5 2.9 0.0 10.4 0.2 0.4 0.9 3.9 0.7 0.7 3.4 15.1 15.3 1.2 4.2 1.9 8.4 0.4 5.5 1.5 2.5 8.8 94.8 27.8 2.0 1.2 1.7 5.3 3.6 0.0 3.7 5.4 1.9 4.4 3.7 5.4 4.7 3.1 5.0 0.0 11.1 0.3 2.1 1.0 9.1 0.1 3.9 0.3 0.2 0.7 11.7 0.0 3.1 8.7 0.0 1.9 14.3 19.5 0.3 0.7 2.4 1.9 3.1 KCTD21 KCASH2 ENSG00000188997 "Potassium channel tetramerization domain containing 21" Q4G0X4 11 78171249-78188626 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041964 Uncertain Approved Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA041964: AB_10795647" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (3.74e-3)" "unprognostic (6.40e-3)" "unprognostic (8.06e-2)" "unprognostic (2.48e-2)" "unprognostic (1.52e-1)" "unprognostic (6.82e-2)" "unprognostic (8.85e-2)" "unprognostic (1.37e-3)" "unprognostic (2.49e-1)" "unprognostic (1.31e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "unprognostic (4.70e-1)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" 7.3 13.4 14.4 6.2 13.6 3.5 4.4 13.1 14.3 5.8 8.7 6.5 5.0 5.0 9.2 9.6 6.2 7.9 6.3 13.7 14.3 5.5 15.9 6.7 5.4 14.7 16.3 13.7 3.5 5.7 5.9 7.7 15.0 4.2 4.8 4.3 5.8 5.2 8.5 4.9 4.5 7.1 12.4 4.6 4.5 4.0 14.6 5.9 11.2 7.0 6.2 7.1 5.9 14.7 5.2 11.8 6.7 5.0 23.8 16.9 4.1 10.1 9.6 7.1 7.1 11.1 7.8 5.0 9.9 11.4 9.5 10.1 6.5 8.4 7.3 6.9 3.9 3.8 15.4 9.8 13.2 2.4 4.7 16.4 15.4 15.5 8.8 14.8 11.0 6.1 8.1 4.5 9.7 7.3 3.8 7.3 3.0 19.0 8.9 5.0 5.1 3.1 8.3 9.3 4.6 7.1 6.4 4.6 4.9 12.1 10.6 2.6 12.9 11.3 11.0 30.0 3.9 8.6 9.2 4.8 5.9 3.9 6.4 2.0 5.4 7.5 0.9 6.0 1.4 0.6 1.4 1.7 3.7 1.4 1.3 1.0 8.3 1.4 5.1 0.8 1.1 2.2 14.4 13.6 13.1 14.3 13.7 14.3 14.7 16.3 15.0 12.4 14.6 14.7 1.9 0.0 2.7 4.6 0.7 1.8 1.2 1.5 0.6 1.7 2.4 2.2 3.5 5.7 2.0 0.0 0.0 1.2 0.6 2.8 1.9 1.5 0.3 1.4 2.5 2.3 0.0 0.0 4.1 2.2 1.1 2.8 1.1 1.9 5.7 7.0 3.6 7.4 2.3 6.7 3.4 1.3 0.0 3.1 1.1 0.5 4.4 1.3 1.8 4.7 2.8 1.0 0.0 4.0 4.2 2.5 1.7 9.1 1.0 1.9 2.3 2.7 1.1 0.9 0.0 1.2 2.9 1.5 2.7 3.6 1.4 1.9 1.8 3.8 1.7 2.1 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492096-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 9.7 9.3 32.4 5.2 34.1 17.1 12.8 41.4 40.7 13.6 35.5 12.5 6.6 13.8 30.9 14.1 13.7 9.9 10.2 37.5 30.2 20.9 17.1 7.7 8.6 32.7 33.9 14.7 8.2 11.2 20.5 12.8 32.2 11.1 9.0 45.8 7.7 10.2 8.7 8.6 8.0 12.6 31.4 11.1 8.3 6.8 31.1 8.5 14.0 12.5 8.8 9.7 14.5 43.0 10.2 9.5 27.8 12.0 23.9 16.9 10.4 12.0 10.7 17.4 20.3 9.2 5.5 20.0 3.9 8.6 20.3 5.4 22.8 7.0 15.4 20.7 10.4 9.3 24.4 11.2 11.3 7.1 7.2 10.4 10.8 13.8 8.7 41.0 11.6 6.9 5.2 9.2 15.2 9.6 11.0 11.3 20.4 9.1 17.8 10.9 7.7 14.3 16.7 4.7 15.5 13.6 6.6 15.5 8.7 21.2 62.9 5.3 6.3 15.6 14.4 20.1 18.4 10.1 16.9 23.6 13.7 14.8 12.2 27.2 16.3 11.4 14.5 17.0 16.9 14.3 10.6 13.8 23.1 11.3 11.9 10.1 5.3 9.6 12.5 8.9 11.4 8.2 32.4 34.1 41.4 40.7 37.5 30.2 32.7 33.9 32.2 31.4 31.1 43.0 5.7 3.2 2.7 30.3 6.9 8.9 10.5 4.1 8.6 20.8 6.7 4.6 8.8 10.0 8.0 9.2 25.0 10.1 10.7 4.2 19.6 8.5 5.0 3.8 6.8 8.7 9.1 8.6 14.8 4.0 6.8 11.9 2.0 3.9 0.0 52.2 8.9 6.9 6.7 25.2 19.7 4.4 10.2 9.1 14.3 2.2 10.8 6.5 12.4 5.6 11.7 23.2 10.3 14.1 19.6 3.7 5.8 12.0 3.7 9.3 4.5 28.4 3.7 19.2 0.0 9.3 8.2 13.8 22.9 11.5 10.1 8.8 5.0 12.9 6.4 4.0 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Neurogenesis "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 21.2 21.6 20.9 14.5 40.6 24.4 19.6 34.9 27.5 22.3 21.6 19.6 11.4 29.3 15.3 15.1 16.6 17.7 21.9 22.1 28.9 22.1 15.7 23.6 13.1 43.9 31.5 37.7 18.8 42.8 16.9 21.4 43.4 20.0 16.5 38.0 14.5 18.0 14.5 16.7 13.8 23.6 35.7 17.1 16.5 10.6 32.0 21.6 20.0 16.7 12.3 16.7 17.9 73.9 13.5 21.3 41.8 26.8 51.4 33.9 21.9 26.2 21.6 16.4 15.0 21.5 13.5 25.2 26.1 39.4 31.5 22.5 37.9 16.1 24.0 36.4 25.7 22.7 15.9 22.6 36.3 23.6 29.9 35.3 24.9 26.1 33.7 25.1 25.9 21.6 44.7 30.8 29.2 14.8 24.2 12.7 22.7 22.3 18.8 22.7 30.7 12.7 21.7 25.4 35.4 59.3 20.8 20.7 23.6 21.7 13.3 26.6 34.4 36.1 19.0 36.6 28.5 22.4 21.1 33.5 21.1 31.2 28.1 4.1 3.4 4.2 3.6 3.9 2.6 1.9 2.6 3.0 2.7 1.8 2.7 3.1 5.3 3.2 4.6 1.8 2.4 2.2 20.9 40.6 34.9 27.5 22.1 28.9 43.9 31.5 43.4 35.7 32.0 73.9 57.1 99.3 115.7 129.6 25.2 32.8 27.6 25.1 19.9 86.2 31.3 25.0 40.2 25.8 48.6 29.5 139.7 21.5 35.0 33.9 0.0 33.3 1.3 32.3 77.8 51.8 43.3 36.4 108.3 23.6 10.0 55.0 39.8 53.1 35.4 144.0 47.8 30.9 28.8 154.8 149.2 23.4 44.7 52.7 46.0 5.9 69.6 45.9 24.9 60.9 44.2 60.5 34.0 162.3 322.2 29.0 29.8 65.5 27.3 25.7 24.5 10.5 34.4 58.0 6.6 65.4 54.2 28.1 23.4 26.4 29.5 10.9 40.2 52.1 23.9 36.0 KLHDC8A FLJ10748 ENSG00000162873 "Kelch domain containing 8A" Q8IYD2 1 205336061-205357090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "ovary: 284.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 50.8;Granulosa cells: 97.0;Muller glia cells: 19.8;Peritubular cells: 21.1;Theca cells: 44.6" "Group enriched" "Detected in many" 5 "glioma: 45.7;thyroid cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.2;HAP1: 8.7;NTERA-2: 2.1;SCLC-21H: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (4.18e-2)" "unprognostic (4.80e-2)" "unprognostic (3.43e-2)" "unprognostic (3.21e-1)" "unprognostic (2.63e-2)" "unprognostic (2.97e-1)" "unprognostic (4.92e-1)" "unprognostic (8.37e-3)" "unprognostic (7.39e-3)" "unprognostic (4.03e-2)" "unprognostic (1.84e-7)" "unprognostic (4.53e-3)" "unprognostic (5.83e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.20e-2)" 0.1 26.5 9.3 0.4 7.3 6.5 0.5 15.0 14.3 2.4 4.6 2.8 0.8 1.6 0.7 4.5 13.9 0.5 0.6 13.9 13.0 0.5 0.2 0.2 0.2 16.6 11.0 284.0 2.1 0.6 18.0 0.0 17.1 0.4 0.6 26.4 1.4 0.2 0.1 0.5 0.8 2.5 11.0 0.3 6.8 6.4 18.5 0.3 3.4 0.0 1.2 0.4 2.5 4.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 7.3 15.0 14.3 13.9 13.0 16.6 11.0 17.1 11.0 18.5 4.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 50.8 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 2.1 7.1 11.6 1.2 0.0 0.0 7.6 0.0 0.2 0.0 97.0 0.4 0.0 0.0 5.0 8.9 0.0 0.0 0.0 0.0 0.2 5.3 0.2 0.0 0.0 0.0 19.8 0.0 3.0 0.2 0.3 0.0 21.1 0.5 0.0 0.0 0.2 0.1 4.8 0.0 0.0 8.1 0.8 5.0 0.0 0.0 0.0 0.0 44.6 0.0 0.0 KLHL24 "DRE1, FLJ20059" ENSG00000114796 "Kelch like family member 24" Q6TFL4 3 183635610-183684519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056337 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA056337: AB_2683103" "unprognostic (3.68e-1)" "unprognostic (1.37e-3)" "unprognostic (1.62e-1)" "unprognostic (1.53e-3)" "unprognostic (8.56e-3)" "unprognostic (3.85e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-2)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "unprognostic (3.31e-1)" "unprognostic (1.39e-3)" "unprognostic (1.08e-1)" "unprognostic (7.85e-2)" "unprognostic (8.40e-2)" "unprognostic (1.02e-2)" 16.5 13.1 8.4 10.5 22.4 41.0 16.1 71.6 33.2 13.7 0.0 14.9 16.0 15.3 10.3 11.5 10.3 13.4 41.3 8.4 9.0 18.5 20.3 18.8 15.8 18.4 17.6 20.0 15.3 41.7 10.4 13.9 21.0 13.9 14.0 16.1 17.8 11.5 48.5 11.2 14.6 11.3 5.1 16.2 15.1 9.0 21.2 17.8 23.3 46.4 14.7 14.0 11.9 28.3 4.4 4.3 9.9 10.5 22.1 12.0 20.6 2.2 16.9 2.7 4.8 2.8 8.0 8.9 30.1 6.1 25.2 6.2 5.7 2.6 4.8 10.1 7.9 5.4 6.9 2.9 18.9 4.7 7.1 24.7 14.0 2.9 9.2 16.7 14.4 13.8 3.5 28.5 3.7 2.1 7.9 6.0 6.4 6.7 6.5 10.0 7.5 28.7 7.8 13.6 17.5 24.5 10.3 32.1 23.5 14.4 11.8 10.4 12.5 3.4 4.4 5.4 2.9 54.1 38.4 37.7 6.0 7.5 2.2 43.1 20.3 25.0 17.3 22.7 14.7 25.7 14.3 15.8 13.8 27.7 20.7 14.8 40.9 16.3 22.5 10.7 20.5 15.3 8.4 22.4 71.6 33.2 8.4 9.0 18.4 17.6 21.0 5.1 21.2 28.3 44.5 112.2 72.3 88.8 73.4 43.6 30.7 21.8 77.4 39.8 33.2 24.8 137.8 27.1 33.4 31.3 70.9 12.1 63.2 32.0 13.7 28.1 16.1 35.5 42.0 39.5 42.3 26.1 99.5 18.9 18.0 44.5 29.6 49.3 26.0 110.1 33.2 47.7 27.1 60.6 104.3 28.5 46.8 51.9 31.4 7.0 30.7 46.5 35.6 68.4 31.3 24.4 41.2 92.0 185.2 18.1 29.3 24.5 48.5 51.9 52.3 27.7 35.8 45.8 32.9 59.7 48.8 27.9 12.4 46.1 43.9 43.8 49.5 45.1 26.0 44.8 KTI12 "MGC20419, SBBI81, TOT4" ENSG00000198841 "KTI12 chromatin associated homolog" Q96EK9 1 52032103-52033810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031203, HPA031204, HPA031205" Approved Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Cytoplasmic bodies" "HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-3)" "unprognostic (3.36e-3)" "unprognostic (4.18e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.74e-1)" "unprognostic (2.94e-1)" "unprognostic (3.72e-2)" "unprognostic (4.06e-2)" "unprognostic (8.08e-3)" "unprognostic (6.59e-2)" "unprognostic (3.36e-3)" "unprognostic (2.39e-1)" "unprognostic (3.59e-2)" "unprognostic (1.64e-2)" 7.5 10.2 4.2 6.9 4.0 16.7 5.9 4.5 4.4 4.5 4.9 6.5 4.9 7.3 4.7 5.8 6.9 3.8 5.1 4.0 5.0 4.9 6.8 4.2 8.7 4.5 4.1 9.2 6.8 3.9 6.4 4.2 4.1 4.0 4.0 2.5 4.0 4.7 4.6 5.5 7.6 4.7 4.1 8.5 7.1 7.2 4.9 6.6 4.0 3.5 7.6 5.5 3.8 4.4 14.0 13.4 5.3 12.5 17.8 14.8 16.6 13.9 17.0 20.1 17.1 15.2 6.7 16.0 15.3 14.5 29.8 15.6 18.7 16.4 13.9 16.5 20.9 16.6 14.6 14.9 12.3 23.8 15.7 13.9 12.5 16.0 8.6 8.7 13.8 14.0 25.2 7.7 17.1 11.1 17.5 26.7 10.3 12.2 14.9 16.3 14.6 21.5 19.4 10.0 9.3 13.5 13.4 23.3 25.8 12.0 4.5 37.2 10.4 16.2 10.1 19.4 26.3 28.6 25.8 25.4 17.9 25.2 12.1 17.0 21.6 16.4 22.1 24.5 24.9 29.8 24.7 27.0 29.4 22.7 29.0 20.7 4.5 24.2 19.3 44.6 26.9 18.8 4.2 4.0 4.5 4.4 4.0 5.0 4.5 4.1 4.1 4.1 4.9 4.4 10.8 3.2 5.1 0.0 14.3 7.1 13.2 14.1 5.7 6.1 5.3 6.1 3.1 8.6 6.3 3.7 0.0 12.1 17.5 1.8 5.9 11.3 2.3 4.4 10.6 8.4 2.4 8.6 0.0 10.9 17.0 8.6 3.1 3.9 6.3 26.3 9.3 5.9 10.0 10.1 0.0 3.9 6.1 6.6 6.4 1.2 11.5 6.0 5.4 0.0 13.6 9.7 10.3 0.0 0.0 10.5 3.4 10.1 9.5 7.8 3.1 11.6 4.7 4.9 19.7 8.1 10.7 20.3 9.3 6.7 7.4 18.3 10.6 28.1 4.7 11.5 KYAT1 "CCBL1, GTK, KATI" ENSG00000171097 "Kynurenine aminotransferase 1" Q16773 9 128832942-128882494 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "Granulosa cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021176, HPA021177, HPA027736" Approved Supported Cytosol NA NA 22000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" "unprognostic (6.51e-2)" "unprognostic (8.67e-3)" "unprognostic (1.05e-2)" "unprognostic (5.98e-3)" "unprognostic (2.15e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-2)" "unprognostic (2.47e-1)" "unprognostic (8.60e-3)" "unprognostic (1.43e-1)" "unprognostic (3.65e-2)" "unprognostic (3.10e-2)" "unprognostic (5.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" 3.5 4.7 12.3 3.6 13.3 2.3 4.0 13.0 15.5 7.2 10.6 4.7 2.5 5.8 2.9 5.3 6.4 2.7 10.3 12.1 11.8 7.8 12.7 3.6 5.0 13.2 12.3 6.2 3.1 5.5 8.7 2.5 12.8 7.4 1.3 7.5 4.2 4.3 12.6 7.7 4.2 3.1 12.3 5.4 4.9 5.6 12.9 8.9 6.1 8.7 4.8 7.2 6.7 18.0 4.8 9.8 9.3 10.6 6.9 11.4 3.0 5.5 8.0 6.2 8.0 3.9 9.7 8.3 2.9 4.6 7.0 14.9 13.9 11.1 9.3 10.0 7.3 5.7 27.7 9.6 7.7 5.0 1.9 4.5 7.1 7.1 7.7 21.8 11.3 22.7 8.2 9.0 8.5 3.1 14.0 3.4 15.2 18.3 7.6 16.4 6.4 18.9 8.7 1.7 10.5 7.4 9.9 2.9 6.2 12.8 6.6 1.6 7.0 4.6 7.9 7.1 5.0 15.2 11.0 11.6 9.6 8.3 3.2 0.1 1.4 2.9 5.1 1.8 4.5 7.7 5.7 6.0 5.5 3.3 5.9 6.7 0.9 3.3 2.9 2.4 7.0 3.3 12.3 13.3 13.0 15.5 12.1 11.8 13.2 12.3 12.8 12.3 12.9 18.0 2.6 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.0 0.0 0.6 0.0 0.0 5.0 0.9 0.0 3.9 1.6 0.0 2.6 3.3 0.7 0.0 0.0 0.0 0.2 2.4 0.7 0.0 4.2 0.0 45.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 7.3 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.3 1.3 0.0 0.0 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111731-25178231 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "HPA041559: AB_2677548, HPA043530: AB_2678532" "unprognostic (9.08e-2)" "prognostic favorable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 17.5 27.3 41.5 13.3 43.2 19.9 22.5 41.1 44.5 23.9 36.5 22.0 16.8 21.2 31.1 22.8 20.5 13.6 36.1 45.1 42.8 26.9 10.9 14.9 16.7 39.9 39.0 28.1 47.2 32.0 32.9 24.1 42.4 20.8 21.3 21.8 21.2 21.3 52.3 28.2 17.1 18.5 40.2 16.2 22.5 35.4 43.4 21.3 18.6 36.2 20.2 18.1 20.6 43.0 40.3 36.3 33.9 47.2 30.2 42.9 34.9 24.7 40.5 35.7 45.9 46.4 35.7 24.4 34.1 37.6 44.2 20.1 35.9 34.3 47.9 24.9 53.3 13.5 35.4 77.3 67.9 32.0 20.9 48.7 37.7 39.9 41.4 51.3 32.3 54.0 21.5 31.2 39.5 102.3 37.9 60.6 52.1 25.3 37.0 44.3 30.9 47.7 40.7 27.9 55.5 34.1 29.0 45.8 58.2 39.9 46.0 14.9 19.1 34.6 24.3 23.4 25.0 39.8 43.9 25.8 42.3 27.5 26.6 33.4 36.5 46.2 39.4 33.5 43.3 42.0 47.8 42.1 35.0 31.6 42.8 39.2 14.6 33.6 37.6 18.1 82.9 42.2 41.5 43.2 41.1 44.5 45.1 42.8 39.9 39.0 42.4 40.2 43.4 43.0 21.0 16.0 19.8 15.3 23.5 24.1 31.1 55.6 33.6 25.7 39.3 42.0 34.8 15.7 29.6 33.1 2.1 164.5 20.9 60.5 49.0 51.7 76.5 22.7 31.4 22.7 51.4 29.5 29.0 66.7 69.4 29.1 20.9 20.2 9.5 197.7 23.2 9.5 46.8 23.5 30.1 46.9 38.7 33.9 20.0 137.5 26.1 27.0 33.8 17.8 31.3 32.0 32.0 28.1 31.7 46.7 45.1 24.0 28.9 34.6 79.4 90.0 30.0 26.1 26.3 22.9 67.7 67.3 52.9 35.6 31.8 163.8 29.6 78.7 43.7 34.7 LDLRAD2 ENSG00000187942 "Low density lipoprotein receptor class A domain containing 2" Q5SZI1 1 21812265-21825225 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.2;Granulosa cells: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 1.2;THP-1: 1.0;TIME: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "basal ganglia: 4.0;midbrain: 5.9" HPA030478 Approved "Secreted - unknown location" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "HPA030478: AB_10601541" "unprognostic (4.16e-2)" "unprognostic (1.22e-1)" "unprognostic (4.13e-2)" "unprognostic (4.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.22e-3)" "unprognostic (1.35e-2)" "unprognostic (4.85e-2)" "unprognostic (7.52e-2)" "unprognostic (3.80e-2)" "unprognostic (5.34e-2)" "unprognostic (5.38e-2)" "unprognostic (1.04e-3)" "unprognostic (7.39e-3)" "unprognostic (3.14e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" 3.7 2.8 0.4 0.8 0.3 1.0 3.0 0.2 0.1 2.7 0.4 4.3 1.6 3.5 0.0 1.7 2.7 0.5 6.8 0.7 1.1 2.2 0.7 1.6 0.7 2.4 3.3 1.1 2.0 0.0 1.5 0.1 1.7 3.7 0.1 0.0 7.2 0.0 1.2 1.3 2.4 0.1 1.7 2.7 3.7 1.4 1.4 0.0 2.2 0.0 0.3 3.9 2.4 0.3 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.0 2.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.3 0.2 0.1 0.7 1.1 2.4 3.3 1.7 1.7 1.4 0.3 2.2 0.0 0.6 0.0 0.6 0.5 0.1 0.4 0.6 0.0 0.1 0.1 0.7 0.0 0.2 1.8 0.0 0.2 0.3 0.0 0.0 0.2 1.7 0.3 1.2 1.6 0.0 1.3 0.2 0.0 0.6 1.3 0.0 0.9 0.0 4.9 0.7 0.2 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.0 1.0 0.5 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.3 0.5 0.0 0.0 0.8 0.0 0.0 1.2 0.7 0.6 1.2 0.1 0.4 0.3 0.4 0.4 0.0 0.0 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.9;Microglial cells: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.9;plasmacytoid DC: 6.3" "Group enriched" "Detected in many" 9 "dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9" "Cell line enhanced" "Detected in many" "GAMG: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 18.2 18.8 10.9 19.6 11.5 18.4 20.5 12.0 13.4 14.0 15.3 17.7 23.8 18.0 18.9 6.3 9.1 22.6 12.2 10.1 11.1 3.1 6.4 19.7 15.2 17.2 13.7 18.5 11.4 10.4 5.7 14.8 14.9 11.4 17.5 5.5 19.3 24.7 2.7 5.7 21.2 22.0 14.6 4.3 14.8 9.1 18.5 14.8 9.1 4.1 14.4 36.3 10.3 18.7 9.8 36.1 10.6 14.1 63.0 18.0 32.7 11.0 28.0 18.7 32.5 12.8 28.4 24.4 4.8 21.7 116.4 16.6 10.2 11.8 30.6 0.2 9.1 24.3 7.2 21.6 46.5 0.1 0.2 20.7 46.6 57.3 88.4 29.6 44.8 0.9 0.2 17.8 42.9 5.2 0.1 1.4 11.8 7.9 10.3 4.7 15.0 6.8 7.1 42.6 2.0 14.4 17.9 6.6 62.5 22.3 3.9 3.0 29.8 21.7 11.8 60.1 33.2 0.7 0.1 34.1 57.5 0.2 39.7 7.9 3.9 4.0 0.0 1.4 0.1 0.6 0.0 0.0 0.9 0.6 0.0 0.0 0.7 0.0 0.5 6.3 0.1 1.3 10.9 11.5 12.0 13.4 10.1 11.1 17.2 13.7 14.9 14.6 18.5 18.7 13.5 3.2 3.4 20.2 5.7 8.7 7.3 5.2 0.6 6.6 18.2 15.6 3.7 1.5 7.6 7.3 0.0 4.0 20.3 34.8 0.0 9.1 1.5 7.5 26.3 21.4 2.4 10.7 15.8 12.9 2.6 38.1 10.7 14.6 0.0 121.9 35.3 1.4 60.1 3.3 7.9 16.3 6.1 40.4 14.7 1.7 19.3 36.3 10.6 209.9 5.5 5.4 0.0 55.3 4.6 17.0 16.1 33.4 3.3 10.4 29.8 0.7 3.9 2.2 6.6 19.1 13.1 0.7 1.7 1.4 4.8 7.3 1.3 22.1 10.0 12.4 LIMS2 "PINCH-2, PINCH2" ENSG00000072163 "LIM zinc finger domain containing 2" Q7Z4I7 2 127638381-127681786 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 510.1" "Cell type enhanced" "Detected in many" "Adipocytes: 109.4;Cardiomyocytes: 91.7;Endothelial cells: 105.1;Granulosa cells: 134.1;Hepatic stellate cells: 134.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 22.5" "Group enriched" "Detected in many" 13 "B-cells: 22.5;T-cells: 10.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 27.0;fHDF/TERT166: 31.2;HHSteC: 32.7;MOLT-4: 40.2;TIME: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058340 Enhanced Supported "Focal adhesion sites" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Focal adhesion sites" "HPA058340: AB_2683683" "unprognostic (2.51e-2)" "unprognostic (1.25e-1)" "unprognostic (5.82e-3)" "unprognostic (4.51e-2)" "unprognostic (9.25e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.53e-7)" "unprognostic (3.98e-2)" "unprognostic (3.73e-1)" "unprognostic (2.29e-1)" "unprognostic (3.78e-2)" "unprognostic (8.86e-2)" "unprognostic (3.33e-1)" "unprognostic (4.60e-3)" "unprognostic (3.64e-2)" "unprognostic (1.77e-1)" "unprognostic (4.00e-2)" 104.6 21.6 29.4 17.9 27.9 0.4 93.9 24.9 32.3 104.4 25.1 510.1 15.8 261.4 16.9 42.1 139.5 25.7 266.4 25.6 24.1 72.7 46.6 114.3 12.9 28.7 27.2 29.0 14.1 6.4 15.6 27.7 29.3 132.1 15.2 0.6 27.1 98.8 33.4 32.8 95.7 81.9 24.3 121.8 123.1 12.0 32.2 13.1 51.6 26.8 5.4 220.5 85.1 24.0 0.8 1.6 0.5 0.0 4.6 1.0 0.3 19.1 27.0 20.2 18.1 4.7 0.1 0.1 10.3 31.2 1.1 0.1 0.3 0.0 4.2 0.0 0.8 0.0 11.9 3.6 32.7 0.0 0.0 0.2 0.0 7.0 0.2 10.7 12.9 15.3 0.0 0.0 10.0 0.0 40.2 1.0 1.3 0.0 2.4 9.0 1.7 1.0 1.3 0.0 0.1 0.2 3.0 1.7 0.7 6.7 0.7 0.0 83.7 0.1 12.9 15.2 0.1 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.3 0.0 15.2 5.3 1.1 0.2 22.5 10.7 4.4 0.3 0.0 0.2 1.2 8.0 2.5 29.4 27.9 24.9 32.3 25.6 24.1 28.7 27.2 29.3 24.3 32.2 24.0 109.4 22.4 6.1 0.3 10.1 9.4 0.3 0.2 1.2 0.2 1.9 17.1 91.7 4.3 1.3 0.0 0.0 0.6 0.8 0.1 0.0 1.2 1.3 2.9 5.3 105.1 0.0 5.7 0.4 0.2 12.4 22.5 1.1 0.9 2.5 134.1 134.6 16.3 1.0 0.0 0.3 0.0 0.0 6.5 13.0 3.1 19.9 1.7 10.6 30.9 0.0 0.3 0.0 4.0 0.3 0.5 0.0 49.7 1.7 0.3 0.0 0.5 0.8 0.9 26.3 4.2 35.4 0.8 2.1 0.6 6.7 1.0 2.3 1.8 0.0 0.3 LMAN2L "DKFZp564L2423, VIPL" ENSG00000114988 "Lectin, mannose binding 2 like" Q9H0V9 2 96705929-96740064 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026600 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA026600: AB_1852939" "unprognostic (3.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-2)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.80e-1)" "unprognostic (6.91e-3)" "unprognostic (1.16e-1)" "unprognostic (5.30e-2)" "unprognostic (8.14e-2)" "unprognostic (2.17e-1)" "unprognostic (1.52e-1)" "unprognostic (3.29e-1)" 10.1 11.0 16.5 4.9 17.4 1.3 12.2 16.6 20.0 15.8 15.9 14.4 5.6 13.8 17.2 9.5 17.1 6.7 19.2 16.6 21.9 17.9 18.1 9.8 5.9 18.1 17.7 21.1 11.9 13.7 17.3 11.6 17.9 15.0 10.6 7.7 10.9 13.6 16.7 11.0 8.2 15.6 16.7 8.6 10.8 11.2 22.9 9.1 15.5 19.1 7.1 13.2 12.5 17.2 21.1 33.3 25.6 26.6 31.9 15.1 23.4 19.3 23.9 39.9 43.5 57.4 15.7 10.2 71.4 47.8 99.2 25.1 36.9 30.2 50.2 27.1 20.4 8.9 21.4 49.0 20.1 15.3 14.3 17.4 28.2 30.5 9.6 34.7 23.7 17.2 20.3 20.5 25.5 14.5 11.0 14.5 13.9 14.9 36.0 23.1 21.1 11.6 32.9 10.9 16.2 8.5 21.8 16.6 20.1 46.8 19.8 26.4 17.3 31.8 22.7 25.1 25.9 13.3 46.1 8.6 18.8 18.1 26.3 37.8 17.5 22.4 14.0 10.6 32.0 20.0 16.2 18.9 14.5 16.9 19.6 16.6 9.5 15.9 16.0 20.8 14.8 18.5 16.5 17.4 16.6 20.0 16.6 21.9 18.1 17.7 17.9 16.7 22.9 17.2 4.7 12.8 6.8 12.4 3.2 3.4 5.4 11.1 2.2 3.1 10.5 7.6 12.2 5.7 6.3 12.9 6.2 17.9 5.2 5.4 9.8 13.7 20.6 4.6 6.9 6.1 9.5 6.5 13.4 7.8 10.4 11.8 2.0 5.6 5.1 16.8 9.3 10.7 9.9 1.7 13.4 5.0 0.0 5.6 1.4 18.0 6.8 2.7 3.6 7.5 12.3 12.2 6.2 11.1 11.0 7.5 3.8 8.6 3.1 4.5 4.6 10.1 6.3 5.1 13.1 4.4 8.1 13.3 14.0 2.5 2.7 13.4 4.0 8.6 6.5 2.1 LMBR1L "FLJ10494, KIAA1174" ENSG00000139636 "Limb development membrane protein 1 like" Q6UX01 12 49097136-49110900 "Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Granulosa cells: 722.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-1)" "unprognostic (6.56e-3)" "unprognostic (1.17e-1)" "unprognostic (1.77e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.50e-4)" "unprognostic (2.72e-2)" "prognostic unfavorable (4.45e-7)" "unprognostic (2.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-3)" 6.5 9.4 12.6 4.0 13.0 4.3 4.4 14.8 18.2 6.4 12.3 8.2 6.4 7.6 6.7 8.8 7.2 5.1 11.6 12.8 13.6 10.3 6.2 5.5 7.3 13.3 12.8 8.6 5.9 5.0 8.5 11.0 13.3 6.6 4.5 5.9 5.6 6.9 6.0 5.2 8.8 6.9 12.5 7.5 5.9 25.7 12.7 11.0 3.9 6.1 6.5 8.7 6.2 14.0 7.5 10.5 13.3 13.7 9.3 13.4 14.5 7.0 11.1 9.3 8.5 10.7 5.9 3.2 5.5 14.4 5.9 3.6 9.8 5.0 5.7 12.3 15.6 7.5 6.1 9.8 17.9 5.3 11.7 15.3 6.8 13.3 7.9 25.4 29.5 13.0 19.7 4.9 8.9 3.3 9.3 14.8 6.2 20.1 7.6 6.5 5.5 3.7 6.9 15.1 7.4 6.5 5.9 5.8 13.4 11.7 5.0 7.0 28.6 6.0 3.7 4.0 2.7 8.9 5.9 4.6 8.8 4.8 3.5 24.1 19.7 51.7 12.9 16.4 11.0 17.3 13.2 14.7 14.1 18.8 18.1 15.4 9.6 6.0 21.1 10.1 22.0 17.4 12.6 13.0 14.8 18.2 12.8 13.6 13.3 12.8 13.3 12.5 12.7 14.0 26.5 6.4 20.0 16.6 26.9 15.4 13.0 13.1 23.9 37.0 14.2 10.9 7.5 7.2 9.9 9.2 20.9 14.8 29.9 15.0 3.9 16.1 104.8 6.1 11.1 27.6 47.1 11.6 14.9 10.2 39.3 21.1 9.7 9.0 17.7 722.7 17.9 8.6 16.7 32.0 14.8 12.5 16.2 13.2 41.5 156.3 13.7 23.4 21.4 14.0 27.6 9.3 27.8 8.5 13.0 17.5 15.5 6.8 36.3 14.0 51.2 3.4 6.8 31.1 13.1 17.6 24.1 14.7 12.5 15.0 14.8 22.3 33.0 18.2 13.2 18.3 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013144 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 165.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 154.4;Granulosa cells: 323.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 7 "granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 9.7 9.3 17.9 21.2 19.9 19.8 9.8 14.6 17.4 9.7 16.6 13.9 62.8 9.8 6.7 10.0 9.5 25.7 7.2 16.1 24.2 26.4 165.8 21.2 24.3 22.7 22.0 13.2 16.4 13.5 10.9 15.7 24.2 9.0 12.5 10.7 7.4 8.0 2.7 3.6 39.9 9.6 15.6 20.3 28.1 22.0 28.8 18.9 12.1 3.0 19.2 9.9 6.0 14.3 8.7 12.0 17.1 6.6 31.7 27.4 10.5 17.4 22.8 18.9 16.9 16.7 7.1 5.4 10.8 30.2 30.2 0.2 13.8 6.3 13.2 11.2 2.7 13.3 10.0 19.4 27.2 11.2 17.0 27.4 4.6 18.5 17.2 28.2 23.4 14.8 12.8 3.5 28.2 7.2 15.0 12.0 5.7 13.7 13.1 26.7 14.0 23.2 17.6 20.0 14.4 10.2 18.4 9.1 6.8 10.7 0.0 18.0 31.2 25.3 28.7 31.7 14.6 5.0 7.9 12.3 22.1 12.2 8.1 8.7 2.4 7.8 11.8 1.5 12.1 1.0 9.2 7.2 1.0 1.7 9.1 6.3 23.4 12.5 0.8 1.5 9.2 3.2 17.9 19.9 14.6 17.4 16.1 24.2 22.7 22.0 24.2 15.6 28.8 14.3 17.7 67.3 44.0 55.2 20.4 5.6 9.8 8.5 5.7 35.7 12.1 11.2 11.2 154.4 23.9 38.6 14.6 25.2 41.9 45.3 17.6 11.8 3.3 48.2 33.3 18.9 14.9 138.1 26.3 19.0 11.3 25.4 103.0 64.4 12.6 323.0 19.2 131.1 23.1 116.1 65.6 36.8 16.2 26.8 8.9 11.0 22.7 31.1 8.8 79.6 31.2 16.7 59.8 37.7 21.0 22.2 21.6 31.2 16.1 21.2 92.4 54.9 17.1 16.7 6.6 16.6 20.1 26.5 73.0 0.6 2.0 49.5 58.9 20.3 14.0 14.1 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967259 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 937.4;heart muscle: 407.8" "Cell type enhanced" "Detected in many" "Adipocytes: 453.0;Cardiomyocytes: 489.0;Granulosa cells: 495.2;Horizontal cells: 206.9;Sertoli cells: 236.7" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 6 "monocytes: 4.2" "Cell line enriched" "Detected in some" 5 "AF22: 391.6" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Group enriched" "Detected in all" 5 "basal ganglia: 79.2;spinal cord: 59.3" HPA048749 Supported Vesicles "Secreted to blood" NA NA 4200000 "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA048749: AB_2680511" "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.07e-4)" 937.4 15.9 6.8 9.1 53.2 0.9 255.4 20.3 12.2 2.7 8.9 12.0 1.5 3.7 0.5 2.8 2.7 8.6 407.8 10.7 9.5 19.1 0.7 62.1 8.5 7.4 7.7 10.6 6.3 181.5 4.1 14.7 7.9 3.8 5.8 11.1 24.4 64.7 86.4 8.3 13.3 4.1 5.5 1.6 8.4 1.0 11.5 4.3 10.6 127.3 2.8 6.1 4.7 8.8 0.0 0.0 391.6 0.1 8.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.8 0.0 0.0 0.1 0.3 0.0 71.5 0.0 0.2 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.1 0.7 9.6 0.0 0.0 0.0 0.0 68.4 0.0 0.0 8.4 0.2 0.0 0.0 0.1 13.5 0.0 1.8 0.0 0.0 8.1 0.0 3.5 0.0 0.1 0.1 0.1 0.1 32.6 0.0 0.9 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 6.8 53.2 20.3 12.2 10.7 9.5 7.4 7.7 7.9 5.5 11.5 8.8 453.0 12.8 104.9 1.0 0.4 1.5 0.1 0.0 0.6 2.8 114.7 5.7 489.0 0.0 0.6 0.0 2.1 0.4 0.9 0.1 15.6 0.0 0.8 0.2 2.5 56.1 0.0 0.0 1.9 0.0 0.7 13.6 0.0 0.3 6.3 495.2 2.9 0.0 108.5 206.9 0.4 1.0 0.0 14.8 4.2 1.3 1.2 38.2 14.2 1.9 2.0 2.3 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.4 2.9 2.7 236.7 91.4 68.1 0.4 0.2 0.2 0.6 0.4 2.3 4.3 2.8 0.1 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753120 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6" "Cell type enriched" "Detected in many" 6 "Granulosa cells: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "NTERA-2: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.2 0.2 0.6 0.2 0.7 0.5 0.4 0.7 2.6 0.2 1.6 0.5 1.2 0.1 0.3 0.0 0.2 0.5 0.1 0.7 1.2 0.1 2.1 0.3 0.1 1.0 1.1 0.3 0.8 0.2 0.2 0.1 1.3 0.4 0.1 1.0 0.1 0.5 0.8 0.4 1.6 0.1 0.7 0.1 0.3 0.8 0.7 0.0 1.5 0.0 0.1 0.1 0.1 0.9 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.1 1.4 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.6 1.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 1.5 0.2 0.1 0.1 0.8 0.2 0.2 0.2 0.1 2.2 0.6 0.7 0.7 2.6 0.7 1.2 1.0 1.1 1.3 0.7 0.7 0.9 0.2 0.0 4.4 4.6 0.1 1.1 4.4 4.0 0.6 0.5 8.6 9.1 0.3 11.5 1.7 0.0 0.0 0.1 0.3 0.8 3.9 1.2 15.2 0.9 0.5 0.3 0.0 0.0 2.2 0.8 0.1 1.5 2.0 2.2 0.0 104.4 1.4 2.2 0.1 0.0 0.6 0.9 2.0 0.8 2.8 3.2 0.0 0.3 5.4 0.0 0.0 3.9 0.0 1.0 2.2 1.2 0.0 0.0 0.0 2.4 12.3 1.0 0.9 0.8 0.0 1.4 8.1 10.5 4.7 1.4 1.1 0.3 0.6 0.0 1.2 0.6 LRP5 "BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2" ENSG00000162337 "LDL receptor related protein 5" O75197 11 68312591-68449275 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Disease variant, Osteogenesis imperfecta, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 129.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 84.7;Proximal enterocytes: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013001, HPA030505" Approved NA NA 1500000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "CAB013001: AB_2533267, HPA030505: AB_2673505" "unprognostic (3.67e-1)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.13e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.94e-2)" "unprognostic (9.63e-2)" "unprognostic (2.54e-1)" "unprognostic (2.78e-1)" "unprognostic (6.82e-2)" "prognostic favorable (3.55e-10)" "unprognostic (2.28e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.42e-2)" 35.6 37.6 9.6 6.9 11.4 3.2 36.9 10.9 11.2 26.0 44.4 32.4 43.1 30.6 4.1 18.5 26.4 21.0 35.7 8.6 9.2 30.3 129.7 23.3 4.3 12.6 11.9 27.9 34.9 11.6 15.9 23.2 11.7 25.1 11.2 1.7 73.3 20.0 10.4 19.3 44.8 11.1 10.1 8.9 31.8 5.6 10.2 9.6 33.4 7.3 2.6 24.5 19.4 10.6 30.9 103.6 11.0 25.4 20.6 11.4 47.0 14.0 12.1 8.3 7.5 58.7 104.2 0.0 87.5 18.2 35.1 38.9 9.9 37.3 1.2 5.0 22.6 21.6 52.8 77.2 20.8 15.8 2.0 16.4 12.5 0.4 13.6 22.3 23.7 18.8 38.5 1.6 6.0 69.5 23.7 62.7 19.6 161.2 41.7 29.6 30.1 49.7 14.2 82.1 10.6 21.6 37.0 49.4 41.0 5.3 34.6 36.2 31.5 0.2 9.0 11.6 15.8 6.3 0.8 6.3 0.0 9.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 9.6 11.4 10.9 11.2 8.6 9.2 12.6 11.9 11.7 10.1 10.2 10.6 37.4 6.4 5.4 17.0 1.1 9.2 8.5 11.3 10.8 0.2 24.4 23.2 5.6 21.5 9.6 7.3 0.0 49.0 0.0 42.7 0.0 11.7 1.1 19.2 6.5 20.4 17.5 10.7 1.1 9.8 6.7 10.6 30.5 12.5 1.3 84.7 31.8 52.5 8.4 0.0 5.7 43.0 18.3 3.2 4.6 1.0 3.1 1.7 1.8 11.2 1.3 8.8 0.0 13.0 5.2 12.5 32.4 9.8 5.7 13.0 54.9 8.5 4.8 0.1 6.6 18.5 10.9 0.8 7.3 7.6 5.3 24.8 1.0 1.3 25.1 13.8 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.0;thyroid gland: 41.5" "Cell type enhanced" "Detected in many" "Astrocytes: 30.7;Bipolar cells: 45.3;Excitatory neurons: 35.9;Granulosa cells: 67.0;Inhibitory neurons: 116.4;Microglial cells: 43.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" NA NA 2000000 "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "HPA073031: AB_2732217" "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavorable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 1.9 1.4 13.6 4.9 14.2 5.3 1.4 13.6 15.4 1.9 15.5 1.4 1.4 1.6 1.8 7.5 2.7 1.3 1.2 13.7 13.3 1.4 0.3 2.9 5.2 11.2 10.6 1.1 0.7 0.4 5.2 2.0 12.9 1.1 1.8 11.9 1.5 1.2 0.7 1.6 2.1 2.0 7.9 2.6 1.0 24.0 13.4 2.8 41.5 0.4 4.8 1.6 2.7 13.3 22.2 37.4 18.0 22.5 10.1 10.3 22.9 30.5 19.1 32.4 24.2 10.4 23.2 29.3 29.5 13.3 48.0 35.7 13.3 25.2 15.9 22.2 11.4 20.8 43.3 20.2 9.5 38.2 31.9 3.4 2.7 33.1 17.0 5.8 26.6 24.8 7.5 14.6 6.5 23.6 21.1 19.8 34.8 21.0 27.4 32.1 25.8 31.6 15.6 15.3 38.7 15.3 13.1 67.0 14.6 11.3 8.4 25.1 25.5 9.5 14.6 23.1 51.4 25.6 37.5 12.8 47.9 54.4 53.3 1.4 0.4 0.2 0.5 0.1 0.4 0.3 0.3 0.3 0.2 0.4 0.2 0.3 1.3 0.4 0.1 1.3 0.5 0.2 13.6 14.2 13.6 15.4 13.7 13.3 11.2 10.6 12.9 7.9 13.4 13.3 0.8 0.0 6.1 30.7 2.2 1.5 2.5 1.6 0.0 45.3 1.2 0.8 2.6 0.0 4.3 0.0 0.0 2.1 8.9 0.3 0.0 2.1 7.4 4.4 2.5 4.1 2.4 3.4 35.9 2.4 1.8 1.7 0.0 10.1 1.3 67.0 0.7 0.1 1.9 26.9 116.4 2.2 2.0 3.2 2.1 5.1 0.6 2.4 0.0 43.1 7.0 1.5 5.2 17.6 2.4 4.4 0.2 2.6 4.4 13.7 0.0 0.1 10.2 2.8 0.0 2.8 2.2 3.6 1.1 4.4 1.4 9.7 3.0 1.8 0.8 8.1 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102913000-102945111 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 76.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 94 "eosinophil: 9.9" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.9" "Cell line enriched" "Detected in many" 5 "LHCN-M2: 1237.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" Yes NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.30e-4)" 8.1 2.4 1.6 1.1 1.7 0.2 12.9 1.6 2.4 22.5 1.7 2.7 1.6 15.7 12.1 6.0 17.3 27.4 13.2 1.7 1.6 2.8 3.5 3.2 2.1 1.6 1.7 76.2 2.3 2.0 2.4 0.6 1.5 5.6 3.3 1.8 2.7 3.2 2.1 3.0 2.3 6.0 1.6 3.3 6.9 5.0 2.3 6.2 3.8 2.8 1.0 4.4 5.8 1.6 0.0 0.0 58.8 0.5 6.0 29.4 0.1 1.6 18.2 0.6 2.8 0.0 0.2 0.0 3.4 1.5 7.3 0.1 0.0 0.0 4.3 0.0 1.4 0.1 0.0 0.1 8.3 0.5 0.2 28.1 0.7 21.5 0.0 141.1 140.9 0.6 0.0 0.1 1237.5 0.0 0.1 0.4 3.1 0.1 0.1 0.1 244.0 0.2 0.2 0.1 1.3 1.3 0.1 0.0 0.1 0.1 0.0 1.7 11.8 0.2 1.5 15.2 2.3 1.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 1.6 2.4 1.7 1.6 1.6 1.7 1.5 1.6 2.3 1.6 3.6 0.0 1.1 4.6 0.2 0.9 0.2 0.9 0.0 3.7 0.7 0.8 1.1 0.0 0.5 1.8 2.1 0.3 0.3 0.0 0.0 1.7 3.5 2.7 15.3 4.4 0.0 0.0 6.9 0.4 0.2 31.3 1.1 4.6 1.3 68.6 6.1 0.5 0.4 0.0 8.7 0.1 2.0 0.0 2.7 2.9 101.9 0.5 5.4 10.3 0.6 0.6 0.0 2.5 5.3 0.2 0.3 31.6 0.0 0.3 0.1 0.3 0.1 2.2 65.7 16.1 17.8 0.6 0.5 0.4 0.6 0.0 0.9 6.6 0.2 0.2 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816015 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Granulosa cells: 1684.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No 120000 "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 81.6 125.1 102.3 52.8 97.8 31.8 162.6 104.9 112.2 174.5 111.7 106.8 54.3 134.3 101.9 67.4 149.0 94.3 142.2 95.5 121.9 141.0 57.5 85.9 48.0 125.4 118.4 255.9 75.5 148.0 195.3 177.1 128.8 208.8 53.5 74.4 103.3 169.9 88.9 60.5 62.5 140.6 108.5 60.8 77.6 63.1 110.1 68.8 149.2 91.4 46.2 111.7 95.7 108.9 34.0 61.4 373.7 111.0 171.6 229.5 66.8 137.9 243.7 106.4 187.5 62.3 84.4 47.1 361.2 279.0 88.5 45.2 106.5 104.2 76.1 84.5 87.0 100.0 68.6 122.1 145.5 25.4 71.8 310.4 43.0 109.3 55.5 223.6 209.9 55.2 24.5 55.7 207.6 94.0 57.0 41.9 134.7 59.1 72.4 37.4 132.9 68.2 148.5 25.3 56.6 149.5 54.7 62.4 330.6 437.5 263.1 42.9 185.0 90.4 141.3 135.9 39.5 35.7 32.7 34.5 132.0 66.7 477.6 178.5 31.9 132.1 119.1 80.0 91.7 59.2 98.1 112.1 41.1 63.9 97.3 112.0 11.8 108.6 140.8 25.8 108.9 127.4 102.3 97.8 104.9 112.2 95.5 121.9 125.4 118.4 128.8 108.5 110.1 108.9 77.9 44.8 42.8 17.6 37.4 42.4 96.4 198.6 43.3 69.8 123.3 97.8 60.5 44.3 175.4 77.3 29.2 231.5 36.9 11.9 246.5 107.4 3.4 42.4 96.8 116.4 58.3 10.3 12.9 53.7 133.7 151.7 20.9 57.1 102.1 1684.0 79.9 16.2 69.1 138.0 20.3 48.8 173.0 19.5 47.4 17.4 233.3 41.1 158.3 21.5 42.1 175.9 44.3 17.6 20.4 47.9 33.7 320.4 46.7 75.2 25.5 149.3 119.9 66.0 157.8 77.7 236.3 12.8 13.7 15.3 34.9 169.2 51.4 58.6 25.3 76.6 MAGEL2 "NDNL1, nM15" ENSG00000254585 "MAGE family member L2" Q9UJ55 15 23643549-23647867 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" Repressor "Autism spectrum disorder, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 23.2;pituitary gland: 8.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.7;Granulosa cells: 5.0;Horizontal cells: 3.3;Inhibitory neurons: 5.8;Leydig cells: 2.8;Muller glia cells: 2.2;Spermatocytes: 2.7" "Cancer enriched" "Detected in some" 4 "testis cancer: 4.3" "Region enhanced" "Detected in many" "hypothalamus: 23.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;JURKAT: 1.2;NTERA-2: 1.9;SuSa: 2.2" "Region enhanced" "Detected in many" "hypothalamus: 17.7" "Low region specificity" "Detected in all" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.18e-1)" "unprognostic (2.63e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-3)" "unprognostic (1.65e-2)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "unprognostic (5.38e-3)" "unprognostic (3.51e-3)" "unprognostic (8.61e-2)" "unprognostic (1.31e-2)" "unprognostic (9.55e-2)" "unprognostic (2.96e-9)" "unprognostic (1.66e-4)" "unprognostic (3.30e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-2)" 0.4 0.2 4.6 0.1 3.2 0.0 0.3 0.1 3.9 2.4 0.0 0.2 0.0 1.5 0.2 0.0 0.5 0.2 0.1 0.9 23.2 0.1 0.0 0.0 0.0 3.8 2.6 2.1 0.8 0.0 8.7 1.3 5.4 0.2 0.0 0.7 0.1 0.4 0.0 0.1 0.1 0.6 2.3 0.3 0.1 1.5 10.6 0.0 0.7 0.1 0.0 0.1 0.9 0.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.1 3.9 0.9 23.2 3.8 2.6 5.4 2.3 10.6 0.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.9 0.0 0.0 0.0 5.0 1.1 0.0 0.0 3.3 5.8 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.0 1.9 0.0 2.2 0.0 2.0 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.7 2.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 MARVELD1 "bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1" ENSG00000155254 "MARVEL domain containing 1" Q9BSK0 10 97713173-97718150 "Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.2;intermediate monocyte: 2.7;myeloid DC: 3.1" "Group enriched" "Detected in many" 18 "dendritic cells: 3.1;monocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 141.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.28e-2)" "unprognostic (2.11e-2)" "unprognostic (1.26e-3)" "unprognostic (3.05e-2)" "unprognostic (1.36e-3)" "unprognostic (8.82e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (5.85e-5)" "unprognostic (1.54e-2)" "unprognostic (7.44e-3)" "unprognostic (3.40e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (3.92e-3)" "unprognostic (7.02e-2)" "unprognostic (1.50e-1)" "unprognostic (3.86e-3)" 35.9 8.9 4.7 12.6 5.4 5.2 26.7 4.5 5.5 56.8 24.5 57.1 7.7 60.0 16.7 19.7 48.1 20.4 24.8 4.6 7.5 12.4 5.6 29.7 6.9 6.4 5.7 40.5 7.0 11.3 20.0 25.0 5.5 44.3 24.5 2.0 19.1 48.5 6.1 30.8 22.3 47.7 5.8 16.0 23.7 6.8 6.6 5.3 15.9 7.0 6.0 46.5 41.3 5.9 42.0 30.7 26.1 99.9 97.8 94.0 27.0 56.4 141.3 51.6 34.5 13.5 70.4 0.0 44.5 105.1 7.3 50.3 22.4 53.5 25.9 3.2 28.0 20.3 24.6 0.0 40.9 28.6 0.0 82.7 137.5 33.2 38.3 95.3 65.0 17.6 5.7 0.1 57.7 24.1 3.8 9.9 19.5 4.5 30.6 26.1 22.4 7.0 27.4 8.9 16.9 17.8 34.0 0.3 59.7 16.0 13.4 33.7 65.8 51.9 21.2 50.7 21.4 0.0 3.1 0.1 26.5 0.1 40.2 0.0 3.2 0.0 0.0 2.7 0.1 0.0 0.0 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 1.0 4.7 5.4 4.5 5.5 4.6 7.5 6.4 5.7 5.5 5.8 6.6 5.9 7.0 9.6 6.3 10.7 0.9 7.6 31.4 13.4 9.6 2.5 7.1 21.0 4.4 11.5 5.7 12.9 6.2 10.5 0.1 31.9 0.0 8.3 0.7 3.1 32.3 10.5 3.0 4.6 2.3 0.9 21.0 29.9 2.0 6.3 2.5 86.6 12.8 0.6 12.9 0.0 2.8 28.9 4.1 32.6 13.4 2.9 23.0 15.6 12.4 7.5 11.7 13.7 0.0 2.5 0.6 1.9 7.0 38.7 0.3 4.0 2.0 0.2 0.7 3.2 0.0 10.0 31.9 0.3 1.6 1.0 5.4 3.4 1.2 13.1 9.4 6.9 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50879080-50954257 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 176.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria NA NA 84000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.1 15.7 12.7 21.9 13.6 15.6 9.3 14.1 16.8 8.9 55.5 30.6 38.3 9.0 8.9 12.8 8.5 12.7 45.0 14.8 15.4 12.6 15.1 11.6 25.8 15.6 16.2 8.0 20.9 32.2 10.0 13.1 16.2 13.8 32.4 14.6 7.2 19.9 26.2 8.8 32.3 18.1 13.9 27.2 26.5 18.8 15.4 21.4 10.9 22.9 22.6 16.8 3.4 14.3 40.5 39.9 52.0 61.0 23.2 25.6 24.2 33.2 24.7 42.2 35.5 18.4 21.8 143.3 12.8 29.7 38.5 32.6 78.1 33.3 48.2 60.0 11.6 36.5 22.8 21.5 68.1 123.9 42.5 16.0 40.3 53.1 85.8 27.8 55.0 83.5 39.9 34.1 29.1 8.4 90.4 12.3 34.8 29.0 15.9 58.0 25.8 41.1 45.9 8.6 63.9 34.0 31.0 18.7 33.0 31.0 14.4 59.0 34.6 30.0 32.7 15.8 44.7 62.9 27.1 70.6 30.2 86.5 32.5 7.5 16.4 20.7 6.5 19.0 5.1 7.1 4.2 7.9 13.3 7.2 3.6 4.5 18.1 9.8 25.7 4.4 4.4 7.4 12.7 13.6 14.1 16.8 14.8 15.4 15.6 16.2 16.2 13.9 15.4 14.3 20.9 9.6 11.9 40.1 32.8 15.2 20.2 13.6 12.5 17.0 10.9 10.0 103.6 11.5 22.6 14.7 14.6 16.7 37.9 39.0 39.2 31.9 18.0 18.5 22.6 18.7 12.0 16.6 35.6 38.6 16.3 19.1 43.3 19.1 16.4 176.4 24.3 9.1 89.7 8.4 45.9 27.3 18.3 93.8 15.1 6.7 11.5 54.5 12.4 47.8 48.3 18.0 48.4 52.3 32.5 35.6 22.3 16.6 61.5 25.0 72.4 17.1 10.6 55.0 6.6 23.0 23.2 59.8 30.6 13.2 10.7 8.6 28.1 22.4 36.5 17.4 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156082465 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 4.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 16.5;Breast glandular cells: 20.8;Breast myoepithelial cells: 20.2;Granulosa cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 60.4;NTERA-2: 55.7;SCLC-21H: 57.4;SH-SY5Y: 105.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062703 Supported Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.3 0.1 0.9 0.5 0.8 0.4 1.2 1.1 0.8 2.2 0.3 0.4 0.4 3.2 0.3 0.7 0.8 0.5 0.2 0.8 0.8 0.8 1.0 0.4 0.2 1.1 0.8 4.4 0.4 0.3 0.2 0.3 0.8 0.8 0.4 1.0 1.1 0.3 0.0 0.5 0.3 0.8 1.1 0.2 0.3 0.5 1.0 0.9 0.4 0.0 0.3 0.8 0.8 1.0 1.1 1.9 60.4 15.2 0.7 0.9 7.3 1.5 0.3 2.5 2.2 3.7 0.9 2.0 7.3 0.7 1.5 1.3 26.5 1.2 2.9 3.2 7.4 1.5 3.2 6.3 1.2 0.9 1.3 1.8 2.0 1.2 1.0 6.2 11.7 14.2 14.9 0.2 3.5 4.2 7.4 1.2 55.7 2.6 8.1 23.6 4.9 0.4 2.1 2.9 57.4 105.2 1.8 6.9 3.7 25.2 12.0 4.7 4.2 3.8 9.4 1.1 3.7 1.4 1.0 3.4 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.1 0.8 0.8 0.8 1.1 0.8 0.8 1.1 1.0 1.0 3.6 0.0 0.5 0.0 0.8 4.0 2.4 3.7 16.5 1.7 20.8 20.2 1.0 0.0 1.7 0.0 10.4 0.8 1.4 0.6 1.9 11.8 0.2 4.3 13.3 7.6 6.0 3.8 0.2 1.5 2.2 4.1 1.1 7.7 0.0 26.8 8.6 6.7 2.2 3.3 0.6 1.8 10.2 1.0 1.5 0.4 5.0 1.2 5.4 0.0 0.0 1.4 0.0 5.5 0.7 3.5 0.2 1.2 0.4 8.3 0.0 11.9 4.3 3.1 0.0 3.4 12.5 0.3 4.3 6.0 3.4 0.3 1.2 4.3 2.5 1.9 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046119 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix: 14.0;testis: 46.8" "Group enriched" "Detected in many" 8 "Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.2 0.4 1.7 1.5 1.6 2.0 1.5 2.8 2.8 14.0 0.0 3.4 0.6 6.2 0.5 0.9 1.3 2.5 2.7 1.8 0.7 0.7 0.9 1.5 2.7 0.7 0.9 5.6 0.6 0.2 0.8 2.3 0.7 2.5 0.7 0.8 2.6 3.2 1.6 1.1 1.1 1.4 0.3 1.1 1.0 46.8 1.9 6.4 0.8 2.0 1.0 1.4 4.1 1.0 0.2 2.5 17.2 65.9 1.4 2.0 4.9 2.1 1.0 3.6 3.2 0.5 0.4 3.2 1.2 3.9 1.1 0.5 8.2 0.3 2.5 0.7 5.3 49.2 2.8 2.2 2.8 0.6 15.1 1.0 1.3 2.0 4.0 8.4 7.6 6.1 2.4 0.0 6.2 1.6 8.3 4.2 22.4 0.1 0.6 11.4 10.4 1.7 0.1 0.0 13.7 26.2 3.5 0.6 2.4 4.8 0.2 0.8 6.9 9.0 10.3 5.0 3.1 6.1 3.4 3.7 2.9 5.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 2.8 2.8 1.8 0.7 0.7 0.9 0.7 0.3 1.9 1.0 3.6 0.0 0.6 0.0 1.3 2.8 0.4 1.4 5.2 3.1 6.0 8.0 4.5 1.5 0.4 0.0 2.1 11.3 1.6 0.7 0.0 0.8 204.7 1.8 13.5 5.3 1.2 7.2 2.1 0.2 8.7 8.3 0.5 1.3 1.3 99.5 2.5 0.2 1.5 0.0 3.4 1.0 0.0 1.0 9.8 201.1 6.5 5.0 7.2 1.0 0.5 5.2 0.0 4.0 1.3 0.5 0.2 4.5 0.8 0.8 0.0 0.0 0.3 2.9 6.6 1.9 16.8 2.7 18.8 5.8 2.0 2.5 2.0 1.0 1.4 0.2 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Melanin biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.7;Extravillous trophoblasts: 142.4;Melanocytes: 195.7;Syncytiotrophoblasts: 92.6" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HeLa: 261.4;SK-MEL-30: 339.8;WM-115: 628.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "HPA042149: AB_2677875, HPA043088: AB_2678308" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favorable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavorable (6.61e-4)" "prognostic unfavorable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 23.3 26.4 25.8 24.1 26.4 30.5 19.3 21.8 33.0 18.9 9.3 17.7 15.0 18.0 12.9 22.7 21.8 9.5 17.6 41.2 18.1 55.0 35.8 29.2 20.3 29.0 23.8 14.7 38.5 13.9 25.9 17.6 28.9 21.4 6.1 10.8 29.7 11.2 16.4 53.7 27.2 11.6 19.2 37.9 22.8 13.6 29.9 24.7 19.0 4.0 10.8 19.5 17.0 58.0 97.6 76.4 18.6 48.9 37.9 29.2 66.9 58.3 31.2 66.6 72.7 33.1 32.4 27.3 43.2 31.2 106.4 60.1 24.3 30.2 23.8 60.0 69.0 15.9 261.4 34.9 47.4 34.9 51.1 26.2 44.9 68.6 15.9 25.5 18.1 40.2 77.1 38.2 17.3 58.0 35.0 61.8 34.9 42.9 62.1 24.3 26.2 115.1 27.9 41.0 70.0 35.5 115.0 53.4 339.8 23.1 18.2 71.6 75.8 30.1 44.4 123.8 67.1 43.8 26.9 25.1 132.4 88.2 628.4 0.1 3.7 2.6 1.8 7.7 1.8 2.3 2.8 1.4 2.7 1.4 2.4 1.9 1.2 0.5 7.7 12.1 0.5 1.7 25.8 26.4 21.8 33.0 41.2 18.1 29.0 23.8 28.9 19.2 29.9 58.0 15.4 6.4 2.8 5.5 12.9 26.5 6.8 4.9 1.8 15.6 19.9 14.0 1.9 8.6 6.1 20.2 6.2 16.8 21.5 11.6 0.0 23.1 120.7 26.9 20.9 13.1 28.1 3.8 10.2 31.4 142.4 10.9 14.8 42.5 0.0 57.3 6.4 22.3 76.9 37.0 8.0 18.4 2.0 24.8 54.4 30.4 2.5 47.7 195.7 13.1 20.7 9.3 5.2 7.5 25.5 34.2 16.2 3.4 12.6 16.7 18.7 34.0 8.1 12.7 13.1 5.4 12.0 4.0 9.0 8.4 25.4 92.6 10.9 11.1 13.2 13.8 MFSD4B "KIAA1919, MGC33953" ENSG00000173214 "Major facilitator superfamily domain containing 4B" Q5TF39 6 111259327-111445354 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 30.7;Cytotrophoblasts: 24.5;Glandular and luminal cells: 22.4;granulocytes: 20.2;Granulosa cells: 34.4;Syncytiotrophoblasts: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031784 Approved "Intracellular and membrane" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA031784: AB_10603775" "unprognostic (2.98e-2)" "unprognostic (1.64e-2)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (7.50e-5)" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (6.84e-2)" "unprognostic (2.94e-2)" "unprognostic (3.41e-1)" "unprognostic (6.04e-3)" "unprognostic (9.27e-2)" "unprognostic (3.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.98e-4)" 1.3 1.7 1.5 1.8 1.6 2.2 2.1 2.0 1.5 2.3 7.2 1.4 3.6 1.5 2.4 1.3 1.7 1.3 1.1 1.3 1.6 2.9 2.6 1.4 1.6 1.0 0.7 1.1 1.3 1.8 1.6 4.7 0.5 1.3 1.7 3.0 1.7 1.8 2.0 2.5 3.4 1.6 0.1 1.6 1.6 4.3 1.7 1.4 2.0 0.9 1.3 1.5 1.1 0.8 1.5 3.3 2.8 7.1 2.8 1.7 4.4 2.1 3.1 3.2 4.2 5.5 2.7 3.9 3.3 2.7 3.1 3.4 5.5 2.2 5.1 2.6 1.4 5.0 5.4 3.6 3.9 3.9 8.3 1.2 3.8 3.7 3.0 4.2 2.7 4.9 5.5 5.9 3.5 2.7 3.5 2.4 2.2 3.5 0.9 3.9 2.4 1.6 4.1 4.0 2.0 2.5 2.2 2.7 1.3 3.0 2.2 5.4 2.1 3.3 1.8 16.7 4.0 2.0 2.9 3.9 4.5 3.2 4.0 4.4 1.4 1.9 1.7 1.7 2.0 2.1 1.1 1.1 1.5 1.2 1.5 1.7 1.9 1.7 1.6 1.8 0.9 1.0 1.5 1.6 2.0 1.5 1.3 1.6 1.0 0.7 0.5 0.1 1.7 0.8 4.2 9.6 30.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.7 2.2 0.0 0.0 13.6 5.5 0.0 24.5 5.3 0.0 1.9 5.6 0.0 15.0 9.4 4.1 0.0 0.0 0.0 3.6 11.5 4.9 0.0 22.4 20.2 34.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.8 0.0 0.0 6.6 10.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 31.1 2.8 5.7 0.0 0.0 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125753580-125775821 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" Heterotaxy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "epididymis: 53.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Granulosa cells: 1.4;Microglial cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.3 0.4 0.6 0.7 0.7 0.2 1.7 0.7 0.2 0.2 0.2 0.5 0.5 53.9 0.5 0.4 0.7 0.8 0.5 0.4 0.1 0.3 0.2 1.0 0.3 0.3 3.7 0.7 0.0 0.1 0.1 0.2 0.5 0.1 1.8 1.2 0.2 0.3 1.2 0.4 0.2 0.1 0.6 0.4 1.0 0.5 0.0 0.5 0.0 0.2 0.2 0.0 0.9 0.4 0.2 0.6 0.4 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.1 0.9 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.3 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.3 0.5 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.7 0.7 0.5 0.4 0.3 0.3 0.2 0.1 0.5 0.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 27 "adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2" "Group enriched" "Detected in some" 5 "Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 1.5;HSkMC: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 75.6 166.5 0.1 1.8 0.1 0.0 44.2 0.0 0.5 0.1 0.8 1.2 0.2 0.0 0.0 0.1 0.0 0.6 2.0 0.1 0.0 0.3 2.4 1.0 0.1 0.2 0.0 2.0 0.7 0.0 0.1 1.7 0.1 0.0 0.2 1.0 2.0 0.0 0.2 1.3 3.5 0.1 0.0 0.0 0.6 0.5 0.0 0.1 0.7 0.2 0.0 1.4 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.7 0.2 0.4 0.2 0.8 0.2 0.5 0.0 1.9 0.1 0.5 0.7 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 1.3 0.0 0.0 0.0 43.7 0.0 1.7 0.1 43.7 0.6 0.0 0.0 0.0 0.0 6.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 1.6 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810063 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 119.6;Theca cells: 114.9" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes 15000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 11.7 22.7 9.3 17.7 13.7 24.0 16.2 15.0 12.7 15.5 12.7 13.0 9.0 27.7 10.2 11.7 17.8 10.9 9.3 8.9 11.5 12.1 19.8 11.6 28.4 12.7 11.7 53.0 31.3 17.0 9.8 20.3 13.0 15.0 12.4 21.6 10.8 15.6 10.5 13.1 9.8 27.2 10.7 12.7 10.9 35.3 11.3 36.3 17.2 11.2 31.0 12.8 12.2 19.9 116.5 77.6 128.4 37.5 42.3 46.3 67.9 63.6 51.1 60.2 59.8 67.2 41.4 158.1 84.5 59.5 82.0 46.0 130.3 74.3 82.1 80.7 69.0 117.0 60.8 71.1 28.8 131.5 37.8 38.6 28.3 60.7 41.6 53.8 40.8 5.3 115.9 69.8 61.8 85.5 144.2 80.1 130.7 81.3 37.7 219.6 204.3 84.7 44.5 76.2 92.8 100.3 79.1 40.4 42.7 124.3 54.6 42.6 33.4 72.2 92.3 54.6 80.6 63.8 79.3 276.2 61.9 77.9 42.4 7.7 3.7 3.8 4.8 6.2 5.5 4.3 5.5 5.0 5.5 4.2 8.4 4.5 2.5 5.9 6.4 2.7 5.3 3.6 9.3 13.7 15.0 12.7 8.9 11.5 12.7 11.7 13.0 10.7 11.3 19.9 19.8 28.9 21.4 5.9 19.2 25.2 22.0 12.3 31.9 25.4 14.4 15.1 8.6 2.8 21.8 7.3 35.5 35.6 20.7 7.4 3.9 15.7 46.4 27.1 31.1 18.4 4.8 47.1 8.5 9.6 21.8 24.0 8.6 31.7 17.7 119.6 13.6 10.2 13.0 15.2 12.1 9.7 20.3 5.6 13.2 17.5 25.4 16.8 3.6 7.5 10.0 22.7 8.2 9.5 27.4 9.1 3.7 22.6 31.1 16.1 2.6 6.7 22.1 31.4 6.6 27.4 33.0 54.3 48.8 22.0 17.5 9.6 19.8 114.9 12.1 11.7 MTCP1 "P13MTCP1, p8MTCP1, TCL1C" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155064034-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Respiratory ciliated cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 1.0 2.1 0.8 1.9 1.1 2.8 1.8 1.7 1.4 1.3 1.1 1.6 2.0 1.7 2.7 1.2 1.4 1.3 1.4 0.8 1.0 1.8 2.5 1.2 2.5 1.1 0.9 2.3 2.6 1.0 1.7 1.0 1.0 1.7 2.0 2.5 1.6 1.4 1.2 4.2 1.8 1.4 0.9 1.9 2.0 5.3 1.0 1.9 1.9 0.7 2.5 1.4 0.9 1.2 1.2 3.9 1.9 3.1 1.2 1.0 2.1 2.4 1.2 1.5 3.7 3.5 6.0 2.2 2.4 0.5 2.4 3.9 2.6 2.8 1.9 1.5 2.5 1.0 13.6 1.9 1.1 2.4 2.5 1.9 1.3 2.5 2.4 1.8 1.4 3.8 0.9 3.9 1.1 1.7 3.2 5.1 0.9 1.5 0.6 3.4 2.0 5.1 2.0 1.7 0.9 1.4 1.7 1.0 1.7 1.3 1.8 1.1 1.5 1.8 3.0 1.7 1.9 8.6 4.1 4.4 3.4 2.9 2.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.7 1.4 0.8 1.0 1.1 0.9 1.0 0.9 1.0 1.2 0.5 0.0 1.5 0.0 0.5 0.3 0.3 0.7 0.6 0.0 0.6 0.5 1.4 1.5 1.4 0.0 0.0 0.2 0.8 0.6 0.0 0.8 0.0 0.7 0.3 0.5 1.8 3.2 0.0 1.2 0.4 0.6 0.0 0.6 0.0 2.2 0.4 2.0 0.4 0.0 0.0 0.0 0.0 1.0 0.3 0.6 1.2 0.8 1.8 0.0 1.0 0.0 1.0 0.0 0.0 1.0 0.2 0.4 0.9 0.3 0.3 0.3 2.4 0.0 0.0 0.6 0.4 0.6 0.2 0.4 0.9 0.3 0.7 0.8 0.5 0.1 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661907-16936288 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 189.5;Muller glia cells: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 5 "monocytes: 2.5" "Cell line enhanced" "Detected in many" "HeLa: 182.1;SK-MEL-30: 205.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli rim,Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoli rim" "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favorable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 13.8 3.0 47.4 6.2 46.3 3.2 7.9 24.6 41.1 6.7 55.1 19.3 22.8 6.2 3.5 9.3 4.3 8.4 4.5 39.8 24.8 14.7 7.7 19.0 1.3 32.6 30.9 15.8 32.2 10.7 9.5 31.5 27.6 5.8 19.1 15.1 11.0 5.0 8.2 15.6 19.5 4.9 27.3 13.9 32.0 15.6 46.4 4.9 37.5 4.4 2.0 11.1 7.8 45.7 68.2 108.3 31.3 14.9 24.7 17.0 35.1 117.2 89.2 35.5 27.4 63.1 10.2 1.5 78.9 52.9 42.3 33.4 139.1 73.7 57.1 0.2 16.7 0.1 182.1 13.7 81.5 0.4 1.5 30.9 26.8 78.5 92.1 57.4 110.5 0.2 0.2 4.8 28.7 10.5 0.2 0.4 80.5 56.6 37.2 26.1 10.3 66.9 22.0 49.6 5.2 2.8 27.0 11.4 205.0 53.2 8.1 9.1 137.8 77.6 23.6 0.7 61.1 0.7 0.5 0.5 38.3 11.2 76.2 0.5 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 0.3 0.1 2.5 0.1 0.1 0.1 47.4 46.3 24.6 41.1 39.8 24.8 32.6 30.9 27.6 27.3 46.4 45.7 53.5 35.3 34.6 158.7 1.4 40.9 31.0 23.0 29.6 11.0 18.6 11.6 3.8 55.8 26.3 31.3 18.8 20.4 0.3 46.4 17.6 110.8 30.2 118.5 20.8 61.3 74.0 0.0 3.9 40.6 63.4 13.7 68.3 116.0 27.8 189.5 77.1 1.7 5.6 82.4 5.4 53.2 20.3 7.1 4.8 9.5 12.8 5.7 67.6 87.1 3.8 233.8 0.0 103.5 23.5 114.7 50.3 19.2 0.4 42.6 28.3 4.2 18.8 9.2 65.7 8.2 31.5 3.8 12.2 30.7 31.8 147.8 2.4 4.1 66.9 38.6 NAGLU NAG ENSG00000108784 N-acetyl-alpha-glucosaminidase P54802 17 42536241-42544449 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038815 Supported "Intracellular and membrane" NA NA 270000000 "Cluster 37: B-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA038815: AB_10697398" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "unprognostic (6.48e-2)" "prognostic favorable (4.17e-4)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.46e-1)" "unprognostic (1.75e-3)" "unprognostic (3.09e-2)" "unprognostic (2.20e-1)" "unprognostic (6.68e-2)" "prognostic favorable (6.90e-4)" "unprognostic (8.07e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.25e-1)" "unprognostic (8.74e-3)" "unprognostic (2.15e-2)" "unprognostic (1.62e-1)" 41.6 37.9 12.5 14.8 21.6 20.3 35.3 16.6 16.7 31.1 28.7 25.1 24.3 34.7 12.8 19.5 27.6 27.4 20.1 12.0 15.0 39.3 59.3 30.8 24.0 18.0 19.2 35.2 63.8 21.3 22.5 26.1 20.1 28.3 16.4 3.1 37.7 18.4 16.0 25.1 30.9 13.8 14.2 40.7 35.1 8.7 19.5 17.1 37.6 9.7 13.4 28.9 23.9 30.0 16.0 55.3 10.8 24.6 106.6 34.5 36.4 24.0 56.9 24.9 31.7 14.9 40.4 20.3 23.7 37.4 54.7 38.3 9.7 11.7 5.5 15.8 20.2 11.2 31.3 31.8 35.3 13.3 27.7 41.4 17.8 13.6 16.9 27.3 32.8 3.6 16.6 39.3 27.9 38.9 2.2 23.0 12.6 34.6 7.0 8.7 23.6 47.2 33.1 36.1 16.2 24.4 12.9 17.6 20.4 15.6 82.1 14.1 25.8 59.3 9.7 23.8 15.7 52.6 25.8 17.6 35.9 14.4 43.1 1.1 2.4 1.9 2.5 1.8 2.4 2.4 1.0 1.3 2.1 1.8 1.8 1.4 1.1 2.1 2.9 2.8 0.2 1.1 12.5 21.6 16.6 16.7 12.0 15.0 18.0 19.2 20.1 14.2 19.5 30.0 14.1 12.8 7.8 17.3 9.0 2.8 6.1 3.9 2.2 15.5 14.2 8.9 3.8 18.6 4.9 18.4 4.2 23.8 11.4 21.1 3.9 18.4 0.3 5.8 14.5 12.2 6.7 4.4 2.3 33.2 14.5 26.4 27.0 12.1 2.5 40.1 24.3 43.7 37.6 15.2 3.1 17.6 0.0 26.0 3.5 2.4 19.9 19.0 16.0 10.3 5.9 13.2 8.2 6.0 19.2 15.8 5.4 12.8 12.9 10.7 23.0 31.8 3.7 6.7 6.6 18.0 12.8 0.4 6.0 6.1 3.4 18.5 6.0 74.6 15.0 6.0 NDFIP1 "MGC10924, N4WBP5" ENSG00000131507 "Nedd4 family interacting protein 1" Q9BT67 5 142108779-142154440 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 678.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009682 Approved "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA009682: AB_1079455" "unprognostic (2.78e-2)" "unprognostic (1.62e-1)" "unprognostic (9.26e-2)" "unprognostic (5.66e-3)" "unprognostic (4.74e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (6.95e-2)" "unprognostic (4.96e-2)" "unprognostic (5.97e-2)" "unprognostic (1.74e-2)" "unprognostic (3.28e-1)" "unprognostic (4.46e-2)" "prognostic favorable (2.39e-7)" "unprognostic (9.18e-2)" "unprognostic (2.06e-1)" "unprognostic (6.23e-2)" "unprognostic (8.76e-2)" 62.1 81.6 87.4 33.8 93.8 26.2 56.3 63.1 100.7 54.7 70.8 40.3 49.3 45.2 135.9 30.2 46.4 45.4 55.1 94.2 96.8 94.8 120.2 49.7 39.0 70.7 73.6 61.5 64.5 152.6 51.7 45.2 77.2 67.7 38.4 164.1 99.5 63.5 45.7 26.6 47.6 40.9 75.3 56.4 50.4 40.8 90.8 41.9 103.4 40.9 34.8 48.3 31.1 73.9 53.3 35.2 61.8 83.6 128.2 72.5 41.4 56.6 59.1 48.0 54.6 39.5 87.3 4.8 115.0 62.2 66.4 51.9 39.6 59.6 56.2 61.2 48.8 69.2 30.8 28.7 55.8 38.3 23.9 55.8 55.3 33.8 43.6 68.4 55.9 54.0 23.4 83.3 60.1 27.4 42.9 12.0 33.2 52.0 33.4 16.1 34.2 122.1 119.1 56.0 65.0 67.3 61.9 91.7 88.3 46.0 64.7 37.6 64.5 58.7 22.1 48.0 56.8 53.6 65.8 22.0 62.1 24.9 45.6 70.4 32.1 26.4 22.9 39.9 29.2 12.8 40.6 28.2 37.0 10.4 80.9 63.9 19.5 23.5 40.1 11.2 50.6 62.4 87.4 93.8 63.1 100.7 94.2 96.8 70.7 73.6 77.2 75.3 90.8 73.9 100.3 57.7 62.6 74.7 76.4 111.5 176.4 133.4 82.0 196.4 134.3 68.5 70.0 143.0 101.4 154.5 141.8 146.9 94.0 98.0 140.8 207.4 20.2 69.5 91.5 103.7 137.6 184.9 189.5 145.3 263.8 164.1 62.7 118.2 60.2 365.2 116.0 169.8 154.1 318.0 184.9 81.9 177.0 205.9 154.9 15.4 116.5 137.0 170.7 69.3 176.1 300.6 87.6 114.1 125.4 179.8 100.5 156.9 107.6 262.6 198.5 173.0 67.7 322.9 131.5 74.3 149.3 26.6 33.2 71.1 101.3 191.5 156.4 678.1 83.3 256.2 NDP "EVR2, norrin" ENSG00000124479 "Norrin cystine knot growth factor NDP" Q00604 X 43948776-43973395 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8;ovary: 46.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 181.3;Muller glia cells: 105.5" "Cancer enriched" "Detected in many" 5 "glioma: 25.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-87 MG: 72.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.5 0.0 31.5 0.0 33.4 0.0 3.3 30.9 35.8 20.9 22.4 0.2 0.1 15.4 22.0 0.0 20.8 0.4 0.3 31.5 29.6 0.1 0.0 0.0 0.2 30.1 33.2 46.2 0.0 0.2 0.1 4.0 31.6 7.1 0.2 19.2 0.1 13.1 0.0 0.6 0.2 11.4 32.4 0.1 0.3 1.0 34.2 0.0 0.2 0.0 0.2 0.5 2.3 32.4 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.1 1.9 0.0 0.0 0.0 1.8 0.0 4.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 2.2 0.0 0.0 0.0 72.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 33.4 30.9 35.8 31.5 29.6 30.1 33.2 31.6 32.4 34.2 32.4 0.0 0.0 0.0 29.0 0.0 0.1 0.0 1.2 0.0 0.6 1.3 0.1 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 9.1 17.7 0.2 0.0 0.0 4.2 0.0 0.3 0.9 0.0 17.0 0.0 181.3 0.0 0.0 0.1 0.0 0.8 0.0 2.0 0.0 0.0 0.7 13.4 0.6 0.0 0.0 0.0 105.5 0.0 1.5 9.5 1.2 0.0 9.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 5.4 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729200 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 128.8;skin 1: 134.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" NA NA 180000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 4.4 4.0 14.8 4.7 25.6 24.3 8.2 17.4 32.3 14.0 0.0 12.4 16.6 3.4 2.3 128.8 4.0 3.4 8.1 30.5 15.3 5.1 4.3 3.4 2.1 23.8 26.5 2.3 18.8 2.7 7.8 7.3 18.4 12.8 12.9 18.5 18.0 6.2 1.9 134.4 12.0 4.5 16.3 3.3 4.6 1.3 26.9 6.7 2.2 1.6 27.9 28.9 36.8 38.8 16.6 13.6 12.6 18.2 6.5 2.1 88.2 6.6 6.1 5.4 3.8 28.8 55.2 21.8 26.1 7.6 10.9 229.2 32.5 117.6 2.4 51.8 4.9 3.0 4.4 13.2 2.6 14.9 35.4 2.0 139.2 17.1 62.5 2.1 16.3 6.2 0.6 113.2 7.2 42.7 0.3 9.0 41.6 55.3 18.7 1.2 75.7 26.3 5.1 157.4 30.6 68.6 22.1 57.4 1.8 18.8 52.3 2.2 9.0 4.8 17.6 39.2 5.9 20.6 28.0 0.2 1.7 11.9 11.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 1.6 0.0 0.0 14.8 25.6 17.4 32.3 30.5 15.3 23.8 26.5 18.4 16.3 26.9 38.8 4.2 0.0 3.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 12.1 27.3 0.0 0.0 4.3 1.8 0.0 4.1 4.1 0.0 0.0 8.7 0.0 4.6 3.2 1.3 0.0 0.0 0.0 12.3 1.3 2.1 0.0 10.9 0.0 68.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 15.5 0.0 0.0 1.9 0.0 0.0 3.3 1.5 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 8.9 1.3 1.7 0.0 0.0 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357115 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Granulosa cells: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8" "Group enriched" "Detected in many" 11 "B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "Daudi: 11.5;HeLa: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 8.0 14.6 2.0 3.1 3.1 4.3 11.6 6.2 5.0 14.7 2.0 9.3 5.8 10.0 1.7 7.3 12.9 3.9 5.8 2.2 1.7 8.8 12.8 8.3 6.1 1.4 0.4 13.3 10.9 3.3 11.0 2.5 0.7 12.4 1.1 2.6 16.6 4.1 9.0 8.9 8.3 1.9 0.0 8.8 10.5 3.7 1.1 2.7 10.7 0.6 3.0 8.2 10.9 2.2 2.2 3.6 2.3 1.4 0.7 0.8 4.5 1.3 0.0 0.5 0.1 0.6 4.0 11.5 2.1 0.2 1.1 6.1 1.4 0.4 0.0 5.7 9.1 2.0 11.8 1.7 0.9 2.1 2.6 0.3 1.7 0.6 0.0 5.6 1.4 1.1 1.4 3.3 0.3 2.9 0.4 6.3 2.1 0.4 0.8 2.1 1.5 0.5 2.1 2.4 1.4 2.8 2.2 1.0 3.2 1.2 4.2 3.5 6.3 1.3 2.3 1.8 1.2 5.2 5.5 9.7 1.1 9.4 1.2 0.0 0.6 0.0 5.2 0.3 1.3 4.8 0.9 1.2 0.2 6.4 1.4 1.4 0.8 15.8 0.2 0.3 0.3 1.4 2.0 3.1 6.2 5.0 2.2 1.7 1.4 0.4 0.7 0.0 1.1 2.2 15.9 22.4 19.2 19.9 33.7 6.4 15.4 10.1 23.3 20.0 22.1 15.9 2.9 10.0 21.9 14.7 10.4 10.8 19.1 13.6 1.9 9.0 20.4 31.8 7.3 16.9 21.6 8.0 33.5 8.3 3.6 7.7 22.4 15.4 11.4 105.6 24.3 11.5 3.4 10.1 29.9 20.0 10.2 5.7 7.0 2.6 19.0 3.3 8.8 8.4 1.7 14.6 55.6 5.5 4.5 7.3 16.0 13.5 9.1 9.2 21.4 8.9 41.9 6.5 6.6 6.6 6.4 1.6 1.5 11.0 5.8 4.8 10.0 2.0 14.5 8.7 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452697-25585531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 37.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 4.0 8.6 4.9 2.0 5.9 0.6 4.0 10.4 6.1 10.1 8.8 9.8 3.2 7.2 7.2 5.8 5.2 3.3 4.0 4.4 6.9 15.1 8.1 4.1 2.2 7.9 7.1 18.9 5.4 8.2 9.9 1.5 7.0 8.8 2.1 4.7 4.4 3.7 4.5 2.4 3.9 3.5 5.5 4.9 6.3 7.7 6.5 15.7 10.2 1.2 2.2 3.6 8.5 6.8 1.0 10.8 23.0 15.1 2.6 7.5 7.1 3.6 3.1 3.1 4.4 2.8 7.5 0.6 5.0 5.6 7.6 0.8 3.4 0.7 2.6 0.5 4.7 1.6 5.0 37.5 5.4 0.6 0.1 9.2 0.7 3.6 0.0 8.8 6.8 17.8 1.9 0.3 3.8 9.6 21.7 0.7 6.5 0.1 1.1 0.5 17.9 0.8 1.5 1.3 22.7 16.0 8.2 3.0 9.1 18.3 4.9 6.4 0.3 0.1 8.6 0.1 0.2 2.3 4.4 0.1 0.2 0.6 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.9 10.4 6.1 4.4 6.9 7.9 7.1 7.0 5.5 6.5 6.8 1.2 0.0 14.6 42.4 0.8 2.0 4.9 2.5 5.7 3.0 2.8 3.3 6.5 12.8 4.8 7.3 25.0 2.8 0.6 0.4 0.0 5.6 0.6 4.2 7.3 2.3 6.1 0.0 7.4 1.2 1.3 8.7 4.6 3.4 0.0 29.6 8.9 8.4 2.3 8.4 32.6 2.3 8.2 0.3 2.0 2.7 13.1 0.8 0.0 12.2 0.0 3.2 2.1 47.3 19.4 2.8 1.5 12.4 0.9 4.5 0.7 8.8 13.7 1.9 6.6 10.8 4.7 2.5 5.0 4.3 0.9 1.5 1.1 21.0 2.5 1.9 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445243-124450035 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Basal squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 5.7 0.5 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.1 12.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 NPAP1 C15orf2 ENSG00000185823 "Nuclear pore associated protein 1" Q9NZP6 15 24675775-24683393 "Predicted intracellular proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.9" "Cell type enriched" "Detected in some" 5 "Granulosa cells: 125.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018828, HPA019562" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Vesicles, Plasma membrane" "HPA018828: AB_2669941, HPA019562: AB_2670190" "unprognostic (4.40e-2)" "unprognostic (1.85e-2)" "unprognostic (6.98e-3)" "unprognostic (7.45e-2)" "unprognostic (9.90e-2)" "unprognostic (1.08e-2)" "unprognostic (5.11e-3)" 0.0 0.0 0.9 0.0 1.8 0.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.5 1.7 0.9 0.0 0.0 0.1 0.9 0.7 0.5 0.4 0.0 0.5 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.1 2.9 1.5 0.0 0.5 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 1.8 0.1 1.1 0.5 1.7 0.9 0.7 0.5 0.5 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.2 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 125.9 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.3 24.1 12.7 0.0 0.0 0.0 0.0 0.5 0.0 0.2 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617285-98629869 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 135.8;pituitary gland: 210.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 93.5;Peritubular cells: 326.1;Sertoli cells: 151.2;Spermatocytes: 85.2;Spermatogonia: 94.8" "Cancer enhanced" "Detected in all" "renal cancer: 41.7" "Region enhanced" "Detected in all" "cerebral cortex: 135.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 717.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 360000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 7.0 39.2 11.2 1.9 13.6 0.5 3.8 10.1 135.8 9.9 2.5 15.3 0.5 5.7 3.5 3.0 2.8 1.1 9.8 39.2 47.3 1.1 2.6 0.9 0.1 13.8 14.5 3.7 21.4 0.6 210.8 0.1 16.2 7.2 0.8 4.7 3.7 1.6 8.9 8.2 5.4 2.5 6.4 13.0 6.7 34.3 45.6 0.5 3.1 6.7 0.3 5.5 6.9 16.8 0.0 0.0 6.5 0.2 0.0 0.5 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 21.1 2.8 1.5 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 717.9 0.0 5.7 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 33.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 13.6 10.1 135.8 39.2 47.3 13.8 14.5 16.2 6.4 45.6 16.8 8.6 0.0 0.6 2.9 0.3 3.8 0.5 0.0 0.0 19.9 0.2 1.4 3.4 5.7 1.3 0.0 4.2 0.0 1.0 4.5 0.0 5.4 12.0 8.5 1.8 16.9 16.0 0.0 22.1 12.8 0.2 11.1 1.5 10.5 0.0 93.5 3.9 0.7 0.5 0.0 5.3 1.2 0.0 0.0 5.4 24.2 14.0 1.3 12.4 5.6 0.0 1.6 0.0 1.0 1.8 2.9 1.1 326.1 1.0 5.2 0.5 0.1 0.0 2.8 151.2 57.2 27.1 85.2 94.8 0.1 3.0 0.1 0.8 12.7 2.3 1.2 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027614-200177420 "Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 17.8;liver: 38.6;pancreas: 61.1" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 276.2" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 1.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 5.4 0.4 0.5 2.6 0.2 0.9 3.7 0.5 0.3 3.4 0.2 11.9 17.4 3.3 1.4 0.9 2.2 8.0 1.0 0.3 2.8 0.7 38.6 2.7 2.1 0.7 0.6 1.0 61.1 0.4 0.1 0.4 0.8 1.6 13.1 0.2 0.5 0.8 1.1 1.1 17.8 4.3 0.4 0.2 1.3 0.8 0.8 0.5 0.9 0.7 1.4 1.8 1.2 0.7 0.0 25.0 0.0 0.1 0.0 0.2 0.6 0.0 0.4 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.7 0.7 14.9 0.0 0.0 3.3 1.1 0.0 0.3 2.7 0.5 0.1 6.4 0.1 0.0 0.0 0.1 0.0 20.4 0.1 0.0 0.3 0.0 0.6 0.0 0.4 0.9 0.0 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.7 4.7 0.3 0.1 1.0 0.2 0.1 0.2 3.4 2.3 2.6 0.3 0.2 0.1 3.2 0.4 0.4 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.4 0.4 0.3 1.5 0.5 0.2 0.5 0.4 0.1 0.5 0.2 0.5 0.3 0.3 2.8 0.7 0.6 0.8 0.4 0.8 0.7 23.7 0.0 1.7 0.3 0.2 1.9 0.1 0.0 0.0 0.2 0.2 0.0 9.9 32.9 0.0 0.0 0.0 0.0 0.3 37.5 0.0 38.2 0.4 0.3 0.3 32.4 4.9 2.7 0.4 54.5 0.0 0.8 0.0 0.2 13.3 276.2 38.6 38.5 0.1 0.0 0.6 13.8 0.0 4.9 1.5 0.3 0.6 0.6 0.0 0.0 3.1 0.0 0.0 1.0 0.3 22.0 21.8 0.0 1.2 0.3 49.9 0.0 0.8 0.3 0.0 0.5 6.1 0.1 0.1 0.0 1.4 0.0 0.3 0.1 32.3 0.2 NSD2 "KMT3G, MMSET, WHSC1" ENSG00000109685 "Nuclear receptor binding SET domain protein 2" O96028 4 1871393-1982207 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 20.3;Granulosa cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015801, CAB068246, CAB068247" Enhanced Supported Nucleoplasm No No "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830" "unprognostic (3.70e-1)" "unprognostic (9.80e-2)" "unprognostic (3.33e-2)" "unprognostic (1.77e-1)" "unprognostic (4.01e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.24e-2)" "unprognostic (6.22e-2)" "unprognostic (7.66e-2)" "unprognostic (2.09e-1)" "unprognostic (9.25e-3)" "prognostic unfavorable (7.19e-4)" "unprognostic (3.89e-2)" "unprognostic (2.95e-1)" "unprognostic (1.31e-1)" "unprognostic (6.15e-2)" 10.1 8.4 12.7 16.5 13.0 54.9 9.9 23.6 15.2 9.4 0.8 19.6 18.6 10.7 7.3 13.6 8.4 8.3 15.8 11.8 11.5 9.8 8.3 12.6 25.4 9.8 8.6 7.7 13.5 12.0 13.8 12.2 12.0 9.7 22.5 28.5 11.6 8.4 16.7 11.6 18.3 12.4 4.4 14.1 12.5 37.2 12.6 59.8 17.4 13.7 24.3 9.7 9.2 14.9 124.0 58.6 168.3 71.2 17.5 26.5 44.2 98.2 85.4 115.2 128.8 44.6 141.4 117.5 31.4 78.0 158.5 50.2 114.4 74.3 195.0 58.3 47.7 151.3 81.7 25.5 18.6 89.5 74.9 9.9 19.8 101.2 89.9 60.1 92.2 123.4 81.7 132.2 95.8 42.1 243.3 99.7 68.8 60.1 77.1 137.8 106.7 42.9 45.4 57.4 115.6 82.7 78.4 29.2 31.7 71.4 68.9 52.2 64.9 109.0 87.4 72.8 188.1 54.1 72.9 113.7 66.0 81.9 108.0 4.0 1.1 1.3 1.0 0.8 1.1 0.9 1.5 1.2 1.2 1.7 1.1 0.8 3.4 1.2 0.5 2.1 2.9 0.7 12.7 13.0 23.6 15.2 11.8 11.5 9.8 8.6 12.0 4.4 12.6 14.9 12.6 12.8 18.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 15.3 9.1 0.0 0.0 8.1 12.9 0.0 15.7 7.2 0.0 3.9 10.4 0.0 13.0 11.7 6.3 0.0 0.0 0.0 7.1 10.0 6.0 0.0 20.3 2.5 69.3 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 11.4 0.0 0.0 4.9 0.0 0.0 4.0 7.3 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 3.4 5.2 3.7 0.0 0.0 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420322 "Metabolic proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.4;lymphoid tissue: 41.7" "Cell type enhanced" "Detected in many" "dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.7;U-266/84: 261.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 78000 "Cluster 39: Non-specific - mRNA processing" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 2.0 5.2 5.3 23.2 5.8 53.4 5.4 7.8 6.5 2.3 4.8 6.4 7.3 2.6 8.4 7.1 4.1 4.6 2.3 5.0 6.2 8.8 19.8 7.6 41.3 6.1 6.7 1.2 13.0 9.7 13.5 6.4 5.5 5.4 5.6 4.8 6.4 2.8 5.2 5.6 22.2 2.4 5.2 32.5 8.5 9.2 5.8 41.7 8.1 1.8 29.0 5.8 2.2 7.3 41.5 72.0 34.8 90.8 0.0 0.0 138.1 0.6 0.0 8.6 0.4 37.2 66.3 167.7 55.6 0.1 3.9 23.8 77.5 0.0 3.2 135.9 57.9 65.2 81.1 39.6 0.0 210.8 22.7 0.0 0.0 0.0 0.0 6.3 0.1 124.1 102.5 174.9 0.0 103.8 112.6 83.4 40.2 12.8 14.8 0.2 0.2 232.7 16.9 38.4 39.8 39.8 51.3 67.7 21.0 15.5 64.8 172.6 0.5 0.1 11.7 0.2 31.8 176.1 261.0 144.9 0.1 116.0 0.3 0.0 2.5 0.9 7.3 3.2 5.8 5.4 5.2 7.2 5.4 3.1 4.3 5.8 0.1 5.5 2.0 5.6 4.8 3.7 5.3 5.8 7.8 6.5 5.0 6.2 6.1 6.7 5.5 5.2 5.8 7.3 0.7 16.0 5.4 16.6 37.3 1.7 1.3 0.5 0.0 25.4 9.6 5.3 11.6 8.6 4.1 5.5 14.6 17.6 57.7 2.9 3.9 5.7 19.2 4.3 1.0 1.0 8.3 41.8 17.9 4.4 5.6 1.1 3.6 8.3 5.1 70.0 3.6 17.0 16.7 35.3 23.4 8.8 4.1 11.3 4.9 23.5 0.6 14.9 1.8 10.3 16.7 3.0 69.0 30.2 17.7 2.6 0.8 0.4 43.7 2.6 2.1 4.5 3.0 19.4 0.0 2.1 1.1 6.4 10.0 3.5 2.4 4.9 37.2 17.8 11.5 1.9 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;pituitary gland: 22.0" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 2.1 2.5 6.4 0.3 8.4 0.1 1.6 0.0 22.5 2.9 0.0 1.3 0.2 4.6 0.0 1.1 2.2 0.2 0.7 11.4 2.9 1.9 0.4 0.3 0.1 6.6 0.6 5.3 0.9 0.0 22.0 0.3 6.8 2.0 0.1 1.9 0.9 0.9 0.1 1.4 0.8 0.5 0.0 0.8 0.8 9.1 2.0 0.1 0.7 0.1 0.0 0.6 2.0 8.2 0.0 1.1 3.0 1.4 2.0 1.2 0.2 0.1 1.0 0.1 0.4 0.4 0.2 0.0 1.0 0.3 7.8 0.1 0.6 0.1 0.0 1.4 0.2 0.1 0.3 0.2 1.4 0.0 0.8 1.3 0.0 0.4 0.5 0.3 3.9 0.2 0.5 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 9.4 0.3 0.2 1.0 1.1 0.1 0.0 1.4 0.0 1.9 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.4 0.0 22.5 11.4 2.9 6.6 0.6 6.8 0.0 2.0 8.2 3.2 0.0 0.0 9.4 0.0 0.1 0.2 0.1 0.6 6.2 0.3 1.9 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.2 0.4 1.4 0.0 0.8 11.1 0.0 0.0 0.9 0.0 0.4 0.0 5.6 0.7 0.0 0.1 13.5 10.3 0.1 0.0 0.0 0.7 0.7 2.5 0.1 0.0 2.8 0.0 3.3 0.0 2.5 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.5 0.7 1.3 2.6 0.2 0.1 0.0 0.1 0.8 0.0 0.0 OCRL "Dent-2, OCRL1" ENSG00000122126 "OCRL inositol polyphosphate-5-phosphatase" Q01968 X 129539849-129592561 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" Hydrolase "Cataract, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012495 Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Microtubules, Centriolar satellite" "HPA012495: AB_1851804" "prognostic unfavorable (2.93e-5)" "unprognostic (3.17e-2)" "unprognostic (2.30e-1)" "unprognostic (6.34e-3)" "unprognostic (9.88e-2)" "unprognostic (1.35e-1)" "unprognostic (2.82e-2)" "unprognostic (2.68e-1)" "unprognostic (3.08e-3)" "unprognostic (2.56e-2)" "unprognostic (6.30e-3)" "unprognostic (1.74e-1)" "unprognostic (4.61e-3)" "unprognostic (4.10e-1)" "unprognostic (5.83e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" 13.9 23.8 12.4 4.7 13.2 5.0 12.7 5.3 13.6 14.9 27.2 16.4 8.0 19.4 16.1 11.6 16.7 8.3 10.7 13.1 20.3 9.5 15.7 10.0 2.8 9.6 14.0 28.4 13.0 34.6 25.6 11.2 17.4 18.5 12.4 9.9 11.0 21.3 14.8 12.4 12.2 15.0 7.6 7.9 14.5 24.6 18.6 4.4 16.8 6.7 3.0 22.8 12.3 8.6 19.3 20.5 17.0 18.7 29.3 24.1 17.1 28.5 22.3 28.2 26.3 14.2 13.3 1.5 46.7 24.1 33.0 11.6 30.5 20.9 29.2 0.1 21.5 5.8 18.5 14.1 21.1 5.7 0.6 20.7 27.3 28.3 27.3 27.7 21.2 8.4 7.9 13.6 28.7 24.2 4.3 8.2 6.2 24.4 30.9 4.2 17.6 11.5 16.1 19.1 20.5 26.1 13.5 18.0 14.6 21.5 13.2 10.0 19.3 23.0 10.6 24.6 29.1 3.8 3.3 3.7 16.2 21.4 18.8 0.0 1.0 0.0 0.1 1.1 0.3 0.1 0.0 0.0 1.2 0.1 0.2 0.1 0.1 0.0 3.6 0.4 0.0 0.4 12.4 13.2 5.3 13.6 13.1 20.3 9.6 14.0 17.4 7.6 18.6 8.6 6.7 3.2 7.8 14.4 2.6 4.7 3.4 5.4 3.4 9.9 9.3 5.6 10.3 4.3 8.8 18.4 6.2 6.4 0.3 14.4 3.9 5.3 31.2 4.9 6.9 6.4 17.5 3.8 20.0 3.6 5.4 7.8 11.7 6.1 0.0 17.0 8.2 11.5 5.0 13.5 23.1 11.8 6.1 11.8 4.0 8.9 23.0 5.8 8.8 21.5 4.3 9.6 0.0 17.6 21.0 8.5 8.3 34.3 1.4 5.9 15.7 5.2 5.4 7.2 0.0 4.5 6.0 6.8 14.6 8.3 7.4 5.7 1.0 7.6 12.2 8.4 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "Granulosa cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 40: Granulosa cells - Unknown function" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901849-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 246.6;Granulosa cells: 144.4;Late spermatids: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 22.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 22.2" "Cell line enhanced" "Detected in all" "SK-BR-3: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli NA NA "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA028515: AB_10602014, HPA050595: AB_2681186" "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavorable (3.91e-6)" "prognostic unfavorable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 19.2 7.6 9.6 8.6 9.3 51.9 12.1 10.9 12.1 8.6 7.0 10.5 7.9 18.4 5.7 8.3 5.9 16.3 14.8 10.6 17.9 17.1 18.5 16.4 10.8 12.4 11.4 17.8 7.9 33.2 9.8 7.0 12.5 10.0 8.9 12.9 7.4 7.8 15.2 5.2 7.1 21.1 14.9 9.3 6.0 23.1 10.2 8.9 14.1 18.8 10.0 11.0 4.7 18.3 32.1 30.6 7.9 16.2 17.5 14.0 9.9 23.5 49.9 21.7 22.2 14.3 29.6 21.9 45.7 13.0 26.1 11.6 16.0 18.8 34.6 33.3 11.7 34.2 11.7 8.0 31.9 17.0 20.4 16.1 23.2 24.5 22.6 20.9 28.6 28.7 19.7 38.3 16.2 24.8 29.7 11.7 4.4 33.6 16.7 13.1 11.5 18.6 33.2 24.2 7.1 18.1 17.3 149.6 29.5 12.9 30.1 27.9 20.2 23.2 20.2 20.1 22.2 35.0 32.2 24.2 38.6 21.9 17.5 22.2 1.6 7.5 1.9 1.2 2.7 3.5 2.8 1.7 1.8 2.0 2.3 2.6 12.4 2.5 1.5 1.3 3.1 1.6 9.6 9.3 10.9 12.1 10.6 17.9 12.4 11.4 12.5 14.9 10.2 18.3 9.8 64.1 14.8 49.3 10.4 6.0 6.9 9.2 2.8 9.0 13.3 6.7 13.9 17.2 12.5 7.3 2.1 6.8 10.6 4.2 9.8 13.6 246.6 11.6 10.8 7.4 9.6 8.6 14.9 16.0 8.4 13.7 2.0 14.1 17.1 144.4 13.6 17.6 16.5 3.3 14.9 3.8 20.3 19.1 9.4 216.8 12.5 15.7 7.2 9.4 13.3 25.3 5.2 7.5 7.8 14.0 3.4 12.4 6.1 7.2 3.0 14.8 15.2 6.0 13.1 18.9 9.0 28.9 8.8 4.5 4.3 1.6 8.3 3.0 5.1 7.6 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 4.9 41.6 2.8 4.9 3.1 1.0 6.5 3.0 3.1 17.0 1.8 24.0 2.7 17.6 18.5 11.0 8.0 4.8 8.8 3.3 4.8 51.3 7.0 28.7 2.4 7.6 4.7 16.1 3.6 2.3 8.2 9.2 6.7 37.6 10.4 19.3 4.9 26.5 1.2 17.8 6.7 32.4 5.2 54.8 23.9 4.2 4.9 5.2 3.0 1.7 2.0 11.9 19.9 8.3 46.9 18.2 35.1 0.2 0.6 1.4 42.1 48.7 19.3 7.8 12.6 15.0 18.0 0.1 27.1 8.6 120.2 109.9 0.1 65.3 16.3 0.4 6.2 0.1 12.1 0.3 35.4 0.2 0.3 16.9 21.4 15.2 5.4 73.5 1.4 0.1 0.1 0.4 12.3 1.1 0.1 0.4 11.0 31.3 3.7 0.1 7.1 2.8 109.8 77.5 2.5 0.3 66.1 3.7 29.3 51.1 0.1 0.7 24.4 45.9 16.8 0.4 8.9 3.4 0.2 0.5 10.6 0.2 60.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 28.9 0.0 0.2 2.8 3.1 3.0 3.1 3.3 4.8 7.6 4.7 6.7 5.2 4.9 8.3 5.7 48.1 80.3 19.2 1.0 0.0 7.7 0.0 13.6 2.3 1.6 9.9 1.0 2.8 3.1 44.1 4.2 42.0 9.5 19.8 5.9 4.7 19.6 2.0 27.3 10.5 0.0 2.7 55.6 0.8 14.7 10.3 8.6 1.5 1.3 124.1 32.5 0.8 11.4 10.1 60.4 0.5 0.0 3.2 0.0 14.9 4.7 5.6 0.0 91.8 0.8 44.5 0.0 43.7 4.4 30.6 1.9 0.0 0.2 15.1 0.0 26.2 0.0 1.2 0.0 10.9 45.2 0.5 0.9 13.5 0.0 38.6 0.7 74.3 2.1 3.9 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070272-66244744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol NA NA 17000 "Cluster 46: Basophils - DNA binding" "Cluster 14: B-cells - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 30.6 24.0 26.4 33.7 28.4 26.0 26.4 28.4 29.0 30.4 11.0 29.7 13.3 26.7 17.7 32.1 22.2 23.6 45.4 27.2 18.5 28.0 11.4 30.2 49.8 18.2 20.4 32.4 26.8 18.7 21.6 18.9 17.1 34.6 10.2 35.1 92.8 22.2 22.4 27.6 25.6 30.3 13.0 34.9 24.9 42.2 20.7 35.1 34.0 17.2 46.2 33.9 29.6 18.8 44.1 45.6 21.1 13.3 38.5 46.1 23.7 59.3 41.9 40.6 25.2 28.4 34.3 27.6 38.2 102.5 37.7 27.9 15.6 42.7 54.4 43.7 18.3 45.0 41.7 41.2 45.8 6.5 34.6 46.8 19.8 37.0 47.2 78.1 39.8 18.2 16.7 52.2 44.7 83.3 48.1 16.8 9.8 12.0 21.2 31.6 21.5 47.9 28.9 43.4 29.8 33.6 61.5 34.5 29.1 33.9 39.7 8.3 54.4 52.2 23.1 71.9 25.6 26.2 19.1 7.4 45.0 10.4 26.0 3.7 1.3 2.8 3.4 1.0 2.2 2.9 3.1 2.9 1.3 4.8 3.5 3.1 7.4 2.0 2.9 0.8 4.0 3.0 26.4 28.4 28.4 29.0 27.2 18.5 18.2 20.4 17.1 13.0 20.7 18.8 19.9 3.2 3.0 93.7 41.3 10.1 17.6 8.8 16.5 31.4 16.5 16.3 16.9 8.6 12.1 12.9 50.1 8.1 31.9 2.8 5.9 20.5 17.0 11.1 17.3 18.2 6.1 14.1 113.5 62.7 10.9 15.8 13.7 16.3 23.5 80.3 26.0 4.6 13.1 92.5 90.0 2.2 6.1 14.5 14.7 27.6 18.6 22.7 10.6 96.5 33.4 13.9 38.1 87.4 49.2 54.7 1.2 18.0 13.5 23.3 1.0 13.1 11.8 41.2 13.1 12.3 16.5 20.6 21.8 16.5 9.9 5.7 36.3 16.5 3.6 17.0 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537370-9839076 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.0;retina: 4.7" "Group enriched" "Detected in some" 4 "Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8" "Cancer enhanced" "Detected in single" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 4.6;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm NA NA "Cluster 6: Brain - Smell perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.0 1.9 3.6 0.0 4.8 0.0 0.4 12.0 8.4 0.1 0.0 0.0 0.0 0.2 0.6 0.2 0.0 1.2 0.0 5.5 0.7 0.2 0.7 0.0 0.0 0.3 1.4 0.0 1.3 0.0 1.2 0.0 0.4 0.4 0.0 4.7 0.3 0.4 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.2 2.1 0.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.8 12.0 8.4 5.5 0.7 0.3 1.4 0.4 0.2 2.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 PARP11 "ARTD11, C12orf6" ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 3.4 5.0 2.7 5.0 2.9 3.2 5.3 2.0 2.9 4.2 2.0 3.6 3.7 6.5 5.4 3.1 4.1 4.0 2.3 2.5 3.4 3.9 4.5 3.8 10.2 3.4 3.2 8.2 2.5 7.8 1.8 3.2 3.3 8.6 4.1 3.3 4.0 4.2 1.8 2.2 3.7 5.2 2.8 6.2 3.3 9.4 3.5 10.4 9.1 2.9 9.4 5.0 1.9 3.5 2.7 2.3 14.0 2.3 4.4 7.2 4.1 3.3 5.5 5.6 5.7 8.7 2.2 8.0 2.0 6.4 6.6 2.2 4.8 4.8 9.0 16.1 4.9 12.0 0.0 6.5 5.1 8.1 4.4 5.9 3.8 4.4 12.4 0.0 4.4 15.3 3.1 6.5 8.1 4.0 4.2 3.1 5.2 2.9 0.3 8.3 9.8 1.8 2.6 6.3 0.9 2.9 3.1 2.8 4.2 15.1 0.5 7.1 8.5 4.9 4.8 7.3 4.4 3.1 7.3 11.7 4.6 4.4 1.2 20.3 8.9 9.2 7.4 7.4 10.0 10.0 8.3 5.5 8.9 8.8 9.2 7.5 8.5 7.7 6.1 7.8 3.7 6.2 2.7 2.9 2.0 2.9 2.5 3.4 3.4 3.2 3.3 2.8 3.5 3.5 8.6 9.6 9.5 16.0 18.3 1.9 4.4 6.7 7.4 10.6 5.7 4.1 3.8 2.8 4.5 1.8 2.1 4.2 17.7 2.6 0.0 3.4 61.5 2.1 9.6 5.3 3.6 12.0 30.8 3.1 1.6 8.4 1.1 1.9 14.7 72.0 6.8 4.1 7.1 3.3 30.8 4.7 2.0 9.8 5.8 45.1 10.5 9.7 1.8 18.7 10.3 5.4 17.5 32.6 18.8 3.3 7.6 8.6 3.7 6.6 2.6 4.1 6.0 6.4 6.6 7.0 9.8 9.9 10.9 3.6 1.8 2.6 15.0 8.9 5.0 3.4 PARP12 "ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1" ENSG00000059378 "Poly(ADP-ribose) polymerase family member 12" Q9H0J9 7 140023749-140062951 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003584, HPA063872" Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA003584: AB_1079568, HPA063872: AB_2685139" "unprognostic (1.46e-3)" "unprognostic (2.93e-2)" "unprognostic (1.73e-1)" "unprognostic (2.71e-2)" "unprognostic (6.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.30e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (7.51e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.12e-7)" "unprognostic (3.31e-2)" "unprognostic (2.76e-1)" "unprognostic (1.75e-2)" "unprognostic (6.01e-2)" 6.4 4.7 4.1 12.3 4.3 15.8 6.6 3.6 5.3 4.0 5.2 12.1 18.3 7.6 9.6 4.8 8.1 9.3 5.9 3.6 4.2 5.0 7.8 15.4 13.4 8.3 4.4 6.3 9.2 10.2 2.3 9.9 5.4 7.0 11.6 1.8 17.2 4.8 2.9 15.0 18.1 7.9 6.3 17.1 13.1 10.4 4.9 10.7 5.8 2.5 9.5 8.7 2.4 5.0 20.8 7.6 0.6 0.8 2.4 5.7 15.1 4.7 10.4 36.3 42.5 4.9 12.6 8.6 11.5 3.9 28.0 9.3 5.4 17.6 6.0 33.4 8.7 9.2 4.9 6.8 15.2 2.4 6.2 5.7 6.7 12.7 15.5 9.9 28.2 10.4 19.0 6.0 2.7 8.4 25.7 14.3 1.3 10.7 18.0 15.2 0.0 2.7 7.1 7.9 4.6 0.0 14.2 7.7 11.2 0.7 9.2 5.6 31.0 4.3 10.2 0.3 14.5 0.5 1.5 2.0 7.9 12.2 5.2 1.2 3.0 4.3 1.5 5.5 1.3 1.7 2.1 1.6 2.1 2.4 0.9 0.7 1.0 2.5 6.4 0.2 5.8 1.2 4.1 4.3 3.6 5.3 3.6 4.2 8.3 4.4 5.4 6.3 4.9 5.0 24.1 6.4 10.6 2.6 17.9 6.5 7.2 4.4 8.0 2.9 6.2 5.5 5.4 7.2 5.8 11.0 2.1 6.0 13.0 48.9 1.9 13.9 0.7 7.0 6.4 18.1 24.0 4.8 1.2 26.0 19.1 6.9 18.3 6.3 19.7 38.2 7.9 10.9 24.2 0.0 2.6 19.4 4.1 13.6 9.7 0.9 7.2 20.5 7.2 26.2 17.5 2.9 11.3 9.5 3.1 35.2 37.0 7.2 8.3 12.4 44.2 6.9 9.0 2.5 0.0 7.3 7.9 35.0 15.6 8.7 9.9 2.1 15.6 8.4 11.6 10.6 PDGFC "fallotein, SCDGF" ENSG00000145431 "Platelet derived growth factor C" Q9NRA1 4 156760454-156971799 "Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.3" "Cell type enhanced" "Detected in many" "Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009134 Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" NA NA 37000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cytosol" "HPA009134: AB_10601981" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (5.79e-2)" "unprognostic (3.67e-2)" "unprognostic (3.97e-1)" "unprognostic (3.41e-2)" "unprognostic (8.78e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.35e-5)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.17e-4)" 4.8 4.0 0.9 1.3 1.0 0.6 7.5 0.4 1.0 9.2 0.7 2.3 2.0 9.9 2.1 3.3 6.7 4.8 2.6 1.0 0.8 5.5 5.1 3.1 1.1 0.8 0.7 7.7 4.3 20.3 0.4 4.5 0.7 8.7 2.0 0.7 8.4 7.0 1.2 1.6 2.8 9.4 0.9 1.3 2.8 0.9 1.1 2.0 6.5 1.2 1.0 3.2 1.2 1.0 2.5 3.7 38.6 25.4 7.0 13.4 1.0 21.5 21.5 12.0 16.1 2.2 9.4 0.0 3.8 60.0 9.2 2.6 10.8 13.4 16.5 0.0 5.0 25.5 3.2 2.4 18.3 3.9 0.3 14.2 6.6 30.6 21.7 56.8 6.0 0.1 0.1 0.1 30.2 0.1 0.0 0.0 0.4 0.0 1.7 0.0 8.1 0.0 22.5 0.9 0.0 0.0 0.0 0.2 0.4 6.0 3.1 1.3 28.3 41.7 0.4 10.9 17.3 0.0 0.0 0.0 16.1 0.0 1.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 1.0 0.4 1.0 1.0 0.8 0.8 0.7 0.7 0.9 1.1 1.0 2.4 6.4 14.2 98.6 0.7 49.6 22.7 12.4 25.0 2.0 14.7 13.6 16.8 58.6 7.8 12.9 0.0 0.6 3.4 0.5 0.0 15.4 30.5 6.9 15.0 7.3 0.0 5.5 64.4 7.1 0.3 18.6 8.2 11.4 1.3 124.1 10.0 15.9 13.0 0.0 32.1 2.1 4.1 34.4 21.6 23.8 5.3 32.1 10.6 85.3 14.2 6.3 0.0 233.2 3.0 18.0 0.5 23.0 1.4 8.7 2.4 18.6 3.5 0.5 6.6 34.8 18.2 0.7 2.9 3.4 13.5 0.5 0.9 13.8 2.1 4.8 PHEX "HPDR, HPDR1, HYP, HYP1, PEX, XLH" ENSG00000102174 "Phosphate regulating endopeptidase homolog X-linked" P78562 X 22032325-22251310 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Biomineralization "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 45.3;Granulosa cells: 161.7" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 37 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 37 "dendritic cells: 4.8" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.7;HUVEC TERT2: 2.8;PC-3: 3.0;TIME: 3.1;U-87 MG: 6.5;WM-115: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.01e-2)" "unprognostic (2.69e-1)" "unprognostic (2.43e-1)" "unprognostic (1.05e-3)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (2.25e-3)" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-2)" "unprognostic (7.53e-2)" "unprognostic (7.45e-2)" "unprognostic (9.84e-8)" "unprognostic (1.18e-1)" "unprognostic (1.58e-1)" "prognostic favorable (2.51e-4)" "unprognostic (7.68e-2)" 0.0 0.0 1.0 0.5 1.0 0.0 0.7 1.8 0.7 0.9 0.4 0.3 0.5 2.0 0.1 0.2 0.1 0.9 0.0 0.8 2.2 0.1 0.0 2.7 1.5 1.6 1.6 1.6 0.0 0.0 0.2 0.1 1.9 0.6 0.0 0.3 0.2 0.4 0.0 0.1 0.6 1.5 1.8 0.4 0.0 0.1 1.3 0.3 1.0 0.3 0.9 0.2 0.3 2.1 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.8 0.0 0.1 0.1 0.0 3.7 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 1.3 0.7 0.7 2.1 0.1 2.8 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.6 0.0 0.4 0.1 0.1 0.1 0.2 1.5 0.5 0.4 1.8 0.0 3.1 0.6 0.1 0.4 0.5 0.0 0.0 0.0 6.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 1.0 1.0 1.8 0.7 0.8 2.2 1.6 1.6 1.9 1.8 1.3 2.1 0.0 0.0 0.0 3.9 0.8 0.0 5.8 2.3 0.0 0.4 3.0 1.8 0.5 0.0 1.6 0.0 0.0 0.2 45.3 0.7 0.0 0.9 0.4 1.3 1.4 0.2 0.0 0.0 2.2 1.2 0.1 2.9 0.0 1.8 0.0 161.7 0.0 0.0 0.0 16.8 1.9 0.5 4.1 0.0 0.4 0.3 1.8 1.2 1.8 0.0 0.0 0.6 0.0 1.5 0.5 0.8 0.0 0.0 0.3 1.8 8.2 0.9 4.5 0.5 0.0 2.1 2.6 0.1 0.4 0.1 0.1 0.8 0.4 18.9 0.4 3.3 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373312-134428791 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 6.7 18.0 6.6 14.2 7.9 8.4 10.8 10.3 9.3 8.3 6.2 9.1 8.9 9.7 32.7 8.2 7.9 6.6 6.7 7.1 8.4 10.2 7.7 6.8 25.3 8.3 7.8 33.3 9.5 16.3 6.2 9.3 8.4 9.2 10.3 12.0 13.2 11.0 5.0 8.3 8.8 8.1 8.6 13.3 9.3 9.2 7.7 20.8 13.2 6.8 29.8 8.6 7.1 11.5 28.2 22.9 98.7 40.8 17.9 22.9 18.7 27.6 22.1 29.1 35.6 13.9 28.5 45.1 61.8 16.9 28.3 24.6 69.4 31.3 48.6 37.2 32.1 44.3 37.7 16.1 19.2 44.2 23.3 15.3 23.2 31.7 39.2 29.1 41.1 43.1 32.6 21.8 35.8 18.7 71.3 21.8 30.1 38.3 31.0 69.6 36.0 34.5 30.7 33.8 34.1 39.9 21.2 19.3 29.5 29.0 18.0 24.0 31.5 26.8 19.2 34.0 42.9 11.1 27.3 60.5 17.7 51.4 34.3 5.9 6.3 4.1 8.0 6.6 8.7 18.7 8.2 7.3 9.5 12.4 9.6 8.2 2.6 11.0 8.4 11.7 9.1 5.5 6.6 7.9 10.3 9.3 7.1 8.4 8.3 7.8 8.4 8.6 7.7 11.5 25.5 22.4 18.4 13.1 42.7 13.0 14.3 28.7 22.2 22.4 17.5 20.3 16.3 11.5 17.8 16.5 18.8 11.8 27.1 9.9 23.5 14.2 3.7 13.0 29.1 18.7 11.4 31.3 27.8 13.8 7.6 17.2 14.8 18.7 24.6 149.5 20.0 15.2 15.1 18.5 23.4 12.5 10.2 15.5 10.2 3.1 20.8 20.2 7.2 29.0 25.3 27.9 21.6 33.2 46.7 14.4 18.7 15.4 23.1 12.3 9.5 19.8 16.5 19.7 26.3 21.0 21.9 10.3 22.0 25.7 11.5 4.7 22.6 69.3 17.7 11.5 PHKA2 "PHK, PYK" ENSG00000044446 "Phosphorylase kinase regulatory subunit alpha 2" P46019 X 18892298-18984114 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 42.7;Hepatocytes: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002912 Approved Approved Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA002912: AB_10961321" "unprognostic (3.90e-2)" "unprognostic (2.06e-2)" "unprognostic (5.10e-2)" "unprognostic (1.43e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.07e-2)" "unprognostic (3.42e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.68e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (2.05e-1)" "unprognostic (1.58e-2)" "unprognostic (7.16e-2)" "prognostic favorable (2.96e-5)" 12.7 9.6 4.6 6.8 6.3 15.0 7.6 6.6 5.5 9.0 6.9 6.8 12.5 10.5 6.5 6.3 9.9 8.1 12.6 5.6 5.4 6.7 34.3 6.4 7.7 6.9 5.6 16.8 15.2 8.1 12.8 10.5 6.7 9.7 6.5 10.6 9.5 7.1 7.8 8.8 10.1 6.2 5.5 9.3 8.6 9.7 6.0 12.6 10.1 14.3 7.4 6.2 8.1 7.3 11.3 10.6 6.1 10.2 8.2 7.5 16.6 4.9 4.1 7.1 7.7 11.3 7.3 13.3 3.6 6.4 11.2 10.3 11.0 12.8 7.6 6.5 11.2 15.9 17.6 13.8 5.8 15.2 19.7 12.6 8.3 8.7 12.5 11.8 7.4 13.8 5.3 8.0 5.0 12.0 16.0 25.2 7.5 5.2 11.2 12.4 12.5 14.9 4.6 5.0 5.2 8.0 14.8 15.3 6.8 20.3 18.9 8.8 13.2 9.6 5.3 10.3 7.6 7.6 6.7 10.1 5.4 8.1 5.2 4.3 3.2 7.2 2.0 3.8 2.1 1.6 1.7 1.5 2.1 1.7 1.9 1.9 5.4 3.0 2.5 1.1 2.3 1.9 4.6 6.3 6.6 5.5 5.6 5.4 6.9 5.6 6.7 5.5 6.0 7.3 6.1 9.6 12.9 27.7 5.7 6.5 5.4 6.0 8.6 11.1 8.0 7.4 20.1 12.8 5.1 9.2 10.4 16.8 3.4 9.6 0.0 7.5 7.2 6.4 11.8 7.3 4.2 14.5 15.2 5.1 17.5 5.3 4.1 7.2 1.3 42.7 20.3 57.4 8.0 5.0 19.9 7.4 4.1 18.9 3.8 5.3 7.5 10.5 5.4 13.1 8.3 17.0 7.2 16.6 16.9 6.3 12.6 7.9 7.4 6.9 12.4 4.8 4.1 13.3 0.0 7.4 5.9 7.9 7.9 8.6 4.7 10.5 7.4 12.1 10.7 3.6 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444441-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.9" "Group enriched" "Detected in some" 6 "Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Immune cell enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 161.8" "Region enhanced" "Detected in many" "white matter: 5.7" "Low region specificity" "Detected in single" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes "Cluster 22: NK-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 0.5 2.5 0.3 1.3 0.0 2.5 0.8 1.1 0.4 0.9 0.0 3.3 3.0 0.8 0.0 3.3 0.3 0.7 0.3 0.1 0.1 0.3 0.3 0.7 1.5 0.2 0.0 0.8 0.2 0.1 0.1 0.6 0.0 0.3 4.1 0.4 0.7 0.1 0.0 2.7 3.1 2.0 0.0 6.0 1.2 0.3 0.1 13.9 0.4 0.0 2.1 1.3 1.3 0.2 42.1 54.1 161.8 73.1 1.5 4.5 12.6 47.9 29.8 78.6 52.5 32.8 17.9 0.0 18.8 39.8 39.9 29.9 82.6 21.6 41.9 64.6 33.9 0.1 33.8 41.2 0.2 1.7 48.9 2.4 1.5 32.2 12.4 8.0 24.8 36.8 10.1 23.0 49.9 30.5 9.2 0.5 70.9 34.0 37.8 74.9 64.8 29.6 12.9 6.4 36.5 51.3 41.7 42.5 39.1 20.4 19.9 4.0 11.9 59.9 48.4 36.0 80.7 8.2 31.5 0.2 23.6 20.4 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 1.0 0.1 0.0 0.3 0.3 0.3 0.0 1.1 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.4 1.2 0.6 0.0 0.0 0.0 0.0 0.6 5.5 0.0 0.7 1.3 21.5 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.0 0.0 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669733-153689010 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.1;intestine: 81.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AN3-CA: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.2 43.7 1.9 48.8 0.0 0.6 6.5 53.3 1.3 4.8 81.7 3.4 6.5 1.7 14.0 4.1 2.6 6.5 49.8 40.8 1.9 0.2 0.6 0.0 19.6 22.8 0.9 0.3 0.5 1.8 2.0 21.1 17.2 3.8 7.9 0.4 37.6 2.0 1.8 13.4 15.7 15.0 0.2 15.9 8.8 65.1 1.4 0.3 0.3 0.1 27.4 2.2 28.5 0.3 0.1 0.4 33.9 0.0 0.0 3.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.4 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.3 0.4 0.3 0.2 0.7 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.7 0.0 0.1 2.7 0.9 0.3 0.4 0.0 0.2 1.2 0.0 0.2 0.2 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 48.8 6.5 53.3 49.8 40.8 19.6 22.8 21.1 15.0 65.1 28.5 0.0 0.0 0.0 18.9 0.0 0.6 0.4 40.9 0.0 21.6 0.3 0.9 3.0 0.0 18.0 0.0 22.9 13.5 0.1 1.7 0.0 0.4 0.3 0.3 4.4 0.3 0.0 0.0 29.0 0.4 63.9 0.5 0.0 0.3 0.0 46.9 0.0 0.0 2.4 0.0 24.2 1.1 12.2 0.0 0.0 0.8 0.0 0.3 1.8 1.0 0.0 3.2 0.0 11.1 13.2 2.9 0.1 0.4 0.0 0.3 20.3 0.4 2.6 19.4 0.0 0.0 4.0 0.6 0.9 0.0 0.6 49.5 0.1 0.6 0.4 1.0 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.1 22.8 45.8 0.9 44.8 0.7 4.7 16.2 54.3 5.8 13.9 3.6 0.7 12.5 16.2 1.2 22.1 5.2 15.0 45.4 53.9 8.7 0.4 1.7 0.3 27.0 30.1 17.2 6.3 15.8 36.7 2.6 35.3 8.8 0.7 35.6 6.0 9.6 1.6 1.2 1.3 7.2 23.3 0.6 1.8 22.5 39.8 30.1 15.4 1.1 0.6 3.1 1.6 34.6 0.0 13.9 19.7 19.6 5.6 12.7 3.5 1.3 0.2 2.4 1.2 0.2 1.6 0.1 18.1 0.9 6.8 0.2 32.9 5.3 1.6 0.1 12.2 0.0 0.5 0.5 9.4 0.2 0.2 3.3 6.5 8.2 0.0 1.8 2.0 11.9 36.3 0.2 35.9 0.1 0.2 0.2 16.5 0.0 0.0 0.0 21.5 0.0 8.2 0.1 16.0 31.3 0.1 0.3 0.0 18.0 0.2 0.3 1.2 0.0 0.2 0.2 6.8 0.1 0.1 0.2 0.3 0.1 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.0 45.8 44.8 16.2 54.3 45.4 53.9 27.0 30.1 35.3 23.3 39.8 34.6 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 0.0 1.8 11.0 0.0 1.9 0.0 0.0 3.9 0.9 0.0 8.4 2.3 0.3 0.0 0.0 0.0 0.0 0.5 2.8 0.0 1.3 0.0 13.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 10.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.0 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.9;pituitary gland: 8.6" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.0 1.1 12.3 0.1 13.0 0.1 0.2 1.6 11.4 0.0 1.5 0.2 0.0 0.1 2.0 0.0 1.2 0.2 0.1 11.0 15.1 0.0 0.0 0.1 0.0 5.9 10.2 0.1 0.0 0.1 8.6 0.0 7.1 0.3 0.0 2.0 0.0 0.4 0.7 0.1 0.1 0.1 5.9 0.0 0.0 0.6 15.9 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 12.3 13.0 1.6 11.4 11.0 15.1 5.9 10.2 7.1 5.9 15.9 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 165.1" "Cell type enhanced" "Detected in many" "Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 165.1 3.9 4.0 8.7 3.0 3.0 74.3 3.2 4.7 9.7 0.6 48.7 23.6 7.0 1.2 6.2 7.0 10.5 14.6 4.0 2.7 14.3 17.1 28.5 4.9 3.7 3.5 14.5 2.8 7.9 0.5 43.6 3.4 5.5 40.6 1.0 5.7 1.7 5.2 6.2 15.1 8.7 3.2 12.0 35.5 6.9 3.5 4.1 13.2 8.1 2.1 67.7 9.1 5.0 44.0 38.6 0.0 0.2 198.7 113.7 247.5 3.7 44.7 5.4 2.1 7.8 111.6 0.0 0.1 4.0 72.9 17.3 14.4 0.7 1.0 106.4 20.3 0.0 8.1 10.3 51.8 0.2 0.1 118.9 9.7 9.8 37.5 20.6 0.7 1.0 0.0 0.0 8.3 11.0 0.1 0.8 0.7 99.2 112.0 0.0 0.0 0.2 30.6 157.5 0.1 1.2 18.8 6.7 2.2 6.7 0.0 34.2 35.0 7.8 10.6 4.6 0.2 0.0 0.1 0.3 3.2 0.5 1.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 3.0 3.2 4.7 4.0 2.7 3.7 3.5 3.4 3.2 3.5 5.0 284.1 3.2 7.2 1.6 0.6 1.0 50.5 0.4 4.6 0.9 1.9 2.8 9.2 1.5 2.5 5.5 0.0 110.4 1.8 93.4 1.9 1.1 4.9 5.2 1.4 26.1 8.4 0.0 39.3 0.7 217.8 12.3 83.1 20.8 8.9 232.9 25.7 3.4 49.9 0.0 74.1 21.3 0.0 19.4 4.8 2.2 4.1 19.1 3.6 38.4 1.8 0.6 0.0 6.6 1.2 17.3 84.1 0.0 1.6 42.1 17.0 14.3 1.5 0.2 13.1 1.9 31.3 10.9 22.8 4.6 1.1 88.9 2.2 0.8 24.5 239.6 PPAT "GPAT, PRAT" ENSG00000128059 "Phosphoribosyl pyrophosphate amidotransferase" Q06203 4 56393362-56435615 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Purine biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036091, HPA036092" Approved Approved "Midbody ring" Yes No 11000 "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Midbody ring" "HPA036091: AB_2674936, HPA036092: AB_10603132" "unprognostic (5.11e-2)" "unprognostic (5.13e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (1.38e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (1.14e-8)" "unprognostic (6.74e-3)" "unprognostic (2.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.88e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.34e-4)" "unprognostic (1.41e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.09e-1)" 2.8 6.1 3.8 5.4 4.0 5.6 7.1 3.7 4.7 4.3 3.6 3.9 4.0 4.6 3.4 4.5 4.4 3.0 2.3 4.1 4.0 6.0 6.1 2.2 8.4 3.4 4.0 7.4 5.9 3.9 2.5 6.7 4.3 3.9 4.8 4.4 5.6 3.1 2.9 4.3 3.2 3.6 3.7 4.3 3.5 8.6 4.1 8.3 5.9 2.9 8.0 6.7 2.6 4.2 23.1 19.0 38.0 18.7 12.2 15.7 31.0 25.2 11.1 20.4 21.6 38.1 27.5 80.6 33.4 11.9 19.0 16.8 74.0 25.4 40.7 21.1 32.8 32.6 22.6 42.2 18.4 65.0 19.5 13.6 19.4 29.0 32.4 12.6 21.8 32.5 83.5 43.3 23.2 20.9 80.6 49.1 50.6 52.0 22.4 67.2 24.9 56.9 34.2 16.2 64.0 31.2 20.1 36.3 23.0 35.4 24.5 13.8 15.3 21.2 36.6 21.4 45.0 32.2 34.5 82.9 23.6 40.7 20.1 4.7 1.8 0.9 3.8 2.7 5.9 7.4 5.1 5.2 2.5 6.1 7.7 7.1 0.5 10.2 3.9 3.2 4.3 3.5 3.8 4.0 3.7 4.7 4.1 4.0 3.4 4.0 4.3 3.7 4.1 4.2 4.8 0.0 5.5 16.6 10.7 31.0 16.0 5.6 28.5 8.4 10.1 9.7 3.8 4.3 8.0 3.7 2.1 29.7 10.3 1.5 9.8 3.7 2.6 5.5 14.1 7.8 4.2 14.9 22.9 2.7 25.2 9.4 4.1 6.9 7.0 66.2 5.3 7.1 7.9 38.7 15.8 4.3 4.1 1.6 6.0 2.6 7.8 5.2 8.8 5.6 3.1 6.4 2.1 5.5 9.1 3.3 2.7 5.7 15.3 15.0 0.8 12.7 6.2 4.7 0.0 9.3 10.8 16.4 27.5 18.3 31.8 7.7 10.7 21.9 9.0 8.7 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 337.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 26.0 30.5 21.9 34.9 23.2 51.9 33.2 23.4 26.6 27.7 22.1 29.0 23.2 31.0 31.9 28.2 28.3 28.6 35.7 23.3 22.9 30.1 30.5 28.0 58.4 17.7 19.7 34.1 19.2 25.9 22.9 29.8 20.4 26.0 31.7 25.8 25.9 28.3 34.1 25.9 28.8 33.9 18.9 36.2 25.7 56.1 23.5 52.8 27.4 31.2 59.1 37.0 22.4 23.3 60.7 54.7 63.5 53.4 56.0 61.3 55.8 68.3 79.1 71.8 59.1 89.1 74.3 99.0 86.4 74.6 33.9 53.6 66.2 72.4 87.6 87.3 68.9 159.5 53.8 81.9 58.8 190.4 88.0 74.4 71.9 57.5 54.6 80.3 89.5 87.3 79.2 76.0 78.9 46.3 107.8 111.7 55.0 166.0 54.2 90.4 73.7 93.3 111.7 50.7 44.7 66.0 61.1 48.7 60.1 60.7 75.1 90.7 63.1 41.5 74.5 39.9 60.7 87.4 129.9 163.3 69.8 337.5 27.7 51.7 23.9 44.1 32.7 26.7 39.4 44.3 41.9 44.5 43.8 35.8 37.9 38.1 14.9 44.6 25.9 41.5 61.5 22.6 21.9 23.2 23.4 26.6 23.3 22.9 17.7 19.7 20.4 18.9 23.5 23.3 28.9 41.7 51.8 46.0 78.4 75.8 68.1 116.9 44.9 60.2 30.8 31.0 32.5 40.0 70.7 42.3 29.2 88.1 77.4 31.8 37.2 62.3 243.3 47.5 56.1 48.1 33.6 58.5 128.7 68.3 75.4 47.0 24.5 60.7 57.0 238.1 36.0 35.5 52.9 37.0 93.2 35.8 71.2 40.6 65.4 76.7 58.4 49.1 64.0 49.6 92.9 46.3 72.1 64.3 85.0 71.4 42.1 52.3 63.4 46.4 45.8 55.6 58.6 60.5 52.6 44.6 47.9 120.3 58.8 50.3 59.1 44.2 81.8 84.0 42.4 50.7 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 356.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 16.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 40.0 11.1 5.1 36.0 12.6 8.3 17.8 8.9 9.9 51.8 15.5 151.0 24.1 222.0 30.5 150.1 52.6 72.5 356.9 5.5 6.5 14.3 8.4 24.8 18.6 17.2 15.3 38.3 7.2 6.2 5.0 34.4 18.0 142.8 64.8 7.6 20.0 198.6 84.1 11.0 30.9 246.4 16.2 30.8 41.5 7.1 9.2 7.7 10.9 80.5 15.1 86.7 23.0 27.3 2.2 4.4 3.3 3.2 4.6 3.3 5.4 1.7 1.7 1.8 1.7 1.9 3.9 2.5 0.8 3.2 4.3 7.0 5.0 2.7 1.9 3.3 3.1 2.5 7.1 1.2 1.1 5.4 2.8 2.6 3.0 2.5 2.6 9.1 1.5 2.8 3.9 2.9 3.1 1.7 4.1 3.4 2.3 2.4 0.9 2.6 8.5 3.7 1.4 8.1 4.0 3.1 3.3 3.9 1.9 4.4 3.4 2.4 1.9 2.5 1.5 1.9 1.5 4.2 4.3 2.7 2.4 4.4 10.2 2.4 1.7 1.5 1.6 1.0 1.4 2.0 1.1 1.0 1.5 2.1 1.3 1.0 16.2 0.7 1.5 1.7 1.7 0.5 5.1 12.6 8.9 9.9 5.5 6.5 17.2 15.3 18.0 16.2 9.2 27.3 12.5 12.8 19.8 181.5 6.0 17.3 49.0 35.6 8.6 59.3 11.1 20.6 836.8 11.5 23.0 12.9 75.0 18.1 8.6 52.9 11.7 10.1 39.2 19.3 16.1 15.2 24.0 5.2 225.7 12.9 8.4 51.4 17.3 7.6 18.9 438.3 16.4 9.6 9.4 26.9 205.0 17.2 63.1 23.5 10.9 13.1 12.2 8.2 8.8 102.1 7.8 10.2 5.2 102.5 647.4 6.3 21.1 51.1 9.6 24.3 12.8 7.1 27.4 30.4 32.9 38.6 162.7 19.3 13.9 7.1 10.9 25.4 10.7 14.2 33.9 28.4 PPP1R12C "AAVS1, DKFZP434D0412, LENG3, MBS85, p84, p85" ENSG00000125503 "Protein phosphatase 1 regulatory subunit 12C" Q9BZL4 19 55090914-55117637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043532 Approved NA NA 29000 "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "HPA043532: AB_10961273" "unprognostic (2.14e-1)" "unprognostic (1.27e-1)" "unprognostic (8.52e-3)" "unprognostic (7.92e-2)" "unprognostic (3.24e-2)" "unprognostic (2.78e-2)" "unprognostic (3.21e-3)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic favorable (4.10e-5)" "unprognostic (9.60e-2)" "unprognostic (3.01e-3)" "unprognostic (8.36e-2)" "unprognostic (3.15e-1)" "unprognostic (3.01e-1)" "unprognostic (2.68e-3)" 103.0 67.3 86.5 49.6 80.5 55.8 96.2 71.7 102.8 158.4 91.4 298.6 61.1 200.7 26.0 80.6 143.2 26.2 283.7 86.6 79.2 96.3 85.8 107.0 44.8 93.3 83.0 104.6 86.3 36.5 108.3 36.8 86.5 137.9 19.4 15.4 60.4 57.7 43.4 75.0 135.9 58.4 69.9 138.9 132.2 150.8 87.1 28.9 85.8 22.3 23.1 173.6 101.4 80.6 52.9 66.7 36.2 43.8 39.8 24.1 84.0 58.8 41.9 35.3 38.9 24.1 37.6 77.9 25.0 33.8 36.0 49.7 12.6 23.2 12.0 63.6 120.7 52.0 67.5 40.2 82.0 38.1 90.1 37.8 29.0 35.1 22.4 29.2 39.7 39.8 40.3 87.1 32.6 32.7 45.4 55.3 26.2 34.8 67.6 62.0 29.9 31.4 32.4 89.2 47.0 37.4 42.1 35.7 37.9 17.9 22.9 76.6 82.9 86.0 41.5 43.1 62.3 43.0 37.7 42.8 78.4 77.5 54.2 0.0 1.5 2.6 1.1 1.2 0.8 1.3 1.0 0.9 0.9 2.5 0.8 1.1 1.6 0.6 2.4 1.5 0.7 0.7 86.5 80.5 71.7 102.8 86.6 79.2 93.3 83.0 86.5 69.9 87.1 80.6 28.2 22.4 15.5 19.9 9.6 11.5 5.1 4.6 1.8 31.3 11.4 12.2 50.3 8.6 8.6 11.0 22.9 6.2 20.4 31.9 1.9 8.4 19.4 9.2 25.4 23.2 5.3 6.5 15.1 15.1 10.3 18.6 33.1 15.1 6.3 96.2 23.6 17.4 15.7 37.0 16.7 18.7 8.2 24.4 16.5 9.1 17.1 20.2 17.8 12.2 14.2 19.1 11.3 10.6 16.2 13.3 20.1 25.6 13.0 7.6 17.1 7.9 7.8 21.7 39.5 15.6 45.5 19.7 13.4 8.9 8.2 10.1 13.2 28.5 13.2 8.7 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733195-103847575 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.0 4.7 3.4 3.2 4.2 0.7 7.4 6.6 8.5 6.8 4.0 7.7 7.1 7.6 2.1 11.6 9.8 4.7 21.2 7.6 3.9 6.9 5.0 9.9 2.7 1.2 2.0 10.9 8.3 7.8 6.5 6.0 1.7 10.7 5.6 8.0 10.2 5.3 7.5 12.5 7.6 5.2 0.3 11.3 10.1 19.1 3.8 2.0 23.4 6.2 5.1 8.0 7.1 4.2 4.9 4.2 0.5 5.4 0.9 0.4 1.9 3.2 2.3 4.0 1.8 3.3 4.4 1.1 11.7 2.2 4.9 9.8 5.8 3.7 3.5 2.2 4.0 0.0 1.3 5.7 3.6 0.5 4.4 1.0 4.4 0.3 4.7 1.7 7.9 2.8 0.7 1.7 2.7 20.3 0.0 0.5 1.0 12.3 5.1 11.3 3.2 2.7 7.8 12.7 6.6 16.9 9.9 7.3 2.5 2.6 18.4 0.7 7.1 2.9 4.0 2.4 3.0 4.0 5.8 8.4 1.8 2.9 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 4.2 6.6 8.5 7.6 3.9 1.2 2.0 1.7 0.3 3.8 4.2 35.1 19.2 39.5 31.0 7.1 13.5 16.6 6.9 18.8 15.8 31.3 20.6 45.4 14.3 11.8 7.3 12.5 2.9 11.9 26.9 3.9 7.9 58.0 37.9 7.9 30.3 15.6 2.7 106.1 6.4 1.0 7.7 37.8 48.5 0.0 83.4 14.3 9.0 2.9 15.2 105.9 14.2 6.1 1.6 5.7 78.4 4.4 3.0 3.6 49.6 0.4 5.8 1.0 31.7 33.2 6.8 18.7 20.3 6.3 13.1 14.6 7.8 8.3 12.9 6.6 10.9 6.7 17.8 15.1 24.1 12.9 2.2 9.0 8.7 15.8 13.7 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379638-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.4;heart muscle: 139.4;skin 1: 219.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 85.6;Granulosa cells: 118.3;Syncytiotrophoblasts: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HBEC3-KT: 130.1;hTCEpi: 189.0;hTERT-HME1: 131.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 20.4 20.1 11.7 2.9 11.7 0.6 29.6 11.5 14.0 44.9 9.5 11.1 5.0 8.2 15.2 179.4 9.6 6.0 139.4 10.8 14.3 24.8 12.6 20.3 2.6 11.9 11.1 8.8 31.5 12.2 11.8 26.6 11.7 30.8 6.8 13.6 55.6 13.3 5.8 219.8 9.1 5.4 10.0 6.4 12.0 3.1 12.7 4.0 17.7 4.4 18.8 23.6 84.9 12.4 72.3 10.7 4.6 3.8 4.7 2.9 61.5 14.5 2.5 17.5 24.3 23.1 70.6 9.5 5.9 11.9 36.5 97.2 4.0 130.1 16.0 24.0 5.9 1.4 36.3 8.7 10.0 1.0 3.4 4.0 189.0 27.9 131.9 79.2 33.2 7.9 8.1 3.6 1.2 64.7 1.8 1.9 5.3 36.9 18.3 7.4 5.6 1.7 22.9 95.0 2.4 7.6 64.5 68.4 1.6 30.0 58.2 1.9 46.3 23.1 60.9 1.8 76.2 35.1 42.1 6.5 3.3 2.9 5.6 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 11.7 11.7 11.5 14.0 10.8 14.3 11.9 11.1 11.7 10.0 12.7 12.4 14.3 35.3 13.0 9.4 2.0 68.7 85.6 38.4 67.2 1.7 21.9 28.6 38.8 20.0 27.8 20.2 10.4 83.2 2.5 17.8 5.9 34.9 0.7 8.7 3.0 13.4 7.2 10.1 0.8 15.8 37.7 5.6 8.6 17.1 4.5 118.3 11.7 2.5 7.6 0.0 0.9 6.9 14.2 1.6 5.0 0.5 5.9 2.2 12.4 9.4 1.9 2.4 2.1 2.5 1.6 50.4 17.2 12.4 6.1 44.2 22.6 3.9 16.3 26.8 6.6 8.4 14.1 2.7 2.1 81.2 71.0 128.5 2.5 2.8 9.0 63.4 PPP1R26 KIAA0649 ENSG00000196422 "Protein phosphatase 1 regulatory subunit 26" Q5T8A7 9 135479079-135488893 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044686, HPA063817" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA044686: AB_10795987, HPA063817: " "unprognostic (1.79e-1)" "unprognostic (8.80e-3)" "prognostic unfavorable (3.98e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.67e-1)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-2)" "unprognostic (1.50e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.93e-4)" "unprognostic (9.23e-2)" "prognostic favorable (6.20e-13)" "unprognostic (4.46e-3)" "unprognostic (8.31e-2)" "unprognostic (3.94e-1)" "unprognostic (2.07e-3)" 5.0 8.2 10.3 2.4 9.9 0.8 6.0 6.2 12.8 6.8 8.2 8.9 6.2 6.3 3.3 7.0 7.2 3.6 12.8 10.7 10.3 11.9 10.2 9.3 1.7 8.8 9.6 7.2 12.9 14.4 15.6 4.1 8.4 9.5 3.3 4.6 10.5 7.1 6.1 4.5 6.4 2.5 7.6 5.6 11.5 7.4 11.2 1.4 10.6 5.1 2.1 9.0 5.7 7.8 12.0 17.9 9.2 9.6 3.9 3.3 0.1 6.5 8.7 8.6 5.6 17.5 20.3 0.0 12.0 6.3 21.9 43.7 8.5 8.3 2.7 0.6 9.7 0.2 28.0 13.0 9.1 5.8 21.3 2.4 15.3 4.3 10.2 9.3 5.4 0.0 12.2 0.1 4.9 27.5 0.2 1.9 13.6 24.4 24.3 0.0 16.3 19.9 8.1 15.8 14.2 20.8 11.4 15.7 12.2 7.0 12.1 5.3 6.7 3.2 14.4 15.5 7.4 8.8 22.3 0.4 6.7 1.2 8.3 0.0 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.1 10.3 9.9 6.2 12.8 10.7 10.3 8.8 9.6 8.4 7.6 11.2 7.8 3.1 3.2 7.7 10.1 0.7 2.2 1.9 4.9 2.8 10.0 8.4 5.7 10.4 15.7 3.8 7.3 8.4 0.6 0.3 8.9 5.9 5.7 0.3 7.5 2.9 3.1 6.6 1.7 3.5 3.3 0.9 2.2 4.1 9.0 2.5 13.6 3.9 5.9 6.0 1.7 4.8 8.9 4.1 3.5 1.6 0.9 1.2 2.3 3.6 1.0 0.9 8.3 2.1 3.5 1.4 7.4 7.1 1.9 1.0 4.7 6.4 5.1 5.8 7.1 0.0 3.4 3.6 0.5 4.0 4.6 1.7 0.3 0.4 5.1 8.3 2.6 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044705-107161811 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 135.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 110.2;Excitatory neurons: 146.3;Granulosa cells: 712.1;Theca cells: 271.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 70.7;Daudi: 99.8;K-562: 61.4;U-698: 254.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria NA NA 570000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favorable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (7.15e-2)" 135.8 44.9 10.7 4.8 12.1 14.2 51.3 5.7 17.5 8.0 5.3 11.1 3.6 6.9 4.4 11.2 7.0 4.9 15.5 13.2 9.5 8.8 2.5 7.6 3.8 6.2 10.2 26.4 8.7 6.5 11.4 15.1 8.3 9.2 6.9 7.5 9.9 4.4 1.5 3.7 11.5 5.1 6.9 16.7 9.1 13.6 7.8 2.6 3.5 6.1 4.0 20.3 6.2 10.1 0.1 1.5 9.1 70.7 36.8 0.0 0.1 3.6 11.5 3.0 2.7 0.0 0.2 99.8 0.8 2.3 8.6 0.1 7.1 0.0 5.5 2.8 7.9 33.3 0.1 0.0 10.3 0.6 4.5 0.5 0.0 0.3 0.0 3.1 42.9 5.4 61.4 2.9 0.1 7.5 14.0 0.4 17.3 0.0 2.8 4.0 0.2 0.0 0.1 0.1 11.6 16.7 5.4 1.2 3.9 22.9 2.1 7.0 24.4 3.5 9.2 0.0 7.1 2.1 0.1 254.8 2.5 17.5 33.9 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.6 10.7 12.1 5.7 17.5 13.2 9.5 6.2 10.2 8.3 6.9 7.8 10.1 39.6 3.2 1.5 9.8 1.9 2.4 1.6 2.1 0.6 33.5 27.9 10.5 35.9 12.8 5.1 7.3 10.4 0.1 3.7 1.7 0.0 2.5 7.9 1.8 16.2 17.4 0.0 110.2 146.3 0.0 0.6 17.5 3.6 0.9 4.5 712.1 19.2 0.0 1.6 5.0 71.9 1.9 4.1 19.6 26.4 8.5 29.8 64.1 17.8 15.9 17.0 6.4 3.1 60.8 10.9 0.1 2.1 53.0 2.0 3.5 0.0 0.8 5.4 11.9 19.7 5.4 57.7 2.5 6.5 0.7 2.4 0.0 3.7 271.7 2.7 4.6 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589997-118595648 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.2;brain: 12.7;pituitary gland: 6.9" "Group enriched" "Detected in some" 4 "Granulosa cells: 7.7;Horizontal cells: 13.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in many" HPA039361 Enhanced NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Granulosa cells - Unknown function" "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.0 5.2 1.0 0.0 3.3 0.0 0.0 1.2 3.3 1.9 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.0 2.8 6.7 0.0 0.3 0.0 6.9 0.0 12.7 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.4 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.1 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 3.3 1.2 3.3 0.3 6.3 2.8 6.7 12.7 0.2 5.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 13.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 PRRT1 "C6orf31, DSPD1, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 40.1;ovary: 11.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 67.5;Cardiomyocytes: 125.5;Granulosa cells: 181.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 38.4;cerebral cortex: 40.1;hippocampal formation: 37.0;white matter: 17.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;SK-MEL-30: 1.6;U-2 OS: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "HPA055149: AB_2682717, HPA059099: AB_2732632" "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 1.6 2.2 38.4 0.3 6.4 0.0 2.0 0.0 40.1 2.7 0.0 2.9 0.6 2.3 0.0 1.5 3.6 0.1 1.6 37.0 4.8 3.1 0.9 1.3 0.1 3.4 2.1 11.9 0.6 0.3 5.6 0.2 2.2 3.1 0.0 1.3 0.9 0.6 0.4 2.0 1.8 0.0 0.0 0.9 2.0 1.3 6.5 0.0 1.9 0.0 0.0 2.4 2.4 17.5 0.0 0.1 0.0 0.5 0.2 0.1 0.2 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.8 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 6.4 0.0 40.1 37.0 4.8 3.4 2.1 2.2 0.0 6.5 17.5 3.2 0.0 0.0 4.9 0.5 4.0 8.0 3.4 14.8 67.5 1.8 3.0 125.5 10.0 1.2 1.8 10.4 6.7 1.7 2.2 1.9 0.1 1.3 1.3 2.3 6.7 9.0 4.2 12.6 0.0 1.0 7.8 4.6 0.5 0.0 181.6 5.0 3.5 1.0 32.0 10.9 5.5 0.0 0.8 2.1 1.2 6.2 1.9 3.6 6.5 0.2 16.0 1.0 3.5 5.0 0.2 3.4 6.4 0.8 3.6 5.5 0.1 3.7 8.7 0.0 3.6 8.0 0.8 1.6 3.8 2.7 3.6 2.2 8.1 4.1 4.8 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893254-67929676 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053927, HPA062763" Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Cytosol" "HPA053927: AB_2682312, HPA062763: " "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favorable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.6 12.8 9.6 14.5 5.2 14.0 12.2 13.5 13.5 19.5 18.2 13.7 19.3 10.0 16.9 18.7 10.1 17.6 11.2 11.5 20.5 16.5 12.7 10.6 15.0 14.9 19.4 26.3 32.9 13.2 7.6 13.4 15.1 10.8 4.0 18.1 12.7 15.3 13.8 15.7 15.7 13.2 12.8 21.4 21.8 13.6 12.0 15.0 13.5 8.5 16.5 9.5 14.9 13.0 22.7 25.2 28.1 38.4 19.3 16.3 15.2 23.0 15.8 14.0 17.2 18.2 12.2 22.7 25.7 12.7 19.2 14.7 15.6 5.3 4.8 16.4 13.9 16.8 22.0 26.3 13.4 8.0 35.7 26.7 18.8 19.6 21.3 23.3 22.5 21.6 5.1 16.7 28.7 18.3 8.6 24.2 14.0 13.9 27.7 9.7 25.3 18.6 16.0 21.8 26.0 47.3 12.8 15.8 9.9 23.5 23.9 20.8 17.7 6.2 15.0 7.7 15.3 8.7 26.2 21.4 8.8 19.9 0.0 2.0 1.9 2.0 2.2 1.4 1.5 1.5 2.0 2.1 1.2 1.2 1.7 1.0 2.1 1.5 1.5 0.8 1.7 12.8 14.5 12.2 13.5 11.2 11.5 15.0 14.9 13.4 13.2 13.6 14.9 5.5 0.0 3.6 4.6 2.9 1.1 3.1 5.2 2.2 11.1 5.3 4.6 2.3 7.2 3.8 5.5 6.2 6.2 3.0 11.5 11.7 6.0 14.4 5.8 6.5 5.2 10.8 3.0 4.6 7.4 4.8 5.4 5.1 4.8 6.3 13.0 5.3 10.3 4.8 6.7 6.1 6.2 10.2 6.3 1.6 22.1 4.7 2.9 5.4 3.7 4.8 11.0 3.1 5.5 9.2 7.6 4.5 7.9 3.0 3.6 10.0 8.1 4.9 6.9 13.1 6.3 6.1 6.7 6.1 5.4 1.6 5.9 3.8 10.7 7.4 2.2 PTCD1 KIAA0632 ENSG00000106246 "Pentatricopeptide repeat domain 1" O75127 7 99416739-99466163 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 29.2" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (4.70e-2)" "unprognostic (3.38e-2)" "unprognostic (4.19e-2)" "unprognostic (6.05e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (4.39e-2)" "unprognostic (2.00e-1)" "unprognostic (4.09e-2)" "unprognostic (1.14e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (7.10e-3)" 3.4 3.6 3.5 2.6 3.5 5.6 3.4 4.2 4.0 3.3 2.8 3.8 2.7 3.7 0.8 4.4 3.8 2.7 4.1 3.2 3.1 3.2 4.7 2.8 3.4 4.1 3.6 3.4 3.6 1.6 2.9 1.8 3.6 4.2 1.3 1.7 3.4 2.1 6.7 4.3 4.0 1.0 3.1 4.9 3.9 4.3 3.6 1.3 3.2 2.6 1.5 3.6 3.4 4.2 4.8 9.8 3.3 9.3 3.1 2.5 9.2 6.6 2.4 4.6 3.3 29.2 5.7 9.6 7.4 1.8 7.7 5.1 4.0 5.9 1.6 7.7 11.2 4.9 8.1 7.2 4.8 5.1 9.0 2.0 3.7 3.8 3.8 3.1 1.4 6.0 10.0 6.4 2.3 13.8 9.0 12.9 6.1 4.8 8.0 5.4 4.3 11.9 2.5 5.1 6.1 6.5 7.4 24.2 6.3 4.7 5.2 5.3 2.7 6.9 8.1 13.7 7.1 9.5 9.1 10.2 7.1 6.7 9.7 1.8 2.0 0.9 3.3 2.3 2.2 1.8 2.1 2.2 1.4 2.5 2.4 3.0 1.9 2.0 1.7 2.1 1.5 1.5 3.5 3.5 4.2 4.0 3.2 3.1 4.1 3.6 3.6 3.1 3.6 4.2 3.5 0.0 5.8 0.0 6.6 6.2 4.0 5.2 4.6 7.9 4.9 4.7 5.8 4.3 4.0 5.5 10.4 9.9 4.1 4.2 1.9 5.3 2.1 4.7 8.6 5.3 7.3 2.5 0.0 6.7 5.6 4.2 3.6 5.2 12.7 12.9 4.6 6.1 6.6 8.4 0.0 6.2 6.1 3.2 6.1 1.8 3.7 3.7 3.6 0.0 3.8 5.6 1.0 0.0 0.0 5.0 2.5 3.0 4.1 3.6 4.5 3.2 5.8 9.3 0.0 8.6 6.7 8.7 7.6 5.1 4.1 5.6 5.7 6.2 6.3 2.6 RAF1 "c-Raf, CRAF, Raf-1" ENSG00000132155 "Raf-1 proto-oncogene, serine/threonine kinase" P04049 3 12583601-12664125 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 175.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 175.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002639, HPA002640, CAB019291" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cytosol" "CAB019291: , HPA002639: , HPA002640: AB_1856047" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (5.92e-2)" "unprognostic (2.17e-3)" "unprognostic (6.51e-3)" "unprognostic (7.66e-3)" "unprognostic (2.66e-3)" "unprognostic (1.53e-2)" "unprognostic (2.72e-1)" "unprognostic (7.66e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-2)" "unprognostic (2.79e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (2.36e-2)" 42.4 34.2 36.7 33.8 37.9 77.4 39.2 42.6 37.4 47.6 40.4 46.8 40.5 45.6 34.0 55.5 43.2 31.0 89.6 36.9 35.8 46.7 68.9 44.7 36.3 38.3 36.9 52.0 50.6 63.6 28.3 39.1 37.0 41.9 42.0 37.4 39.6 38.0 194.9 56.0 43.4 45.5 36.7 48.3 55.5 26.8 38.1 52.8 48.8 122.5 47.7 46.1 46.2 39.8 49.9 57.9 85.5 66.6 74.3 59.6 168.0 73.9 129.1 100.1 112.5 46.6 41.3 52.7 34.6 120.1 51.6 31.9 93.4 67.5 103.8 91.4 70.2 72.0 69.4 42.9 74.2 70.1 64.7 55.3 67.8 102.3 82.0 67.6 73.1 78.2 52.6 136.0 98.3 88.6 91.1 47.8 86.5 64.0 76.4 72.6 75.7 66.4 60.9 76.9 26.1 56.2 61.1 59.8 40.9 66.1 99.1 91.5 51.1 65.6 62.5 55.7 85.0 103.3 178.4 112.3 57.2 80.4 73.9 40.4 32.7 62.5 22.3 32.6 22.5 19.5 21.9 22.3 30.3 20.4 21.9 22.8 175.1 29.8 34.2 13.5 28.3 28.2 36.7 37.9 42.6 37.4 36.9 35.8 38.3 36.9 37.0 36.7 38.1 39.8 28.5 22.4 37.6 47.7 36.1 34.4 35.2 22.1 27.9 56.7 27.5 22.6 29.0 35.8 25.7 27.6 66.7 40.0 41.5 31.3 13.7 25.6 8.8 33.2 37.1 32.7 29.3 46.7 46.1 37.0 46.8 32.3 27.5 43.8 34.2 78.7 36.0 41.2 28.6 43.7 52.9 31.0 30.5 39.3 43.4 4.6 39.1 34.7 26.6 44.0 49.5 31.9 51.5 65.4 64.0 35.5 29.9 41.3 43.3 46.9 47.3 20.1 31.2 81.9 32.9 56.2 39.1 28.3 33.6 31.8 43.5 62.3 40.8 35.6 31.2 47.1 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 1366.7;pancreas: 632.7" "Group enriched" "Detected in many" 4 "Granulosa cells: 5988.6;Theca cells: 3228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SH-SY5Y: 835.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 64.4" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA 41000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 23.7 377.1 64.6 18.4 65.2 1.3 49.5 64.9 72.7 53.8 251.4 30.3 32.3 180.2 64.2 35.4 390.2 182.9 60.1 65.5 67.8 46.9 140.8 26.8 18.6 83.1 69.0 1366.7 632.7 46.8 257.8 63.6 64.7 44.8 14.2 23.2 50.2 41.3 15.2 31.3 26.2 119.3 68.2 47.0 29.3 56.1 75.2 9.4 23.0 15.5 12.0 65.7 24.3 67.5 7.8 2.9 7.4 164.2 0.3 0.0 0.9 0.1 0.0 0.0 0.1 0.4 76.1 0.0 53.8 0.1 2.6 0.1 38.2 0.5 0.0 0.1 5.3 0.1 2.7 75.5 155.1 0.2 0.1 3.0 0.0 0.1 0.0 160.9 0.0 0.0 0.2 29.9 0.2 0.0 0.2 0.5 18.4 0.2 0.0 0.1 32.0 0.5 0.1 0.1 19.6 835.4 35.3 0.1 0.1 13.9 3.2 1.1 0.0 0.3 120.0 0.2 0.3 0.6 0.5 0.5 1.3 0.0 2.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 64.6 65.2 64.9 72.7 65.5 67.8 83.1 69.0 64.7 68.2 75.2 67.5 24.8 32.1 5.9 8.8 3.5 17.6 53.5 91.9 2.8 26.3 70.4 47.8 21.4 77.2 30.3 23.9 2.1 3.2 1.0 0.1 13.7 1013.0 4.8 199.6 961.4 103.8 43.1 13.5 0.5 1042.7 6.2 158.8 19.9 58.1 0.0 5988.6 343.7 6.9 16.5 3.3 0.3 2.3 42.7 10.6 3.4 16.2 27.1 25.1 8.8 5.6 13.5 159.9 0.0 4.0 16.0 563.0 0.0 4.5 2.9 56.6 2.6 4.7 10.3 7.2 26.3 220.9 534.7 11.6 4.9 6.2 34.9 3.8 10.2 3228.5 2.7 32.7 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849665 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 343.8" "Cell type enriched" "Detected in some" 5 "Granulosa cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 15 "basophil: 86.7" "Lineage enriched" "Detected in many" 39 "granulocytes: 86.7" "Cell line enhanced" "Detected in many" "K-562: 44.7;U-266/70: 42.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 2.3 1.8 1.4 1.8 1.4 11.6 3.6 1.6 2.0 1.7 0.4 2.1 2.9 2.2 1.2 2.3 4.2 1.6 3.4 1.4 2.3 1.2 1.8 1.0 2.9 1.7 1.1 1.9 1.7 40.0 0.9 1.5 1.6 5.3 3.0 4.2 1.7 1.3 1.0 2.2 2.1 2.7 0.8 1.0 5.0 343.8 2.2 7.4 0.9 1.3 2.6 2.0 1.6 2.1 11.3 6.5 10.1 4.5 4.2 7.5 3.4 7.6 8.4 8.2 8.9 4.7 10.0 7.0 11.5 6.7 5.7 5.7 7.7 3.4 8.5 6.5 4.9 11.7 10.2 6.7 0.8 17.2 16.4 3.8 1.5 9.7 12.4 3.5 2.8 0.0 44.7 29.8 20.5 15.1 2.8 13.5 5.5 4.6 6.6 14.0 18.8 12.6 2.5 4.0 8.6 9.7 7.3 9.6 2.4 2.9 16.2 14.8 1.4 6.1 5.4 8.2 9.3 42.5 31.1 2.7 12.6 22.3 5.6 86.7 0.4 5.7 0.3 0.1 0.4 0.0 0.4 0.4 0.7 0.0 0.1 0.3 0.4 2.2 0.2 0.2 1.8 0.4 1.4 1.4 1.6 2.0 1.4 2.3 1.7 1.1 1.6 0.8 2.2 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 0.0 1.3 0.0 0.0 3.2 0.8 0.0 0.0 1.6 0.0 2.8 1.6 0.6 0.0 0.0 0.0 1.5 2.4 1.5 0.0 1.7 1.3 26.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.6 1.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.5 0.5 4.7 0.0 0.0 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HHSteC: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 1100000 "Cluster 35: T-regs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 28.3 24.3 9.9 3.8 9.7 10.2 24.6 8.5 11.8 25.5 7.8 26.5 11.1 25.3 1.6 24.1 23.0 10.9 19.5 8.7 9.0 22.9 78.5 18.7 5.4 10.4 9.3 29.7 42.6 11.1 20.0 5.9 9.5 23.5 3.2 1.4 22.0 6.9 45.4 27.1 16.7 7.7 9.0 14.9 27.7 23.2 9.6 4.6 19.8 10.5 2.7 24.0 18.6 9.7 20.3 19.2 5.6 19.1 13.9 11.8 24.4 18.5 10.1 8.2 6.2 11.6 13.7 4.5 13.0 29.1 17.4 10.8 3.9 15.8 1.5 6.0 19.7 6.7 4.4 48.5 69.3 2.4 14.2 22.5 9.9 14.7 24.9 16.5 15.8 15.2 8.5 16.9 6.6 24.1 15.1 6.5 5.5 13.5 20.1 10.2 7.0 10.6 9.5 11.8 9.7 24.9 7.1 10.7 54.7 6.2 32.1 13.7 6.1 13.1 17.9 12.7 10.2 22.9 4.5 5.0 16.8 4.4 11.7 1.0 1.9 2.0 1.7 0.5 0.6 1.0 1.1 1.6 1.4 1.2 1.1 0.6 0.7 0.2 0.7 1.1 2.5 0.6 9.9 9.7 8.5 11.8 8.7 9.0 10.4 9.3 9.5 9.0 9.6 9.7 24.3 6.4 12.4 30.7 7.6 9.7 11.9 8.3 6.8 26.9 33.3 35.4 12.8 18.6 5.6 23.9 25.0 5.5 14.2 20.9 7.9 7.8 3.7 14.9 24.4 12.1 11.4 5.7 20.7 15.1 3.3 27.2 18.8 19.0 1.3 52.5 21.8 47.1 9.6 11.8 20.3 14.0 12.2 15.2 6.3 13.3 21.8 14.7 10.6 16.9 6.2 29.8 3.1 20.6 13.5 12.4 16.3 19.9 4.9 15.9 14.0 31.3 6.8 27.8 0.0 28.0 19.4 14.4 6.2 9.0 10.2 3.7 10.4 32.8 13.5 8.7 RGP1 KIAA0258 ENSG00000107185 "RGP1 homolog, RAB6A GEF complex partner 1" Q92546 9 35749287-35758585 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020414, HPA021085" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "HPA020414: AB_1852289, HPA021085: AB_1852291" "unprognostic (2.10e-1)" "unprognostic (3.22e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.09e-4)" "unprognostic (2.22e-1)" "unprognostic (5.42e-2)" "unprognostic (1.51e-3)" "unprognostic (1.81e-3)" "unprognostic (9.77e-2)" "prognostic favorable (8.55e-13)" "unprognostic (2.46e-2)" "unprognostic (1.68e-1)" "unprognostic (3.03e-3)" "unprognostic (1.18e-1)" 9.8 10.4 7.5 8.7 6.9 5.6 8.5 6.6 6.7 7.9 3.4 12.9 10.7 8.8 7.8 8.6 8.3 6.0 12.9 7.3 7.8 11.5 7.4 9.1 7.5 5.8 6.3 10.1 10.7 19.1 10.5 9.3 6.0 8.7 13.4 7.8 11.0 11.4 17.3 9.4 11.6 9.8 5.6 7.4 10.3 6.4 8.0 8.9 12.2 18.6 9.6 8.0 6.5 5.9 18.0 16.6 18.9 15.8 17.3 18.6 11.1 13.9 20.1 18.9 17.4 14.2 6.7 13.9 9.7 17.8 34.9 9.9 18.3 26.2 15.5 18.6 10.7 11.9 32.9 10.7 16.3 13.0 16.1 18.8 32.8 19.9 24.0 27.0 22.7 10.6 8.2 7.5 17.3 8.5 4.0 4.7 7.9 14.7 19.2 13.2 13.5 9.9 16.5 12.4 13.8 14.9 12.3 17.0 11.2 16.6 14.2 6.2 29.0 15.1 18.9 10.5 11.8 11.1 16.5 14.3 21.5 5.4 19.7 1.1 0.2 0.4 0.7 0.4 1.1 0.8 0.5 0.8 0.1 1.0 0.6 0.7 0.7 1.1 0.6 0.6 0.5 0.2 7.5 6.9 6.6 6.7 7.3 7.8 5.8 6.3 6.0 5.6 8.0 5.9 13.9 6.4 12.6 0.0 23.4 5.7 24.5 14.8 9.1 40.8 15.0 10.0 16.6 18.6 15.8 27.6 20.9 10.9 19.1 46.1 13.7 20.1 17.5 9.8 8.3 14.9 43.3 8.6 0.2 17.6 10.6 7.5 18.8 14.9 5.7 33.4 16.1 16.4 7.5 16.8 0.1 26.0 22.4 7.7 6.1 36.8 8.4 5.7 1.8 0.0 11.1 18.8 25.7 0.0 0.1 20.6 38.3 10.9 15.2 25.3 36.3 14.2 17.7 22.3 6.6 11.8 9.3 16.6 6.1 8.1 5.3 10.3 16.4 7.1 28.9 28.8 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein" Q9H310 1 156369211-156385219 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 9.8" "Group enriched" "Detected in some" 4 "Granulosa cells: 89.9;Theca cells: 91.3" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in single" 17 "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.8 1.9 0.0 0.0 0.1 0.0 2.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 22.0 0.0 0.0 0.0 0.0 19.6 0.3 10.3 0.3 0.0 0.1 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.1 0.0 89.9 0.0 10.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.8 2.3 0.4 0.0 0.4 0.0 0.0 91.3 0.0 0.1 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064676-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1" "Cell type enhanced" "Detected in many" "dendritic cells: 10.6;Granulosa cells: 12.2;NK-cells: 14.4;Plasma cells: 8.2;Respiratory ciliated cells: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 16.1" "Group enriched" "Detected in all" 5 "granulocytes: 16.1;T-cells: 10.4" "Cell line enhanced" "Detected in many" "HDLM-2: 30.8;U-266/84: 61.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 0.8 0.2 2.2 1.5 2.3 2.1 0.8 2.1 4.1 0.3 1.7 0.5 0.5 1.4 1.0 0.4 2.6 0.5 0.5 2.2 2.2 0.3 0.3 1.2 3.6 2.3 2.1 0.3 0.2 0.2 0.3 0.6 2.1 0.2 0.8 0.8 0.4 0.2 0.2 2.6 0.9 0.5 1.9 2.5 0.6 1.5 2.1 1.6 0.3 1.1 1.9 0.4 0.4 2.4 1.7 3.4 2.2 4.8 1.2 0.2 2.1 1.4 4.8 9.1 9.9 3.2 2.9 4.7 1.5 0.4 4.7 1.8 1.5 1.8 3.9 30.8 0.4 4.9 2.9 1.9 1.0 2.4 10.1 0.5 0.8 4.5 1.4 0.6 3.5 8.3 6.1 14.8 3.3 1.7 2.3 13.3 3.0 6.0 3.9 4.7 3.2 7.9 0.7 0.2 1.0 2.9 1.4 1.3 8.4 2.6 0.5 3.5 1.3 2.7 4.4 5.3 1.7 17.8 61.0 3.0 2.3 7.2 1.2 16.1 0.3 0.7 7.6 1.8 10.4 2.0 3.2 4.1 0.8 2.9 1.0 3.8 0.7 1.4 1.7 1.0 6.7 1.4 2.2 2.3 2.1 4.1 2.2 2.2 2.3 2.1 2.1 1.9 2.1 2.4 2.8 0.0 0.0 0.3 6.8 1.3 0.5 1.9 4.0 1.8 1.2 1.7 1.5 1.5 1.8 0.0 0.0 0.1 10.6 0.1 0.0 0.5 0.5 2.8 0.3 2.6 0.0 8.0 6.9 0.2 0.5 1.4 0.5 0.4 0.0 12.2 1.8 0.1 1.8 3.3 2.3 0.2 0.0 0.3 2.0 0.6 0.0 3.7 0.0 0.0 4.5 0.6 14.4 0.5 0.3 0.2 0.0 0.0 8.2 0.4 0.1 0.1 12.0 0.4 0.0 1.3 1.8 0.9 5.4 4.8 2.0 0.1 5.7 0.2 0.4 0.2 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 397.3;Peritubular cells: 314.8;Skeletal myocytes: 347.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.3" "Group enriched" "Detected in many" 4 "granulocytes: 7.3;T-cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 250.6;HaCaT: 332.7;SuSa: 315.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 22: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 79.8 38.3 58.8 11.9 81.2 8.1 23.8 59.1 64.2 27.7 12.1 22.5 14.8 13.1 27.0 17.0 16.5 19.7 33.7 55.6 47.8 28.3 21.7 16.9 6.8 81.5 56.4 83.0 111.1 55.6 13.2 54.0 52.1 28.8 20.8 29.0 41.9 20.6 29.8 13.2 16.6 20.6 50.6 11.3 22.6 21.4 64.5 8.3 19.9 32.7 2.3 25.5 13.4 67.4 53.7 20.4 51.1 55.1 188.4 108.5 0.5 91.0 86.4 34.7 54.0 96.5 9.6 0.2 250.6 45.8 88.5 332.7 27.7 6.6 59.4 2.2 36.6 18.3 185.8 28.9 148.6 4.3 25.5 176.6 4.8 52.0 0.9 147.6 27.0 15.5 74.7 13.4 139.3 14.8 5.8 14.9 19.7 33.4 33.4 8.2 100.3 6.5 29.1 35.6 90.3 118.9 71.8 31.0 85.7 315.9 23.6 26.3 44.5 46.1 195.7 31.1 35.8 13.5 28.3 2.7 14.8 1.1 76.8 0.1 0.6 7.3 1.9 0.3 0.7 0.5 1.4 1.6 0.1 0.1 1.8 0.4 0.4 0.3 1.0 0.8 0.8 0.6 58.8 81.2 59.1 64.2 55.6 47.8 81.5 56.4 52.1 50.6 64.5 67.4 23.4 176.3 13.3 229.9 5.4 10.8 65.8 25.9 13.6 68.3 81.2 44.1 79.4 44.3 49.8 141.6 20.9 62.2 15.7 21.4 60.7 69.7 11.4 55.3 118.6 15.7 92.0 32.6 35.2 111.0 139.7 201.3 3.1 76.8 100.1 178.3 14.3 77.3 33.3 6.7 57.3 66.9 14.2 23.0 11.6 22.1 397.3 20.4 42.7 30.0 3.7 270.3 71.1 117.6 64.8 40.7 70.1 314.8 7.1 53.8 19.9 3.1 33.7 35.9 32.9 347.6 99.2 4.6 8.8 10.1 27.4 115.2 9.8 177.2 84.5 102.2 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810546 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Cell type enhanced" "Detected in some" "Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3" "Cancer enhanced" "Detected in many" "breast cancer: 6.6;glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA060928: AB_2684387" "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 0.4 1.1 17.6 0.2 22.8 0.0 1.1 6.9 35.9 7.2 0.0 0.6 0.1 1.9 0.4 0.5 8.1 0.6 0.6 22.5 12.1 0.1 0.0 0.9 0.1 15.5 9.2 6.1 0.0 0.0 12.0 0.0 10.6 2.5 0.5 2.9 1.1 0.9 1.0 0.4 0.4 2.6 7.7 0.0 1.8 10.5 10.9 0.2 5.0 1.6 0.4 0.1 1.5 20.1 0.0 0.5 0.5 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.9 0.1 2.0 0.0 19.3 0.2 0.0 0.0 8.2 0.0 0.8 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 13.4 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 39.9 20.4 14.0 0.0 0.2 0.5 6.1 0.7 0.0 0.0 9.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 22.8 6.9 35.9 22.5 12.1 15.5 9.2 10.6 7.7 10.9 20.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.1 1.8 0.0 11.3 0.0 0.0 0.4 0.0 0.4 0.0 110.3 0.0 0.0 0.1 38.7 14.4 0.8 0.0 0.0 0.0 2.9 7.2 0.2 0.0 0.0 0.0 1.0 0.0 2.0 0.6 0.1 0.1 13.2 0.0 0.0 0.0 0.0 0.0 1.4 26.3 0.2 1.2 1.2 5.7 0.0 0.1 0.0 0.0 0.5 0.5 0.0 RUFY4 "FLJ46536, ZFYVE31" ENSG00000188282 "RUN and FYVE domain containing 4" Q6ZNE9 2 218034960-218090581 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;lymphoid tissue: 2.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 9.5;Langerhans cells: 4.0;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "Karpas-707: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA037980 Uncertain NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA037980: AB_10672501" "unprognostic (1.27e-3)" "unprognostic (4.60e-3)" "unprognostic (9.39e-3)" "unprognostic (6.79e-2)" "unprognostic (5.92e-2)" "unprognostic (6.57e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-2)" "unprognostic (1.31e-3)" "unprognostic (1.50e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-1)" "unprognostic (2.41e-14)" "unprognostic (1.36e-2)" "unprognostic (1.13e-3)" "unprognostic (3.45e-1)" "unprognostic (1.43e-5)" 0.1 0.2 0.5 0.9 0.6 0.8 0.1 0.4 1.8 0.1 0.4 0.2 0.7 0.0 0.0 0.4 0.2 0.5 0.0 0.9 0.4 0.1 0.2 0.4 1.1 0.4 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.1 0.5 0.1 0.5 0.1 0.0 0.3 0.7 0.0 0.5 2.2 0.6 0.1 0.4 1.7 0.1 0.0 0.8 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.4 1.8 0.9 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.0 0.0 0.0 2.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.3 4.0 0.3 0.0 0.9 0.0 1.0 2.0 0.0 0.0 13.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor like tyrosine kinase" P34925 3 134065303-134250859 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 31.8 25.2 15.7 15.7 16.2 17.1 42.8 15.4 19.8 40.2 19.9 34.5 20.1 46.1 40.0 29.6 33.4 24.3 30.3 14.5 15.3 25.4 22.3 25.3 18.9 15.9 15.6 82.1 24.5 29.7 17.0 36.6 15.5 36.3 26.2 15.9 26.9 43.9 25.3 34.7 21.4 40.6 16.3 22.9 23.2 47.0 16.5 21.2 40.9 32.2 20.5 34.7 32.6 16.4 78.8 20.6 63.3 48.7 79.8 84.4 48.8 51.0 117.7 66.4 74.2 65.6 58.8 15.3 82.4 63.1 63.7 71.6 45.5 64.3 94.5 25.9 20.5 40.6 22.4 42.4 62.2 20.0 34.4 56.1 74.0 41.2 82.2 72.5 56.5 26.4 14.5 7.5 66.0 37.6 28.0 25.9 53.4 65.2 24.3 13.7 48.4 32.4 54.5 57.3 31.0 45.6 61.7 44.5 79.1 40.5 55.7 35.8 42.1 54.8 49.6 57.8 41.8 3.1 4.2 8.3 34.8 33.1 39.6 4.6 0.8 1.6 1.1 0.8 1.3 0.6 2.0 1.3 0.3 1.2 1.9 1.5 0.3 1.6 0.8 0.0 0.5 0.5 15.7 16.2 15.4 19.8 14.5 15.3 15.9 15.6 15.5 16.3 16.5 16.4 62.5 12.8 27.9 31.6 20.6 41.3 36.6 26.3 39.3 23.1 45.4 37.2 34.9 18.6 23.7 44.1 29.2 19.4 23.1 15.9 0.0 15.9 16.2 27.6 41.7 31.0 13.9 13.2 69.5 21.1 14.7 41.3 15.8 32.7 17.7 121.2 40.7 24.1 11.3 13.5 59.7 20.9 12.2 18.6 21.6 7.4 33.2 16.1 14.2 65.6 12.8 26.8 13.4 65.9 57.9 21.7 19.7 32.7 12.9 42.8 15.4 10.5 13.9 39.8 46.0 33.8 38.1 24.6 40.9 33.7 38.1 10.8 18.4 50.8 22.2 38.9 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598604-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 1499.3;choroid plexus: 781.0" "Cell type enhanced" "Detected in many" "Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 360.9" "Lineage enriched" "Detected in all" 6 "T-cells: 360.9" "Group enriched" "Detected in some" 7 "SK-MEL-30: 547.1;WM-115: 992.8" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 300000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 151.1 25.7 877.1 10.5 1072.5 2.3 87.0 1254.5 1191.2 28.6 781.0 121.0 7.4 2.4 12.1 14.6 6.9 14.3 28.1 858.4 989.0 3.6 3.2 6.4 21.4 1491.0 1054.2 5.6 5.0 0.3 44.7 0.8 1359.0 29.3 14.2 14.1 19.3 26.2 3.6 15.8 36.3 6.8 1162.2 26.2 23.6 2.4 998.8 18.4 5.2 6.4 20.3 15.9 26.9 1499.3 0.5 0.0 110.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 15.9 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 2.5 0.0 0.0 547.1 0.0 0.1 0.5 0.0 0.3 0.3 0.0 3.2 0.0 0.3 0.0 1.4 6.7 992.8 0.1 0.5 0.2 360.9 9.5 103.3 0.2 1.0 67.6 16.3 1.4 3.2 153.1 3.2 58.7 10.1 3.9 0.0 63.6 877.1 1072.5 1254.5 1191.2 858.4 989.0 1491.0 1054.2 1359.0 1162.2 998.8 1499.3 4.5 3.2 4.8 126.3 4.6 16.8 0.7 0.0 17.6 1.3 41.2 124.8 6.0 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.1 0.4 0.1 0.1 2.7 0.0 2.7 0.9 0.0 0.1 4.4 0.5 0.2 0.0 261.7 4.6 0.4 9.3 0.0 1.4 0.0 0.0 38.6 206.8 1.7 5.6 37.0 99.6 9.4 33.3 25.7 63.8 83.4 332.1 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 4.7 0.0 5.6 7.8 0.1 0.1 0.7 12.6 0.1 37.9 0.0 0.2 0.4 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28259246-28323849 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;skeletal muscle: 44.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Excitatory neurons: 38.2;Granulosa cells: 26.3;NK-cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 28.8;AN3-CA: 20.9;NTERA-2: 29.6;REH: 32.6;SCLC-21H: 45.5;SH-SY5Y: 42.6" "Region enriched" "Detected in all" 5 "cerebellum: 275.9" "Low region specificity" "Detected in all" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.1 2.4 8.0 0.9 7.0 1.3 0.8 26.8 15.0 0.7 0.0 0.3 0.3 0.9 0.4 0.6 0.7 0.2 2.1 11.6 6.7 1.8 0.2 0.8 1.7 6.6 7.6 0.5 1.9 2.9 5.6 0.0 6.7 1.5 0.3 5.0 2.7 0.2 44.1 1.1 0.6 0.1 3.2 1.9 0.8 2.5 12.8 10.0 2.5 9.1 0.8 0.3 0.3 7.9 0.3 0.4 28.8 20.9 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.2 1.4 0.7 0.2 0.0 0.4 0.5 8.8 0.2 0.1 3.0 1.2 0.1 0.3 0.9 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.2 0.2 11.2 0.0 1.8 0.0 3.6 14.0 0.3 29.6 1.9 0.2 32.6 1.6 0.6 0.1 1.8 45.5 42.6 0.8 2.7 0.4 3.5 3.3 0.1 0.8 0.1 4.3 0.4 0.2 0.3 0.0 0.5 0.1 0.5 1.6 0.3 0.0 0.0 1.5 0.0 0.5 0.0 0.4 0.8 0.0 0.1 0.4 1.0 0.0 0.7 0.0 0.0 0.5 0.1 8.0 7.0 26.8 15.0 11.6 6.7 6.6 7.6 6.7 3.2 12.8 7.9 0.2 3.2 0.5 1.0 0.6 0.6 0.7 1.4 3.4 13.0 6.3 2.9 3.6 2.8 2.5 0.0 81.3 0.0 11.1 0.1 1.9 8.2 1.2 2.4 0.3 0.3 6.0 0.4 38.2 5.6 0.0 0.4 0.0 1.8 0.0 26.3 0.0 0.2 0.1 0.0 13.8 0.8 4.1 0.0 0.8 3.9 0.6 0.4 0.0 0.0 0.7 4.1 36.0 5.0 1.7 3.6 0.0 0.0 2.3 1.5 0.1 0.7 1.7 2.7 0.0 2.5 2.7 2.4 2.1 1.0 0.1 0.1 5.6 0.2 1.2 0.4 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "adrenal gland: 995.8" "Cell type enhanced" "Detected in many" "Adipocytes: 133.9;Granulosa cells: 114.6;Hepatocytes: 159.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 6.2;myeloid DC: 8.9;plasmacytoid DC: 21.0" "Group enriched" "Detected in many" 6 "dendritic cells: 21.0;monocytes: 6.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 148.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved "Vesicles,Lysosomes,Rods & Rings" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Lysosomes, Rods & Rings" "CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201" "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavorable (1.83e-5)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 59.2 995.8 12.3 4.0 22.7 1.3 55.4 7.2 13.2 12.9 21.7 14.7 12.5 13.7 0.9 9.2 13.1 12.9 10.5 12.3 8.9 6.8 235.7 15.3 6.2 11.0 10.0 54.8 9.6 4.0 15.2 111.5 12.0 13.0 9.2 12.0 21.2 2.3 9.8 26.4 14.9 7.8 7.2 12.7 8.8 19.1 15.5 2.9 11.7 5.0 10.4 12.3 12.7 11.5 30.1 50.0 22.2 51.4 12.3 23.1 0.0 24.2 20.0 21.4 12.1 56.7 61.7 91.6 66.4 12.4 31.1 39.2 58.0 109.3 13.2 45.5 51.4 18.5 53.1 68.3 33.2 35.9 17.2 39.5 19.7 41.0 32.5 36.7 57.2 9.1 41.5 21.5 4.3 27.7 12.9 23.5 22.8 30.7 66.0 51.0 18.8 148.7 0.8 32.9 38.8 12.1 126.5 95.9 70.2 13.3 55.8 29.9 4.6 2.6 23.8 14.3 29.8 10.1 3.8 15.7 11.3 29.0 23.9 0.0 6.2 0.0 0.2 3.0 0.1 2.3 0.0 0.2 8.9 0.9 0.0 0.0 0.8 0.0 0.6 21.0 0.0 3.8 12.3 22.7 7.2 13.2 12.3 8.9 11.0 10.0 12.0 7.2 15.5 11.5 133.9 3.2 2.7 25.8 8.6 5.6 3.6 9.0 6.8 6.1 14.8 17.0 6.5 8.6 5.3 3.7 29.2 10.7 10.5 46.7 3.9 5.4 18.1 1.0 5.3 44.2 10.7 8.2 21.0 7.4 13.8 7.9 11.7 3.4 1.3 114.6 21.4 159.4 51.6 16.8 24.8 13.1 8.2 14.8 11.4 12.6 9.0 16.7 48.0 74.9 5.9 52.9 0.0 23.1 27.3 5.8 12.9 5.3 8.0 9.9 10.0 2.9 4.7 7.5 0.0 3.1 5.0 25.0 1.6 6.5 3.1 43.4 1.8 60.0 9.4 4.4 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197280-43343372 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 26.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Extravillous trophoblasts: 13.3;Granulosa cells: 37.2;Peritubular cells: 45.5;Theca cells: 14.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 10.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HMC-1: 49.8;THP-1: 20.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 190000 "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 1.8 6.1 0.8 0.8 1.1 0.1 1.2 0.1 1.4 0.9 4.1 3.8 5.9 1.1 0.1 3.6 1.2 0.8 0.2 0.6 3.8 3.5 5.1 6.8 0.0 1.7 10.2 26.4 0.1 9.1 3.8 2.6 7.0 1.9 2.0 0.4 3.6 0.5 9.6 0.6 7.7 0.5 0.3 5.7 7.0 7.1 1.2 0.1 3.1 1.9 0.0 3.3 0.7 0.4 0.0 0.0 2.2 7.8 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.1 0.3 0.1 0.7 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.2 0.2 49.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.1 0.2 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.3 0.1 20.4 0.0 0.3 0.2 0.6 0.0 2.1 4.3 0.0 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.1 1.4 0.6 3.8 1.7 10.2 7.0 0.3 1.2 0.4 0.2 9.6 1.7 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.9 0.1 1.4 0.0 0.6 0.0 0.0 0.2 0.2 0.0 1.9 0.1 3.0 1.3 1.2 1.3 0.0 0.0 0.4 0.0 13.3 2.6 0.5 3.4 1.3 37.2 0.4 1.9 0.8 0.0 0.3 0.2 0.0 0.0 0.4 4.6 7.8 0.2 0.0 0.0 0.1 4.1 0.0 0.0 0.3 0.1 0.0 45.5 0.4 0.0 0.0 0.4 0.7 0.2 0.0 0.4 1.2 3.8 2.0 0.0 0.1 0.4 2.8 14.3 0.0 0.1 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818509-82901166 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 40000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 98.7 103.3 52.2 78.4 54.3 119.4 111.4 62.4 70.1 145.5 94.9 107.1 124.2 119.7 162.1 92.6 90.9 122.1 110.7 54.0 61.4 133.6 174.8 96.2 88.2 58.4 58.7 152.8 192.6 116.4 108.4 143.2 58.7 113.4 127.2 87.9 134.0 111.3 96.8 107.8 111.0 131.5 50.9 76.5 110.1 77.8 54.4 93.8 168.0 85.6 102.1 113.1 94.1 63.9 146.2 65.2 183.6 130.4 318.9 394.5 133.3 264.8 295.4 146.0 179.2 113.2 182.3 188.3 113.7 532.2 84.6 68.1 183.3 176.2 200.4 193.4 72.7 115.3 110.5 302.1 316.4 124.4 140.7 380.5 217.7 223.5 254.3 251.2 240.5 83.8 178.4 181.1 264.2 128.6 164.9 99.6 126.1 154.0 58.3 121.2 100.1 140.3 237.2 83.0 118.6 131.2 105.7 180.7 174.9 184.8 142.1 137.8 248.2 190.7 98.9 169.0 168.8 135.1 62.4 256.7 190.6 147.8 224.2 84.3 66.9 51.2 65.1 74.0 80.5 60.0 57.6 64.3 73.3 50.0 56.9 54.6 19.2 89.9 83.1 61.1 52.7 71.8 52.2 54.3 62.4 70.1 54.0 61.4 58.4 58.7 58.7 50.9 54.4 63.9 62.6 105.8 85.3 50.9 58.1 60.5 60.5 64.1 56.9 52.3 54.5 43.7 85.5 51.5 109.8 47.8 54.2 57.3 61.0 62.8 27.4 65.8 30.6 90.1 164.6 65.0 38.3 41.2 61.0 71.2 85.3 125.2 100.9 119.7 75.2 241.0 65.0 94.0 45.9 42.1 60.0 99.4 50.8 51.2 55.3 19.3 139.1 63.8 51.6 67.5 60.4 36.5 38.1 74.9 72.6 67.5 46.3 126.0 152.2 76.3 121.0 65.9 100.5 66.9 52.6 86.5 98.9 30.3 34.6 62.2 74.2 81.5 55.4 78.9 54.9 101.1 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975045-224039318 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 1091.9" "Cell type enriched" "Detected in many" 8 "Granulosa cells: 4466.0" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2" "Group enriched" "Detected in many" 15 "NK-cells: 23.2;T-cells: 12.9" "Cell line enhanced" "Detected in many" "BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000277 Approved "Golgi apparatus" "Secreted in female reproductive system" NA NA 910000 "Cluster 48: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "HPA000277: " "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 28.0 19.8 120.3 75.7 125.9 6.5 14.3 128.6 158.7 28.1 71.1 22.7 28.2 17.4 5.6 36.2 20.8 46.0 100.0 115.9 145.9 39.3 10.8 14.5 30.9 158.1 152.6 145.6 8.5 3.4 8.7 1091.9 134.4 26.4 21.8 5.4 12.6 7.5 6.6 11.2 27.0 119.6 141.1 30.9 8.9 57.6 146.4 17.0 26.1 10.8 44.0 146.9 27.6 132.0 3.1 83.8 29.4 32.6 1172.5 438.7 4.4 1492.9 851.5 118.1 112.7 4.8 7.0 0.4 32.5 6425.1 188.0 5.0 3.5 102.5 101.0 0.6 26.8 16.6 49.9 22.7 57.7 12.8 1.5 128.3 68.5 342.0 505.6 304.6 9.0 5.4 0.5 1.9 412.1 4.5 2.3 3.9 56.2 31.8 92.3 10.3 25.2 64.5 1100.2 97.5 43.0 7.1 284.4 0.5 2966.9 385.2 1.2 6.4 1056.5 692.5 96.6 214.4 72.7 6.3 13.3 0.8 443.5 11.1 2183.6 0.0 0.0 0.0 0.7 0.0 0.5 0.8 0.6 0.6 0.0 1.2 12.9 6.8 0.5 23.2 0.0 0.2 0.7 2.7 120.3 125.9 128.6 158.7 115.9 145.9 158.1 152.6 134.4 141.1 146.4 132.0 13.5 0.0 1.1 233.1 3.1 23.3 16.0 132.2 351.7 5.3 7.9 8.5 5.3 0.0 4.6 7.3 0.0 106.1 11.3 19.5 11.7 13.0 2.6 5.3 17.7 20.9 24.0 23.1 86.1 33.2 524.3 556.7 5.6 5.9 2.5 4466.0 23.2 0.0 45.5 0.0 11.4 4.7 0.0 0.8 26.9 9.9 401.4 9.7 142.3 23.4 3.5 2.5 2.1 199.6 13.5 22.1 14.9 98.9 5.6 27.2 2.0 146.2 1.7 3.5 13.1 5.2 146.6 4.2 70.9 34.8 14.5 133.9 10.7 18.9 3.1 7.2 SF3A1 "Prp21, PRPF21, SAP114, SF3a120" ENSG00000099995 "Splicing factor 3a subunit 1" Q15459 22 30331988-30356919 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000690, HPA030083" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA 87000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear speckles" "HPA000690: AB_1079933, HPA030083: AB_10602183" "unprognostic (8.61e-2)" "unprognostic (1.60e-1)" "unprognostic (3.21e-2)" "unprognostic (7.54e-2)" "unprognostic (5.06e-3)" "unprognostic (1.79e-1)" "unprognostic (5.54e-3)" "unprognostic (3.30e-1)" "unprognostic (3.83e-1)" "unprognostic (2.59e-1)" "unprognostic (2.58e-1)" "unprognostic (3.26e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.25e-1)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (1.13e-1)" 36.2 29.7 14.1 45.4 19.0 58.0 35.0 19.2 20.5 33.4 12.6 31.2 29.8 36.3 20.5 34.0 31.8 21.3 28.0 15.3 12.7 25.5 27.5 31.0 44.1 16.6 14.8 46.4 32.9 42.8 24.3 29.0 14.1 29.4 27.0 36.4 33.3 28.1 51.1 40.5 32.8 29.9 13.3 42.0 31.8 49.2 15.9 42.6 31.6 25.8 41.4 33.2 32.8 20.7 86.2 58.9 79.4 77.6 46.4 41.3 94.8 66.5 42.7 71.4 52.8 78.8 55.9 106.4 44.6 47.7 55.9 80.4 101.6 70.8 77.7 97.4 88.4 99.3 69.1 65.3 41.8 202.1 106.3 41.7 49.6 89.5 72.4 40.1 52.1 56.6 112.5 108.0 52.8 49.1 99.4 46.2 132.0 65.7 48.4 139.5 99.4 86.8 40.9 93.6 82.2 74.9 84.4 50.8 78.4 52.5 62.3 65.4 72.9 90.2 80.0 65.1 124.4 83.2 108.2 106.9 69.4 73.8 95.0 6.7 8.9 14.1 10.9 9.8 11.2 10.4 11.0 11.8 9.2 11.0 12.0 11.2 14.1 11.0 13.0 5.6 14.5 8.0 14.1 19.0 19.2 20.5 15.3 12.7 16.6 14.8 14.1 13.3 15.9 20.7 32.4 57.7 66.5 12.1 60.8 26.1 25.4 19.0 37.0 17.6 25.7 24.4 27.6 34.3 30.5 31.3 16.7 32.5 49.2 30.8 17.6 25.7 106.1 30.5 23.1 32.6 25.1 36.1 7.5 29.4 39.7 29.1 35.2 29.1 52.6 76.3 28.2 28.4 40.6 26.9 9.4 30.7 16.2 37.2 28.3 116.8 35.1 39.8 17.8 5.6 58.5 27.1 46.4 6.0 7.1 28.8 31.3 37.6 45.5 26.4 31.8 17.0 39.4 20.3 46.0 29.0 27.3 64.3 41.6 37.8 27.3 34.6 55.8 26.7 33.9 25.8 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 143.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.6;Granulosa cells: 58.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 143.8" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 121.0;SH-SY5Y: 54.1" "Region enriched" "Detected in all" 5 "cerebellum: 240.6" "Region enriched" "Detected in all" 4 "cerebellum: 106.2" HPA057381 Approved Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 6.1 22.7 21.9 4.3 20.5 1.0 6.3 143.8 27.8 14.4 0.2 13.4 13.1 11.9 4.7 5.0 10.5 6.6 9.0 21.5 19.5 4.4 38.6 5.6 2.7 12.8 16.9 23.7 3.1 4.4 8.3 1.9 15.9 10.1 5.3 7.1 6.7 5.9 3.8 12.7 8.4 7.5 9.4 4.3 6.7 8.4 21.4 2.4 7.5 4.7 1.9 10.2 11.7 13.4 0.1 1.4 24.0 0.7 1.8 0.9 11.2 3.0 2.1 6.7 9.5 3.6 11.6 1.3 9.5 4.2 6.6 2.1 9.2 0.7 3.2 2.2 4.2 0.8 2.2 24.8 1.0 0.1 8.0 2.2 0.6 0.9 0.2 5.0 5.2 12.0 5.0 0.5 9.5 4.1 5.5 0.9 9.6 4.5 0.6 15.0 19.1 0.5 2.3 0.5 121.0 54.1 0.7 0.8 0.4 7.4 1.2 2.4 0.3 0.8 10.0 0.7 0.4 1.1 0.9 1.1 0.3 0.6 3.8 0.1 0.6 0.5 1.3 0.6 1.4 0.8 0.5 0.8 0.6 1.5 0.7 0.5 0.8 2.0 0.6 0.9 0.1 0.5 21.9 20.5 143.8 27.8 21.5 19.5 12.8 16.9 15.9 9.4 21.4 13.4 4.1 0.0 0.6 3.3 4.2 3.6 5.8 1.7 0.0 50.6 3.6 5.5 2.8 0.0 1.3 0.0 0.0 1.1 2.6 2.1 0.0 0.8 7.9 1.1 3.5 5.7 13.1 0.0 5.9 1.3 0.5 5.8 1.5 2.2 2.5 58.8 5.3 11.7 0.6 10.1 6.9 10.9 2.0 1.0 15.0 15.3 4.4 2.9 8.8 5.6 0.1 5.9 2.1 9.0 1.8 0.7 5.6 4.1 0.7 3.5 18.0 1.1 0.8 5.0 6.6 6.7 9.6 5.4 2.9 1.4 2.6 0.7 2.8 1.8 4.6 9.7 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 23.1;ovary: 65.5" "Group enriched" "Detected in some" 7 "Granulosa cells: 196.9;Theca cells: 192.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 1.4;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 6 "granulocytes: 1.4;monocytes: 1.3" "Cell line enriched" "Detected in single" 16 "HEL: 10.1" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 1.1 7.3 0.5 1.8 0.8 0.4 0.4 0.4 0.7 0.3 0.6 0.5 0.8 0.3 0.2 0.1 0.9 0.3 0.4 0.6 0.6 0.4 1.7 1.7 0.6 1.4 1.0 65.5 2.7 0.1 0.2 1.8 1.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 1.0 1.2 0.8 23.1 4.7 1.5 1.6 0.1 0.2 0.1 0.0 0.6 0.2 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 10.1 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.3 1.4 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.1 0.5 0.8 0.4 0.7 0.6 0.6 1.4 1.0 1.3 0.8 1.6 1.4 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.6 0.0 0.6 0.2 0.3 1.0 0.0 0.0 0.0 1.1 0.1 4.3 0.0 0.3 0.0 196.9 5.3 0.6 7.9 0.0 0.0 0.0 0.0 26.8 0.2 0.1 0.0 6.1 0.0 5.6 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 7.5 1.7 0.7 0.0 0.1 0.1 0.2 192.3 0.0 0.0 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 8.8 6.9 5.9 9.7 6.0 9.8 9.6 8.5 6.7 9.1 5.7 8.6 9.8 9.4 7.6 7.7 6.0 6.9 7.3 4.9 7.7 10.8 12.2 6.8 12.1 7.0 6.8 8.6 6.8 9.7 4.9 9.6 7.0 7.6 9.4 8.0 7.3 7.5 6.7 13.4 8.5 9.2 6.4 9.5 8.4 5.6 8.2 13.6 10.1 7.4 12.0 7.2 5.6 7.1 16.3 4.4 22.9 21.2 27.6 21.4 22.0 13.9 12.4 18.9 25.3 12.2 9.1 30.6 12.5 11.8 8.0 15.7 24.3 16.7 27.0 19.4 13.3 16.4 13.9 15.6 26.3 18.8 12.9 21.0 19.6 14.1 22.4 13.6 17.5 26.2 25.2 17.7 15.7 62.7 37.1 19.9 52.1 10.5 12.3 21.2 43.7 15.3 16.0 13.5 15.7 18.5 20.0 23.2 25.5 20.8 12.6 72.0 13.9 15.6 19.0 26.8 19.0 16.4 14.1 29.1 23.7 31.1 34.0 6.0 1.7 2.0 2.2 2.3 2.8 2.0 2.2 2.2 2.2 2.1 2.6 2.8 1.2 2.6 2.4 2.7 1.7 1.4 5.9 6.0 8.5 6.7 4.9 7.7 7.0 6.8 7.0 6.4 8.2 7.1 29.2 25.6 14.8 13.1 32.7 31.9 26.7 40.0 30.1 10.7 22.7 23.2 41.0 20.0 30.2 31.3 10.4 29.7 43.9 30.3 50.9 27.1 34.8 20.1 34.9 26.3 18.6 29.9 16.2 25.7 33.6 27.9 18.8 26.8 19.7 77.1 27.1 40.0 27.7 8.4 19.7 21.4 48.8 19.7 26.6 58.1 28.3 24.8 23.2 4.7 25.4 15.8 32.0 10.1 16.6 31.1 18.3 19.9 37.7 30.5 25.7 62.8 21.3 16.1 19.7 26.5 28.8 35.5 39.6 33.0 36.4 36.0 37.4 48.3 21.2 23.6 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957593 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 39: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 20.7 10.4 35.7 11.8 36.1 4.3 7.5 37.8 99.4 7.1 37.8 46.8 32.5 28.6 22.8 15.3 13.1 14.8 67.9 33.5 35.2 11.4 55.6 4.9 9.5 38.6 35.9 7.9 2.0 10.0 5.2 34.0 37.0 14.4 35.3 68.9 3.5 11.2 67.5 13.0 16.6 39.2 37.0 6.6 26.6 29.8 38.3 11.7 8.6 59.6 11.6 11.9 7.1 38.2 111.1 24.0 86.9 74.3 61.9 52.1 272.7 64.6 51.1 52.0 80.9 85.4 67.1 113.8 82.3 61.6 32.6 113.1 126.3 124.8 96.8 75.6 105.2 108.9 63.4 112.9 104.6 123.2 9.9 72.2 144.6 75.7 146.4 79.2 131.4 53.8 131.3 78.0 61.9 19.9 70.2 70.1 271.4 36.7 74.5 67.9 130.7 92.8 67.3 1.9 86.9 46.5 121.8 3.8 97.5 130.0 3.7 48.9 80.9 45.4 72.0 89.3 93.1 39.7 33.9 116.7 137.1 78.5 56.0 0.0 1.4 0.0 1.5 1.6 1.7 0.9 1.8 2.0 2.5 0.3 0.8 1.5 0.1 0.6 0.3 0.2 6.1 0.8 35.7 36.1 37.8 99.4 33.5 35.2 38.6 35.9 37.0 37.0 38.3 38.2 15.1 0.0 2.6 8.5 16.5 89.3 6.5 39.9 87.6 16.9 16.5 9.9 126.3 10.0 5.7 0.0 158.4 77.4 20.3 99.8 0.0 2.5 107.2 14.3 70.7 22.8 3.5 20.2 9.8 3.3 67.6 32.8 67.2 35.8 8.9 322.8 6.4 37.5 15.4 20.2 11.6 17.3 20.3 9.0 15.7 118.3 11.8 12.8 39.2 20.6 4.3 184.8 0.0 9.0 23.8 7.4 7.7 7.5 25.5 16.5 9.3 10.8 3.9 277.5 0.0 38.2 22.1 45.3 23.6 29.6 39.5 46.0 20.9 49.6 23.3 1.3 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 127.3;kidney: 100.3;liver: 103.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 12.2;plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 6 "dendritic cells: 6.6;granulocytes: 12.2" "Cell line enhanced" "Detected in many" "A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced NA NA 18000 "Cluster 49: Eosinophils - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 1.9 127.3 2.1 0.8 2.6 2.7 1.3 3.5 15.8 29.4 9.3 2.0 1.3 16.2 2.5 1.9 7.4 3.8 5.4 15.7 1.6 100.3 103.9 7.0 1.6 3.0 2.5 7.7 0.3 1.4 16.5 0.4 3.1 6.3 1.0 1.2 2.6 12.3 34.1 25.0 1.3 7.7 2.5 3.7 1.2 14.5 4.3 1.5 6.2 37.7 1.3 1.0 10.6 3.3 0.1 21.3 0.6 16.7 0.5 0.1 0.1 0.6 0.5 2.5 2.3 0.0 0.6 0.2 3.9 3.1 8.3 0.1 7.4 0.6 0.6 0.1 9.8 0.2 10.6 41.5 0.2 0.2 0.5 0.4 3.7 1.9 0.3 2.8 5.9 0.0 0.0 0.0 0.0 3.0 0.1 0.4 2.2 0.3 0.8 0.2 0.2 0.2 0.0 1.3 3.9 3.4 7.0 0.1 1.9 5.6 7.1 1.9 0.0 0.1 0.8 0.3 2.0 31.0 13.1 0.1 0.8 0.1 3.6 0.3 1.4 12.2 0.3 0.9 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.0 0.1 6.6 0.0 0.5 2.1 2.6 3.5 15.8 15.7 1.6 3.0 2.5 3.1 2.5 4.3 3.3 0.5 6.4 3.7 0.7 1.3 4.7 2.3 0.4 6.2 0.9 0.1 0.8 4.1 4.3 0.1 1.8 0.0 0.0 1.7 0.0 3.9 0.1 15.5 3.0 1.3 1.2 0.0 0.0 3.5 0.0 0.0 4.4 0.0 9.2 5.7 189.2 0.0 43.3 1.5 0.0 14.4 0.0 0.0 2.9 1.2 4.8 3.7 2.5 1.8 3.7 0.4 1.4 0.0 2.5 0.3 0.0 0.0 1.5 3.9 2.3 0.0 52.9 0.8 0.9 6.6 67.8 3.3 0.6 1.1 1.1 6.7 0.0 1.7 0.3 0.0 1.5 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076526 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "choroid plexus: 492.1" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019339 Enhanced Uncertain "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 28.4 34.8 16.9 19.2 29.4 12.7 23.7 29.1 21.9 38.9 492.1 45.0 22.5 40.3 4.9 21.0 31.1 19.7 31.3 39.4 23.2 38.6 52.3 33.2 13.1 32.8 27.9 31.9 52.5 72.4 13.8 27.0 32.0 28.2 7.1 4.7 23.1 14.0 18.8 21.7 29.3 16.5 20.2 27.0 82.2 13.7 32.7 12.4 25.4 12.3 6.3 31.9 25.8 40.2 60.9 196.9 37.8 78.9 37.6 17.9 87.1 72.9 37.0 56.9 48.0 113.0 91.6 35.8 154.1 35.0 84.6 58.2 38.2 31.4 9.8 105.3 59.1 48.5 91.9 57.5 59.6 25.2 147.0 29.0 27.4 65.6 15.7 60.9 31.3 50.6 151.8 27.1 44.3 118.0 69.2 43.3 90.4 80.7 73.2 55.2 21.2 42.2 44.6 41.0 31.5 113.9 67.0 118.4 62.0 27.3 51.2 46.7 72.0 78.1 39.1 77.5 106.5 31.2 47.7 20.5 118.7 61.4 160.6 0.0 1.6 0.4 0.8 1.6 0.7 0.9 0.7 0.7 1.0 0.3 0.7 0.8 0.2 0.1 1.0 2.1 0.2 0.9 16.9 29.4 29.1 21.9 39.4 23.2 32.8 27.9 32.0 20.2 32.7 40.2 15.6 9.6 8.2 9.8 7.2 11.1 5.9 13.6 15.4 7.7 14.5 11.9 4.0 18.6 9.6 20.2 25.0 36.1 14.2 17.6 17.6 35.7 1.0 21.9 18.9 13.6 27.6 2.5 0.4 35.8 9.4 13.6 30.1 17.0 47.1 62.1 17.9 34.6 26.0 15.2 1.4 12.1 16.2 16.1 12.0 1.6 13.7 17.0 26.6 4.7 11.6 21.6 3.1 3.0 16.8 43.8 14.0 19.9 9.9 5.9 24.9 19.1 11.4 8.2 13.1 12.8 17.6 3.1 7.9 10.6 7.0 91.5 8.5 11.2 22.1 4.5 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073578-34106260 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 96.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 6.9 5.9 8.6 4.5 9.2 1.9 6.6 5.7 11.4 3.7 96.0 4.5 2.6 6.8 5.2 3.1 4.8 2.5 2.4 10.7 17.0 29.0 5.9 3.9 4.9 9.3 9.9 3.9 1.9 3.2 4.1 10.6 9.2 2.9 5.2 5.6 2.8 3.5 2.5 6.7 3.7 2.9 8.2 2.4 3.9 6.2 20.3 3.9 25.2 2.6 4.8 3.8 3.4 9.2 10.5 9.3 19.0 13.4 15.5 12.7 9.1 11.8 35.7 7.2 10.9 15.5 22.5 16.9 9.3 24.0 13.5 5.3 23.3 6.7 12.2 17.7 6.0 17.5 9.0 5.2 4.1 7.6 7.1 6.1 17.0 19.7 7.8 22.0 4.4 13.7 17.6 3.9 18.7 7.1 8.1 6.1 9.6 4.0 9.0 8.1 3.4 7.7 28.1 14.5 9.9 4.6 24.5 6.4 5.6 11.3 3.9 8.0 4.2 14.0 10.7 27.1 4.8 20.1 18.5 12.4 28.2 10.9 9.6 0.0 0.2 0.0 0.6 0.2 0.5 0.1 0.3 0.4 0.2 0.1 0.4 0.6 0.1 0.2 0.1 0.5 0.1 0.1 8.6 9.2 5.7 11.4 10.7 17.0 9.3 9.9 9.2 8.2 20.3 9.2 18.8 16.0 10.2 0.0 33.3 0.0 46.5 0.0 129.1 33.8 37.4 34.9 11.4 10.0 13.0 138.0 20.9 27.4 43.0 39.1 21.5 4.0 9.0 38.7 59.9 16.4 49.3 17.0 0.0 5.5 19.7 42.3 18.3 42.5 41.3 148.6 5.0 20.7 15.2 37.0 0.0 69.3 0.0 14.4 0.0 7.2 6.5 41.0 0.0 0.0 23.3 6.7 16.5 0.0 0.0 7.6 49.7 20.7 54.1 88.4 16.3 9.4 8.7 20.9 13.1 15.4 33.7 14.8 18.5 39.7 0.0 28.2 48.3 14.0 36.3 69.5 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 16.4 11.8 9.0 10.9 10.3 10.6 17.2 21.7 10.5 18.5 11.2 14.9 11.9 20.6 9.8 15.7 16.3 12.8 14.1 11.7 10.0 16.1 19.1 13.1 12.7 9.0 8.2 24.0 21.4 19.9 11.3 18.9 9.4 21.8 14.3 18.3 14.0 18.0 24.9 14.6 12.1 18.9 8.0 13.9 15.2 14.2 11.9 17.7 21.4 24.9 14.5 13.5 13.1 13.8 16.4 22.5 59.4 16.6 23.9 36.6 31.4 27.7 32.2 39.4 49.6 13.0 3.8 25.9 7.8 25.6 19.6 24.9 33.6 13.2 40.7 19.3 14.8 20.6 20.5 15.9 23.7 34.8 13.1 16.6 21.9 19.1 27.8 37.0 28.7 14.0 21.9 25.8 23.5 9.0 18.8 10.0 31.2 9.1 14.3 23.3 30.6 26.9 18.2 7.4 34.4 20.3 27.0 5.0 18.8 24.8 13.3 19.4 20.0 34.5 13.3 8.8 19.7 30.6 28.6 26.2 21.2 12.8 22.6 0.3 0.6 0.6 1.0 0.4 1.1 0.7 1.0 0.8 1.2 0.9 1.2 1.5 1.0 1.0 0.4 1.0 1.4 0.5 9.0 10.3 21.7 10.5 11.7 10.0 9.0 8.2 9.4 8.0 11.9 13.8 32.5 22.4 29.1 55.2 21.0 25.6 20.9 15.1 18.8 17.1 27.3 20.4 38.8 24.3 19.3 22.0 20.9 20.7 24.0 22.7 11.7 16.9 10.6 30.4 36.6 26.2 39.6 12.4 37.0 12.5 20.6 30.3 28.5 35.2 4.5 132.4 28.5 44.1 15.1 15.2 39.0 32.1 16.2 28.5 20.9 16.2 33.2 21.1 28.4 49.6 16.9 20.4 17.5 41.2 72.5 20.1 21.0 30.5 24.8 36.3 26.7 22.6 22.4 20.0 26.3 32.2 34.2 17.2 18.8 20.9 27.3 12.6 20.1 22.1 24.5 29.7 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 53.8 55.2 23.3 44.6 28.1 71.6 65.9 35.5 28.5 48.0 29.1 49.9 51.1 37.4 58.5 71.3 52.9 33.1 31.2 22.9 23.2 26.4 54.9 46.7 66.0 27.7 26.7 38.3 89.5 42.8 36.7 47.8 27.0 52.7 46.6 17.6 78.0 49.0 25.3 97.0 49.8 32.4 25.5 60.6 68.2 42.7 25.6 70.2 33.8 34.2 70.1 52.3 55.9 31.7 142.9 87.9 21.3 93.0 133.6 196.1 139.7 52.5 64.1 97.5 61.7 101.7 76.8 163.0 32.5 79.0 43.9 99.4 65.7 99.1 57.3 61.1 169.5 109.3 40.3 141.7 102.3 159.5 128.9 154.3 122.0 55.3 42.1 56.4 78.3 110.8 89.5 101.7 57.2 279.1 203.8 132.3 51.3 202.0 96.9 195.0 77.8 185.0 66.9 96.0 80.2 145.9 79.2 228.4 97.1 69.3 212.2 121.7 58.4 67.7 52.5 61.4 90.7 119.8 113.2 113.5 54.1 129.6 50.4 4.2 9.1 8.8 9.4 8.4 5.6 7.2 9.9 9.8 12.1 9.5 6.3 8.5 10.8 8.0 10.0 10.1 11.5 6.0 23.3 28.1 35.5 28.5 22.9 23.2 27.7 26.7 27.0 25.5 25.6 31.7 14.8 28.9 42.4 19.9 18.2 22.9 23.6 14.3 26.2 9.7 47.1 41.0 5.9 30.0 25.2 16.5 6.2 54.9 21.1 36.0 3.9 16.9 1.0 17.6 25.3 17.4 33.0 12.6 7.2 19.6 38.2 25.8 18.8 20.7 14.0 88.1 25.7 83.3 22.0 11.8 5.8 42.0 12.2 36.9 19.6 5.4 49.4 23.1 14.2 8.4 31.9 16.9 15.5 6.6 10.7 21.0 26.2 30.9 12.6 19.0 30.0 11.6 23.8 12.4 32.9 21.9 14.6 12.3 22.4 29.7 31.1 52.9 16.7 101.7 40.8 24.1 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777447-36863538 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 63.9" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Cluster 21: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.6 14.2 13.4 3.6 18.1 1.1 6.2 63.9 16.4 9.5 0.0 12.3 1.9 10.9 3.8 7.0 9.6 4.8 9.5 12.8 14.4 7.8 0.9 6.2 2.5 14.6 15.0 10.4 2.8 7.3 4.9 6.2 12.6 9.0 2.8 4.5 4.7 8.8 2.4 8.6 5.8 8.4 8.8 4.6 6.4 7.9 15.1 2.9 12.2 3.9 3.1 11.2 7.4 21.9 13.4 18.0 21.5 23.2 12.2 11.2 5.6 11.6 12.5 16.1 9.5 7.3 2.1 6.0 4.2 20.4 14.0 17.8 17.3 10.8 16.8 0.9 3.4 9.7 18.5 9.7 6.4 2.1 9.0 6.3 13.0 15.4 10.9 7.0 10.6 6.5 6.9 1.2 17.8 13.0 6.9 5.1 5.5 1.3 13.8 16.1 19.9 2.3 9.5 4.0 25.5 15.9 24.1 26.1 7.5 9.4 33.3 14.4 16.3 40.2 7.7 19.9 25.7 2.4 0.6 5.8 17.1 2.8 26.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 13.4 18.1 63.9 16.4 12.8 14.4 14.6 15.0 12.6 8.8 15.1 21.9 16.5 0.0 1.8 18.9 4.4 12.6 5.4 6.3 13.6 26.3 9.6 8.9 16.1 5.7 6.7 20.2 37.5 15.6 11.3 1.7 1.9 3.8 0.9 8.6 20.5 14.5 6.0 1.3 19.9 1.5 10.2 12.0 0.5 21.9 10.8 33.0 10.4 0.6 10.0 23.5 30.3 1.5 0.0 7.6 10.7 2.4 12.2 8.1 5.4 21.5 4.5 17.8 0.0 54.8 50.9 1.4 2.4 18.8 1.8 6.0 2.1 1.5 3.9 3.8 13.1 23.2 16.9 0.5 1.3 13.7 16.1 3.3 1.4 14.0 3.0 2.9 SOWAHC "ANKRD57, C2orf26, FLJ21870" ENSG00000198142 "Sosondowah ankyrin repeat domain family member C" Q53LP3 2 109614364-109618990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 147.6;Granulosa cells: 151.0;Squamous epithelial cells: 137.1;Suprabasal keratinocytes: 199.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 160.4;hTCEpi: 50.8;RT4: 66.2" "Low region specificity" "Detected in all" HPA056131 Enhanced Approved Cytosol No No "Cluster 37: Intestine - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA056131: AB_2683047" "unprognostic (6.76e-2)" "unprognostic (6.96e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.87e-1)" "unprognostic (8.91e-3)" "unprognostic (1.63e-2)" "unprognostic (1.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (5.11e-3)" "prognostic favorable (3.56e-5)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (3.50e-1)" "unprognostic (2.54e-2)" 6.3 3.6 2.5 3.5 3.2 0.6 9.4 3.0 2.7 8.0 7.6 11.3 5.1 5.1 3.9 33.3 4.5 8.4 2.0 2.7 4.3 14.0 29.3 7.0 2.9 4.8 6.2 13.0 3.6 5.2 1.9 4.2 4.1 7.0 8.7 5.5 8.3 7.3 1.1 19.3 7.3 6.2 4.0 3.3 5.9 6.5 4.2 4.3 7.9 2.1 7.5 23.1 12.0 4.5 19.3 3.6 10.8 5.9 5.3 8.8 35.1 41.3 24.1 7.1 7.4 17.0 6.0 0.0 16.6 6.3 13.4 18.1 2.5 27.1 7.7 160.4 18.0 0.0 8.6 24.3 4.9 0.0 4.8 4.7 50.8 15.3 10.9 5.9 1.8 0.0 0.3 0.1 5.5 6.4 0.0 1.7 7.6 17.5 16.2 0.0 2.4 0.3 10.7 66.2 13.5 5.8 14.2 2.5 11.3 10.5 5.3 0.4 2.7 5.6 21.6 3.3 3.0 5.3 5.5 0.1 6.6 0.6 13.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 3.2 3.0 2.7 2.7 4.3 4.8 6.2 4.1 4.0 4.2 4.5 18.9 16.0 9.8 2.9 1.2 147.6 43.2 32.0 93.9 15.7 30.5 22.7 3.6 20.0 14.7 12.9 10.4 4.3 0.7 61.1 3.9 15.9 37.8 28.7 21.1 10.8 15.6 2.7 0.2 7.1 28.6 15.6 13.3 76.9 0.0 151.0 6.8 53.2 8.0 0.0 1.2 32.7 10.2 7.0 15.1 13.7 11.8 6.2 19.6 0.0 3.4 7.3 2.1 1.5 2.4 14.2 34.2 15.1 0.6 21.0 21.5 25.1 5.5 20.7 13.1 12.1 20.8 20.8 13.2 137.1 199.3 10.0 2.2 5.3 36.7 80.9 SOX4 ENSG00000124766 "SRY-box transcription factor 4" Q06945 6 21593751-21598619 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" "Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 45.7" "Group enriched" "Detected in all" 5 "dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0" "Cell line enhanced" "Detected in many" "AN3-CA: 254.1;MOLT-4: 229.9" "Region enhanced" "Detected in all" "olfactory bulb: 54.2" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 11.8 4.3 4.7 9.2 5.0 24.0 17.9 8.8 6.7 21.5 2.8 11.9 12.5 57.8 15.0 5.4 13.5 20.4 6.4 4.2 6.5 16.8 6.4 19.3 5.8 3.5 5.0 51.7 10.2 3.6 4.1 6.1 4.1 14.5 14.4 6.4 17.5 6.8 3.5 8.8 11.6 17.4 4.0 5.4 17.5 9.9 7.1 73.4 8.6 6.1 7.4 21.1 7.7 4.2 8.5 24.4 60.5 254.1 22.0 5.5 98.7 3.8 7.8 4.6 4.1 16.7 16.5 2.9 100.2 6.2 3.5 25.1 32.0 17.9 3.3 36.6 66.8 2.7 11.5 11.2 3.5 9.0 2.1 9.6 18.1 2.1 7.3 64.1 72.3 138.8 0.6 0.2 5.2 20.6 229.9 21.6 45.3 12.7 23.1 99.7 5.3 0.4 44.1 78.3 78.9 141.2 35.9 41.1 14.0 74.9 20.1 30.9 55.7 7.1 23.1 1.7 18.6 1.5 0.1 71.8 2.4 30.6 28.5 33.3 19.3 2.1 0.5 11.7 0.1 7.0 0.3 0.3 8.7 6.6 2.2 1.6 0.8 7.4 22.0 45.7 2.1 4.7 4.7 5.0 8.8 6.7 4.2 6.5 3.5 5.0 4.1 4.0 7.1 4.2 235.0 198.7 50.4 0.7 36.2 112.5 129.2 660.7 676.7 99.7 586.1 676.5 297.4 423.2 457.3 154.5 12.5 74.8 104.4 247.6 66.5 1128.5 6.1 669.0 624.2 264.5 340.8 114.3 3.2 604.4 409.4 247.3 313.0 650.9 60.6 1047.5 119.2 6.8 35.5 48.8 4.6 263.0 1320.3 78.0 266.7 12.2 12.2 94.0 243.7 3.7 91.4 189.1 17.5 70.4 1.0 1288.2 153.8 11.3 40.9 151.1 76.7 132.5 162.1 31.6 6.6 234.2 439.9 4.9 236.8 400.7 93.1 30.2 36.6 69.6 299.4 272.5 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904358 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 20.9 14.9 25.3 11.9 28.1 20.9 24.2 29.0 27.5 30.0 13.1 26.7 18.2 26.3 15.7 44.3 28.6 18.7 18.1 25.4 30.6 22.8 19.3 20.4 15.9 25.0 26.0 31.4 21.3 49.6 13.9 28.4 26.1 20.6 27.2 15.5 20.2 27.0 15.7 56.5 18.8 29.6 24.1 24.3 15.2 39.0 26.4 32.7 31.2 19.6 27.8 28.6 34.2 31.4 30.0 29.2 43.4 27.4 56.2 37.7 30.5 22.5 66.6 47.4 37.9 30.5 29.9 27.4 0.1 39.4 42.0 35.6 44.8 48.4 48.9 21.9 27.5 23.6 16.2 23.4 59.2 27.4 29.3 38.1 75.9 40.7 38.1 56.0 47.1 41.5 26.5 13.4 41.2 26.3 36.7 22.0 29.2 27.8 20.6 21.6 36.6 19.7 36.8 83.8 29.7 31.9 42.8 19.6 34.7 46.1 58.9 18.7 35.4 21.9 29.5 13.6 17.1 30.9 60.3 26.4 32.5 22.3 36.9 4.8 1.2 1.1 1.3 1.2 1.8 1.3 1.6 1.7 2.1 1.6 1.5 1.7 2.2 1.3 1.1 2.7 1.4 0.7 25.3 28.1 29.0 27.5 25.4 30.6 25.0 26.0 26.1 24.1 26.4 31.4 35.2 19.2 20.8 79.3 25.3 55.1 32.3 29.4 43.3 37.8 35.2 24.1 21.2 20.0 19.8 40.5 27.1 42.0 21.2 47.2 1.9 19.3 8.6 20.9 26.9 33.0 27.1 14.5 97.2 24.7 29.0 33.2 25.0 29.7 4.5 68.7 37.5 33.1 38.3 37.0 112.6 33.7 22.4 38.1 39.3 8.0 28.6 34.5 26.6 79.6 26.6 23.0 16.5 141.3 192.3 22.8 34.9 35.0 22.0 33.4 34.0 18.1 18.1 22.4 13.1 32.3 27.4 55.6 41.1 76.9 84.7 64.6 22.4 35.0 35.4 37.6 SPRR2B ENSG00000196805 "Small proline rich protein 2B" P35325 1 153070224-153070840 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 50.1;skin 1: 39.0" "Group enriched" "Detected in some" 13 "Granulosa cells: 5.8;Leydig cells: 6.2;Theca cells: 3.9" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 77.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.52e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 15.2 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 SPRR2F ENSG00000244094 "Small proline rich protein 2F" Q96RM1 1 153112121-153113516 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 264.7;lymphoid tissue: 70.2;ovary: 112.5" "Cell type enriched" "Detected in some" 29 "Granulosa cells: 681.7" "Group enriched" "Detected in many" 5 "cervical cancer: 16.0;head and neck cancer: 53.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "K-562: 2.7" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-2)" "unprognostic (2.41e-2)" "unprognostic (4.37e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.96e-1)" "unprognostic (1.78e-3)" 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.0 264.7 1.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 112.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.1 0.0 0.1 70.2 0.1 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 18.8 0.0 0.0 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 23.0 0.0 0.7 0.0 0.0 0.0 0.2 4.5 0.0 0.3 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" A0A0U1RRN3 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 34 "testis: 487.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 7.5;Distal tubular cells: 23.5;Endometrial stromal cells: 6.9;Granulosa cells: 18.4;Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 4.4;HeLa: 7.6;Hep G2: 4.5" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.9 1.8 1.4 1.4 1.5 0.9 2.7 3.2 2.9 1.7 3.8 1.5 0.2 2.0 3.7 1.3 1.6 1.2 1.5 1.4 2.6 2.0 0.7 0.8 0.7 2.2 1.7 2.4 1.1 0.9 1.6 1.2 1.9 2.0 2.3 3.5 1.7 1.4 1.5 14.1 1.0 1.3 0.9 1.2 0.9 487.5 1.8 0.4 1.7 0.3 0.8 0.9 1.3 2.7 0.5 4.4 1.7 2.3 1.5 2.3 2.1 0.3 0.5 0.9 1.0 3.4 1.2 0.8 0.2 0.4 0.9 0.9 0.0 0.0 0.0 1.3 1.6 0.5 7.6 4.5 0.2 0.6 1.3 0.9 0.3 0.2 1.0 1.1 0.9 0.0 1.2 0.3 0.3 1.6 0.1 1.6 1.2 1.1 2.7 0.1 0.5 0.3 1.8 1.8 0.4 0.2 1.6 0.1 0.0 0.6 0.9 0.0 0.9 1.6 1.3 0.8 0.1 0.0 0.2 0.0 0.6 0.9 1.1 0.2 0.3 0.6 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.1 0.1 0.3 0.2 1.4 1.5 3.2 2.9 1.4 2.6 2.2 1.7 1.9 0.9 1.8 2.7 2.8 3.2 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 6.0 0.0 0.0 1.3 5.5 0.0 1.0 1.5 0.0 23.5 3.2 0.0 4.9 6.9 1.1 0.0 0.0 0.0 5.0 1.1 1.8 0.0 3.9 0.0 18.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 14.3 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.0 0.0 SSBP3 "CSDP, FLJ10355, SSDP, SSDP1" ENSG00000157216 "Single stranded DNA binding protein 3" Q9BWW4 1 54225433-54413479 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA071780: " "unprognostic (1.44e-2)" "prognostic favorable (2.48e-9)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.94e-1)" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.59e-2)" "unprognostic (3.93e-2)" "unprognostic (3.34e-1)" "unprognostic (7.08e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-3)" "unprognostic (2.50e-1)" "unprognostic (6.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.96e-1)" 26.3 46.1 35.4 21.2 45.9 42.0 15.1 32.5 72.6 49.4 8.0 29.6 28.6 48.4 20.1 31.3 40.2 26.4 24.9 47.7 24.4 19.6 27.5 20.1 19.9 15.9 21.3 103.8 21.3 13.8 5.5 27.9 15.4 32.8 25.5 37.8 23.0 36.0 30.7 39.8 29.3 35.3 15.1 28.2 45.7 27.0 20.9 67.8 15.5 15.8 19.8 19.1 19.4 44.0 13.4 9.6 91.9 56.9 43.2 26.1 153.4 30.0 31.3 13.1 11.2 18.9 11.2 8.6 45.9 31.1 11.7 39.6 49.1 19.1 16.0 69.9 21.7 96.5 47.0 28.0 36.8 25.1 47.4 39.1 20.1 23.1 6.0 25.3 66.4 64.7 97.5 17.2 18.1 19.4 136.2 66.6 161.2 51.4 40.8 94.5 37.7 33.0 24.2 15.2 117.1 70.1 35.3 59.9 19.7 83.1 27.0 38.6 61.7 24.9 36.9 37.1 20.2 29.3 32.7 20.5 43.3 90.8 10.9 0.0 1.2 3.3 5.6 0.7 3.5 0.9 4.4 4.9 1.1 0.3 5.8 5.8 0.1 0.6 0.7 0.4 0.4 1.7 35.4 45.9 32.5 72.6 47.7 24.4 15.9 21.3 15.4 15.1 20.9 44.0 31.8 12.8 12.1 31.6 6.8 29.7 37.2 13.8 15.9 97.4 16.9 36.6 17.4 41.5 14.9 23.9 8.4 56.9 36.1 73.6 9.8 30.2 36.5 65.5 38.4 37.4 111.7 60.8 100.0 25.2 46.9 41.4 47.4 48.2 7.6 93.1 47.5 97.8 26.0 42.1 37.1 78.5 14.2 33.9 25.4 42.5 91.6 19.2 23.2 38.4 21.5 68.5 51.5 45.2 78.4 64.6 33.9 136.9 10.0 20.4 38.7 10.8 27.7 48.5 26.3 21.2 37.2 2.9 35.8 27.2 25.9 23.7 20.2 144.9 46.2 30.8 ST3GAL3 "MRT12, SIAT6" ENSG00000126091 "ST3 beta-galactoside alpha-2,3-sialyltransferase 3" Q11203 1 43705824-43931165 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.0;tongue: 82.9" "Cell type enhanced" "Detected in many" "Astrocytes: 59.7;Excitatory neurons: 94.4;Granulosa cells: 52.5;Inhibitory neurons: 120.1;Microglial cells: 57.1;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051102 Uncertain "Intracellular and membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA051102: AB_2681344" "unprognostic (8.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (3.20e-1)" "unprognostic (9.72e-2)" "unprognostic (7.01e-2)" "unprognostic (4.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (7.00e-2)" "unprognostic (3.68e-3)" "unprognostic (1.67e-2)" "unprognostic (1.30e-1)" "unprognostic (4.35e-1)" "unprognostic (6.60e-2)" 12.9 14.7 28.5 5.0 27.3 11.0 11.0 30.8 32.5 14.6 22.8 19.4 2.6 16.7 9.8 8.3 12.8 6.9 26.1 27.2 29.4 9.9 13.5 8.7 6.1 27.9 29.0 14.9 8.0 6.7 17.8 6.5 29.2 13.2 4.4 24.5 8.3 13.3 88.0 7.0 6.6 13.1 23.2 7.6 9.6 22.6 30.8 4.9 8.4 82.9 3.7 16.7 10.1 28.1 4.3 2.7 23.4 11.0 17.4 21.9 3.0 15.5 30.8 14.1 13.7 2.6 6.6 7.0 8.6 19.0 7.7 3.8 2.8 10.2 15.7 8.7 5.8 15.0 10.6 7.5 14.7 6.6 7.1 12.1 7.4 9.7 21.3 26.1 12.1 18.4 8.8 13.1 25.3 2.7 7.0 11.7 9.2 1.0 8.1 11.4 3.3 6.1 11.0 2.4 9.3 13.8 5.5 2.5 14.1 9.6 3.5 30.3 10.4 8.3 3.9 13.3 15.4 10.4 6.1 6.9 11.7 15.7 15.3 1.7 2.1 1.2 3.3 1.1 2.9 2.2 2.1 2.5 1.5 2.8 3.5 2.6 2.4 2.2 1.9 3.3 2.9 3.3 28.5 27.3 30.8 32.5 27.2 29.4 27.9 29.0 29.2 23.2 30.8 28.1 6.7 6.4 19.3 59.7 6.6 3.3 3.0 4.1 5.7 9.4 4.6 3.3 34.5 1.5 3.8 3.7 0.0 3.1 2.7 2.2 5.9 2.6 19.4 2.4 6.6 7.6 2.4 8.4 94.4 2.4 1.6 9.0 1.5 2.8 24.1 52.5 4.6 8.6 3.1 18.5 120.1 1.4 4.1 2.2 3.1 14.5 3.7 4.5 3.6 57.1 3.6 6.1 5.2 66.9 66.2 2.7 0.2 11.7 4.2 2.2 0.1 6.3 4.9 17.8 19.7 5.8 9.8 8.5 5.1 2.7 1.3 1.0 6.0 15.7 1.7 10.0 ST6GAL2 "KIAA1877, SIAT2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0;thyroid gland: 28.7" "Group enriched" "Detected in some" 4 "Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Group enriched" "Detected in many" 77 "amygdala: 6.9;basal ganglia: 7.4;cerebral cortex: 11.0;hippocampal formation: 10.8;thalamus: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 0.5 0.1 6.9 0.2 7.4 1.0 0.7 0.0 11.0 1.7 0.0 1.1 0.2 2.6 0.3 1.8 0.7 5.1 0.5 10.8 0.0 0.4 2.6 0.6 0.3 0.0 0.0 0.6 0.1 0.1 0.1 1.5 0.0 0.8 2.3 1.9 0.8 0.8 0.1 0.7 0.4 2.0 0.0 0.1 0.6 5.3 4.6 0.1 28.7 0.0 0.3 0.6 1.0 0.1 0.0 5.3 2.8 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.3 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 6.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.4 0.0 5.9 0.0 0.0 9.6 0.2 0.0 6.1 3.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.5 0.1 0.2 0.0 9.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.9 7.4 0.0 11.0 10.8 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 58.8 0.0 0.9 0.2 0.0 18.8 6.6 0.2 3.4 1.4 0.0 0.6 1.8 0.0 0.0 0.0 4.7 0.0 0.1 0.4 0.8 12.2 0.3 1.2 6.3 78.7 0.0 0.0 1.7 0.0 0.5 0.0 111.5 2.2 0.0 0.2 0.0 44.8 3.3 0.0 0.0 0.0 1.2 0.3 0.1 0.0 2.8 0.0 0.9 0.0 94.0 1.9 0.0 1.0 0.7 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.2 2.9 0.1 1.1 4.3 0.0 0.3 0.1 0.1 3.2 0.0 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380503-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5" "Group enriched" "Detected in many" 5 "granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1" "Low region specificity" "Detected in many" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 2.8 5.1 1.4 0.6 1.9 0.4 1.9 3.6 3.9 7.0 5.0 3.6 0.1 1.4 0.3 2.1 3.2 2.7 0.7 0.8 4.3 2.5 0.9 11.1 0.4 2.3 2.5 2.5 0.1 10.1 1.1 0.3 6.9 13.8 0.7 5.8 1.3 4.4 1.6 1.2 0.4 3.4 1.9 0.6 0.9 1.9 2.1 0.7 0.5 5.3 0.2 3.7 2.2 0.5 7.7 3.3 1.6 0.0 6.5 2.1 0.1 19.9 0.4 4.0 4.6 0.0 0.0 0.0 7.8 46.8 13.0 34.1 2.4 8.2 4.1 0.0 7.2 1.1 10.0 0.2 0.0 20.3 0.4 2.4 0.2 0.1 0.7 27.6 0.0 1.8 0.0 0.4 0.5 0.0 4.1 0.2 13.8 0.0 3.0 0.0 0.0 0.0 10.8 0.0 6.2 49.1 7.9 5.2 0.1 13.6 0.0 2.0 8.5 0.5 19.1 0.6 30.3 0.0 0.0 0.0 48.1 7.9 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.5 0.0 1.4 1.9 3.6 3.9 0.8 4.3 2.3 2.5 6.9 1.9 2.1 0.5 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.7 2.3 0.8 0.9 0.0 1.3 0.0 0.0 0.0 0.1 0.0 5.9 0.2 5.2 0.9 0.5 0.4 0.0 2.1 0.6 0.0 0.1 1.5 0.0 2.1 6.3 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.2 5.3 0.0 4.8 0.0 0.0 0.0 21.6 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 5.0 1.8 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 STK11IP "KIAA1898, LIP1, LKB1IP, STK11IP1" ENSG00000144589 "Serine/threonine kinase 11 interacting protein" Q8N1F8 2 219597857-219616451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 15.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036837, HPA036838, HPA053192" Approved Enhanced Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075" "unprognostic (3.37e-1)" "unprognostic (1.33e-1)" "unprognostic (3.51e-1)" "unprognostic (1.97e-1)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (1.22e-3)" "unprognostic (8.36e-2)" "unprognostic (9.36e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.63e-4)" "unprognostic (9.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-3)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" 7.6 10.0 12.0 9.5 12.4 19.5 7.1 11.3 13.8 9.2 12.6 9.8 9.2 9.2 15.0 9.6 10.4 9.5 8.0 12.4 10.6 11.2 5.9 9.3 14.0 12.0 11.9 24.5 9.5 7.5 21.5 8.2 12.3 9.9 7.8 12.3 8.1 6.5 5.8 18.4 10.0 8.3 10.0 15.1 8.6 31.2 12.0 19.5 11.1 4.3 11.1 9.0 8.3 11.8 10.1 15.4 16.1 11.0 5.6 9.9 16.5 8.7 7.6 13.9 11.7 14.3 16.7 5.8 8.7 8.4 12.6 24.4 7.7 18.7 10.3 8.7 11.7 15.1 17.2 11.6 7.4 15.9 38.2 9.6 16.5 11.7 5.9 14.2 8.6 9.7 11.4 8.5 7.9 19.7 9.3 19.6 16.2 4.8 8.4 17.5 5.9 4.5 13.8 15.8 10.6 16.8 5.7 13.8 12.0 12.9 8.8 15.3 6.5 15.0 12.6 14.5 8.6 9.4 4.5 10.8 11.4 8.7 9.5 1.5 4.3 5.3 2.6 5.8 2.1 1.7 1.2 2.1 7.7 1.2 1.0 1.0 1.4 3.7 6.5 15.1 2.1 2.6 12.0 12.4 11.3 13.8 12.4 10.6 12.0 11.9 12.3 10.0 12.0 11.8 3.5 6.4 6.7 12.4 3.9 2.3 2.1 6.3 1.2 7.8 5.1 5.5 3.6 1.5 7.8 7.3 18.8 10.0 10.3 14.6 1.9 5.0 14.0 11.9 4.0 4.6 13.1 6.9 10.7 6.5 5.6 5.3 17.3 5.8 12.7 29.7 4.2 3.3 8.4 11.8 8.0 8.8 6.1 8.6 5.7 30.9 25.4 8.9 3.6 8.4 7.0 4.9 4.1 8.5 7.4 4.2 3.3 14.7 2.8 1.7 5.4 2.7 19.9 12.6 13.1 3.2 4.9 18.5 13.8 3.5 2.7 16.1 4.5 5.4 8.8 2.8 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 291.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 5 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 23.4 49.7 188.4 21.3 197.6 11.4 20.0 112.5 291.7 29.2 16.6 26.5 5.5 30.0 5.0 11.6 27.9 10.9 17.1 215.0 162.0 24.8 3.7 23.6 25.8 259.6 158.1 50.5 16.4 17.5 102.2 10.0 266.1 24.3 5.2 38.8 11.7 12.7 4.3 20.2 24.8 14.7 100.8 48.2 15.1 9.0 159.3 43.5 63.9 3.7 12.4 21.9 19.0 179.9 10.4 11.6 74.4 125.1 1.9 7.3 5.1 12.0 0.4 35.8 16.8 73.6 13.7 0.5 36.3 4.6 2.0 68.6 52.2 1.3 11.1 5.2 14.0 5.1 17.0 27.6 9.9 3.9 42.0 15.3 0.3 11.5 2.9 1.5 1.3 34.4 98.8 2.2 9.6 11.7 142.0 17.7 76.5 2.4 81.7 143.8 12.1 58.0 60.9 2.0 192.5 146.6 5.7 3.4 14.9 5.9 2.1 25.9 1.9 0.8 20.4 0.8 2.6 4.9 10.4 3.6 2.1 14.3 48.8 1.1 0.0 1.1 2.5 0.1 2.7 0.2 5.2 4.5 0.1 0.6 6.2 5.3 0.1 0.0 0.1 1.1 0.9 2.0 188.4 197.6 112.5 291.7 215.0 162.0 259.6 158.1 266.1 100.8 159.3 179.9 5.8 6.4 2.5 16.3 17.1 8.2 6.9 11.9 8.6 108.5 4.7 14.7 2.3 4.3 3.2 3.7 52.1 11.7 13.4 1.1 13.7 4.0 10.0 1.6 17.9 7.8 37.2 4.6 56.9 2.5 4.0 25.4 2.0 2.7 4.5 254.2 6.8 0.0 2.3 109.4 67.1 0.6 4.1 2.2 7.6 18.8 30.1 3.5 7.2 7.5 4.6 37.2 16.5 21.1 11.3 2.2 0.1 35.7 5.3 4.5 0.1 5.0 0.8 44.5 13.1 3.0 20.9 3.3 6.7 1.6 4.3 8.8 28.6 51.0 0.6 2.7 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388989 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6" "Low region specificity" "Detected in many" HPA034530 Approved Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 6.2 2.0 15.5 1.1 16.1 0.5 5.2 16.9 17.2 21.9 12.9 3.4 1.5 11.1 8.0 2.3 9.3 27.1 10.9 13.6 18.9 18.2 3.7 10.3 1.8 18.8 27.3 27.9 2.9 1.0 5.2 13.0 20.4 6.6 2.2 8.6 1.6 8.9 3.1 0.7 3.2 5.5 18.1 1.4 2.0 1.4 19.0 5.0 4.5 6.2 1.3 3.8 5.3 15.8 0.0 0.1 9.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 1.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.0 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 16.1 16.9 17.2 13.6 18.9 18.8 27.3 20.4 18.1 19.0 15.8 13.3 0.0 0.5 10.4 0.0 0.3 0.7 0.0 0.0 2.0 0.4 0.3 0.7 37.1 0.0 9.2 0.0 0.3 0.0 0.0 0.0 0.3 5.9 10.9 3.1 13.2 0.0 2.7 0.6 0.2 0.1 4.9 0.0 3.8 0.0 15.3 17.9 0.0 0.9 1.7 0.5 0.0 0.0 1.3 1.0 1.1 1.5 0.4 0.0 7.5 0.1 12.3 0.0 17.6 0.4 0.1 0.0 4.5 1.4 0.7 0.0 7.7 0.0 1.0 0.0 1.4 1.8 0.6 0.7 0.0 0.4 0.3 0.2 7.2 0.0 0.2 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63761899-64226433 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 198.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 454.6;Rod photoreceptor cells: 568.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 73.8" "Group enriched" "Detected in many" 11 "granulocytes: 73.8;T-cells: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 48.8;SiHa: 29.8;U-698: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.1 6.0 8.8 3.4 9.2 7.9 28.0 21.1 8.7 15.4 89.5 13.3 4.5 18.1 9.9 24.3 14.3 5.5 58.3 9.6 7.6 29.0 19.5 18.4 8.5 7.7 9.6 35.9 37.7 66.6 16.7 9.9 7.5 11.5 4.4 24.8 16.1 3.7 198.5 39.7 11.4 4.6 7.0 10.0 12.4 13.1 11.4 5.5 24.4 96.7 6.1 13.6 19.0 6.9 23.2 8.7 11.0 3.5 11.3 3.2 12.3 1.3 1.6 2.7 4.2 2.8 3.3 48.8 2.3 1.7 2.6 11.0 6.2 3.5 3.2 8.9 3.5 0.4 7.9 0.7 3.0 1.0 0.3 4.4 15.1 3.4 2.2 2.6 7.0 7.5 0.4 4.8 1.8 11.2 6.2 0.3 3.4 5.4 3.3 6.9 14.5 1.8 20.0 13.6 9.9 8.2 29.8 3.8 7.0 5.5 5.0 0.3 7.3 4.2 7.5 1.5 4.5 4.9 3.5 27.5 1.8 0.0 5.7 0.5 0.1 73.8 38.5 0.3 27.6 5.2 24.3 28.0 0.0 5.3 11.8 18.5 30.1 3.9 0.3 1.2 30.1 3.4 8.8 9.2 21.1 8.7 9.6 7.6 7.7 9.6 7.5 7.0 11.4 6.9 414.4 307.7 140.1 8.5 44.9 111.3 138.9 46.4 174.2 27.4 70.3 59.1 261.4 105.8 184.5 202.3 183.5 168.8 226.8 51.0 19.6 108.2 9.4 249.9 71.2 238.8 46.2 10.5 9.5 55.4 65.7 59.6 126.9 365.2 25.9 454.6 73.5 33.3 17.7 6.7 13.9 60.9 59.0 5.7 13.2 14.3 100.9 12.8 48.0 128.4 8.9 107.2 300.7 33.2 6.6 71.7 27.9 53.4 180.3 65.0 35.9 72.2 196.1 568.7 111.7 73.5 167.0 13.0 17.0 104.6 87.5 224.0 222.1 69.5 80.6 80.6 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 68.3" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9" "Region enriched" "Detected in many" 5 "hypothalamus: 30.1" "Low region specificity" "Detected in all" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 3300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 6.9 4.1 6.9 2.2 13.2 2.3 6.0 4.5 5.1 21.7 14.1 9.8 2.1 43.1 3.1 3.9 17.8 4.0 3.2 5.2 13.1 5.6 10.5 4.7 0.7 8.4 9.3 68.3 8.3 1.2 18.8 3.6 7.4 12.7 9.7 1.3 6.1 7.2 2.3 2.0 4.9 32.7 6.1 3.3 7.4 6.8 18.0 0.6 8.8 4.9 1.7 6.1 10.2 7.9 0.3 6.0 1.6 0.0 8.5 4.8 0.1 7.7 4.9 8.0 14.3 0.7 7.6 0.0 2.0 5.4 6.9 6.8 29.5 2.3 8.4 0.0 2.6 0.1 10.8 0.4 2.1 0.0 60.0 1.7 0.5 7.3 0.4 3.1 20.5 0.0 3.0 0.0 3.8 2.0 0.1 0.0 1.2 21.2 0.0 0.0 2.4 0.0 7.0 40.8 14.5 0.6 3.1 11.5 1.7 3.0 7.1 0.6 34.9 4.2 8.8 20.9 1.9 0.1 0.0 0.1 5.2 0.0 4.8 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.8 6.9 13.2 4.5 5.1 5.2 13.1 8.4 9.3 7.4 6.1 18.0 7.9 15.6 28.9 1.7 41.8 0.5 0.1 7.7 3.1 1.2 0.2 19.0 6.6 3.8 18.6 8.0 3.7 0.0 0.4 0.7 29.1 3.9 8.9 1.6 4.3 25.8 13.5 0.0 5.0 0.5 2.3 0.4 20.0 26.5 6.2 3.8 58.1 11.4 38.6 1.3 0.0 1.0 26.9 8.2 1.6 1.9 3.8 72.7 7.2 3.6 8.4 0.5 5.4 0.0 10.6 0.2 7.2 27.1 41.8 0.5 11.9 5.8 2.6 8.1 0.6 52.6 38.1 11.8 2.6 4.4 2.6 0.9 0.0 0.9 18.0 9.6 13.8 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 (MAP3K7) binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 8.1 7.6 3.6 8.0 4.5 16.8 8.9 3.9 6.7 8.5 20.6 9.6 7.7 18.0 8.9 16.6 9.7 8.1 8.6 5.3 4.0 14.3 27.1 9.0 8.9 5.2 6.5 12.2 24.9 31.8 6.5 11.6 4.7 14.6 9.5 23.9 9.7 12.6 10.7 9.7 7.9 13.3 3.1 8.5 12.5 15.3 4.4 9.7 10.0 8.9 12.6 7.2 8.3 5.7 40.2 9.5 9.6 9.8 7.3 11.0 10.1 12.2 15.3 8.0 9.1 10.8 33.5 18.1 7.3 14.2 15.5 20.4 14.8 31.0 11.6 31.2 14.2 16.9 10.9 26.4 6.3 18.0 12.7 8.0 18.2 13.8 35.0 13.9 13.5 13.5 19.7 14.4 10.6 19.4 14.4 9.1 11.5 7.2 15.9 9.1 16.8 13.5 13.3 11.6 8.0 11.3 13.6 20.3 26.0 17.8 17.5 7.1 13.0 8.9 13.0 44.8 11.3 18.6 15.3 17.8 13.9 8.3 12.7 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.9 0.2 0.0 0.1 0.1 3.6 4.5 3.9 6.7 5.3 4.0 5.2 6.5 4.7 3.1 4.4 5.7 9.6 12.8 13.2 14.0 10.2 9.1 7.9 7.2 6.8 7.4 10.0 5.3 11.4 20.0 10.5 11.0 12.5 15.1 11.0 12.3 3.9 8.4 1.5 13.0 23.0 8.8 7.2 39.2 23.2 6.9 4.9 5.6 12.8 11.9 14.5 28.6 10.0 26.0 7.7 11.8 22.3 10.8 6.1 16.0 13.7 3.4 10.8 12.6 5.4 20.6 11.5 6.7 3.1 21.6 21.2 9.9 11.2 16.1 7.3 12.6 7.3 11.2 19.6 20.4 0.0 6.3 6.7 3.3 2.2 9.6 10.1 22.4 10.9 24.4 9.8 13.2 TLL2 ENSG00000095587 "Tolloid like 2" Q9Y6L7 10 96364608-96513926 "Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;heart muscle: 3.6;tongue: 1.9" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 82.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "RPTEC TERT1: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.28e-2)" "unprognostic (7.54e-4)" "unprognostic (1.50e-1)" "unprognostic (3.31e-3)" "unprognostic (2.67e-1)" "unprognostic (2.14e-3)" "unprognostic (1.31e-2)" "unprognostic (3.52e-4)" "unprognostic (7.08e-2)" "unprognostic (2.50e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (4.98e-4)" "unprognostic (2.90e-1)" "unprognostic (8.41e-2)" "unprognostic (1.95e-4)" "unprognostic (2.30e-1)" 0.0 0.1 1.3 0.1 1.5 0.2 0.0 0.6 1.7 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.3 3.6 1.2 1.3 0.0 0.0 0.0 0.1 2.6 1.0 0.1 0.2 0.0 0.4 0.1 2.9 0.1 0.1 0.2 0.2 0.0 0.9 0.0 0.3 0.1 2.2 0.1 0.3 0.1 4.7 0.0 0.1 1.9 0.0 0.0 0.0 2.0 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.1 0.2 0.1 0.2 0.1 0.0 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.6 0.1 0.1 0.4 0.0 20.1 0.0 0.7 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.6 1.7 1.2 1.3 2.6 1.0 2.9 2.2 4.7 2.0 0.4 0.0 1.1 0.3 0.7 0.1 0.5 1.9 0.0 0.0 0.0 0.0 5.5 1.5 1.0 0.0 0.0 2.4 0.1 0.0 0.0 0.2 6.9 0.2 0.1 1.4 0.0 0.0 1.9 0.6 0.1 2.4 1.5 0.5 0.0 82.4 0.0 0.0 0.3 0.0 5.6 1.7 2.0 0.3 1.4 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 18.6 0.7 0.0 0.0 1.4 0.8 1.0 0.2 0.2 0.0 0.0 0.7 0.4 0.2 2.6 0.0 0.4 3.4 0.3 0.1 0.2 0.6 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 246.0" "Cell type enhanced" "Detected in all" "Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 38.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 63.4 246.0 27.8 2.6 28.5 4.1 29.1 32.8 33.9 17.4 64.1 7.8 9.4 3.4 17.0 39.6 12.8 7.0 47.3 30.0 29.7 18.9 86.4 10.1 3.4 34.0 32.0 36.5 69.9 36.3 19.5 3.9 32.5 41.1 3.9 6.0 46.9 6.0 7.1 68.2 8.3 1.9 30.1 5.1 35.6 11.5 32.6 5.6 15.5 3.7 8.4 5.5 22.1 35.1 7.7 10.9 27.3 35.1 8.1 1.3 15.4 1.8 4.5 2.7 3.0 26.0 35.8 16.3 26.9 2.2 1.0 13.3 11.6 21.2 1.9 16.7 5.0 10.2 2.7 54.5 18.8 4.2 10.6 3.7 5.0 14.6 3.9 12.6 3.9 28.7 5.8 13.9 0.8 69.2 8.3 18.6 12.6 18.4 11.2 22.4 1.2 39.9 86.2 12.6 27.2 30.5 1.2 28.2 6.1 19.5 143.9 11.4 3.1 0.4 3.4 3.8 2.3 27.1 18.1 8.4 2.5 5.9 1.0 1.1 1.6 3.4 9.1 1.5 7.0 12.4 5.6 7.8 1.5 11.9 11.8 9.0 1.1 12.5 0.9 38.1 5.6 4.9 27.8 28.5 32.8 33.9 30.0 29.7 34.0 32.0 32.5 30.1 32.6 35.1 4.0 9.6 43.7 23.5 12.7 1.9 6.2 33.6 5.7 19.2 52.2 38.5 99.4 52.9 36.6 44.1 10.4 72.9 16.3 23.3 17.6 27.1 28.8 17.9 2.6 5.7 59.4 13.7 11.6 27.7 4.6 4.3 31.1 16.5 7.0 482.7 5.0 220.6 15.6 25.2 15.3 21.8 52.9 6.3 2.7 59.3 9.9 5.8 12.4 2.8 9.4 204.7 7.2 17.1 36.5 21.7 23.7 2.2 12.9 31.3 29.0 77.5 37.9 23.6 13.1 1.6 21.8 13.3 17.9 18.0 7.0 82.1 8.3 204.8 19.0 10.4 TMEM106A MGC20235 ENSG00000184988 "Transmembrane protein 106A" Q96A25 17 43211835-43220041 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 21.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 26.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 26.7" "Cell line enhanced" "Detected in many" "HMC-1: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (9.71e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (9.61e-5)" "unprognostic (4.95e-3)" "unprognostic (8.62e-2)" "unprognostic (1.79e-1)" "unprognostic (9.11e-2)" "unprognostic (1.76e-1)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (2.99e-2)" "unprognostic (6.08e-2)" "unprognostic (7.89e-3)" "unprognostic (1.39e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (8.30e-2)" 4.9 2.4 1.7 10.2 2.1 3.3 4.1 1.2 2.9 3.8 2.4 3.6 4.0 3.6 1.7 1.5 3.3 3.6 2.1 1.6 2.5 21.9 3.5 5.2 6.9 6.2 3.0 7.8 3.1 2.4 1.6 10.1 3.8 2.5 5.3 0.8 2.8 3.1 1.1 1.3 3.4 8.8 2.8 9.7 4.8 3.3 6.1 4.0 5.3 1.5 6.1 4.8 2.4 4.1 3.1 0.9 0.4 0.2 3.8 4.1 2.3 7.8 5.0 6.7 10.5 2.3 6.4 4.5 1.5 12.1 2.6 1.3 0.8 1.0 7.8 7.1 0.0 3.2 2.7 10.7 2.2 0.1 16.8 2.6 0.2 12.5 0.3 2.4 6.0 5.3 0.1 3.2 8.5 1.3 5.5 2.1 0.3 0.0 0.0 4.0 1.3 2.7 2.9 0.2 0.6 0.0 1.5 3.7 1.8 1.6 5.5 4.5 6.8 3.3 0.4 3.3 1.6 5.0 0.5 1.4 2.8 5.4 6.7 26.7 5.1 5.7 1.5 5.6 0.7 1.9 1.0 1.5 4.2 3.2 0.7 1.3 1.4 2.1 2.0 6.0 2.9 2.2 1.7 2.1 1.2 2.9 1.6 2.5 6.2 3.0 3.8 2.8 6.1 4.1 4.5 3.2 4.5 1.3 13.6 2.4 11.0 2.4 0.6 4.3 6.5 4.2 1.2 0.0 3.9 7.3 2.1 5.0 22.7 3.9 3.9 2.0 5.9 2.6 7.1 6.5 3.0 2.5 1.0 4.0 8.3 6.6 10.7 3.9 8.2 45.6 5.0 1.7 45.3 0.0 1.0 4.5 0.0 44.8 35.6 2.7 14.0 25.2 0.0 17.8 16.5 1.2 14.4 3.5 4.0 5.5 3.4 7.2 5.4 10.9 2.1 17.8 6.0 3.7 13.1 4.0 4.6 7.4 3.6 0.5 1.7 5.2 7.3 3.2 2.9 13.1 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526583-105530202 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 31.2;Muller glia cells: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 2.0 1.0 4.8 0.5 5.0 0.2 2.4 2.9 6.4 4.6 0.4 2.4 0.2 4.3 0.1 1.0 4.6 0.1 2.3 5.7 3.1 2.6 2.6 1.7 0.3 5.8 4.8 2.4 2.4 0.6 5.1 0.2 3.8 3.7 0.0 0.0 1.4 0.4 0.3 1.5 1.8 0.2 2.6 3.4 1.8 1.2 3.3 0.1 2.6 0.0 0.0 2.1 2.1 3.9 0.0 4.0 0.4 3.6 0.0 0.2 0.7 2.4 0.5 0.4 0.0 0.0 1.3 1.2 8.1 0.0 0.7 0.4 0.4 0.1 0.0 0.5 1.9 0.0 0.4 1.4 0.6 0.0 1.4 0.2 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.1 0.2 0.0 1.2 0.1 10.2 6.7 0.0 0.1 0.1 0.0 5.3 2.0 0.4 0.0 2.0 0.0 2.4 0.3 1.4 1.1 2.1 0.2 0.4 0.6 0.0 0.0 0.1 0.5 5.4 0.0 0.0 0.0 0.6 0.0 1.0 2.1 1.2 0.6 0.2 0.6 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.2 4.8 5.0 2.9 6.4 5.7 3.1 5.8 4.8 3.8 2.6 3.3 3.9 10.6 0.0 0.5 2.3 2.8 4.6 2.6 0.1 2.2 5.1 8.9 10.8 1.5 1.5 0.7 5.5 0.0 0.2 0.7 0.0 0.0 1.0 1.7 5.4 5.5 9.5 0.0 3.4 5.7 0.2 2.2 4.6 1.1 1.4 0.0 31.2 10.8 2.3 0.4 10.1 4.8 0.0 0.0 0.6 4.8 2.2 4.4 0.4 7.2 2.8 0.0 14.4 1.0 12.1 11.5 0.0 0.0 6.4 0.5 1.8 0.0 0.1 1.6 1.6 0.0 4.0 3.2 0.7 3.1 0.4 2.6 0.3 3.2 1.8 0.2 0.6 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 134.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3" "Cancer enhanced" "Detected in all" "breast cancer: 23.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 13.1 43.1 12.9 4.6 15.3 1.9 22.0 9.7 16.8 15.1 6.3 7.7 7.4 4.9 134.9 3.6 7.4 6.5 12.7 15.7 12.7 17.3 13.9 6.2 14.7 12.9 15.9 31.5 3.4 5.4 8.4 9.8 14.7 12.6 4.3 4.5 17.0 7.6 6.9 4.3 6.9 6.9 12.0 14.3 5.0 3.2 12.2 9.1 11.4 9.7 12.8 5.0 5.2 12.5 0.1 1.0 8.8 10.9 0.1 0.1 0.4 1.9 4.7 1.3 1.2 0.0 0.6 0.3 0.9 0.3 3.6 0.2 5.0 0.0 1.4 0.4 2.3 0.7 1.2 0.1 0.0 0.0 1.0 4.5 0.6 0.0 0.0 0.8 2.7 5.3 0.0 0.0 0.2 32.2 0.6 0.8 3.9 0.0 0.5 1.0 0.2 1.2 0.2 4.8 20.1 3.5 0.5 0.4 2.8 4.1 0.5 0.2 0.8 0.5 0.3 0.1 1.1 0.1 0.5 0.4 0.6 0.1 2.2 2.6 0.3 0.5 0.2 0.2 0.1 1.0 0.3 0.2 0.1 1.1 0.2 0.2 1.4 0.5 0.3 0.6 0.1 0.1 12.9 15.3 9.7 16.8 15.7 12.7 12.9 15.9 14.7 12.0 12.2 12.5 30.7 0.0 1.1 36.6 0.2 2.4 3.5 1.9 0.6 1.1 19.3 13.6 10.1 5.7 6.1 14.7 2.1 88.6 1.4 0.2 0.0 7.2 5.5 2.6 11.2 24.8 1.2 3.0 35.6 2.5 1.3 13.1 0.5 10.5 6.3 104.7 25.4 20.4 5.7 1.7 24.2 1.1 0.0 1.0 3.6 2.9 14.3 1.8 1.8 7.5 7.8 14.8 0.0 17.6 13.1 1.4 0.2 9.8 1.2 4.9 0.4 2.6 7.1 2.2 0.0 3.9 7.8 1.1 4.1 1.6 1.1 117.3 0.6 1.8 4.3 0.9 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 663877-677406 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved "Endoplasmic reticulum,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "Endoplasmic reticulum" "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.5 19.9 9.3 6.3 9.1 8.8 18.5 8.8 11.7 14.8 7.6 12.3 8.9 17.7 9.7 14.8 15.8 8.5 11.6 9.6 10.0 13.2 10.1 11.0 8.4 9.8 9.4 28.3 25.2 12.4 9.7 9.9 9.8 9.5 6.2 12.0 14.3 7.0 27.3 15.4 10.1 9.5 9.4 9.2 13.3 12.2 10.2 7.0 12.8 12.2 6.4 13.6 13.1 10.4 17.4 14.1 20.3 21.7 23.9 35.4 19.0 23.8 19.0 20.2 19.5 1.9 27.6 25.1 44.5 31.1 10.7 24.0 7.2 26.3 17.8 37.1 16.6 14.4 7.6 28.7 25.9 13.5 11.9 24.6 26.4 35.1 26.7 18.2 5.9 39.1 14.7 14.7 30.5 48.1 32.7 32.1 13.8 15.1 21.4 17.8 9.9 17.8 21.0 16.3 14.4 24.9 13.1 22.7 25.4 9.5 16.2 25.6 19.5 19.0 25.5 12.6 36.7 19.3 34.4 21.8 20.7 14.4 13.1 3.8 16.1 6.9 11.8 15.7 11.3 18.4 13.5 9.5 16.6 14.8 14.8 14.4 1.0 18.5 18.4 22.3 17.1 13.1 9.3 9.1 8.8 11.7 9.6 10.0 9.8 9.4 9.8 9.4 10.2 10.4 49.2 22.4 32.8 4.6 39.4 35.9 29.7 46.0 61.5 19.8 68.3 108.2 28.3 31.5 39.2 27.6 8.4 72.5 28.1 26.0 31.3 34.1 14.2 37.5 53.7 41.0 19.8 37.9 4.1 46.3 62.1 47.1 27.0 53.1 29.8 77.6 38.2 37.4 49.1 20.2 3.9 39.4 36.7 37.4 31.5 13.1 63.3 31.2 40.9 2.8 36.4 49.8 20.6 4.5 10.2 36.6 50.7 51.1 43.1 40.1 51.0 45.8 32.1 33.7 19.7 31.8 48.8 93.3 68.1 72.6 43.2 81.1 30.0 63.5 41.7 40.4 TMEM200A "KIAA1913, TTMC" ENSG00000164484 "Transmembrane protein 200A" Q86VY9 6 130366017-130443067 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 39.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.5;Distal enterocytes: 23.3;Endometrial stromal cells: 18.6;Enteroendocrine cells: 24.6;Granulosa cells: 49.9" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 5 "NK-cells: 4.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 40.8;hTEC/SVTERT24-B: 67.1;hTERT-RPE1: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014396 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA014396: AB_2204904" "unprognostic (1.07e-1)" "unprognostic (4.89e-2)" "unprognostic (2.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.62e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (2.91e-1)" "unprognostic (7.25e-2)" "unprognostic (9.29e-2)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.27e-3)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (1.91e-3)" 5.7 17.1 1.7 3.9 2.5 0.1 5.9 0.1 2.2 11.1 0.0 11.1 7.3 39.3 5.3 1.2 12.9 6.4 0.6 4.5 2.7 13.6 0.4 6.8 3.8 0.9 4.6 15.6 1.5 0.8 5.3 3.3 1.5 2.7 22.3 11.2 1.6 1.4 0.6 2.0 8.3 18.7 0.8 1.0 6.3 2.7 3.8 4.7 5.6 0.4 3.4 5.6 3.5 0.8 0.1 0.1 0.2 0.0 11.7 14.6 0.1 10.6 13.0 11.1 19.6 16.6 0.0 0.0 0.0 22.3 2.5 2.5 1.0 0.0 40.8 15.5 0.0 0.0 0.0 0.8 5.3 0.3 0.0 16.7 0.0 67.1 13.3 33.5 0.4 0.3 0.0 1.5 5.2 0.0 0.0 0.1 8.4 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 13.4 12.5 4.0 1.1 1.9 8.2 0.0 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.8 0.4 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.1 1.7 2.5 0.1 2.2 4.5 2.7 0.9 4.6 1.5 0.8 3.8 0.8 0.5 0.0 0.5 1.3 0.2 2.0 0.1 0.1 1.2 26.5 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.5 0.4 23.3 0.0 0.0 2.0 5.2 18.6 0.8 24.6 2.7 7.1 0.0 1.7 3.6 2.0 0.7 0.0 49.9 0.0 0.0 0.2 13.5 4.3 1.6 0.0 0.0 0.9 1.8 5.9 0.3 1.8 1.9 0.0 0.5 0.0 1.0 0.3 0.1 6.0 10.5 3.3 0.0 4.6 9.9 0.0 2.1 0.0 0.8 8.4 3.3 2.6 0.1 1.4 0.5 5.8 11.3 4.0 0.1 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" A0A1B0GTI8 13 51813347-51845177 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 4.2;basal ganglia: 15.9;cerebral cortex: 10.0" "Immune cell enriched" "Detected in single" 89 "neutrophil: 40.1" "Lineage enriched" "Detected in single" 89 "granulocytes: 40.1" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" "Low region specificity" "Detected in many" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.1 0.0 4.2 1.0 15.9 1.0 0.1 1.1 10.0 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.0 0.2 1.8 2.1 1.7 0.1 0.3 0.1 1.1 0.5 1.1 0.1 0.4 0.0 0.6 0.2 0.6 0.0 0.1 2.9 0.1 0.0 0.5 0.6 0.5 0.0 0.2 0.6 0.1 0.5 2.0 0.7 0.0 0.4 0.9 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 40.1 0.0 0.0 0.0 0.0 0.0 4.2 15.9 1.1 10.0 2.1 1.7 0.5 1.1 0.6 0.2 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM8B "C9orf127, FP588, LINC00950, NAG-5, NGX6, NGX6a" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 36.1;Granulosa cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 51.2" "Lineage enriched" "Detected in many" 24 "dendritic cells: 51.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA052130: AB_2681740, HPA062701: AB_2684839" "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favorable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 10.4 21.1 19.9 3.1 16.0 1.8 12.3 11.5 20.7 21.7 3.6 19.9 5.1 20.1 6.2 5.7 20.8 6.7 15.9 20.3 13.9 15.8 6.4 10.2 3.6 14.2 15.3 33.6 11.8 17.8 30.6 4.5 13.9 23.9 5.5 7.7 18.1 14.2 12.8 9.3 9.5 6.9 12.7 8.5 17.7 19.1 18.5 5.2 22.7 9.6 2.6 19.3 15.7 12.4 3.1 3.4 11.7 9.2 12.9 10.7 1.4 2.8 5.5 3.1 3.8 1.4 0.8 2.5 6.5 7.7 9.1 1.2 3.1 4.7 2.5 1.9 5.2 0.7 2.5 3.4 9.1 0.2 0.2 10.1 6.1 3.2 3.4 10.0 1.8 11.5 1.2 6.9 5.5 1.2 6.6 1.4 1.6 2.7 4.6 7.2 2.4 6.2 3.3 1.5 2.8 8.1 4.3 1.8 4.1 3.8 3.2 1.1 2.9 7.3 2.2 7.2 1.1 8.6 2.8 2.8 6.7 1.2 4.6 0.7 2.1 0.2 0.5 0.1 0.3 0.6 0.4 0.4 8.2 0.5 0.4 0.4 0.9 0.7 0.1 51.2 0.2 1.3 19.9 16.0 11.5 20.7 20.3 13.9 14.2 15.3 13.9 12.7 18.5 12.4 4.4 12.8 12.2 18.9 3.3 4.5 9.1 8.1 8.0 4.1 12.1 11.4 11.7 10.0 9.1 14.7 2.1 34.1 36.1 8.2 1.9 5.7 25.4 7.7 8.4 3.2 6.7 0.8 12.4 4.0 9.2 9.2 11.2 6.3 1.3 47.3 1.8 4.0 3.2 1.7 13.0 7.0 12.2 1.3 11.2 14.0 14.6 5.3 10.6 10.3 3.6 9.1 2.1 12.1 7.2 3.6 8.0 19.5 2.6 9.0 3.0 4.5 7.5 5.3 6.6 7.1 8.7 8.6 5.2 1.9 1.6 13.0 3.6 8.1 7.8 10.0 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500452 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 43.0;Granulosa cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: AB_2681207" "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 21.3 55.9 50.3 13.9 46.4 18.4 21.7 27.7 54.9 21.9 30.5 25.1 18.8 24.4 5.4 21.1 30.7 15.8 27.8 40.7 31.5 29.7 20.2 25.6 14.1 40.1 36.8 27.7 23.7 20.3 30.1 14.2 30.5 19.9 13.6 27.7 21.1 13.2 63.4 22.9 28.2 10.7 34.8 29.7 25.0 27.1 47.1 18.0 27.4 25.8 8.6 20.5 15.3 35.8 15.3 40.7 33.6 52.6 16.1 18.8 45.6 9.2 20.0 15.4 15.4 13.7 22.6 20.6 30.3 15.9 23.6 19.9 15.8 25.6 8.8 19.4 23.1 22.0 18.4 22.9 21.2 23.7 45.2 30.9 14.5 15.0 13.4 13.9 28.1 18.3 22.6 24.4 20.7 19.1 53.3 18.8 14.4 19.3 16.2 36.2 37.2 19.2 16.0 40.7 28.1 30.5 10.2 47.4 28.7 25.3 29.8 29.3 16.0 16.5 19.0 16.5 13.8 53.2 17.2 12.2 17.2 23.8 20.8 0.1 2.6 3.0 3.5 1.6 2.6 1.0 1.6 2.5 2.5 2.5 1.3 2.2 0.7 2.4 1.4 3.3 2.1 2.9 50.3 46.4 27.7 54.9 40.7 31.5 40.1 36.8 30.5 34.8 47.1 35.8 12.8 12.8 11.1 0.0 5.8 0.0 3.3 0.0 6.2 43.0 10.9 9.1 0.0 12.8 6.2 9.2 31.3 16.1 8.8 18.0 0.0 8.1 4.7 10.1 6.8 8.2 7.3 10.7 0.0 9.5 11.0 4.4 28.1 8.6 6.3 41.5 13.9 8.9 15.4 20.2 0.0 10.5 0.0 12.4 0.0 1.9 6.8 8.9 0.0 0.0 5.6 15.2 4.1 0.0 0.0 6.0 9.1 9.1 8.1 3.3 19.6 3.4 2.9 33.6 6.6 7.5 6.0 14.9 8.8 9.7 0.0 20.1 6.9 19.0 9.3 3.1 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319200-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.4;pancreas: 322.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 341.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 4.3 26.0 5.2 7.3 6.3 6.7 11.7 6.6 9.0 5.7 6.5 14.3 16.4 6.7 4.7 7.4 13.1 10.2 3.4 6.3 5.4 7.1 113.4 17.4 7.1 14.9 14.2 18.1 322.0 6.5 1.6 6.8 14.9 10.8 12.6 6.3 3.7 3.3 15.5 9.8 11.2 5.7 5.0 4.6 38.8 58.0 7.4 7.6 4.2 9.1 8.2 26.6 5.2 6.8 46.1 120.4 214.8 105.5 28.0 40.2 70.5 44.1 27.9 67.9 90.3 341.0 34.3 126.3 46.4 17.0 140.1 48.7 137.1 75.0 52.7 60.3 102.1 47.8 56.9 143.0 25.7 76.9 36.4 84.0 10.0 66.4 27.5 8.3 21.1 80.1 101.3 92.1 22.7 81.8 120.0 72.4 95.6 187.7 30.6 94.8 236.5 112.8 85.6 210.6 154.1 67.0 70.0 55.1 36.3 118.2 97.0 35.8 13.8 72.8 56.8 62.9 81.7 74.3 159.0 115.9 14.6 54.7 44.3 0.7 2.2 2.2 7.8 2.7 9.2 11.1 6.4 9.4 16.1 5.5 10.4 9.8 1.0 9.5 1.0 9.3 6.6 5.2 5.2 6.3 6.6 9.0 6.3 5.4 14.9 14.2 14.9 5.0 7.4 6.8 4.2 9.6 61.5 3.3 7.7 14.5 6.0 32.8 18.8 11.3 22.5 21.5 9.0 121.5 19.1 14.7 16.7 34.2 5.0 6.1 15.6 23.3 22.3 7.5 14.3 7.1 38.8 40.3 2.9 196.4 84.0 14.4 49.5 11.4 1.3 212.9 6.4 226.9 22.0 3.3 4.5 16.2 26.4 6.7 34.7 49.1 13.4 9.9 16.0 0.0 11.4 8.2 4.1 4.0 1.0 47.7 3.5 11.3 15.3 13.9 4.0 6.3 12.2 9.1 6.6 10.4 12.4 91.3 65.5 22.7 11.2 10.7 6.4 65.1 29.4 7.9 TMSB15A "TMSL8, TMSNB" ENSG00000158164 "Thymosin beta 15A" P0CG34 X 102513682-102516739 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.0;prostate: 15.8" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8" "Group enriched" "Detected in many" 4 "glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1" "Low region specificity" "Detected in all" NA NA 130000 "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (5.33e-3)" "unprognostic (3.09e-2)" "unprognostic (1.70e-2)" "unprognostic (5.82e-3)" "unprognostic (1.34e-1)" "unprognostic (4.03e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-3)" "unprognostic (2.96e-4)" "unprognostic (2.14e-1)" "unprognostic (7.83e-2)" "unprognostic (2.07e-1)" 1.0 1.0 1.1 1.1 1.2 1.0 5.1 1.7 2.1 5.1 1.4 0.9 0.4 5.0 0.7 0.3 1.9 1.2 1.9 1.2 1.1 2.4 0.1 7.1 4.0 1.3 1.0 4.7 0.9 0.8 0.8 0.5 1.3 15.8 1.1 1.4 3.9 1.2 0.3 0.5 0.6 2.3 1.1 0.4 0.5 4.8 1.2 13.0 5.9 0.3 2.8 0.7 2.3 1.1 0.1 0.0 571.5 107.7 2.4 0.3 0.2 12.4 0.7 1.7 4.8 0.0 0.7 0.0 1.3 2.1 28.5 0.0 110.2 0.7 1.2 0.0 5.6 10.3 1.7 0.3 0.3 0.2 10.1 1.4 0.0 1.1 0.0 14.3 6.7 5.5 1.0 0.0 41.2 0.1 113.4 0.2 148.0 0.0 1.4 0.2 259.9 0.0 11.7 0.2 98.1 148.1 14.0 0.9 0.3 22.0 1.4 3.2 2.4 0.3 62.6 1.4 10.5 11.8 2.1 0.0 6.7 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 1.2 1.7 2.1 1.2 1.1 1.3 1.0 1.3 1.1 1.2 1.1 1.4 0.0 0.0 0.0 0.0 0.8 0.9 0.1 1.8 0.3 7.3 12.8 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.5 0.3 0.5 5.6 1.2 0.0 0.8 0.0 0.0 0.5 4.6 0.0 1.2 0.0 25.9 2.5 0.0 0.5 0.0 0.0 0.6 0.0 0.6 0.5 0.1 0.3 0.1 1.8 0.0 0.0 0.7 1.0 0.5 0.0 0.0 0.1 2.6 0.3 13.8 0.1 0.4 0.0 0.1 6.6 1.2 13.5 3.4 19.8 1.8 0.0 0.3 0.7 0.9 0.9 1.0 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 30.4 18.3 10.8 29.0 8.9 51.8 30.1 16.2 14.2 40.8 2.2 56.3 25.3 57.6 16.4 26.0 43.5 22.4 22.1 10.3 0.5 22.9 19.8 32.0 16.1 6.2 1.7 46.0 29.5 35.0 22.2 30.6 1.6 36.1 22.6 12.2 28.8 34.3 24.0 33.2 29.0 36.4 1.3 25.2 33.8 22.6 5.1 17.2 32.6 11.1 14.6 40.8 31.9 3.2 72.8 63.4 51.5 43.4 42.9 50.6 133.8 50.4 47.3 27.4 29.0 26.3 62.4 49.3 48.3 74.7 60.8 79.7 30.2 60.5 23.0 21.6 19.2 31.4 56.6 43.1 37.1 104.3 111.2 51.2 70.0 54.8 63.2 39.5 31.3 43.6 45.4 27.2 35.3 120.0 24.6 127.2 4.5 47.5 48.0 27.0 25.7 37.3 22.3 91.3 22.3 53.4 38.8 102.5 37.0 23.1 106.9 106.1 78.7 78.3 109.6 47.0 36.7 38.6 44.1 46.2 44.1 72.6 94.1 14.2 3.8 3.6 1.7 1.5 1.2 2.2 1.2 1.0 1.4 2.3 0.9 1.7 20.8 3.2 2.1 5.4 1.9 0.2 10.8 8.9 16.2 14.2 10.3 0.5 6.2 1.7 1.6 1.3 5.1 3.2 25.6 9.6 29.0 59.7 7.4 9.3 3.7 9.8 13.6 51.7 15.8 25.9 7.5 14.3 12.4 14.7 2.1 14.5 20.4 33.6 1.9 5.0 14.4 22.2 29.7 17.3 31.3 9.7 40.9 6.6 3.8 17.8 19.4 36.2 14.0 48.3 29.6 25.4 11.2 50.5 45.6 30.4 8.2 41.8 12.4 18.8 18.3 22.8 5.4 71.2 25.9 31.0 11.3 32.6 20.3 9.0 10.6 19.9 12.1 6.5 7.4 5.4 11.1 4.0 19.7 18.4 21.2 0.4 2.1 12.5 8.8 10.0 12.3 18.6 25.1 3.8 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826819-36945057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 45.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 115.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 115.1" "Cell line enhanced" "Detected in many" "Daudi: 67.9;HMC-1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 7.4 4.6 1.7 14.0 2.5 10.0 6.4 5.2 7.5 24.6 0.0 14.8 11.1 18.0 5.2 3.2 45.0 9.6 6.2 1.8 2.3 3.4 9.9 8.8 18.7 1.9 0.5 15.6 2.4 3.2 6.7 5.2 1.8 16.5 13.4 1.4 6.8 6.3 1.1 2.3 16.7 8.8 3.4 13.1 8.2 2.4 3.3 17.5 6.2 2.5 20.8 16.6 10.0 0.7 1.4 1.7 0.4 0.0 4.5 17.9 0.0 1.4 9.1 3.9 8.0 0.0 7.2 67.9 2.8 5.3 13.5 0.5 0.2 1.0 0.7 3.7 0.1 11.6 4.8 0.0 5.5 3.1 26.1 5.7 3.5 3.1 0.2 1.1 5.4 7.6 9.5 9.9 2.4 0.1 8.9 1.3 0.5 0.0 1.9 2.5 0.3 1.4 1.5 3.3 0.6 0.0 7.2 1.9 0.7 0.8 1.2 3.8 3.7 3.4 1.3 0.2 1.2 9.3 2.2 15.8 0.6 2.6 0.4 7.3 2.0 11.5 14.9 2.9 10.7 10.9 12.3 15.3 1.4 17.5 11.0 10.6 115.1 8.5 3.9 0.2 11.6 3.0 1.7 2.5 5.2 7.5 1.8 2.3 1.9 0.5 1.8 3.4 3.3 0.7 5.4 16.0 7.8 18.3 18.8 0.8 1.3 1.7 6.8 4.4 1.6 2.3 3.6 1.5 4.0 3.7 2.1 1.3 16.5 40.9 0.0 3.1 0.4 6.1 15.1 5.5 5.4 12.6 56.5 1.8 1.6 7.1 18.8 8.8 6.3 73.0 5.7 17.7 5.0 0.0 91.8 16.7 0.0 6.6 0.8 0.0 4.4 7.4 5.4 52.5 8.7 1.6 26.8 23.6 13.2 3.2 16.9 6.0 21.9 1.6 16.7 0.9 5.2 0.7 0.0 2.6 5.2 0.3 0.3 2.6 0.9 0.7 21.8 3.7 4.0 1.5 TRAPPC4 "PTD009, SBDN, TRS23" ENSG00000196655 "Trafficking protein particle complex 4" Q9Y296 11 119018763-119025454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039752, HPA041371" Approved Approved Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA039752: AB_2676664, HPA041371: AB_2677439" "unprognostic (5.26e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (1.18e-2)" "unprognostic (9.42e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (1.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-2)" "unprognostic (7.49e-3)" "unprognostic (3.64e-1)" "unprognostic (1.17e-1)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" 20.8 37.8 14.6 4.3 14.8 8.2 20.2 15.3 18.6 17.9 15.5 22.9 8.4 17.9 11.8 21.3 18.0 5.2 27.2 14.4 16.7 36.8 26.1 19.5 8.1 15.6 15.0 15.5 25.5 13.5 29.2 5.6 15.0 20.8 6.1 9.2 18.9 12.3 38.3 19.6 23.6 4.0 15.3 22.1 22.6 31.5 14.7 16.9 17.6 18.2 6.1 19.3 16.0 16.2 15.5 14.1 16.9 20.2 25.2 19.3 8.7 59.6 44.3 45.6 40.0 35.1 6.4 18.6 40.3 27.2 23.6 14.5 32.0 25.9 32.9 31.5 15.3 28.5 14.2 40.0 33.4 25.3 14.8 25.1 29.2 40.1 30.1 23.5 42.3 20.7 34.7 7.3 28.8 38.6 30.0 24.9 13.7 30.0 44.4 26.3 13.1 25.9 34.7 20.2 7.4 16.2 10.5 13.1 15.4 19.8 58.5 21.5 24.9 10.5 18.8 13.1 19.7 9.2 18.9 45.9 11.8 20.1 18.5 68.3 37.0 77.0 50.8 45.8 53.5 59.1 59.6 59.8 37.2 55.5 54.7 59.6 32.6 54.6 58.3 52.4 96.4 61.2 14.6 14.8 15.3 18.6 14.4 16.7 15.6 15.0 15.0 15.3 14.7 16.2 50.3 38.5 34.4 7.5 38.8 51.4 59.1 166.1 37.5 60.1 38.4 38.7 30.8 41.5 83.4 71.7 14.6 90.7 61.1 30.4 140.8 107.6 41.9 46.0 39.1 47.7 67.6 45.3 9.0 76.2 56.5 45.1 15.3 33.2 62.1 335.0 46.1 21.8 80.4 38.7 11.7 33.5 152.5 27.3 30.7 16.4 44.4 33.1 30.2 10.3 76.3 88.5 41.2 10.1 15.0 103.4 44.3 60.9 26.9 51.1 83.0 206.1 89.0 61.2 46.0 21.6 82.2 78.2 67.0 28.7 59.0 87.3 52.7 49.1 36.8 52.4 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 104.3;Muller glia cells: 100.3" "Cancer enhanced" "Detected in all" "melanoma: 74.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 48.8" "Group enriched" "Detected in many" 8 "B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8" "Cell line enhanced" "Detected in many" "AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 43.3 63.1 29.1 38.9 29.9 16.8 38.3 36.1 35.2 21.7 30.5 27.0 17.8 44.4 43.4 15.5 23.4 28.8 51.0 31.6 37.7 92.3 21.0 39.8 72.7 31.4 30.8 97.8 26.2 18.0 20.0 46.6 29.7 33.0 13.4 137.8 20.4 25.6 14.3 16.9 25.2 34.2 29.7 79.7 41.8 28.5 32.4 39.3 23.9 19.5 69.6 48.4 19.5 28.0 0.2 0.4 138.8 183.5 48.9 44.7 0.2 7.9 7.5 4.9 7.9 0.9 15.3 16.3 5.5 16.9 0.8 2.3 10.3 16.1 4.2 18.3 28.9 185.7 0.4 2.7 60.7 10.7 68.0 41.7 16.0 20.3 5.6 48.9 22.1 23.8 258.0 0.3 7.9 1.7 24.4 44.8 66.1 7.0 18.0 0.0 46.2 6.7 31.9 23.4 118.9 56.6 1.1 7.4 189.3 41.4 0.2 1.1 13.9 65.3 32.0 0.6 17.8 0.1 0.2 22.9 35.2 36.3 246.7 1.7 0.2 3.2 12.7 0.0 15.8 9.6 26.1 13.8 1.2 12.2 15.0 9.2 0.5 19.3 0.2 0.1 48.8 8.9 29.1 29.9 36.1 35.2 31.6 37.7 31.4 30.8 29.7 29.7 32.4 28.0 52.2 3.2 8.3 25.5 12.5 6.1 9.1 26.9 19.4 55.0 7.9 8.6 17.1 12.8 15.6 16.5 31.3 2.6 17.5 0.7 7.9 17.2 4.3 9.7 11.6 43.9 0.0 22.1 13.5 104.3 0.2 11.3 20.9 15.9 34.2 77.3 59.6 6.7 5.8 20.2 6.9 0.4 28.5 5.1 8.2 14.3 77.3 3.8 30.2 13.1 3.0 100.3 26.8 59.8 2.7 45.3 0.2 74.4 21.0 11.6 0.3 1.0 17.9 66.7 52.6 9.9 41.2 1.0 6.0 5.7 5.4 0.8 27.1 30.5 0.8 32.5 TRIM24 "hTIF1, RNF82, TIF1, Tif1a" ENSG00000122779 "Tripartite motif containing 24" O15164 7 138460259-138589996 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "AF22: 146.5;HMC-1: 196.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043495, HPA061717" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA043495: AB_10962915, HPA061717: AB_2684592" "unprognostic (2.40e-1)" "unprognostic (9.52e-3)" "unprognostic (2.23e-1)" "unprognostic (3.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.94e-4)" "prognostic favorable (6.57e-4)" "unprognostic (4.01e-2)" "unprognostic (8.93e-2)" "unprognostic (2.53e-1)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (1.62e-1)" "unprognostic (2.25e-2)" "unprognostic (5.54e-2)" "unprognostic (6.34e-2)" 7.5 25.7 6.0 6.9 6.8 10.6 9.1 5.8 7.0 6.4 5.2 8.1 10.0 8.8 8.4 9.0 5.7 5.3 10.4 6.0 7.1 8.0 23.1 11.4 8.0 6.8 6.4 30.0 10.8 14.2 3.8 12.3 6.3 11.7 9.2 12.2 8.3 5.2 13.9 8.6 9.7 7.6 6.2 7.2 11.6 27.3 8.2 17.3 9.1 16.4 7.8 7.5 6.1 9.0 15.0 18.1 146.5 42.7 9.6 8.9 11.4 13.7 14.4 10.5 10.2 28.7 13.6 28.7 13.2 13.2 21.5 7.9 71.9 11.4 15.4 22.1 17.7 63.1 13.1 88.9 13.1 49.8 196.8 7.9 11.8 8.8 13.9 7.3 25.0 15.4 72.6 17.1 12.7 29.2 85.2 44.8 56.3 77.6 16.0 66.5 17.3 24.2 23.6 43.9 30.3 68.8 25.5 22.6 7.5 50.6 15.5 32.3 10.7 12.1 9.9 21.4 19.1 15.6 18.2 47.8 20.1 32.1 18.0 0.3 0.6 1.0 0.5 0.6 0.1 0.2 0.4 0.3 0.5 0.3 0.4 0.5 0.9 0.6 0.3 0.3 0.7 0.2 6.0 6.8 5.8 7.0 6.0 7.1 6.8 6.4 6.3 6.2 8.2 9.0 29.0 51.3 46.9 26.1 9.5 13.9 13.4 13.8 10.8 13.6 14.7 14.4 39.7 20.0 18.8 7.3 16.7 28.4 14.9 12.2 5.9 7.1 70.4 16.7 22.9 18.9 10.1 31.3 27.9 12.4 15.2 16.0 20.4 25.2 40.4 85.2 14.3 31.9 10.3 40.4 46.6 10.9 14.2 9.5 14.9 38.7 14.0 13.8 14.2 21.5 12.2 23.3 9.2 64.3 67.1 9.5 9.5 16.1 13.7 12.2 6.8 10.6 14.5 22.4 13.1 21.5 17.6 72.8 14.7 22.2 11.8 22.2 15.8 34.6 19.4 12.8 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 112 "basophil: 11.2" "Lineage enriched" "Detected in single" 112 "granulocytes: 11.2" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 61.3" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 21.6" "Cell type enhanced" "Detected in many" "Granulosa cells: 41.9;Horizontal cells: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 6.0;Hep G2: 10.5" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 2.8 3.7 1.0 1.3 1.7 2.5 3.5 4.7 2.1 5.0 0.7 2.1 3.6 2.9 0.5 1.4 6.4 1.1 2.0 1.0 1.4 4.2 5.6 1.9 2.3 1.1 1.0 4.3 6.0 1.3 3.6 0.4 1.1 4.5 0.2 0.9 2.1 1.6 2.6 2.4 3.3 0.2 0.8 3.2 21.6 11.3 1.3 1.1 4.6 0.4 0.4 2.2 3.1 1.8 1.0 3.2 1.3 1.9 0.0 0.6 0.5 0.4 0.1 0.0 0.7 0.0 1.5 1.8 0.3 0.2 0.2 1.1 0.3 0.0 0.1 4.1 6.0 1.1 2.8 10.5 0.6 0.6 4.2 1.7 0.0 0.2 0.3 0.9 0.0 2.5 0.6 4.9 0.0 0.7 1.7 2.1 0.1 0.3 1.0 2.8 0.2 0.9 0.3 0.0 1.6 1.2 2.0 0.7 1.9 0.5 0.5 1.9 1.2 0.9 1.4 1.3 0.8 2.3 1.4 1.8 1.2 2.6 1.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.3 0.3 0.0 0.2 0.3 0.2 1.0 1.7 4.7 2.1 1.0 1.4 1.1 1.0 1.1 0.8 1.3 1.8 3.8 0.0 0.5 0.0 15.5 0.9 3.2 3.1 4.6 21.9 5.1 4.2 2.5 1.5 3.3 5.5 18.8 2.1 8.7 1.6 5.9 1.8 5.9 9.2 13.4 2.8 4.9 3.4 0.1 4.7 0.7 4.7 16.8 5.6 0.0 41.9 2.9 3.0 3.0 32.0 0.1 3.2 4.1 2.4 1.2 11.4 6.5 3.1 1.8 0.0 2.5 5.8 9.2 0.0 0.1 2.9 4.0 3.8 11.2 3.3 10.0 4.7 5.4 14.5 0.0 14.6 4.1 9.1 2.5 3.3 2.0 1.1 6.8 14.2 3.4 2.6 TRIOBP "DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara" ENSG00000100106 "TRIO and F-actin binding protein" Q9H2D6 22 37697048-37776556 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003747, HPA019769" Enhanced NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA003747: AB_1858328, HPA019769: AB_1858329" "unprognostic (2.94e-1)" "prognostic favorable (4.29e-4)" "unprognostic (2.79e-1)" "unprognostic (4.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.44e-3)" "unprognostic (3.77e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-2)" "unprognostic (5.56e-2)" "unprognostic (2.40e-1)" "unprognostic (1.99e-1)" "unprognostic (4.38e-3)" "unprognostic (1.31e-1)" "unprognostic (2.81e-1)" "unprognostic (3.20e-2)" "unprognostic (1.67e-2)" 56.3 46.5 15.4 27.3 16.6 25.7 50.8 14.7 14.9 73.1 22.1 70.6 23.9 71.8 12.8 78.5 66.1 27.8 74.6 12.8 13.2 37.2 21.6 51.6 17.4 20.0 17.2 55.7 32.7 31.1 16.9 44.2 16.5 45.3 17.0 4.8 44.3 33.3 24.3 32.0 38.0 31.0 16.6 53.1 53.6 26.1 16.9 16.7 48.2 14.3 12.5 66.5 65.7 17.3 65.9 53.1 33.2 26.4 73.1 118.1 47.5 113.0 111.9 57.7 42.1 11.8 44.8 24.5 30.4 69.6 31.6 52.7 9.2 63.7 18.1 39.6 29.1 6.8 41.6 22.4 75.5 32.1 28.9 47.1 29.8 52.0 24.5 125.3 71.9 20.6 6.4 34.6 45.5 39.3 14.4 23.1 20.2 65.4 63.2 25.1 23.9 17.2 41.0 52.8 16.2 25.4 50.9 46.5 59.7 32.8 25.4 23.0 151.9 87.2 38.6 60.6 27.0 30.4 9.1 15.4 82.7 13.0 104.3 7.7 7.6 12.2 1.8 7.5 0.6 1.3 1.5 1.8 4.1 2.4 1.2 1.8 18.2 1.9 12.5 1.9 2.5 2.0 15.4 16.6 14.7 14.9 12.8 13.2 20.0 17.2 16.5 16.6 16.9 17.3 102.0 19.2 29.7 17.9 10.7 6.2 48.3 18.3 18.8 22.8 40.1 45.1 65.2 62.9 23.3 58.8 2.1 105.7 14.7 63.8 15.6 42.7 30.3 32.6 107.0 91.6 22.9 28.2 4.7 51.6 34.2 65.5 58.1 34.2 6.3 128.1 124.6 17.1 42.7 16.8 4.6 52.1 6.1 56.0 7.5 10.6 113.1 31.2 14.2 27.2 32.0 29.6 8.2 7.5 14.0 62.8 46.9 92.2 9.5 41.9 24.8 15.8 23.9 7.3 52.6 17.7 31.8 49.8 23.4 57.2 6.1 116.0 12.7 22.5 40.6 57.9 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724034-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Astrocytes: 93.7;Excitatory neurons: 144.6;Granulosa cells: 91.8;Inhibitory neurons: 184.4;Microglial cells: 49.6;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 164.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles NA NA "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 5.2 4.7 7.3 1.9 7.9 0.3 4.7 10.9 7.5 9.1 5.8 7.6 1.2 11.1 5.2 3.6 8.6 5.4 10.1 7.9 7.0 3.2 0.8 3.3 1.9 7.1 5.6 14.2 1.4 6.5 10.3 3.5 7.7 7.0 2.5 22.8 2.9 7.8 1.2 3.6 3.9 10.6 6.1 2.8 3.2 4.8 6.1 1.5 5.1 3.6 1.0 6.3 6.9 7.9 4.2 5.7 10.8 1.2 9.7 23.9 4.8 6.8 10.5 8.4 12.2 1.7 1.1 0.0 2.1 7.0 14.2 0.3 3.0 3.2 12.2 1.0 4.1 6.8 2.6 2.9 4.0 0.4 0.0 11.4 3.2 7.9 9.4 14.2 4.9 0.0 0.2 0.0 12.1 2.6 0.4 0.5 6.0 0.1 3.1 0.0 5.0 0.0 5.9 0.1 6.7 4.8 8.1 0.0 1.5 9.9 3.3 0.1 4.3 10.1 1.6 14.0 9.1 3.9 1.8 2.1 7.7 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 7.9 10.9 7.5 7.9 7.0 7.1 5.6 7.7 6.1 6.1 7.9 6.2 3.2 0.5 93.7 2.9 2.9 1.6 1.2 7.4 17.9 0.9 1.8 12.0 1.5 0.6 5.5 16.7 0.2 0.3 0.0 0.0 0.3 3.6 0.5 10.8 4.6 1.8 0.4 144.6 0.2 0.2 13.2 0.0 0.9 0.0 91.8 3.6 0.0 0.1 13.5 184.4 0.0 0.0 0.0 1.6 2.9 8.4 0.5 1.8 49.6 0.1 7.7 0.0 154.8 164.8 0.1 0.0 10.9 1.5 0.9 0.0 0.7 3.0 16.0 0.0 10.4 12.0 9.8 2.8 0.7 1.1 0.3 2.2 1.7 0.0 0.3 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627108-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 6 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "NTERA-2: 121.7;RT4: 153.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 29.6 18.2 7.2 4.9 7.5 0.6 34.2 7.2 8.9 26.9 26.8 40.0 19.7 20.5 14.8 46.8 39.5 16.7 8.6 7.4 9.0 36.5 70.2 11.3 3.0 8.7 9.3 53.4 20.2 34.7 36.9 20.0 8.2 18.9 33.1 6.2 52.6 10.3 4.6 9.7 18.5 7.2 8.9 8.7 14.8 74.9 9.6 4.2 19.3 5.3 6.8 32.2 24.1 12.0 24.8 23.0 80.6 42.2 28.7 16.6 30.4 12.9 17.3 20.3 47.6 54.9 37.7 0.0 53.3 12.2 16.9 19.9 0.3 19.7 25.8 0.1 33.3 3.8 14.9 62.0 17.1 0.1 2.5 30.2 9.3 19.5 6.6 34.4 49.3 0.0 0.0 0.1 21.7 19.8 0.1 0.3 121.7 35.4 18.4 0.0 35.5 0.0 33.0 153.5 4.7 20.3 11.6 10.0 18.5 61.9 16.6 3.3 12.7 16.0 24.4 24.3 8.6 0.1 0.2 0.3 13.4 0.0 11.5 0.3 0.0 0.1 0.3 0.0 1.1 0.1 0.8 0.3 0.0 0.1 2.1 1.2 0.3 0.1 0.1 0.1 0.0 0.3 7.2 7.5 7.2 8.9 7.4 9.0 8.7 9.3 8.2 8.9 9.6 12.0 147.0 3.2 10.1 14.4 2.3 7.1 41.0 75.7 29.0 0.6 72.5 46.1 8.2 50.1 89.4 93.8 0.0 28.7 1.1 94.9 23.5 80.3 422.5 54.0 21.4 37.4 33.6 4.8 0.9 12.6 40.7 25.6 21.9 19.2 0.0 684.8 47.5 104.0 4.5 0.0 0.8 47.9 193.3 10.2 3.1 1708.3 32.9 3.1 10.6 1.0 1.0 48.2 0.0 9.5 0.4 18.7 55.5 35.7 0.3 33.0 43.5 43.8 193.9 1.9 19.7 17.1 43.1 20.9 32.4 23.3 5.4 13.5 2.5 49.4 94.3 89.7 TTC8 "BBS8, RP51" ENSG00000165533 "Tetratricopeptide repeat domain 8" Q8TAM2 14 88824153-88881078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.8;Theca cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.8" "Cell line enhanced" "Detected in all" "SH-SY5Y: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.19e-2)" "unprognostic (1.08e-1)" "unprognostic (5.47e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.49e-1)" "unprognostic (7.10e-2)" "unprognostic (5.00e-3)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic favorable (7.77e-4)" "unprognostic (3.54e-2)" "unprognostic (2.51e-1)" "prognostic favorable (4.89e-4)" "unprognostic (1.65e-2)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (3.80e-2)" 8.3 38.9 13.9 6.6 14.6 9.3 18.6 11.8 14.2 15.5 20.4 9.4 6.0 13.5 35.9 13.0 23.2 15.5 11.5 14.9 19.3 13.6 13.2 8.9 4.3 14.0 14.4 68.9 12.0 22.5 22.4 6.8 12.7 23.6 9.9 37.4 10.0 18.6 2.6 8.8 5.8 14.4 13.3 6.8 8.4 23.7 16.5 5.9 37.1 4.2 5.0 16.4 5.0 13.4 19.8 28.1 16.7 16.2 35.1 43.5 14.0 24.0 37.6 31.8 21.5 7.9 37.2 8.7 20.6 30.3 19.3 28.5 18.1 19.4 32.2 6.6 7.3 5.5 9.1 11.1 25.4 10.6 1.9 27.3 23.9 23.0 19.9 30.4 19.3 11.6 20.5 9.8 27.3 33.9 10.9 10.2 8.9 10.3 27.0 3.3 23.0 5.2 31.3 30.6 19.6 118.5 38.0 21.3 22.4 11.5 52.6 8.3 11.7 22.6 11.9 20.2 16.6 1.2 6.8 3.8 33.3 2.8 9.9 13.8 0.7 3.8 0.4 0.9 0.6 0.4 0.5 0.5 1.9 2.2 0.2 0.4 0.7 1.7 1.5 0.7 0.0 0.5 13.9 14.6 11.8 14.2 14.9 19.3 14.0 14.4 12.7 13.3 16.5 13.4 3.7 3.2 9.0 38.8 2.1 8.8 8.0 12.3 19.4 17.0 11.7 9.1 6.0 10.0 11.2 9.2 39.6 10.2 0.6 4.3 13.7 13.5 8.1 24.1 10.6 4.9 10.8 4.8 51.1 6.2 9.7 12.8 6.1 11.7 0.0 66.8 5.3 8.0 6.7 20.2 53.4 6.1 6.1 3.5 6.6 7.4 19.6 4.4 7.2 14.0 0.4 12.5 1.0 51.3 21.3 7.8 2.4 25.2 3.7 4.9 2.3 15.5 28.3 41.7 19.7 5.8 12.2 14.6 6.9 8.3 6.5 1.8 1.2 69.0 6.6 4.7 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.7" "Group enriched" "Detected in many" 6 "Excitatory neurons: 29.0;Granulosa cells: 92.1;Inhibitory neurons: 28.4;Langerhans cells: 47.6;monocytes: 29.1;Oligodendrocyte precursor cells: 23.6" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;NTERA-2: 1.3;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.0 1.2 4.5 1.1 4.8 1.8 0.6 3.0 5.7 1.6 1.0 0.8 0.8 0.9 0.5 0.6 1.5 0.9 1.4 4.4 4.4 1.0 1.1 0.9 2.0 3.3 3.8 3.6 1.0 0.0 2.2 0.1 3.8 2.0 0.2 2.2 0.7 0.9 0.5 0.7 1.3 0.6 2.8 1.7 0.8 1.0 4.3 0.8 0.9 0.0 0.6 0.7 0.8 3.6 0.1 0.4 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.2 0.1 0.6 0.3 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.3 1.3 0.1 0.0 0.6 0.1 0.2 0.0 0.4 0.2 2.1 0.1 0.2 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.3 0.1 1.0 0.1 0.3 0.3 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 4.5 4.8 3.0 5.7 4.4 4.4 3.3 3.8 3.8 2.8 4.3 3.6 0.2 0.0 1.8 5.2 0.8 1.1 0.0 0.1 0.6 6.4 0.1 0.4 0.6 0.0 0.1 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.7 0.6 0.4 0.4 0.0 0.0 29.0 0.6 0.6 3.3 0.0 0.3 0.0 92.1 0.0 0.2 0.8 1.7 28.4 0.0 0.0 1.0 47.6 0.3 2.8 4.5 1.8 1.9 29.1 4.7 0.0 23.6 1.1 0.3 0.0 1.5 0.2 0.0 0.0 1.3 0.2 1.3 0.0 0.2 3.6 2.2 3.1 0.1 1.0 1.4 0.5 0.1 0.1 0.1 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30729131-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 79.9" "Group enriched" "Detected in many" 5 "Early spermatids: 167.4;Granulosa cells: 191.2;Hepatocytes: 65.7;Late spermatids: 180.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 10.2 17.3 17.0 7.1 12.0 8.8 14.1 12.2 16.1 10.4 0.0 12.5 13.1 10.4 49.9 10.7 13.2 13.5 4.9 13.3 5.4 22.1 44.1 8.7 8.1 10.3 4.2 79.9 33.0 20.5 2.8 15.6 10.6 16.3 16.3 11.6 8.5 18.6 3.7 16.9 12.1 10.8 1.7 11.1 12.4 37.1 9.2 14.3 25.9 5.4 9.7 10.4 3.3 12.7 16.4 17.0 11.7 12.2 17.9 25.2 14.3 29.5 17.2 15.2 19.6 27.6 6.1 26.8 23.2 24.5 25.9 14.8 3.1 16.8 24.6 23.9 27.2 77.0 14.0 33.0 27.3 18.1 41.8 20.2 17.4 25.6 12.7 13.6 14.1 12.8 71.9 21.8 35.5 16.1 18.6 14.6 22.9 52.2 12.9 21.4 10.9 18.3 27.7 22.4 6.4 17.7 8.3 26.0 52.1 14.1 16.8 30.4 17.3 17.0 7.8 8.2 28.3 8.8 29.2 19.7 15.0 29.0 25.5 0.0 4.6 0.6 6.2 4.9 5.4 4.7 3.3 5.8 5.2 1.9 3.0 5.5 0.8 2.8 2.4 6.5 3.2 2.7 17.0 12.0 12.2 16.1 13.3 5.4 10.3 4.2 10.6 1.7 9.2 12.7 20.5 3.2 8.2 5.5 5.2 0.0 5.4 0.0 8.0 2.5 7.5 7.6 4.3 17.2 3.1 14.7 20.9 23.8 10.7 7.5 7.9 9.7 167.4 9.1 18.6 12.4 8.5 12.8 5.4 5.3 20.2 22.8 9.7 11.3 14.0 191.2 21.4 65.7 22.0 11.8 7.8 9.7 0.0 16.7 0.0 180.4 14.3 8.9 0.0 6.5 11.6 8.1 12.3 4.5 16.3 3.1 6.0 9.8 6.7 4.9 6.9 25.4 0.7 2.2 6.6 8.7 10.4 16.1 24.2 13.0 0.0 15.2 6.6 27.1 11.8 4.4 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724577-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 219.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" NA NA 170000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 35.0 38.7 13.1 32.3 14.7 13.0 39.0 15.6 19.0 44.3 26.1 33.9 35.6 32.3 64.2 50.1 30.1 32.0 57.4 14.9 16.1 38.7 76.8 30.4 32.5 16.7 14.4 56.9 57.5 37.7 31.5 43.7 16.4 39.9 36.9 39.2 54.7 37.5 219.2 36.2 33.7 35.7 14.9 26.3 40.8 43.1 15.6 30.7 53.4 138.7 39.7 40.2 27.6 19.2 46.8 36.0 49.5 66.7 118.6 155.8 45.5 106.2 129.4 57.2 69.2 36.2 70.4 60.6 64.0 98.0 49.2 52.8 74.9 66.5 85.6 67.2 29.3 41.8 31.4 76.3 93.0 55.8 46.2 89.2 80.6 59.8 116.4 110.6 87.1 41.7 73.7 67.9 85.8 30.9 55.4 29.5 67.9 98.2 21.3 36.3 47.2 49.2 85.5 53.1 39.4 38.3 39.1 82.4 67.3 73.6 60.6 45.1 67.4 52.2 32.2 95.8 40.7 63.6 36.6 29.5 77.6 33.1 63.2 21.9 13.1 11.9 16.4 18.7 22.2 9.8 13.6 15.7 16.8 11.2 13.9 13.8 8.1 22.2 26.9 13.4 15.1 13.7 13.1 14.7 15.6 19.0 14.9 16.1 16.7 14.4 16.4 14.9 15.6 19.2 34.5 60.9 84.5 59.1 43.2 38.0 52.8 59.6 51.2 33.3 35.0 28.4 126.9 28.6 71.7 25.8 43.8 47.9 32.6 32.0 35.2 38.4 11.1 35.7 57.5 36.4 40.1 20.8 70.9 48.6 49.0 62.7 61.2 55.0 48.8 126.2 32.9 62.0 42.8 26.9 68.7 63.7 40.7 38.0 35.1 10.9 78.6 41.3 28.4 60.9 54.8 32.8 45.3 77.4 113.7 48.5 33.4 68.4 106.9 78.2 44.3 50.4 66.4 51.2 39.5 54.0 50.5 73.8 68.2 58.7 40.3 90.6 37.8 36.3 41.9 63.8 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 25.8 47.5 18.7 26.6 24.5 43.5 26.4 31.0 26.4 26.9 21.6 24.4 21.7 25.3 20.4 23.0 22.3 18.9 21.6 19.3 20.4 18.2 23.8 23.1 35.1 20.1 20.4 31.1 24.6 25.2 26.9 27.3 21.7 23.5 26.0 57.0 31.2 18.6 23.1 29.5 28.7 22.9 18.5 36.0 32.5 20.6 20.8 26.9 28.6 19.5 34.5 23.1 24.6 36.0 43.9 20.5 47.0 34.0 40.1 49.0 46.4 54.0 36.5 35.3 46.6 19.1 43.2 49.1 35.6 48.8 27.5 39.2 59.0 43.4 53.6 48.3 42.1 104.3 75.7 34.5 35.5 53.0 53.7 39.8 36.6 36.1 39.7 48.1 106.1 36.2 83.8 133.2 44.0 21.9 44.2 68.5 29.7 44.5 36.8 61.3 47.2 57.3 40.7 36.2 57.1 35.6 50.4 45.7 122.7 62.3 23.4 63.0 76.1 37.7 30.9 46.7 31.8 105.6 81.7 48.1 36.3 64.5 56.6 82.1 19.5 35.0 12.2 9.4 13.9 28.6 17.8 17.9 21.1 29.8 20.5 13.1 16.8 12.2 10.9 15.3 21.4 12.6 18.7 24.5 31.0 26.4 19.3 20.4 20.1 20.4 21.7 18.5 20.8 36.0 37.9 54.5 42.1 32.0 55.4 22.2 25.1 30.3 33.0 86.5 22.2 24.5 65.3 21.5 24.4 20.2 62.6 61.4 48.3 17.8 25.4 28.5 71.4 33.3 48.5 32.5 21.7 88.1 66.4 20.0 56.3 42.0 33.1 41.4 49.9 200.4 27.5 22.1 29.2 50.5 74.2 31.3 32.6 22.6 28.1 47.7 34.8 34.4 58.7 52.5 55.9 30.7 36.0 54.3 112.3 23.8 16.4 51.6 150.1 20.7 24.1 20.2 27.3 69.2 32.9 51.7 39.8 52.7 47.4 35.1 25.7 32.6 41.8 54.8 31.6 21.6 VAV2 ENSG00000160293 "Vav guanine nucleotide exchange factor 2" P52735 9 133761894-133992604 "Plasma proteins, Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 48.3;Inhibitory neurons: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3" "Group enriched" "Detected in many" 22 "B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003224 Uncertain Approved Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA003224: AB_1080554" "unprognostic (1.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (6.57e-2)" "unprognostic (1.16e-3)" "unprognostic (1.83e-2)" "unprognostic (3.74e-3)" "unprognostic (4.73e-2)" "unprognostic (9.16e-2)" "prognostic favorable (7.39e-7)" "unprognostic (8.64e-3)" "unprognostic (3.00e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (3.97e-2)" 8.4 26.8 9.3 10.7 8.8 3.0 7.7 7.4 9.8 12.0 10.9 11.8 20.9 9.9 7.2 6.7 12.2 10.8 7.4 11.6 9.9 21.3 46.1 16.8 13.3 11.6 16.0 5.5 38.6 10.8 8.0 13.1 13.2 10.2 9.6 3.0 13.2 8.9 2.0 6.1 22.4 6.9 8.9 13.9 9.5 4.4 9.9 6.2 13.8 2.3 13.3 11.4 7.9 8.4 12.5 21.6 33.3 13.5 9.0 15.1 85.8 24.6 13.5 20.3 12.2 33.0 19.0 3.6 19.6 24.6 26.2 72.8 31.6 53.0 10.4 21.3 7.3 4.2 28.3 37.2 33.4 10.3 1.6 15.0 33.5 17.9 25.3 13.6 22.9 7.3 7.3 6.0 14.2 63.5 0.8 5.1 16.3 54.3 20.5 33.9 28.2 12.1 46.1 22.4 36.9 24.9 64.7 42.7 8.8 21.3 26.0 14.5 18.7 28.6 16.0 28.7 34.5 0.4 0.3 6.8 19.1 8.8 18.0 0.0 0.8 0.0 0.0 2.0 0.0 3.3 0.0 0.0 1.1 2.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.5 9.3 8.8 7.4 9.8 11.6 9.9 11.6 16.0 13.2 8.9 9.9 8.4 4.8 0.0 5.4 20.5 11.2 5.1 3.0 10.1 4.0 1.9 6.7 5.6 4.7 21.5 7.5 36.8 0.0 1.3 0.6 27.0 3.9 9.2 2.5 6.9 6.4 6.6 28.2 0.4 8.5 12.5 18.3 5.0 9.7 13.9 0.0 24.6 6.8 48.3 6.2 0.0 40.9 9.8 6.1 5.4 7.2 7.9 7.2 7.7 1.8 8.4 9.3 4.2 2.1 31.2 2.6 24.7 15.6 6.0 3.3 6.3 35.7 13.6 3.3 1.8 13.1 6.4 8.8 0.1 3.8 2.1 2.7 1.0 1.7 12.0 13.5 2.1 VPS35 "FLJ10752, MEM3, PARK17" ENSG00000069329 "VPS35 retromer complex component" Q96QK1 16 46656132-46689518 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040802 Supported Supported Endosomes,Lysosomes NA NA 500000 "Cluster 51: Monocytes - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Endosomes, Lysosomes" "HPA040802: AB_2677142" "unprognostic (1.11e-2)" "unprognostic (8.70e-2)" "prognostic favorable (7.74e-4)" "unprognostic (4.75e-2)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "prognostic unfavorable (2.10e-6)" "unprognostic (5.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-2)" "unprognostic (3.33e-3)" "unprognostic (2.49e-1)" "prognostic favorable (9.75e-5)" "unprognostic (3.68e-3)" "unprognostic (2.43e-1)" "unprognostic (1.34e-1)" "unprognostic (6.89e-3)" 5.4 4.2 2.9 3.0 3.0 9.5 4.6 2.6 3.2 4.2 2.8 4.2 1.9 4.3 1.9 4.7 4.0 1.4 6.1 3.0 2.5 3.7 1.7 4.1 2.9 3.0 2.4 4.7 4.4 5.2 3.3 2.1 3.2 3.0 1.8 4.1 4.5 2.4 4.6 6.1 4.9 1.7 2.1 4.2 4.5 2.7 2.8 3.9 2.7 2.7 1.8 4.5 4.2 3.4 3.2 5.0 4.1 2.8 6.5 7.3 2.1 3.8 5.4 6.4 3.7 4.3 2.7 4.2 2.3 6.5 3.3 3.9 7.5 7.5 9.1 1.6 6.4 3.9 3.8 3.0 5.4 5.2 5.8 5.8 5.5 7.3 4.5 6.3 6.6 6.0 3.1 1.8 6.5 2.9 4.0 5.0 1.4 3.0 6.6 5.4 5.4 5.2 5.2 4.4 1.8 2.1 4.1 3.2 1.8 4.5 1.9 2.6 3.9 1.9 1.9 4.3 2.7 2.3 3.2 4.9 3.4 4.0 1.3 1.8 1.3 1.3 0.7 1.7 0.7 0.8 0.7 0.6 1.5 1.0 1.0 0.7 1.5 0.8 2.3 0.6 1.1 1.1 2.9 3.0 2.6 3.2 3.0 2.5 3.0 2.4 3.2 2.1 2.8 3.4 65.9 51.3 59.4 20.5 84.3 72.5 80.0 98.6 72.8 56.5 77.9 75.9 102.9 57.2 83.4 68.0 60.5 134.5 44.9 65.9 54.8 111.7 111.2 136.4 92.3 63.3 80.8 52.6 43.1 72.5 102.2 70.1 88.7 88.4 72.2 211.1 54.7 40.2 123.4 45.4 42.5 79.7 107.8 108.3 87.9 32.4 77.9 113.6 46.2 30.0 153.0 71.4 45.3 28.6 31.3 101.1 101.9 72.2 41.7 77.0 164.6 103.7 188.9 82.6 46.0 57.5 88.9 207.9 118.0 101.5 87.7 113.1 51.5 95.9 97.6 84.5 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8 subunit of CORVET complex" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 10.9 9.6 18.7 10.0 22.1 23.2 10.6 24.2 24.0 12.7 29.1 11.4 8.3 12.3 16.3 10.1 9.0 11.1 19.6 20.4 23.6 10.6 8.5 10.7 10.5 25.1 21.4 14.3 8.9 15.8 16.3 12.1 26.3 10.9 14.7 16.4 7.9 10.1 28.6 12.9 9.3 12.9 17.1 13.3 13.0 16.9 26.1 11.6 14.9 15.3 10.7 10.4 10.3 36.4 18.0 10.7 15.9 15.9 32.5 28.8 10.6 17.7 18.8 12.3 17.0 13.6 9.0 19.1 29.3 26.9 50.4 20.8 17.3 21.0 23.6 34.8 15.4 20.4 13.0 8.1 20.0 14.3 27.0 20.6 19.4 17.6 17.5 22.6 31.4 17.7 10.9 13.5 22.7 12.8 11.6 8.5 10.5 18.4 10.1 14.1 30.6 15.0 12.2 30.8 16.2 10.6 19.9 20.8 15.6 23.6 33.2 7.5 27.9 18.8 10.5 19.6 15.3 16.5 21.5 25.9 21.6 17.7 15.5 19.0 6.6 22.9 5.0 5.2 4.9 4.4 5.4 5.2 8.1 5.5 8.0 5.4 23.9 5.7 6.6 2.3 4.8 4.3 18.7 22.1 24.2 24.0 20.4 23.6 25.1 21.4 26.3 17.1 26.1 36.4 11.8 12.8 11.5 66.3 17.9 10.5 9.2 8.3 11.4 24.5 8.7 8.3 24.6 11.5 9.7 9.2 18.8 12.8 10.8 17.3 7.9 7.7 22.2 11.0 17.5 12.8 18.0 11.6 154.1 4.6 6.7 14.7 21.9 14.3 2.5 124.3 12.5 7.7 20.2 11.8 132.2 16.6 12.2 19.1 16.7 16.5 10.5 21.2 10.6 89.9 32.0 10.1 32.0 86.5 149.2 6.4 12.7 12.8 14.4 9.4 9.2 8.8 14.4 17.3 6.6 13.0 10.0 94.3 27.8 15.8 16.1 7.7 17.8 11.8 13.2 13.0 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014236-49115522 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 18.7 41.5 7.1 3.2 9.0 0.3 9.8 8.0 6.6 22.3 7.7 7.8 2.5 12.3 7.4 7.8 8.5 10.5 12.3 6.2 7.6 12.3 3.9 10.9 3.5 8.9 9.3 35.2 1.5 26.8 5.1 10.4 9.2 13.5 5.6 2.3 3.4 11.7 5.6 4.9 4.9 11.4 8.6 2.3 5.6 9.4 8.4 6.5 27.8 5.9 4.6 12.0 7.5 9.4 0.0 0.0 3.1 0.1 1.3 0.7 0.1 2.6 4.1 0.9 0.2 0.0 0.1 0.1 0.1 6.1 3.4 0.1 0.2 0.0 0.4 3.2 1.4 0.2 0.1 0.1 0.1 0.1 0.0 4.7 0.0 4.2 0.0 0.0 0.0 0.8 8.6 0.1 0.8 0.1 0.0 0.2 0.6 0.0 0.0 0.0 9.3 5.0 0.0 0.1 0.1 7.9 0.1 0.0 0.0 0.4 0.1 0.3 0.0 10.6 1.2 24.0 0.1 0.0 6.8 0.0 11.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.3 0.1 0.1 0.0 0.0 7.1 9.0 8.0 6.6 6.2 7.6 8.9 9.3 9.2 8.6 8.4 9.4 9.4 3.2 17.5 17.3 1.3 6.5 1.6 0.1 0.6 5.4 1.2 1.1 16.7 0.0 9.4 0.0 2.1 0.4 3.7 0.2 1.9 0.1 88.5 0.8 10.7 6.2 0.0 0.0 11.1 0.0 0.3 29.7 0.0 0.7 12.6 96.9 5.3 5.0 0.7 5.0 7.0 0.0 0.0 2.2 11.1 140.6 9.6 2.9 7.2 4.7 1.0 9.1 2.1 20.1 33.3 0.2 0.1 14.7 0.7 0.8 0.0 9.4 3.8 2.9 59.2 20.6 37.7 1.3 4.4 0.4 4.3 0.4 2.0 44.7 0.0 0.7 WASF3 "KIAA0900, SCAR3, WAVE3" ENSG00000132970 "WASP family member 3" Q9UPY6 13 26557683-26688948 "Cancer-related genes, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.0;retina: 56.4" "Cell type enhanced" "Detected in many" "Astrocytes: 161.6;Early spermatids: 104.1;Horizontal cells: 82.4;Inhibitory neurons: 127.5;Oligodendrocyte precursor cells: 69.9" "Cancer enhanced" "Detected in all" "glioma: 14.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037086, HPA066228" Enhanced NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "CAB037086: AB_1080585, HPA066228: " "unprognostic (1.42e-1)" "unprognostic (3.65e-2)" "unprognostic (2.25e-1)" "unprognostic (7.57e-2)" "unprognostic (8.23e-2)" "unprognostic (3.34e-1)" "unprognostic (6.19e-2)" "unprognostic (8.37e-2)" "unprognostic (8.98e-2)" "unprognostic (2.99e-1)" "prognostic favorable (2.21e-4)" "unprognostic (8.86e-3)" "unprognostic (2.93e-3)" "unprognostic (6.35e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-3)" "unprognostic (9.18e-2)" 19.6 15.9 49.6 2.8 52.4 0.3 14.7 60.0 50.0 9.3 2.6 7.4 1.0 9.1 4.9 3.9 11.2 4.0 8.7 48.9 48.1 6.9 6.9 7.4 2.6 40.2 51.1 20.9 5.2 6.7 8.6 0.5 31.3 9.0 3.1 56.4 6.1 9.3 7.8 4.7 3.8 7.6 28.8 5.1 7.2 13.0 50.3 1.6 17.0 5.0 1.7 7.4 7.6 45.2 0.0 0.2 39.4 0.1 82.8 16.4 3.6 17.6 24.7 26.4 11.7 0.0 3.7 15.3 2.1 39.5 10.2 3.6 10.7 11.4 20.7 0.0 9.9 1.0 0.0 15.0 12.3 5.8 11.2 33.7 10.7 5.6 17.1 5.4 35.2 5.0 0.5 0.1 8.3 3.2 0.0 0.2 10.5 0.6 3.8 0.0 21.5 0.1 2.9 7.3 9.2 18.9 8.6 7.4 11.5 8.4 0.0 0.6 20.1 19.3 7.4 10.1 9.1 0.0 0.0 15.1 9.3 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 49.6 52.4 60.0 50.0 48.9 48.1 40.2 51.1 31.3 28.8 50.3 45.2 11.2 25.6 2.0 161.6 0.2 2.2 2.8 1.7 2.8 46.2 4.9 6.5 9.8 4.3 1.9 9.2 33.3 0.1 0.3 0.9 11.7 2.3 104.1 1.3 4.6 8.3 20.4 0.0 49.4 2.7 0.3 15.7 2.0 2.3 14.7 62.8 12.5 8.2 0.3 82.4 127.5 1.3 0.0 1.9 2.7 35.3 14.6 4.3 5.4 30.9 0.7 46.7 1.0 69.9 41.0 2.0 0.0 29.0 0.1 5.1 0.0 3.3 1.2 41.2 6.6 32.0 9.1 7.2 18.7 2.0 1.4 0.0 0.2 5.1 0.5 1.9 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 100.4;Hep G2: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.64e-2)" 39.4 20.2 43.7 6.8 71.2 0.7 36.0 34.3 47.2 51.9 34.5 44.8 12.2 75.4 14.0 11.3 58.6 12.4 64.3 35.9 36.8 16.8 17.1 43.8 5.9 34.4 43.7 87.1 20.1 7.2 50.2 16.6 36.6 34.6 3.4 6.9 14.6 36.3 16.0 26.8 22.0 17.0 33.7 29.3 29.1 31.8 44.1 2.9 48.1 7.5 2.3 57.8 29.1 32.1 14.1 35.3 9.1 33.9 37.2 10.2 100.4 23.0 32.7 15.8 14.6 24.8 37.2 5.5 34.3 26.3 74.8 8.0 6.8 14.2 6.4 5.7 14.1 0.0 11.0 83.0 34.5 0.0 1.1 33.7 18.8 15.0 13.6 12.3 25.3 2.5 0.6 24.3 9.7 28.0 1.1 0.3 13.5 20.3 38.0 3.4 9.6 7.5 6.7 52.4 6.1 15.4 12.2 17.4 13.1 9.6 31.5 0.3 19.9 19.8 22.8 19.1 14.8 26.0 10.1 0.5 23.9 0.2 18.3 0.0 0.7 0.0 2.7 0.9 3.9 2.4 1.3 2.1 0.2 1.2 1.3 1.5 0.0 1.5 1.1 0.4 0.8 1.4 43.7 71.2 34.3 47.2 35.9 36.8 34.4 43.7 36.6 33.7 44.1 32.1 38.4 131.4 12.4 40.5 3.6 2.4 1.9 2.5 2.2 4.9 9.7 6.0 42.5 5.7 5.7 25.8 0.0 22.2 1.0 2.0 0.0 5.5 10.3 18.1 12.6 21.1 33.5 0.0 2.7 4.4 120.2 15.4 13.3 25.5 1.3 71.4 21.4 10.7 19.0 3.3 4.7 5.7 4.1 1.3 2.4 19.1 40.0 2.5 12.4 12.2 0.7 31.7 0.0 9.5 2.4 10.9 1.6 57.9 19.0 4.7 3.7 3.7 12.1 5.0 13.1 3.6 15.1 10.8 14.6 2.2 3.4 39.7 1.6 11.0 4.7 2.1 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 41.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 45.1;Granulosa cells: 149.4;Leydig cells: 50.7;Peritubular cells: 100.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 22.1;cerebral cortex: 49.9;hippocampal formation: 40.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 18.1;HEK 293: 4.1;K-562: 6.6;NTERA-2: 5.1;RPMI-8226: 11.3;SK-MEL-30: 4.5" "Region enhanced" "Detected in all" "hippocampal formation: 213.9" "Region enhanced" "Detected in all" "hippocampal formation: 156.3" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria NA NA "Cluster 42: Non-specific - Transcription" "Cluster 47: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favorable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.0 5.6 8.7 1.0 22.1 0.5 1.1 0.0 49.9 0.4 0.0 0.7 2.9 3.3 19.7 1.2 8.8 1.4 4.0 40.3 4.2 2.5 0.5 0.5 0.7 0.4 2.6 41.7 1.7 1.2 0.9 0.2 0.1 4.4 0.5 3.8 4.0 4.8 25.0 0.9 2.6 4.1 0.5 1.0 5.9 18.8 7.4 0.4 2.0 8.8 0.7 1.4 0.2 8.1 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 18.1 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.1 0.0 0.1 0.0 0.0 5.1 0.0 3.6 0.0 0.0 11.3 0.0 0.0 1.8 1.5 0.1 0.1 4.5 2.4 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.1 0.0 8.7 22.1 0.0 49.9 40.3 4.2 0.4 2.6 0.1 0.5 7.4 8.1 1.5 0.0 0.0 6.2 0.0 2.2 1.5 0.6 1.2 8.2 4.9 4.6 9.3 0.0 1.4 3.7 2.1 0.0 0.3 0.5 3.9 3.8 1.8 5.0 0.4 4.1 1.8 3.0 45.1 3.5 0.1 7.3 11.7 1.2 0.0 149.4 0.4 0.5 4.5 5.0 27.0 0.7 0.0 0.0 1.0 4.8 50.7 1.0 5.4 1.9 0.0 6.2 0.0 2.0 1.9 2.4 1.5 100.4 0.1 1.1 5.5 5.5 5.1 2.9 6.6 7.2 16.0 4.4 9.9 0.9 0.4 0.0 1.0 8.7 2.0 0.4 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 11.7;testis: 9.9" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 193.3;Granulosa cells: 199.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.5;AN3-CA: 3.4;HAP1: 5.2;NTERA-2: 9.1;SiHa: 4.5;SuSa: 3.8;U-2 OS: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA077678: AB_2686850" "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.2 2.5 1.6 0.1 1.7 0.1 0.6 0.3 1.9 0.6 0.0 0.3 0.2 0.5 11.7 0.2 0.8 0.3 0.7 1.0 4.6 1.0 3.6 0.3 0.1 1.6 4.8 3.0 0.3 0.9 2.4 0.3 2.4 0.9 0.0 3.3 0.3 0.8 0.1 0.3 0.2 0.5 0.6 0.2 0.6 9.9 4.5 0.1 0.6 0.1 0.1 0.5 0.4 1.2 0.0 0.0 4.5 3.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 5.2 0.1 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.2 0.6 0.0 0.9 0.1 1.4 1.3 4.5 0.0 0.5 3.8 0.4 0.0 0.2 0.0 3.9 0.0 1.0 0.0 3.3 0.0 1.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 0.3 1.9 1.0 4.6 1.6 4.8 2.4 0.6 4.5 1.2 1.9 0.0 2.3 18.3 0.7 3.7 4.3 0.3 9.1 24.9 5.8 6.9 193.3 2.8 3.2 7.3 14.6 0.2 0.0 0.1 5.9 1.7 6.4 2.0 7.8 8.5 0.0 0.8 14.5 0.0 0.3 6.7 0.0 4.9 6.3 199.5 20.3 48.3 0.1 35.3 29.7 0.0 2.0 0.8 1.5 20.4 15.8 0.6 0.0 3.7 0.0 19.5 0.0 48.2 19.2 0.2 0.0 43.6 0.0 6.0 0.0 3.9 0.2 43.3 6.6 4.8 10.5 43.8 46.3 2.1 1.1 0.1 1.5 9.8 0.0 1.4 YAP1 YAP65 ENSG00000137693 "Yes1 associated transcriptional regulator" P46937 11 102110447-102233424 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038884, HPA038885, CAB069915, HPA070359" Enhanced Supported "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli, Cell Junctions" "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 57.2 27.8 19.1 25.9 19.1 0.3 42.7 18.6 17.1 62.5 44.3 41.5 27.2 78.1 45.9 74.7 65.6 49.3 48.1 15.9 22.1 39.3 33.5 45.7 13.0 31.8 30.2 93.1 22.3 37.0 9.9 83.1 21.8 59.2 30.1 12.9 40.6 83.7 48.3 44.2 27.4 100.5 27.3 14.7 31.6 15.0 27.0 13.8 85.9 58.2 22.7 60.9 52.6 20.2 56.9 52.1 141.5 69.6 151.1 143.1 118.7 130.4 147.8 124.2 101.5 130.2 134.9 0.0 105.4 171.6 92.1 98.0 71.0 186.4 130.6 16.8 25.5 0.1 67.3 89.5 115.3 0.1 2.5 115.2 119.4 136.6 220.2 138.4 39.4 6.7 0.0 0.1 142.1 27.2 2.6 0.4 66.8 135.9 49.3 0.1 79.7 0.3 90.9 99.5 0.4 4.7 153.6 57.2 43.5 129.1 103.2 0.8 43.4 175.4 68.8 89.6 55.7 0.1 0.2 0.8 51.0 0.2 130.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 19.1 18.6 17.1 15.9 22.1 31.8 30.2 21.8 27.3 27.0 20.2 28.4 35.3 69.4 145.3 1.5 113.7 47.8 43.5 71.2 0.4 48.1 43.8 39.2 62.9 37.2 92.0 0.0 91.4 0.4 16.2 11.7 27.6 6.7 61.8 53.3 28.9 7.3 0.0 1.5 18.3 20.3 49.0 23.9 85.1 0.0 127.2 26.0 45.2 10.6 0.0 1.6 13.1 14.2 1.6 21.5 4.6 37.9 2.2 44.4 60.0 1.0 27.6 0.0 5.0 0.7 25.2 16.3 40.6 0.1 66.0 27.2 26.1 41.6 1.2 39.5 21.6 62.0 2.5 5.3 59.5 123.2 61.6 2.1 15.9 27.8 65.6 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697797-183812624 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 7.4 4.8 5.4 8.9 7.4 14.5 7.9 8.1 8.8 8.5 0.0 9.1 5.4 9.0 4.7 8.2 10.3 6.5 6.6 6.4 5.2 6.1 3.4 10.0 12.9 2.4 3.7 15.1 5.4 9.9 8.6 11.2 3.0 8.2 6.8 15.6 8.0 7.3 5.5 8.5 7.0 11.9 1.9 8.9 5.8 8.0 4.2 16.9 9.7 4.8 11.8 8.7 8.4 7.0 38.1 11.3 32.4 14.5 15.5 22.8 35.8 22.1 17.0 32.1 37.5 27.8 13.3 34.7 39.8 19.5 49.9 23.9 31.8 21.2 32.7 28.5 18.8 35.0 12.2 13.7 23.9 26.3 19.4 15.6 16.3 23.1 27.8 32.1 33.1 35.2 14.0 28.3 24.5 10.2 38.3 20.2 29.3 13.8 22.0 53.5 30.5 42.0 12.9 16.6 31.3 22.3 16.4 55.4 29.2 27.1 27.5 17.8 28.2 29.5 21.3 15.1 25.0 26.9 22.6 57.6 22.9 25.8 21.3 0.1 4.6 1.2 1.9 2.0 1.3 1.9 1.7 1.4 1.6 1.3 1.3 1.5 8.5 1.3 7.1 2.1 0.7 1.8 5.4 7.4 8.1 8.8 6.4 5.2 2.4 3.7 3.0 1.9 4.2 7.0 13.8 35.3 2.3 41.4 7.0 2.0 3.3 7.0 8.6 19.5 5.6 7.5 10.1 5.7 5.9 5.5 10.4 4.8 7.4 4.4 0.0 5.7 2.4 10.5 18.3 15.3 8.5 6.3 95.6 4.0 9.7 9.2 7.1 9.8 7.0 42.1 7.5 3.0 7.1 13.5 62.1 6.0 6.1 8.7 6.7 3.3 9.9 10.1 1.8 40.3 6.6 5.8 5.2 71.9 80.0 7.1 3.1 9.4 9.5 5.3 4.7 1.0 11.2 15.8 0.0 10.1 10.4 3.1 12.3 8.7 3.4 2.1 8.8 9.7 4.8 2.8 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513694-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 129.8;Inhibitory neurons: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: AB_2686548" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 8.4 9.7 5.2 11.3 5.8 9.9 10.1 8.8 6.6 8.9 7.8 8.7 9.3 9.2 8.6 9.4 8.3 8.0 7.6 6.1 5.1 8.5 12.6 7.4 13.8 5.3 5.8 11.0 8.7 15.5 8.7 6.9 5.3 8.1 10.0 18.3 8.9 7.4 11.5 11.3 10.1 7.9 5.1 11.4 9.2 14.8 4.7 10.2 9.2 10.9 12.9 9.8 8.9 7.1 16.0 14.2 18.1 30.7 9.8 12.9 19.7 12.1 13.4 15.2 23.6 10.0 8.8 29.1 8.5 10.2 19.5 15.3 22.0 27.2 19.8 12.6 19.9 15.8 25.8 13.6 14.5 12.8 13.4 10.6 10.3 9.6 17.4 14.3 21.5 13.0 15.8 13.0 13.6 5.3 17.8 9.1 8.4 4.7 9.2 7.4 15.6 22.7 12.7 20.9 14.4 12.0 16.3 11.7 12.7 11.3 16.6 11.4 18.8 23.2 8.1 12.1 16.7 13.3 18.0 18.0 13.3 14.4 10.1 0.0 2.8 2.9 2.8 1.9 3.3 7.3 3.2 3.0 2.4 5.1 3.4 2.9 1.0 4.3 3.3 3.6 2.6 1.2 5.2 5.8 8.8 6.6 6.1 5.1 5.3 5.8 5.3 5.1 4.7 7.1 27.4 28.9 32.8 61.0 39.6 13.3 21.8 14.7 15.9 59.9 17.6 17.7 17.7 14.3 25.3 12.9 83.4 13.7 34.0 12.3 0.0 17.8 47.5 15.5 24.5 24.0 7.2 16.6 129.8 18.6 8.3 22.4 34.1 17.2 12.6 69.0 20.0 25.7 17.3 52.2 146.3 14.2 20.3 30.0 13.2 44.2 19.9 26.8 12.4 95.5 23.9 21.4 16.5 94.5 97.6 18.0 7.8 14.7 20.0 14.4 16.0 17.8 24.9 88.9 26.3 34.0 26.6 93.8 37.8 19.2 14.3 18.1 33.0 33.4 16.7 18.5 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087285 "Predicted intracellular proteins, Predicted secreted proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.7;JURKAT: 31.0;MOLT-4: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted to blood" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" Nucleoplasm "HPA055995: AB_2683000" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 10.3 3.3 9.3 1.9 14.2 2.6 8.8 9.4 10.8 6.7 7.5 4.2 3.9 10.2 7.4 2.4 7.0 3.5 4.6 7.8 9.2 10.0 10.7 5.0 1.9 16.0 12.2 7.9 7.6 8.4 3.9 2.4 10.9 5.1 4.3 3.8 6.0 6.6 2.7 2.6 3.3 8.7 9.9 3.6 6.4 1.9 13.5 4.8 11.2 3.8 1.9 3.0 3.7 17.1 5.2 4.2 5.4 29.7 22.1 1.5 0.3 1.7 5.0 2.6 6.9 9.1 2.4 0.0 10.9 3.4 1.1 0.6 2.9 1.8 2.3 1.7 5.8 4.0 9.1 10.4 13.1 5.5 1.5 24.6 6.8 1.3 5.1 4.2 8.3 31.0 0.0 11.0 1.6 5.2 29.4 0.8 3.5 1.4 2.5 12.1 10.3 1.7 12.3 2.0 5.9 12.4 6.1 5.0 8.7 2.1 7.5 3.8 3.3 2.3 4.5 5.1 7.0 8.0 8.2 11.5 3.6 10.4 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 9.3 14.2 9.4 10.8 7.8 9.2 16.0 12.2 10.9 9.9 13.5 17.1 10.5 0.0 2.8 8.1 1.7 1.3 3.8 0.3 4.0 8.4 13.5 13.6 10.7 12.8 2.0 12.9 12.5 1.5 2.0 3.1 17.6 4.1 3.3 16.5 13.5 11.7 16.2 5.0 3.3 6.0 0.3 9.3 11.7 12.5 1.3 20.2 12.1 31.8 9.6 3.3 8.5 5.3 0.0 13.6 4.9 2.2 17.7 9.0 7.2 5.6 5.1 13.8 3.1 16.1 18.3 2.7 3.4 11.3 1.4 5.6 1.9 17.2 0.1 17.0 0.0 21.4 7.7 1.5 3.4 2.2 1.4 0.3 1.2 25.6 7.1 1.8 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437659-143541447 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 16.4 12.7 6.0 5.6 6.1 17.2 14.4 6.3 9.4 11.8 2.7 13.4 11.7 12.3 1.0 14.6 11.3 2.2 11.4 6.6 3.6 25.0 45.9 14.5 5.0 6.3 4.7 12.0 10.5 2.9 8.2 3.6 6.4 12.1 1.5 1.9 11.0 3.5 21.1 16.9 21.5 2.6 3.7 19.1 11.8 19.4 6.2 5.3 14.0 2.9 2.5 12.2 12.0 6.8 11.3 16.1 5.1 12.4 3.1 3.6 13.7 6.4 4.5 8.0 6.5 8.8 10.3 8.0 11.2 5.3 4.3 12.9 4.1 6.6 1.7 16.7 14.2 10.0 10.6 14.2 7.6 5.0 8.9 8.0 6.1 6.6 4.7 3.7 5.9 7.6 17.1 14.5 3.3 29.3 24.1 9.7 9.4 9.2 26.0 13.9 4.1 25.6 5.9 6.8 13.1 8.7 12.4 10.9 7.1 2.6 17.5 9.4 8.2 7.0 21.1 15.4 11.3 13.2 9.4 6.8 9.1 11.6 7.8 6.5 4.6 6.3 3.9 5.5 4.5 3.2 4.6 4.8 3.7 2.7 5.8 4.8 9.1 2.2 3.6 3.2 3.4 5.4 6.0 6.1 6.3 9.4 6.6 3.6 6.3 4.7 6.4 3.7 6.2 6.8 6.9 0.0 2.3 10.7 8.4 7.0 3.4 4.5 5.7 7.3 5.1 3.4 1.4 4.3 3.4 5.5 8.4 7.9 4.0 14.2 1.9 6.5 8.8 5.6 6.1 5.5 10.7 12.8 9.8 7.3 9.4 5.4 20.4 7.2 5.7 28.1 5.0 13.2 8.5 5.0 9.9 11.2 6.1 9.8 6.0 7.9 5.3 10.9 3.6 6.5 6.4 6.1 7.2 4.0 10.5 7.6 2.3 5.7 8.4 4.4 16.7 11.2 3.5 7.5 13.1 4.0 5.8 22.8 14.8 6.3 8.7 12.3 7.2 3.8 9.0 5.5 ZDBF2 "FLJ45338, KIAA1571" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "HPA039121: AB_2676357, HPA050311: AB_2681081" "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 2.3 4.1 1.8 0.9 3.5 0.6 1.6 3.4 1.8 3.0 7.8 2.4 0.4 2.6 1.7 1.1 3.2 1.2 2.3 2.3 3.8 1.4 1.5 1.3 1.1 1.2 1.4 9.5 5.0 1.5 8.0 2.3 1.1 1.8 0.6 5.5 1.7 1.4 2.7 1.1 1.7 1.3 0.4 1.4 2.0 1.7 3.5 0.9 2.0 1.5 0.9 1.7 2.0 0.4 1.4 0.2 4.4 0.8 1.7 1.4 6.9 1.4 1.5 0.7 0.9 0.4 1.2 0.0 0.6 1.5 2.6 0.3 3.0 1.1 1.3 1.4 2.9 0.0 3.4 0.1 2.2 1.3 2.9 1.4 1.9 1.4 2.7 5.1 2.1 1.1 0.2 1.9 2.1 0.2 0.4 0.0 6.2 0.1 1.6 0.0 4.6 0.0 0.8 0.6 2.4 5.6 2.6 0.0 2.5 10.0 0.1 0.0 2.6 0.7 2.3 0.5 1.1 4.1 1.1 0.2 3.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 3.5 3.4 1.8 2.3 3.8 1.2 1.4 1.1 0.4 3.5 0.4 6.9 3.2 3.9 15.7 19.3 4.0 1.9 3.1 7.4 26.9 4.4 3.3 9.2 1.5 4.4 11.0 14.6 5.2 9.7 0.6 0.0 2.8 4.1 1.9 7.5 5.1 7.8 0.8 75.0 2.2 6.9 11.7 4.6 0.6 12.7 44.4 3.3 3.4 0.5 8.4 56.5 1.3 4.1 0.3 4.2 5.1 4.4 2.3 1.8 18.7 0.1 8.7 0.0 26.2 3.1 1.2 0.5 5.3 23.4 3.5 1.0 2.3 10.6 18.1 0.0 19.2 9.2 4.4 9.0 6.0 3.3 9.0 13.5 24.5 0.5 0.8 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: AB_2680652" "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 1.2 1.3 2.2 0.9 2.0 1.9 1.7 2.0 1.9 2.1 0.7 1.3 0.6 2.3 1.2 0.6 1.7 1.0 1.9 2.1 2.6 1.5 1.6 1.2 1.2 2.0 2.2 3.8 1.1 2.9 1.6 1.6 2.3 1.6 1.0 4.1 1.2 1.7 3.2 0.6 1.0 1.9 1.8 1.1 1.1 4.2 3.0 2.4 2.1 4.6 1.1 1.2 0.9 2.4 2.0 1.9 8.6 5.4 3.4 3.2 3.5 2.1 3.2 3.1 3.0 5.0 1.4 6.5 2.2 2.5 3.4 1.4 5.8 2.8 3.7 3.6 3.9 3.8 3.4 7.7 4.5 3.1 1.9 4.3 3.3 2.9 4.9 3.2 2.4 4.6 7.0 3.1 2.9 2.0 7.7 3.3 4.7 0.7 1.8 9.0 6.3 1.4 2.5 2.8 6.8 6.8 2.6 2.3 2.3 4.1 2.8 5.0 2.4 5.0 3.3 2.0 3.3 4.1 3.6 7.5 1.7 2.5 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.1 2.2 2.0 2.0 1.9 2.1 2.6 2.0 2.2 2.3 1.8 3.0 2.4 1.2 16.0 2.3 4.2 2.4 0.8 2.7 1.3 0.6 7.4 2.0 1.9 3.8 0.0 0.6 1.8 14.6 3.4 1.5 1.1 0.0 1.6 4.4 2.4 3.9 2.1 4.9 0.4 3.3 0.9 2.1 2.5 0.5 2.9 1.3 7.2 0.7 3.2 1.6 6.7 4.9 1.7 2.0 2.4 1.5 2.1 5.0 1.3 1.8 2.8 1.7 4.1 2.1 1.5 4.1 2.2 0.8 3.8 4.1 2.5 1.1 1.4 2.3 8.9 0.0 3.6 1.9 11.4 8.2 1.0 0.6 4.1 1.5 3.9 1.3 1.4 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 4.5 4.2 4.3 4.0 4.5 5.0 4.5 6.0 5.8 6.5 4.6 4.8 2.9 4.6 4.6 3.0 5.4 3.2 3.6 4.0 4.4 6.3 5.3 4.5 6.6 4.6 4.3 6.3 6.5 4.4 7.7 3.4 4.7 5.7 3.4 6.7 4.2 3.6 3.0 3.7 5.7 2.9 4.1 8.4 4.6 2.8 4.7 7.6 8.8 3.6 6.2 4.6 4.4 5.3 3.6 4.8 5.8 5.6 3.2 3.6 2.2 4.5 5.3 6.4 7.7 3.7 4.7 9.2 3.2 2.9 6.1 4.3 9.7 2.6 7.7 6.6 5.6 4.6 6.3 4.7 4.0 8.6 7.2 3.2 5.5 5.5 6.5 7.7 3.9 8.9 4.0 6.7 6.0 2.7 6.7 15.2 9.2 2.4 5.4 5.7 11.0 10.2 5.6 2.4 5.4 7.3 7.3 2.3 4.3 12.6 5.9 7.5 3.9 5.1 5.5 7.6 3.8 8.7 7.6 7.1 3.5 7.2 3.4 1.8 1.9 4.2 3.3 1.9 3.8 4.4 3.0 3.1 2.4 2.9 4.6 3.9 4.2 3.0 5.5 1.8 3.2 2.5 4.3 4.5 6.0 5.8 4.0 4.4 4.6 4.3 4.7 4.1 4.7 5.3 3.5 12.8 7.0 6.2 5.8 0.3 1.0 1.3 3.4 6.7 2.3 2.0 4.4 5.7 2.4 1.8 2.1 2.1 4.7 0.6 0.0 2.8 0.2 3.6 4.1 3.5 7.7 7.8 6.6 1.8 1.4 2.5 1.1 2.5 0.0 10.3 4.2 2.5 1.7 1.7 7.4 4.1 2.0 3.7 0.7 0.4 2.5 4.0 3.6 4.7 4.9 3.8 6.2 5.0 8.0 2.7 3.0 1.9 6.0 1.1 0.9 2.1 4.4 2.9 0.0 4.0 4.5 2.8 3.2 1.7 1.1 0.8 3.8 6.5 2.5 1.1 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090077-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 44.2 77.1 15.2 7.4 10.7 4.5 35.5 32.0 17.9 33.9 14.3 83.3 22.4 41.6 9.4 49.2 29.6 5.4 42.0 22.0 14.8 20.6 17.1 32.8 2.5 20.7 25.7 30.7 24.7 12.4 23.5 6.5 20.3 38.3 10.3 11.0 28.2 21.7 34.0 45.6 33.1 9.3 13.6 13.1 33.3 11.9 17.8 10.9 32.3 5.9 3.6 44.7 36.1 9.1 8.1 26.6 33.6 49.5 4.5 4.3 48.1 9.8 15.0 4.9 7.7 15.5 17.7 12.0 7.2 3.7 5.4 59.1 10.8 31.4 3.4 24.6 11.5 7.1 42.2 32.7 2.8 1.5 10.9 6.6 25.9 8.0 14.7 6.5 6.0 11.0 6.9 3.5 2.7 22.4 16.2 11.3 47.5 15.3 5.7 33.7 5.6 3.1 3.8 44.0 38.2 34.4 13.5 7.9 7.8 6.7 9.5 4.2 1.2 6.0 26.4 14.7 4.0 6.1 4.2 2.7 3.8 6.0 11.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.4 0.0 0.0 15.2 10.7 32.0 17.9 22.0 14.8 20.7 25.7 20.3 13.6 17.8 9.1 5.6 3.2 10.7 12.7 1.8 14.8 13.3 13.5 11.4 36.6 14.4 19.6 7.6 10.0 4.3 3.7 27.1 9.6 3.4 33.0 1.9 10.3 9.2 2.5 1.9 6.3 7.8 8.2 3.5 11.3 1.0 6.0 5.1 4.6 14.7 35.1 9.3 8.0 7.4 11.8 4.9 17.4 10.2 7.5 11.8 5.6 9.9 5.9 8.8 7.5 0.8 33.0 1.0 13.6 2.5 7.8 10.0 12.4 3.9 12.0 23.6 6.8 4.3 27.4 13.1 9.3 14.7 8.9 8.7 13.5 15.6 12.4 5.2 6.3 26.6 12.7 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334147-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 76.3;Peritubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 57.3" HPA000566 Approved Approved Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 8.5 77.5 10.1 5.1 10.5 3.1 7.6 10.6 9.7 7.9 10.1 5.2 3.9 8.4 17.6 2.8 8.5 7.2 4.4 9.5 11.9 5.5 13.5 4.1 6.3 11.3 10.8 42.6 10.1 32.3 11.0 3.1 11.1 7.2 4.3 5.2 6.5 14.5 4.8 2.4 6.1 7.3 11.7 11.1 6.0 8.5 12.9 6.3 6.9 7.3 8.0 4.7 3.0 12.7 10.2 4.1 8.4 6.1 10.0 9.6 4.1 7.0 11.7 4.4 6.6 4.3 2.1 17.0 14.0 13.3 6.7 1.7 10.1 6.2 6.5 4.1 7.8 5.7 3.8 6.6 13.4 7.0 4.8 11.4 4.5 3.7 7.2 7.2 5.5 9.2 8.5 0.0 8.1 7.4 8.2 5.8 3.7 10.3 7.2 9.6 9.3 6.0 3.3 6.1 4.3 5.8 3.5 0.3 8.4 5.2 1.5 13.0 5.8 6.5 7.8 10.9 9.1 57.3 16.9 32.9 5.9 13.5 4.6 0.3 0.8 0.1 1.6 0.7 1.9 1.9 1.5 1.5 0.7 2.0 2.1 1.8 0.0 1.4 0.7 1.3 2.4 1.0 10.1 10.5 10.6 9.7 9.5 11.9 11.3 10.8 11.1 11.7 12.9 12.7 26.1 0.0 4.6 7.8 10.9 3.3 4.0 3.6 3.4 6.5 6.2 3.9 5.2 10.0 2.3 9.2 12.5 1.4 9.8 2.6 7.9 2.8 1.3 4.5 15.3 6.6 0.0 8.2 3.8 5.0 4.4 10.5 8.6 8.8 2.5 76.3 7.5 28.3 2.5 0.0 4.8 5.8 4.1 6.0 3.5 4.4 14.3 3.5 3.6 2.8 4.5 6.5 6.2 7.5 3.7 3.9 3.2 39.5 28.7 6.1 2.1 8.3 1.6 2.8 13.1 12.8 11.8 3.5 3.7 4.3 2.3 0.8 7.0 21.5 5.3 2.1 ZNF285 ZNF285A ENSG00000267508 "Zinc finger protein 285" Q96NJ3 19 44382298-44401608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 5.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.0" "HPA046100, HPA049212" Uncertain NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "HPA046100: AB_2679538, HPA049212: AB_2680677" "unprognostic (3.23e-2)" "unprognostic (1.90e-3)" "unprognostic (6.42e-2)" "unprognostic (9.86e-2)" "unprognostic (1.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.20e-2)" "unprognostic (2.91e-3)" "unprognostic (3.60e-2)" "unprognostic (6.41e-2)" "unprognostic (2.07e-2)" "unprognostic (2.42e-6)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.46e-1)" "unprognostic (1.55e-3)" 1.1 2.0 4.6 0.9 4.6 0.2 2.5 5.5 5.5 1.6 3.3 2.1 0.8 1.9 1.6 1.0 2.8 1.1 2.4 4.4 4.7 2.1 0.6 0.7 1.3 4.3 4.3 6.3 1.1 2.5 2.0 1.1 4.4 2.0 1.1 5.6 0.9 1.9 1.8 0.8 0.9 1.9 4.2 1.6 1.4 2.9 4.8 1.7 2.8 2.3 1.4 2.0 1.2 5.4 0.1 3.1 3.0 0.0 2.3 2.4 0.1 1.1 1.1 1.5 2.0 0.5 1.9 0.0 1.6 0.7 2.0 1.0 0.0 2.1 2.6 0.0 2.0 4.4 1.2 0.9 3.3 0.6 0.0 1.9 0.0 0.6 6.0 4.4 2.7 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.8 0.8 1.5 0.0 0.0 1.9 1.6 2.5 1.3 2.2 0.1 0.5 0.0 2.9 3.7 1.5 2.6 1.6 1.3 0.8 0.1 1.9 4.2 0.0 1.5 0.0 1.9 1.8 0.1 0.0 0.1 0.2 0.1 1.6 0.3 0.2 0.5 4.0 2.2 2.3 0.0 1.2 0.4 0.4 0.6 0.6 4.6 4.6 5.5 5.5 4.4 4.7 4.3 4.3 4.4 4.2 4.8 5.4 0.7 0.0 0.0 2.9 0.9 0.3 0.5 0.5 0.0 2.4 0.8 0.8 3.7 0.0 0.9 1.8 4.2 0.5 0.2 0.3 0.0 0.9 1.5 1.0 0.6 0.8 1.2 1.7 5.8 0.6 0.5 0.4 0.0 0.7 0.0 3.9 1.8 0.2 0.4 1.7 3.6 0.6 2.0 0.0 0.6 0.2 0.3 0.4 0.0 0.0 0.1 1.1 3.1 4.5 5.9 0.2 0.2 1.2 0.0 0.9 0.8 0.6 0.6 0.9 0.0 1.1 0.5 3.9 3.0 0.0 0.1 0.0 0.4 1.4 1.1 0.4 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 36.1" "Low region specificity" "Detected in all" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 3.6 1.0 2.3 2.6 3.2 2.7 4.5 3.8 2.8 6.5 2.3 3.6 2.7 7.4 2.3 5.1 4.4 3.3 3.2 2.3 2.9 7.4 1.2 2.4 3.0 3.0 3.1 10.2 5.5 0.8 2.4 1.5 3.1 5.4 2.7 9.1 2.8 2.3 0.9 4.4 3.8 4.0 2.6 3.9 4.7 6.4 2.9 2.8 6.9 1.5 2.9 4.5 4.9 3.5 2.1 4.7 28.2 0.0 2.4 5.8 0.0 7.1 5.6 6.1 8.7 2.4 3.5 0.0 6.1 5.9 18.3 4.2 0.0 16.2 9.5 0.0 9.3 0.0 36.1 3.9 5.0 0.2 0.1 8.9 5.0 12.7 14.7 8.6 10.4 0.1 0.0 15.1 6.1 0.0 0.0 1.5 27.2 0.0 0.0 0.0 4.1 8.5 4.4 5.3 15.9 26.2 16.7 14.3 9.8 17.1 9.4 0.0 4.6 8.1 3.4 5.9 12.9 0.5 0.2 0.0 0.8 0.1 17.1 0.0 0.1 0.3 0.1 0.4 0.0 0.2 0.2 0.0 0.3 1.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 2.3 3.2 3.8 2.8 2.3 2.9 3.0 3.1 3.1 2.6 2.9 3.5 2.0 0.0 0.5 0.3 1.8 1.5 3.1 2.3 7.4 4.0 2.3 1.7 0.6 1.5 2.7 7.3 0.0 0.7 1.9 0.3 1.9 2.5 3.2 1.8 5.3 2.3 3.0 4.0 0.8 1.6 2.2 3.8 13.3 1.9 0.0 11.5 1.8 0.2 0.5 0.0 1.9 1.4 2.0 1.0 1.2 0.9 2.5 0.8 0.0 5.6 1.5 3.3 3.1 5.5 6.7 1.8 0.1 1.2 0.3 2.0 0.6 1.8 0.8 4.3 6.6 4.1 2.8 7.2 3.7 5.9 2.3 0.8 1.2 2.7 1.8 3.0 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.5;Granulosa cells: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 47: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030887: AB_10602688, HPA063624: AB_2685064" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 70.6 57.4 82.5 12.0 73.1 2.2 58.4 64.8 109.9 75.5 47.5 107.9 29.5 69.8 28.0 31.9 62.1 31.9 109.4 79.3 70.9 52.8 67.0 50.6 10.5 77.8 81.7 88.6 50.5 49.6 60.9 18.3 69.7 78.6 18.3 11.8 51.3 43.8 175.5 38.8 47.9 37.4 68.3 39.6 67.9 12.6 88.4 14.1 59.9 147.0 7.9 88.4 54.3 79.7 32.5 21.4 39.7 63.3 83.2 91.8 33.9 12.0 78.2 53.7 47.0 9.4 22.6 0.0 45.7 64.8 8.5 12.4 16.5 30.8 17.2 0.1 35.0 6.2 24.9 13.3 91.0 0.9 0.3 80.3 57.2 25.4 22.0 80.0 57.1 0.0 16.7 0.0 48.2 16.0 0.1 23.5 40.9 13.4 37.4 35.8 21.2 3.5 28.2 13.8 43.8 87.1 15.1 12.5 43.8 25.5 9.5 16.9 27.1 34.4 24.8 51.6 18.4 41.8 24.8 0.1 31.7 0.0 48.6 1.5 0.5 0.4 0.6 0.5 0.4 0.1 0.1 0.3 0.2 0.7 0.4 0.7 0.0 0.2 0.1 0.4 0.0 0.2 82.5 73.1 64.8 109.9 79.3 70.9 77.8 81.7 69.7 68.3 88.4 79.7 29.5 9.6 11.1 11.8 4.6 7.8 11.8 7.1 2.2 20.8 32.8 37.1 126.5 20.0 5.5 16.5 14.6 3.3 6.5 38.8 5.9 13.0 3.8 9.4 28.2 22.1 36.5 0.8 5.8 16.8 5.1 29.2 8.6 14.2 14.7 178.1 32.5 43.0 10.9 50.5 8.5 27.8 8.2 21.1 10.8 7.7 37.9 13.3 5.4 7.5 3.8 48.8 1.0 8.5 14.9 16.0 21.7 37.2 3.4 11.3 48.3 30.7 3.3 20.7 13.1 22.1 27.6 0.7 1.2 3.2 3.7 3.0 3.6 23.9 24.7 12.8 ZNF43 "HTF6, KOX27, ZNF39L1" ENSG00000198521 "Zinc finger protein 43" P17038 19 21804946-21852125 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 37.8" HPA050271 Uncertain NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA050271: AB_2681070" "unprognostic (9.25e-3)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-2)" "unprognostic (1.25e-1)" "unprognostic (4.16e-3)" "unprognostic (3.61e-2)" "unprognostic (2.47e-3)" "unprognostic (4.45e-3)" "prognostic favorable (3.16e-5)" "unprognostic (2.73e-2)" "unprognostic (1.01e-1)" "unprognostic (3.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-3)" "unprognostic (1.43e-3)" 3.9 4.0 1.6 5.5 4.1 10.7 7.8 10.6 3.0 4.9 1.1 4.4 3.6 6.3 4.6 3.6 6.8 4.0 4.5 1.5 5.2 5.0 1.4 4.2 8.4 2.9 1.9 11.2 3.0 6.7 2.6 4.8 3.2 7.2 5.3 6.7 3.5 4.9 3.1 7.3 4.2 4.4 0.8 6.6 4.8 8.7 2.9 10.1 8.7 4.1 6.8 3.6 3.1 7.7 0.4 3.7 25.0 19.8 2.7 5.9 10.4 6.6 2.7 8.3 11.4 0.3 3.8 5.9 7.5 4.2 7.7 0.5 0.3 0.7 13.8 0.8 6.5 0.3 1.6 2.9 1.3 0.2 7.2 5.6 0.9 8.9 0.4 2.1 1.9 21.8 0.4 1.1 6.3 4.3 37.8 9.1 18.0 0.5 5.4 22.0 9.8 6.6 5.4 18.9 16.7 12.6 0.1 0.1 2.2 11.3 9.6 5.1 0.4 0.7 0.8 6.0 7.0 1.5 11.3 10.2 0.3 0.8 0.8 30.7 4.5 6.2 8.8 4.6 8.4 18.8 11.5 9.9 4.6 19.1 18.6 12.7 4.5 9.0 4.0 8.5 8.1 3.9 1.6 4.1 10.6 3.0 1.5 5.2 2.9 1.9 3.2 0.8 2.9 7.7 17.0 12.8 15.1 19.2 14.4 2.0 8.1 1.4 2.8 16.0 10.6 12.2 13.2 8.6 9.9 3.7 10.4 9.4 10.6 3.7 17.6 11.0 36.3 11.6 13.6 16.0 11.4 16.2 9.5 9.4 7.6 12.8 5.1 16.6 16.4 52.0 16.8 0.4 4.8 8.4 14.1 4.2 6.1 4.4 4.4 9.8 14.0 6.6 1.8 18.7 6.5 12.5 20.6 26.7 23.1 7.6 4.0 9.4 7.7 8.8 2.4 7.4 6.6 9.6 6.6 13.8 13.3 21.3 15.7 3.3 2.0 5.9 10.8 41.0 7.1 4.4 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345944-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in many" "Adipocytes: 7.7;Granulosa cells: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 5.5" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 1.6 1.0 2.5 1.0 4.3 0.5 1.7 3.4 2.3 1.8 5.7 1.1 0.6 1.9 1.1 0.9 2.1 0.6 1.2 2.0 4.5 2.1 2.0 1.2 1.3 10.0 6.0 4.9 1.7 1.3 0.9 1.0 7.7 1.7 1.3 1.2 0.9 2.1 0.8 1.3 0.8 1.6 3.9 1.7 0.9 1.3 6.1 1.2 2.0 1.5 1.0 1.8 1.5 5.3 0.2 0.0 1.7 2.2 1.0 0.5 0.1 2.3 0.6 2.0 1.6 1.6 0.5 2.0 0.7 1.2 0.8 0.4 1.4 1.1 1.9 0.0 0.2 0.1 3.2 1.5 0.8 0.0 1.9 0.9 1.2 0.8 0.3 0.1 0.2 1.4 2.9 0.2 1.8 1.5 2.4 0.3 1.4 0.3 1.0 0.1 2.5 0.1 0.8 1.3 0.1 0.4 0.0 0.0 0.0 1.9 2.2 1.5 0.0 2.6 1.3 3.3 1.4 2.0 5.5 0.0 0.1 0.0 1.0 0.5 0.3 2.2 0.8 0.5 0.5 2.5 0.5 0.5 0.5 0.4 1.3 0.8 0.6 0.4 0.4 0.5 0.0 0.3 2.5 4.3 3.4 2.3 2.0 4.5 10.0 6.0 7.7 3.9 6.1 5.3 7.7 0.0 2.6 1.0 2.4 0.4 1.1 2.2 1.8 1.6 1.9 1.9 2.8 1.5 0.6 1.8 6.2 0.4 1.6 0.7 1.9 0.9 1.0 0.9 1.6 3.2 1.2 0.4 0.9 0.9 0.4 2.5 0.0 1.2 2.5 7.0 3.6 1.6 1.5 0.0 1.5 0.7 2.0 2.4 0.6 0.5 0.6 1.5 3.6 1.9 1.6 2.2 3.1 0.5 1.3 0.2 0.1 0.4 2.7 0.8 0.3 3.7 1.8 1.7 0.0 4.8 3.9 2.4 2.5 1.2 0.6 0.4 1.3 0.6 0.5 0.6 ZNF492 "KIAA1473, ZNF115" ENSG00000229676 "Zinc finger protein 492" Q9P255 19 22634324-22667671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6;testis: 1.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 6.9;Granulosa cells: 5.4;Spermatocytes: 8.1;Spermatogonia: 9.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.6;HAP1: 3.3;NB-4: 4.3;NTERA-2: 4.1;U-2197: 3.9" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.14e-1)" "unprognostic (1.24e-3)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (1.47e-2)" "unprognostic (6.75e-2)" "unprognostic (1.08e-3)" "unprognostic (5.63e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.91e-2)" "unprognostic (2.65e-1)" "unprognostic (8.93e-2)" "unprognostic (6.04e-2)" 0.3 0.0 0.2 0.1 0.1 2.6 0.7 0.8 0.5 0.3 0.2 0.2 0.0 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.3 0.1 0.1 0.5 0.2 0.3 0.0 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 1.9 0.1 0.7 0.3 0.1 0.3 0.1 0.1 0.3 0.0 0.0 1.4 0.1 0.0 0.0 5.6 0.9 0.0 0.4 0.5 0.0 0.0 0.0 2.0 0.7 2.4 0.0 3.3 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 2.2 0.9 0.1 0.0 0.5 0.0 4.3 4.1 0.0 0.1 0.0 0.0 0.6 0.5 1.0 0.0 2.3 0.0 0.0 0.3 0.9 1.7 1.5 0.0 0.0 2.1 3.9 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.8 0.5 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.9 0.0 3.8 1.3 1.0 0.5 1.2 0.0 1.8 1.8 1.0 1.1 1.0 0.0 0.6 0.0 0.0 1.0 0.4 0.2 0.0 0.5 0.7 0.5 1.2 1.3 0.0 6.9 0.3 0.2 2.4 1.1 0.0 0.6 1.3 5.4 1.1 0.1 0.1 3.3 0.2 0.2 0.0 0.3 1.1 0.4 0.9 0.5 0.0 1.9 0.1 1.0 0.0 3.0 0.6 0.2 0.2 0.4 0.0 0.9 0.0 0.0 1.5 2.4 0.0 0.6 1.2 8.1 9.1 0.6 0.6 0.5 0.5 0.8 0.3 0.7 ZNF525 KIAA1979 ENSG00000203326 "Zinc finger protein 525" 19 53365693-53392217 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Granulosa cells: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.77e-2)" "unprognostic (7.10e-3)" "unprognostic (2.62e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "unprognostic (8.88e-3)" "unprognostic (6.96e-3)" "unprognostic (1.07e-3)" "unprognostic (2.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.95e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-1)" "unprognostic (7.18e-2)" "unprognostic (3.42e-2)" "unprognostic (1.13e-2)" 3.1 4.6 3.7 4.2 3.9 4.9 5.6 10.0 4.0 4.5 4.6 3.9 3.9 4.3 6.0 4.2 4.6 3.7 2.4 3.7 3.5 6.2 2.4 3.4 7.9 3.5 3.5 7.6 6.1 14.1 5.5 4.9 4.2 7.3 5.2 5.0 4.5 3.4 1.0 8.4 5.3 2.6 2.8 6.4 5.6 10.8 3.8 6.5 5.2 1.8 6.1 4.8 5.3 5.4 1.2 0.4 2.3 4.5 2.4 0.9 16.3 3.9 4.0 4.0 7.0 3.8 4.6 7.0 3.3 2.3 6.8 6.0 0.2 4.7 6.0 0.4 15.7 1.7 7.1 3.0 2.7 0.3 9.5 3.8 6.4 2.3 7.0 2.7 1.3 9.1 8.2 0.6 4.7 4.1 10.6 8.8 9.8 6.1 8.8 0.8 6.2 8.9 3.7 18.5 3.9 5.0 6.2 9.5 3.1 9.2 6.8 8.5 1.6 0.8 4.9 4.4 5.9 7.1 19.2 18.3 0.3 0.9 4.8 2.6 1.2 3.0 1.5 1.4 2.8 3.5 2.3 2.4 1.5 2.6 2.7 2.3 2.5 3.2 0.8 2.2 1.9 2.1 3.7 3.9 10.0 4.0 3.7 3.5 3.5 3.5 4.2 2.8 3.8 5.4 3.5 3.2 4.6 2.6 5.3 3.7 9.7 3.3 5.2 4.3 3.1 3.7 13.7 4.3 4.7 1.8 0.0 7.0 5.3 2.5 1.9 4.2 22.3 6.1 2.9 4.1 7.8 2.1 2.4 2.8 5.2 4.1 0.5 10.6 6.3 27.9 1.8 1.1 2.8 3.3 4.3 3.6 0.0 0.8 4.0 2.4 2.5 2.3 1.8 1.9 2.0 1.9 7.2 2.5 5.8 3.3 2.4 1.2 1.0 8.9 2.4 1.7 3.3 3.0 0.0 5.9 3.3 3.1 4.2 2.9 4.5 13.5 4.9 4.8 3.4 8.6 ZNF572 FLJ38002 ENSG00000180938 "Zinc finger protein 572" Q7Z3I7 8 124973295-124979389 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 4.1" "Low region specificity" "Detected in all" HPA066838 Approved Approved "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA066838: AB_2685734" "unprognostic (8.65e-2)" "unprognostic (3.11e-1)" "unprognostic (5.59e-2)" "unprognostic (2.33e-2)" "unprognostic (1.49e-3)" "unprognostic (8.37e-2)" "unprognostic (4.11e-2)" "unprognostic (1.81e-2)" "unprognostic (3.36e-1)" "unprognostic (8.88e-2)" "unprognostic (8.67e-2)" "unprognostic (2.42e-2)" "unprognostic (1.43e-1)" "unprognostic (8.95e-3)" "unprognostic (2.89e-1)" "unprognostic (2.82e-1)" "unprognostic (6.17e-2)" 0.6 0.3 0.9 1.0 1.3 0.1 1.8 1.0 1.2 1.1 0.7 1.0 0.9 1.4 2.2 0.5 1.5 0.7 0.9 0.8 1.0 1.7 0.9 0.7 1.9 1.4 1.1 2.3 1.0 0.6 0.4 1.5 1.1 1.4 1.3 1.9 1.3 1.5 0.2 0.8 0.9 0.8 1.1 1.5 1.4 3.6 1.1 1.9 1.8 0.2 1.9 1.1 0.8 1.6 1.0 0.5 1.1 0.0 1.5 1.7 0.0 0.3 0.1 1.3 0.7 1.4 0.7 2.5 1.6 0.4 0.2 1.9 0.6 0.0 1.1 0.0 0.5 0.0 0.7 1.7 1.2 0.0 1.2 1.3 1.6 1.3 0.0 0.3 0.8 0.0 1.5 0.0 1.7 4.1 0.0 0.0 0.0 2.4 0.0 1.6 2.8 0.3 0.7 0.7 2.5 2.4 1.5 2.4 2.6 2.1 1.0 1.6 0.5 1.5 1.7 0.4 0.0 0.0 1.4 1.1 0.3 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.4 0.6 0.2 0.1 0.1 0.6 0.8 0.5 0.0 0.7 0.2 0.0 0.0 0.1 0.9 1.3 1.0 1.2 0.8 1.0 1.4 1.1 1.1 1.1 1.1 1.6 0.2 0.0 0.0 3.9 0.8 0.1 0.2 0.0 0.0 1.0 0.3 0.4 0.6 0.0 0.6 0.0 0.0 0.9 0.2 0.2 1.9 0.3 0.5 0.9 0.5 0.4 0.0 0.4 1.3 0.2 0.3 0.4 0.0 0.3 0.0 1.6 0.4 0.3 0.4 0.0 2.5 0.1 0.0 0.3 0.0 0.4 0.0 0.2 0.0 2.8 0.6 2.3 1.0 2.5 2.7 0.0 0.1 1.2 0.0 0.1 0.1 1.0 0.9 0.6 0.0 0.1 0.2 2.4 2.8 0.3 0.0 0.3 0.3 0.5 0.6 0.1 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050064: AB_2681003" "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 10.3 13.9 10.3 7.1 11.2 3.4 10.5 12.5 12.5 10.7 6.0 12.4 9.4 11.4 4.8 11.1 9.8 7.9 11.7 10.1 9.8 12.0 18.7 6.8 8.4 11.3 11.5 11.8 9.4 8.7 15.0 5.1 11.3 15.1 4.8 5.3 10.7 6.8 14.0 9.0 9.7 5.5 9.9 9.3 10.2 13.6 12.1 7.6 9.1 10.7 5.2 11.9 10.1 11.2 21.9 24.9 9.1 11.6 11.7 10.5 8.1 17.8 11.6 17.5 19.4 12.2 16.2 14.3 19.7 13.4 10.2 8.6 13.0 12.6 4.7 15.6 22.3 10.5 16.7 15.4 9.9 14.2 18.8 9.1 15.4 15.3 6.0 8.7 12.6 12.3 13.3 18.0 13.2 21.4 20.0 6.3 6.4 18.0 21.0 16.7 8.0 14.1 10.5 19.2 16.7 10.5 11.7 23.3 9.3 6.5 11.0 16.2 13.2 23.3 13.1 10.5 26.5 9.4 11.4 10.0 20.1 16.4 20.6 10.5 15.2 16.2 17.2 15.4 15.5 28.2 17.2 14.6 15.9 18.6 18.5 14.6 8.5 19.3 15.6 25.4 18.9 11.5 10.3 11.2 12.5 12.5 10.1 9.8 11.3 11.5 11.3 9.9 12.1 11.2 12.7 6.4 7.3 1.3 11.3 10.6 8.7 17.1 11.4 23.2 15.1 20.1 13.1 10.0 12.7 14.7 31.3 13.7 11.0 16.8 21.5 18.9 34.2 8.6 12.5 13.5 11.4 8.6 3.4 18.9 20.3 13.4 6.6 7.9 9.5 42.0 14.6 20.3 15.4 23.5 3.1 11.9 6.1 6.3 9.2 96.2 13.4 6.6 19.6 0.0 11.1 24.8 12.3 4.0 3.7 19.3 13.0 15.4 9.6 18.0 30.6 32.4 10.7 33.4 6.6 11.3 11.3 28.4 19.4 11.8 12.4 5.7 8.7 14.7 16.0 10.9 ZNF579 FLJ35453 ENSG00000218891 "Zinc finger protein 579" Q8NAF0 19 55576774-55580848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 43.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062812 Approved Approved Nucleoplasm NA NA "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA062812: AB_2684873" "unprognostic (1.76e-2)" "unprognostic (1.43e-2)" "unprognostic (4.09e-2)" "unprognostic (9.08e-2)" "unprognostic (2.87e-1)" "unprognostic (5.95e-2)" "unprognostic (4.79e-2)" "unprognostic (2.87e-2)" "unprognostic (5.39e-2)" "unprognostic (1.71e-1)" "unprognostic (5.85e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (5.27e-2)" "unprognostic (3.46e-1)" "unprognostic (1.57e-1)" "unprognostic (4.08e-3)" 11.5 9.1 8.7 3.3 7.8 4.5 9.3 17.1 10.0 10.0 5.3 11.6 4.5 14.7 6.8 6.7 12.7 7.9 14.3 8.5 9.2 18.4 11.8 10.1 4.7 12.3 11.1 13.5 15.3 3.3 12.6 2.5 10.6 12.0 2.6 6.7 8.4 4.5 33.4 6.6 8.8 4.1 7.5 8.8 20.9 3.7 9.3 3.0 16.7 13.4 2.1 9.9 6.5 9.5 7.9 15.9 8.6 8.8 13.1 9.6 11.0 15.3 4.2 8.4 8.5 5.4 9.3 13.1 6.1 8.9 2.7 7.6 5.2 8.3 8.8 2.6 43.9 8.3 32.5 10.1 13.2 4.9 6.5 24.0 8.9 6.4 6.7 18.8 4.7 4.6 16.6 4.2 17.0 10.4 7.3 6.7 7.8 4.3 24.6 12.4 7.8 5.5 11.4 14.9 10.4 14.6 10.2 7.6 7.8 16.7 4.0 7.0 10.9 11.0 10.6 3.4 9.7 11.6 10.3 7.2 5.6 7.8 5.7 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 8.7 7.8 17.1 10.0 8.5 9.2 12.3 11.1 10.6 7.5 9.3 9.5 10.3 3.2 6.7 4.2 4.7 3.3 7.9 1.7 6.2 13.3 8.9 8.0 5.2 18.6 1.5 5.5 12.5 0.7 4.5 4.3 3.9 6.0 0.0 8.6 7.6 6.8 11.4 2.5 2.7 4.8 0.6 5.3 15.3 9.8 4.5 17.2 13.6 7.2 5.1 15.2 3.4 7.1 0.0 5.7 2.8 0.5 8.4 3.8 3.6 3.7 1.8 15.9 3.1 2.5 3.6 6.6 2.0 12.4 2.5 9.4 2.1 11.1 3.0 8.9 13.1 4.7 9.2 0.9 0.9 3.7 3.3 0.4 3.5 13.6 6.1 9.3 ZNF723 ZNF723P ENSG00000268696 "Zinc finger protein 723" P0DPD5 19 22832291-22858667 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 3.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 25 "testis cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (4.37e-2)" "unprognostic (5.02e-2)" "unprognostic (7.20e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF738 ENSG00000172687 "Zinc finger protein 738" Q8NE65 19 21358930-21379302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 38.6;Sertoli cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 49.5;NTERA-2: 51.6" HPA059135 Uncertain NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "HPA059135: AB_2683918" "unprognostic (1.00e-1)" "unprognostic (1.59e-1)" "unprognostic (4.48e-2)" "unprognostic (4.35e-3)" "unprognostic (4.47e-2)" "unprognostic (1.37e-1)" "unprognostic (1.55e-2)" "unprognostic (6.22e-2)" "unprognostic (4.27e-3)" "prognostic favorable (2.27e-4)" "unprognostic (2.10e-1)" "unprognostic (3.51e-2)" "unprognostic (7.39e-5)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.20e-2)" 3.4 2.7 4.7 3.6 6.8 13.3 3.7 7.0 7.0 4.8 3.5 3.0 3.2 5.8 4.1 3.7 3.9 2.9 2.7 4.6 5.3 3.6 0.7 3.3 6.9 6.5 6.2 9.3 2.8 2.3 2.6 7.0 6.2 3.8 4.1 5.5 3.7 3.1 1.6 3.5 3.5 4.1 5.3 4.1 3.3 5.0 6.2 6.9 3.9 1.4 6.6 3.5 4.0 9.0 3.2 1.7 49.5 18.7 5.9 4.7 33.2 11.8 4.8 23.1 23.7 3.8 14.7 10.6 12.1 4.5 13.8 8.5 17.8 5.8 31.4 14.0 13.2 7.9 3.6 3.1 3.3 0.2 2.8 4.2 3.4 13.2 7.1 8.0 10.2 29.0 0.1 0.4 14.2 3.3 41.4 14.4 51.6 0.0 8.5 42.4 19.3 6.4 5.9 7.6 22.0 10.9 4.1 0.2 6.4 34.7 5.3 30.5 6.4 2.6 2.8 14.3 10.7 1.1 17.7 28.4 0.2 0.2 5.0 5.6 3.4 4.7 2.0 3.8 1.8 4.0 2.5 2.5 3.0 4.4 2.4 2.4 5.2 4.5 4.8 3.0 4.3 1.7 4.7 6.8 7.0 7.0 4.6 5.3 6.5 6.2 6.2 5.3 6.2 9.0 5.3 9.6 1.1 5.2 8.9 3.4 6.2 7.8 4.0 10.4 7.1 6.7 1.6 4.3 4.6 14.7 14.6 24.2 8.7 1.4 7.9 6.1 2.3 5.3 7.6 7.9 4.2 10.1 5.7 7.6 24.3 8.4 4.6 5.2 2.5 38.6 5.7 0.1 11.1 0.0 8.8 2.5 6.1 10.6 5.1 2.2 5.3 8.1 5.4 5.6 2.0 4.2 6.2 13.6 23.7 6.5 0.6 4.1 6.3 3.8 1.4 1.5 3.5 15.1 32.9 3.7 8.5 17.2 20.0 7.7 1.8 15.6 5.5 19.7 4.8 5.7 ZNF74 "Cos52, Zfp520, ZNF520" ENSG00000185252 "Zinc finger protein 74" Q16587 22 20394115-20408461 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 47.9" HPA003354 Approved Supported "Nucleoplasm,Actin filaments" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Actin filaments" "HPA003354: AB_1080747" "unprognostic (1.40e-1)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (1.02e-1)" "unprognostic (8.13e-3)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-1)" "unprognostic (1.20e-3)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (5.58e-2)" "unprognostic (3.04e-1)" "unprognostic (7.91e-2)" "unprognostic (1.44e-3)" 1.7 2.4 5.0 1.2 5.1 0.6 2.1 4.4 5.2 4.5 3.9 4.3 1.3 4.7 1.9 3.2 3.1 0.8 2.3 5.1 5.2 2.8 2.4 1.9 1.5 4.8 4.8 4.4 4.2 2.7 5.4 1.5 4.8 3.6 1.4 1.7 2.9 3.0 4.7 2.9 2.2 2.4 4.4 2.6 3.1 1.3 5.2 2.5 2.5 2.4 1.1 3.9 3.0 5.2 4.3 4.1 10.4 15.8 2.9 2.8 8.2 4.0 2.9 4.8 4.5 5.7 2.0 0.1 5.6 3.2 1.6 5.2 7.8 5.1 2.7 2.8 17.8 4.9 2.0 8.1 4.8 10.7 5.1 3.1 8.6 3.7 4.2 3.6 4.8 9.3 47.9 0.1 3.4 7.1 10.2 6.6 11.6 8.9 7.2 14.0 6.1 1.6 3.1 4.6 22.8 14.1 4.4 7.9 9.3 5.2 3.6 5.1 3.4 4.6 9.5 5.8 3.0 5.2 6.2 0.1 1.1 6.1 4.0 0.0 1.2 0.9 2.0 1.0 1.6 1.1 1.5 2.4 1.9 1.0 1.8 1.7 0.0 3.8 0.7 1.3 1.4 1.9 5.0 5.1 4.4 5.2 5.1 5.2 4.8 4.8 4.8 4.4 5.2 5.2 1.4 3.2 2.0 3.6 2.1 1.5 1.9 1.6 2.8 5.1 3.6 3.0 3.1 2.8 2.5 0.0 2.1 3.1 3.8 0.9 3.9 3.8 0.5 2.3 3.7 1.7 4.2 2.1 8.5 2.4 4.6 3.5 3.1 2.0 0.0 5.6 2.5 1.7 2.2 3.3 8.8 2.3 2.0 0.6 0.3 0.3 7.2 1.0 0.0 2.8 1.6 2.6 3.1 6.0 6.6 2.5 1.0 4.9 0.9 4.0 1.5 1.7 0.6 2.1 6.6 2.7 3.2 4.3 3.0 1.8 1.0 1.1 2.7 4.4 2.8 1.1 ZNF747 MGC2474 ENSG00000169955 "Zinc finger protein 747" Q9BV97 16 30530367-30535347 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003203, HPA069173" Uncertain Approved Centrosome,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Centrosome, Cytosol" "HPA003203: AB_1080753, HPA069173: AB_2686097" "unprognostic (3.82e-2)" "prognostic favorable (6.53e-4)" "unprognostic (3.73e-2)" "unprognostic (1.31e-2)" "unprognostic (4.01e-2)" "unprognostic (4.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.22e-3)" "unprognostic (2.45e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.46e-4)" "unprognostic (1.01e-2)" "unprognostic (2.60e-3)" "unprognostic (2.27e-1)" "unprognostic (4.66e-2)" "unprognostic (3.00e-1)" "unprognostic (1.01e-1)" 6.7 7.4 7.1 4.0 7.4 2.7 6.8 7.7 7.3 7.6 5.8 8.8 4.1 8.4 3.3 5.4 7.8 3.0 8.8 6.8 6.4 7.1 10.8 5.2 4.4 7.5 7.3 7.3 6.2 7.6 6.9 2.5 7.4 7.6 3.8 4.6 5.6 6.1 9.7 6.2 7.1 4.1 6.4 7.4 7.2 6.2 7.3 5.3 7.0 6.2 3.9 8.2 5.8 7.9 4.6 4.4 1.3 7.1 5.5 4.8 7.1 3.7 5.6 5.3 5.1 2.6 5.8 9.9 2.5 4.4 0.7 6.7 3.3 4.7 2.3 11.9 7.3 8.6 4.7 4.1 6.0 4.0 11.8 5.5 5.9 4.3 6.6 3.5 3.5 12.3 2.4 8.2 3.7 5.0 18.1 5.5 8.4 2.4 2.9 21.3 0.5 9.2 4.7 2.3 9.8 8.6 5.6 3.7 4.2 3.3 7.2 7.9 2.8 6.7 3.0 5.3 0.1 15.7 11.8 5.5 1.4 6.1 8.1 7.7 3.1 4.4 2.7 1.7 3.1 4.6 3.1 3.1 3.9 5.3 5.2 4.0 1.7 4.4 1.5 5.1 2.4 3.0 7.1 7.4 7.7 7.3 6.8 6.4 7.5 7.3 7.4 6.4 7.3 7.9 5.7 3.2 6.3 1.3 5.8 1.5 3.4 4.8 4.6 8.7 6.1 5.7 6.0 5.7 3.1 0.0 4.2 2.6 8.3 4.4 7.9 6.2 2.6 4.9 5.4 6.2 7.3 8.6 1.9 5.8 2.3 5.8 2.6 3.9 3.8 8.6 6.8 8.7 7.0 6.7 2.0 4.4 0.0 8.8 1.6 1.2 5.9 4.3 0.0 0.0 10.4 7.1 7.2 3.5 2.8 5.2 12.6 9.8 3.6 3.9 9.7 7.6 5.8 7.5 13.1 6.9 5.4 13.1 4.2 4.2 1.1 1.2 4.0 5.7 5.0 2.1 ZNF765 ENSG00000196417 "Zinc finger protein 765" Q7L2R6 19 53389793-53430413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 27.8;Granulosa cells: 36.9;Leydig cells: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "prognostic unfavorable (9.11e-4)" "unprognostic (4.56e-2)" "unprognostic (1.66e-1)" "unprognostic (7.05e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.17e-4)" "unprognostic (7.38e-2)" "unprognostic (6.76e-3)" "unprognostic (5.78e-2)" "unprognostic (1.75e-1)" "unprognostic (6.84e-2)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.31e-1)" "unprognostic (1.16e-1)" "unprognostic (2.89e-2)" 2.7 3.8 1.8 2.6 2.9 4.2 3.6 2.6 2.3 2.9 2.8 3.4 3.1 2.6 2.9 2.6 2.8 2.4 1.9 1.9 2.7 2.8 2.0 3.1 3.9 2.7 2.3 8.7 4.6 8.8 2.0 4.7 2.7 4.2 3.8 2.1 2.8 1.8 1.8 4.2 2.8 2.2 1.8 3.4 2.9 3.5 2.4 4.4 3.2 1.6 3.8 2.7 2.9 4.4 6.0 5.4 2.9 8.8 3.4 3.1 8.6 3.9 5.5 3.1 4.3 4.3 3.8 12.0 4.2 4.1 4.3 4.8 7.9 4.2 6.6 5.4 10.9 12.9 5.6 3.6 3.8 0.7 7.7 6.0 6.8 5.3 3.6 3.8 3.7 6.5 9.2 9.0 8.3 3.7 9.7 4.2 5.3 7.5 5.7 6.5 11.0 7.9 4.2 22.5 4.6 4.2 10.8 5.7 2.6 8.2 4.7 6.5 7.8 7.6 4.5 3.2 5.2 6.1 13.5 13.5 2.4 1.0 6.0 3.6 2.5 5.4 3.6 3.3 5.1 5.0 3.7 4.4 3.3 4.0 3.9 3.8 2.5 4.0 2.3 2.0 3.2 2.8 1.8 2.9 2.6 2.3 1.9 2.7 2.7 2.3 2.7 1.8 2.4 4.4 9.1 0.0 3.1 0.7 5.9 2.2 7.1 2.1 5.7 7.2 4.8 3.7 4.4 10.0 1.6 1.8 0.0 9.2 5.7 6.5 1.9 4.5 3.2 4.7 5.0 7.4 7.3 6.3 0.8 2.8 27.8 7.1 4.1 5.8 5.7 36.9 22.9 3.1 5.2 8.4 2.2 6.4 0.0 4.8 1.6 1.4 37.3 4.3 1.8 4.7 5.6 5.0 4.1 2.5 5.6 3.4 4.8 17.0 4.7 11.8 4.4 3.4 1.7 2.6 13.1 8.9 4.7 6.4 11.3 4.1 3.4 23.0 4.8 15.2 7.1 9.3 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352284-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.0" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" No No "Cluster 11: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Intermediate filaments" Cytosol "HPA030839: AB_2673630, HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 0.7 2.7 2.3 1.2 4.2 1.0 3.4 4.3 3.6 2.6 0.0 4.6 2.2 2.8 4.1 1.4 3.0 2.9 2.8 1.9 2.6 1.4 1.1 1.1 0.7 0.7 1.0 1.1 3.9 3.1 3.0 0.7 0.8 2.4 7.1 4.0 3.9 5.7 6.2 3.1 2.0 1.8 0.0 0.6 2.6 2.2 2.7 1.5 2.7 7.2 0.9 1.9 1.6 3.3 1.7 0.7 2.1 2.4 0.9 0.5 5.0 1.0 1.7 1.3 1.6 2.7 2.0 0.6 2.0 1.3 3.7 2.5 2.2 3.7 1.3 1.2 4.2 1.8 9.0 1.3 1.6 1.0 1.3 0.5 4.4 1.9 1.8 3.6 2.3 3.4 2.0 0.8 2.1 1.6 1.4 0.9 0.6 4.5 2.5 1.3 1.8 0.5 2.6 4.6 4.8 2.0 2.0 3.1 0.8 2.4 2.1 0.2 1.1 1.4 1.3 1.1 2.2 5.2 3.8 0.4 2.3 2.8 0.7 1.4 0.3 0.7 0.2 0.1 0.1 0.2 0.2 0.3 0.6 0.4 0.2 0.2 1.2 0.7 0.2 0.3 0.1 0.1 2.3 4.2 4.3 3.6 1.9 2.6 0.7 1.0 0.8 0.0 2.7 3.3 0.6 6.4 3.2 0.3 0.7 0.8 2.5 1.0 2.2 6.4 2.4 2.4 4.9 0.0 1.1 0.0 0.0 1.7 0.2 6.8 1.9 2.8 15.4 1.7 2.3 1.0 2.4 0.0 2.5 2.0 1.1 0.9 4.1 3.2 0.0 45.3 0.0 1.5 0.8 8.4 2.3 3.3 0.0 0.3 0.7 11.0 0.3 0.8 0.0 0.0 0.2 2.0 0.0 1.5 1.1 1.7 5.5 2.2 0.7 1.4 1.9 1.1 0.7 5.3 0.0 1.7 1.9 11.8 4.5 1.3 0.3 1.4 0.5 0.3 5.5 2.0 ZNF775 MGC33584 ENSG00000196456 "Zinc finger protein 775" Q96BV0 7 150368790-150398630 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 21.2;Granulosa cells: 26.5;Horizontal cells: 30.3;Muller glia cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 18.9;RPMI-8226: 23.0" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (9.67e-3)" "unprognostic (6.96e-2)" "unprognostic (1.06e-2)" "unprognostic (8.47e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (5.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (1.49e-1)" "prognostic favorable (2.84e-4)" "unprognostic (1.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.84e-2)" "unprognostic (1.28e-2)" 3.3 3.7 9.1 2.6 12.2 1.7 3.1 10.1 10.1 6.9 5.1 9.8 3.0 7.4 1.8 2.3 6.2 1.1 4.5 7.9 7.6 3.6 1.7 3.3 3.0 11.2 10.1 8.8 3.8 2.1 7.1 1.4 9.5 6.3 1.9 2.4 3.0 2.4 5.4 3.0 4.1 1.4 9.1 4.2 4.0 6.3 10.8 3.4 3.6 1.0 2.0 6.4 4.0 13.7 1.4 4.4 4.7 4.5 1.6 1.6 1.2 1.9 2.5 2.4 3.1 1.4 3.7 6.3 4.8 1.2 4.3 1.7 1.5 1.7 0.2 10.1 6.5 4.4 1.0 2.6 3.6 1.1 1.8 1.8 2.2 2.9 0.5 2.6 4.2 7.8 9.9 4.7 1.4 1.2 18.9 4.9 14.4 2.6 6.9 8.9 7.4 23.0 0.4 1.5 13.8 18.3 1.7 0.5 6.9 3.7 1.0 3.8 3.8 5.1 2.9 3.9 3.7 9.5 3.6 4.5 5.0 4.3 5.7 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.1 9.1 12.2 10.1 10.1 7.9 7.6 11.2 10.1 9.5 9.1 10.8 13.7 3.9 0.0 0.0 9.4 8.9 2.7 0.8 2.8 0.6 21.2 2.2 4.7 8.1 0.0 1.4 0.0 10.4 1.3 2.4 7.1 0.0 0.9 2.5 2.9 3.8 4.3 15.6 0.4 1.4 0.6 1.0 3.2 1.5 2.0 4.5 26.5 1.4 1.2 3.1 30.3 2.1 7.1 2.0 1.2 6.2 1.3 4.1 1.7 5.4 3.7 1.6 29.0 3.1 5.0 11.5 1.0 2.5 4.9 1.2 1.3 1.6 1.1 2.5 13.7 0.0 4.4 6.4 1.4 2.1 0.2 3.8 0.4 2.5 12.8 7.7 0.1 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467733-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 18.1" HPA056406 Uncertain Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 1.2 1.1 0.9 1.5 1.3 1.4 2.2 1.1 1.1 1.1 1.4 1.8 1.8 1.3 3.9 1.2 1.8 1.4 0.7 1.0 1.2 1.3 0.7 1.4 2.2 1.4 1.4 1.8 1.3 2.4 0.6 3.6 1.3 4.9 1.7 0.6 1.2 1.1 0.4 2.0 1.7 1.0 1.0 1.9 1.9 1.6 1.3 2.2 1.9 0.5 2.1 1.4 1.2 1.8 0.9 0.8 2.6 4.3 2.2 2.6 6.0 2.4 2.4 1.6 2.3 4.6 2.7 6.9 2.3 2.3 3.0 1.4 6.3 2.7 3.0 0.0 9.9 6.9 1.8 5.2 1.1 0.0 7.1 2.2 2.2 1.8 1.3 0.9 1.4 4.9 3.8 0.1 2.6 1.3 9.2 3.8 3.3 0.8 2.4 5.6 5.7 3.4 1.5 18.1 1.1 2.5 0.0 4.5 1.6 5.6 1.8 3.4 2.3 0.9 3.1 0.1 2.3 3.6 5.5 7.5 0.0 0.0 4.7 1.8 1.1 0.8 1.7 1.6 1.7 1.6 1.6 1.9 1.2 2.4 3.0 2.3 0.5 3.6 3.0 1.1 1.3 1.4 0.9 1.3 1.1 1.1 1.0 1.2 1.4 1.4 1.3 1.0 1.3 1.8 3.4 6.4 1.8 0.3 4.4 1.8 3.1 1.4 4.6 0.7 1.9 1.8 1.9 5.7 2.6 0.0 0.0 5.0 4.3 2.5 1.9 2.2 1.7 2.6 3.2 4.0 0.0 3.4 0.3 1.2 10.1 4.1 3.6 2.6 0.0 7.0 13.6 1.2 2.8 3.3 1.0 3.2 2.0 3.0 1.7 0.9 2.5 2.6 3.6 1.0 3.7 1.1 3.1 2.0 2.8 1.5 3.4 2.2 1.5 5.0 1.2 0.8 2.0 0.6 0.0 4.0 3.4 0.9 4.1 2.2 1.6 8.9 2.8 2.6 3.9 2.3 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615610-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 4.1 2.8 24.8 2.3 24.7 0.6 4.5 20.4 24.0 9.6 11.8 12.9 1.1 11.3 4.4 4.3 9.2 4.5 10.5 23.7 23.7 4.9 0.5 3.7 2.9 27.8 27.9 12.0 7.0 5.5 6.6 2.8 25.1 7.8 1.7 5.1 5.4 8.6 27.1 3.1 4.4 6.6 25.6 3.5 4.9 2.6 24.8 3.3 7.9 20.2 2.0 10.1 4.9 21.0 0.0 1.6 4.7 20.1 0.2 0.0 0.2 0.4 0.0 2.1 0.4 3.6 0.8 0.0 7.8 0.0 0.7 0.0 7.2 0.2 2.0 0.0 2.6 0.6 0.0 3.8 2.8 0.0 0.1 0.7 0.6 0.2 0.1 2.0 0.0 1.6 3.2 0.1 1.3 0.1 0.5 2.7 7.5 0.0 0.0 2.3 7.8 0.1 1.5 7.6 6.3 29.5 0.0 0.3 1.2 3.9 1.1 4.3 0.0 1.5 19.5 0.0 1.9 0.4 0.1 0.1 0.0 0.0 7.8 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 24.8 24.7 20.4 24.0 23.7 23.7 27.8 27.9 25.1 25.6 24.8 21.0 4.3 0.0 0.0 2.0 1.0 0.5 1.5 0.2 1.2 13.2 3.2 4.4 10.4 0.0 0.6 7.3 6.2 0.0 2.0 0.1 0.0 0.6 1.6 7.5 4.3 3.2 1.8 0.4 1.5 0.7 0.0 4.4 0.5 2.3 0.0 15.1 2.5 0.0 0.1 5.0 2.7 0.0 0.0 0.0 0.9 2.4 5.3 0.2 3.6 1.9 0.1 13.2 1.0 2.0 2.8 0.4 0.1 8.6 1.3 3.3 0.0 0.2 2.3 10.4 13.1 6.4 5.4 0.5 0.5 0.4 0.3 0.3 1.8 6.9 0.1 0.7 ZNF93 "FLJ12488, HPF34, TF34, ZNF505" ENSG00000184635 "Zinc finger protein 93" P35789 19 19900913-19963464 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 35.2" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.49e-1)" "unprognostic (2.28e-2)" "unprognostic (9.05e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-2)" "unprognostic (8.25e-2)" "unprognostic (4.88e-3)" "unprognostic (1.66e-1)" "unprognostic (6.80e-5)" "prognostic favorable (9.31e-6)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (3.18e-6)" "unprognostic (7.35e-2)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (6.06e-2)" 1.7 1.1 1.3 3.6 2.4 3.2 3.4 4.0 2.2 3.3 0.5 2.1 1.1 4.6 3.0 1.4 2.0 3.2 1.3 1.1 1.2 2.2 1.1 1.9 5.1 1.1 0.9 4.5 3.1 1.9 1.1 3.1 1.0 3.0 2.8 3.4 2.0 2.2 1.8 4.1 1.6 4.0 0.6 3.1 2.4 4.0 1.5 6.2 7.1 1.5 5.0 3.3 1.4 2.4 0.1 0.0 19.1 21.8 1.9 1.7 18.3 7.6 4.2 15.9 19.3 4.6 4.0 5.6 6.4 4.4 13.3 0.7 0.0 0.4 19.8 0.2 1.0 0.1 0.7 0.4 1.4 0.1 0.3 2.8 1.5 14.6 1.4 2.9 0.5 0.2 3.7 0.7 15.5 2.1 24.1 11.7 35.2 0.0 4.4 21.5 19.0 8.0 4.5 12.7 10.8 7.9 0.4 1.9 3.5 21.5 6.4 13.5 0.4 15.6 0.7 15.8 11.0 2.7 11.6 13.9 0.3 3.0 5.4 3.9 2.5 7.2 1.1 3.0 1.5 4.0 2.1 1.8 2.5 6.0 2.9 1.6 5.3 4.0 3.1 2.2 4.0 1.4 1.3 2.4 4.0 2.2 1.1 1.2 1.1 0.9 1.0 0.6 1.5 2.4 3.0 3.2 2.0 2.6 5.1 1.0 5.2 1.0 0.0 1.5 3.5 4.6 3.3 2.8 2.7 1.8 2.1 5.0 1.8 1.1 7.9 5.7 3.4 6.5 3.8 3.1 0.0 2.1 2.2 6.2 14.7 3.6 2.6 9.2 7.0 15.2 1.4 0.1 8.4 3.3 3.7 2.0 4.1 3.7 2.2 1.5 1.2 5.2 1.8 1.9 5.4 2.4 2.1 7.1 4.1 5.2 0.8 3.0 5.8 2.6 0.5 1.7 3.5 2.9 0.0 1.1 5.7 9.6 10.5 2.5 2.7 5.1 2.8 3.1 2.0 3.9